FN Clarivate Analytics Web of Science
VR 1.0
PT J
AU Noske, GD
   Gawriljuk, VO
   Fernandes, RS
   Furtado, ND
   Bonaldo, MC
   Oliva, G
   Godoy, AS
AF Noske, Gabriela Dias
   Gawriljuk, Victor Oliveira
   Fernandes, Rafaela Sachetto
   Furtado, Nathalia Dias
   Bonaldo, Myrna Cristina
   Oliva, Glaucius
   Godoy, Andre Schutzer
TI Structural characterization and polymorphism analysis of the NS2B-NS3
   protease from the 2017 Brazilian circulating strain of Yellow Fever
   virus
SO BIOCHIMICA ET BIOPHYSICA ACTA-GENERAL SUBJECTS
LA English
DT Article
DE Yellow Fever virus; Flavivirus; Protease; NS3; NS2B
ID DENGUE VIRUS; ZIKA VIRUS; STRUCTURE REFINEMENT; CRYSTAL-STRUCTURE;
   HELICASE; MODEL; INHIBITION; ACTIVATION; FEATURES; COMPLEX
AB Background: The Yellow Fever virus (YFV) is transmitted by mosquitos and causes an infection with symptoms including fever, headaches and nausea. In 20-50% of the cases, the disease may evolve to a visceral stage, reaching high mortality rates. YFV NS2B-NS3 protease has been identified as an important drug target.
   Methods: Herein, we describe the crystal structure of the NS2B-NS3 protease from the 2017 YFV Brazilian circulating strain using X-ray crystallography. Furthermore, we used a combination of biochemical and biophysical assays to characterize the enzyme and investigate the impact of the polymorphisms observed in different YFV circulating strains.
   Results: Surprisingly, the crystal structure of YFV protease seems to adopt the closed conformation without the presence of a binding partner. Although D88E and K121R mutants exhibited a lower affinity for the substrate, both revealed to be more processive, resulting in a similar catalytic efficiency in relation to the WT protease. Still, both mutants showed an accentuated decrease in stability when compared with the WT.
   Conclusions: The crystal structure of YFV NS2B-NS3 in closed conformation might be an important tool for the development of new drugs, as well as understanding the activation mechanism of viral proteases. Biochemical analyses indicate that the NS2B-NS3 protease of the circulating strain of YFV is more stable than previous strains.
   General significance: The YFV NS2B-NS3 protease is the first flaviviral structure described in its closed conformation when in a free form, implying that external factors might induce the activation of the enzyme.
C1 [Noske, Gabriela Dias; Gawriljuk, Victor Oliveira; Fernandes, Rafaela Sachetto; Oliva, Glaucius; Godoy, Andre Schutzer] Univ Sao Paulo, Phys Inst Sao Carlos, Av Joao Dagnone,1100 Jardim Santa Angelina, BR-13563120 Sao Carlos, Brazil.
   [Furtado, Nathalia Dias; Bonaldo, Myrna Cristina] Fundacao Osvaldo Cruz, Inst Oswaldo Cruz, Lab Biol Mol & Flavivirus, Rio De Janeiro, Brazil.
RP Godoy, AS (corresponding author), Univ Sao Paulo, Phys Inst Sao Carlos, Av Joao Dagnone,1100 Jardim Santa Angelina, BR-13563120 Sao Carlos, Brazil.
EM andregodoy@ifsc.usp.br
RI Godoy, Andre/AAF-2432-2020
OI Godoy, Andre/0000-0002-0613-9164
FU Sao Paulo Research Foundation - FAPESP (CEPID)Fundacao de Amparo a
   Pesquisa do Estado de Sao Paulo (FAPESP) [2013/07600-3, 2016/19712-9,
   2018/05130-3]; Diamond Light Source for beamtime [mx22129]; Preventing
   and Combating the Zika Virus; MCTIC/FNDCT- CNPq/MEC-CAPES/MS-Decit
   [426767/2018-7, 88881.130684/2016-01]; INOVA-Fiocruz [VPPIS-004-FIO18]
FX The authors would like to thank the funding from the Sao Paulo Research
   Foundation - FAPESP (CEPID grant #2013/07600-3 and post-doctoral grants
   2016/19712-9 and 2018/05130-3). The authors would like to thank Diamond
   Light Source for beamtime (proposal mx22129), and the staff of beamline
   124 for support. Part of this study is funded by grants from Preventing
   and Combating the Zika Virus, MCTIC/FNDCT- CNPq/MEC-CAPES/MS-Decit
   (Grants 426767/2018-7 and 88881.130684/2016-01) and INOVA-Fiocruz (Grant
   VPPIS-004-FIO18).
CR Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925
   Afonine PV, 2012, ACTA CRYSTALLOGR D, V68, P352, DOI 10.1107/S0907444912001308
   Aleshin AE, 2007, PROTEIN SCI, V16, P795, DOI 10.1110/ps.072753207
   Ashkenazy H, 2016, NUCLEIC ACIDS RES, V44, pW344, DOI 10.1093/nar/gkw408
   ASLANIDIS C, 1990, NUCLEIC ACIDS RES, V18, P6069, DOI 10.1093/nar/18.20.6069
   Assenberg R, 2009, J VIROL, V83, P12895, DOI 10.1128/JVI.00942-09
   Boldescu V, 2017, NAT REV DRUG DISCOV, V16, P565, DOI 10.1038/nrd.2017.33
   Bonaldo MC, 2017, MEM I OSWALDO CRUZ, V112, P447, DOI 10.1590/0074-02760170134
   Carpp LN, 2011, MICROBES INFECT, V13, P85, DOI 10.1016/j.micinf.2010.10.010
   Chandramouli S, 2010, J VIROL, V84, P3059, DOI 10.1128/JVI.02044-09
   Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073
   Chen WN, 2014, FEBS LETT, V588, P2206, DOI 10.1016/j.febslet.2014.05.018
   Chen X, 2016, CELL RES, V26, P1260, DOI 10.1038/cr.2016.116
   Couto-Lima D, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-05186-3
   de Godoy AS, 2019, CURR OPIN STRUC BIOL, V59, P65, DOI 10.1016/j.sbi.2019.02.014
   Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340
   Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493
   Erbel P, 2006, NAT STRUCT MOL BIOL, V13, P372, DOI 10.1038/nsmb1073
   Evans PR, 2013, ACTA CRYSTALLOGR D, V69, P1204, DOI 10.1107/S0907444913000061
   Garske T, 2014, PLOS MED, V11, DOI 10.1371/journal.pmed.1001638
   Gomez MM, 2018, J GEN VIROL, V99, P536, DOI 10.1099/jgv.0.001033
   Hammamy MZ, 2013, CHEMMEDCHEM, V8, P231, DOI 10.1002/cmdc.201200497
   Hayes EB, 2010, VACCINE, V28, P8073, DOI 10.1016/j.vaccine.2010.10.015
   Hill ME, 2019, BIOCHEMISTRY-US, V58, P776, DOI 10.1021/acs.biochem.8b00978
   Holm L, 2016, NUCLEIC ACIDS RES, V44, pW351, DOI 10.1093/nar/gkw357
   Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337
   Karplus PA, 2015, CURR OPIN STRUC BIOL, V34, P60, DOI 10.1016/j.sbi.2015.07.003
   Karplus PA, 2012, SCIENCE, V336, P1030, DOI [10.1126/science.1218231, 10.1126/science.121823]
   Kuhn RJ, 2002, CELL, V108, P717, DOI 10.1016/S0092-8674(02)00660-8
   Lei J, 2016, SCIENCE, V353, P503, DOI 10.1126/science.aag2419
   Li HD, 2019, NEURON, V101, P1089, DOI 10.1016/j.neuron.2019.01.010
   Li Y, 2018, STRUCTURE, V26, P555, DOI 10.1016/j.str.2018.02.005
   Li Y, 2017, FEBS LETT, V591, P2338, DOI 10.1002/1873-3468.12741
   Luo D, 2008, J VIROL, V82, P173, DOI 10.1128/JVI.01788-07
   Luo DH, 2015, ANTIVIR RES, V118, P148, DOI 10.1016/j.antiviral.2015.03.014
   Luo DH, 2010, J BIOL CHEM, V285, P18817, DOI 10.1074/jbc.M109.090936
   Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206
   McGuinness I, 2017, NEUROHOSPITALIST, V7, P157, DOI 10.1177/1941874417708129
   Mir D, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-07873-7
   Monath T P, 2001, Lancet Infect Dis, V1, P11, DOI 10.1016/S1473-3099(01)00016-0
   Monath TP, 2012, EXPERT REV VACCINES, V11, P427, DOI [10.1586/ERV.12.6, 10.1586/erv.12.6]
   Nitsche Christoph, 2019, Biophys Rev, V11, P157, DOI 10.1007/s12551-019-00508-3
   Noble CG, 2012, J VIROL, V86, P438, DOI 10.1128/JVI.06225-11
   Paules C.I., 2017, NEW ENGL J MED, V376, DOI [10.1056/NEJMpl 702172, DOI 10.1056/NEJMPL702172]
   Phoo WW, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms13410
   Possas C, 2018, MEM I OSWALDO CRUZ, V113, P1, DOI 10.1590/0074-02760170361
   Potterton E, 2003, ACTA CRYSTALLOGR D, V59, P1131, DOI 10.1107/S0907444903008126
   Robert X, 2014, NUCLEIC ACIDS RES, V42, pW320, DOI 10.1093/nar/gku316
   Sampath A, 2009, ANTIVIR RES, V81, P6, DOI 10.1016/j.antiviral.2008.08.004
   de Abreu FVS, 2019, MEM I OSWALDO CRUZ, V114, DOI 10.1590/0074-02760190076
   Terwilliger TC, 2008, ACTA CRYSTALLOGR D, V64, P515, DOI 10.1107/S0907444908004319
   Terwilliger TC, 2008, ACTA CRYSTALLOGR D, V64, P61, DOI 10.1107/S090744490705024X
   Weiss MS, 2001, J APPL CRYSTALLOGR, V34, P130, DOI 10.1107/S0021889800018227
   Yao Y, 2019, J AM CHEM SOC, V141, P6832, DOI 10.1021/jacs.9b02505
   Yildiz M, 2013, ACS CHEM BIOL, V8, P2744, DOI 10.1021/cb400612h
NR 55
TC 2
Z9 2
U1 2
U2 4
PU ELSEVIER
PI AMSTERDAM
PA RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS
SN 0304-4165
EI 1872-8006
J9 BBA-GEN SUBJECTS
JI Biochim. Biophys. Acta-Gen. Subj.
PD APR
PY 2020
VL 1864
IS 4
AR 129521
DI 10.1016/j.bbagen.2020.129521
PG 11
WC Biochemistry & Molecular Biology; Biophysics
SC Biochemistry & Molecular Biology; Biophysics
GA KT0FI
UT WOS:000518686000009
PM 31931019
DA 2020-12-01
ER

PT J
AU Delatorre, E
   de Abreu, FVS
   Ribeiro, IP
   Gomez, MM
   dos Santos, AAC
   Ferreira-de-Brito, A
   Neves, MSAS
   Bonelly, I
   de Miranda, RM
   Furtado, ND
   Raphael, LMS
   da Silva, LDF
   de Castro, MG
   Ramos, DG
   Romano, APM
   Kallas, EG
   Vicente, ACP
   Bello, G
   Lourenco-de-Oliveira, R
   Bonaldo, MC
AF Delatorre, Edson
   Santos de Abreu, Filipe Vieira
   Ribeiro, Ieda Pereira
   Gomez, Mariela Martinez
   Cunha dos Santos, Alexandre Araujo
   Ferreira-de-Brito, Anielly
   Alberto Santos Neves, Maycon Sebastiao
   Bonelly, Iule
   de Miranda, Rafaella Moraes
   Furtado, Nathalia Dias
   Souza Raphael, Lidiane Menezes
   Fernandes da Silva, Lucileis de Fatima
   de Castro, Marcia Goncalves
   Ramos, Daniel Garkauskas
   Martins Romano, Alessandro Pecego
   Kallas, Esper Georges
   Paulo Vicente, Ana Carolina
   Bello, Gonzalo
   Lourenco-de-Oliveira, Ricardo
   Bonaldo, Myrna Cristina
TI Distinct YFV Lineages Co-circulated in the Central-Western and
   Southeastern Brazilian Regions From 2015 to 2018
SO FRONTIERS IN MICROBIOLOGY
LA English
DT Article
DE yellow fever virus; Brazilian outbreak; lineages; amino acid changes;
   phylogeography
ID YELLOW-FEVER; VIRUS; EVOLUTIONARY; PERFORMANCE
AB The current outbreak of yellow fever virus (YFV) that is afflicting Brazil since the end of 2016 probably originated from a re-introduction of YFV from endemic areas into the non-endemic Southeastern Brazil. However, the lack of genomic sequences from endemic regions hinders the tracking of YFV's dissemination routes. We assessed the origin and spread of the ongoing YFV Brazilian outbreak analyzing a new set of YFV strains infecting humans, non-human primates (NHPs) and mosquitoes sampled across five Brazilian states from endemic and non-endemic regions between 2015 and 2018. We found two YFV sub-clade 1E lineages circulating in NHP from Goias state (GO), resulting from independent viral introductions into the Araguaia tributary river basin: while one strain from 2017 clustered intermingled with Venezuelan YFV strains from 2000, the other YFV strains sampled in 2015 and 2017 clustered with sequences of the current YFV outbreak in the Brazilian Southeastern region (named YFV2015-2018 lineage), displaying the same molecular signature associated to the current YFV outbreak. After its introduction in GO at around mid-2014, the YFV2015-2018 lineage followed two paths of dissemination outside GO, originating two major YFV sub-lineages: (1) the YFVMG/ES/RJ sub-lineage spread sequentially from the eastern area of Minas Gerais state to Espirito Santo and then to Rio de Janeiro states, following the Southeast Atlantic basin; (2) the YFVMG/SP sub-lineage spread from the southwestern area of Minas Gerais to the metropolitan region of Sao Paulo state, following the Parana basin. These results indicate the ongoing YFV outbreak in Southeastern Brazil originated from a dissemination event from GO almost 2 years before its recognition at the end of 2016. From GO this lineage was introduced in Minas Gerais state at least two times, originating two sub-lineages that followed different routes toward densely populated areas. The spread of YFV outside endemic regions for at least 4 years stresses the imperative importance of the continuous monitoring of YFV to aid decision-making for effective control policies aiming the increase of vaccination coverage to avoid the YFV transmission in densely populated urban centers.
C1 [Delatorre, Edson; Paulo Vicente, Ana Carolina] Fundacao Oswaldo Cruz, Inst Oswaldo Cruz, Lab Genet Mol Microorganismos, Rio De Janeiro, Brazil.
   [Santos de Abreu, Filipe Vieira; Ferreira-de-Brito, Anielly; Alberto Santos Neves, Maycon Sebastiao; Bonelly, Iule; de Miranda, Rafaella Moraes; de Castro, Marcia Goncalves; Lourenco-de-Oliveira, Ricardo] Fundacao Oswaldo Cruz, Inst Oswaldo Cruz, Lab Mosquitos Transmissores Hematozoarios, Rio De Janeiro, Brazil.
   [Santos de Abreu, Filipe Vieira] Inst Fed Norte Minas Gerais, Salinas, Brazil.
   [Ribeiro, Ieda Pereira; Gomez, Mariela Martinez; Cunha dos Santos, Alexandre Araujo; Furtado, Nathalia Dias; Souza Raphael, Lidiane Menezes; Bonaldo, Myrna Cristina] Fundacao Oswaldo Cruz, Inst Oswaldo Cruz, Lab Biol Mol Flavivirus, Rio De Janeiro, Brazil.
   [Gomez, Mariela Martinez] Inst Invest Biol Clemente Estable, Div Biol Mol & Genet, Dept Biol & Mol, Montevideo, Uruguay.
   [Fernandes da Silva, Lucileis de Fatima] Secretaria Saude Goias, Lab Cent Saude Publ Dr Giovanni Cysneiros, Goiania, Go, Brazil.
   [Ramos, Daniel Garkauskas; Martins Romano, Alessandro Pecego] Minist Saude, Coordenacao Geral Vigilancia Doencas Transmissive, Dept Vigilancia Doencas Transmissiveis, Secretaria Vigilancia Saude, Brasilia, DF, Brazil.
   [Kallas, Esper Georges] Univ Sao Paulo, Dept Mol Infecciosas, Hosp Clin HCFMUSR, Fac Med, Sao Paulo, Brazil.
   [Bello, Gonzalo] Fundacao Oswaldo Cruz, Inst Oswaldo Cruz, Lab AIDS & Imunol Mol, Rio De Janeiro, Brazil.
RP Delatorre, E (corresponding author), Fundacao Oswaldo Cruz, Inst Oswaldo Cruz, Lab Genet Mol Microorganismos, Rio De Janeiro, Brazil.
EM edsonod@ioc.fiocruz.br
RI Delatorre, Edson/J-8330-2015
OI Delatorre, Edson/0000-0002-5746-0820; Ribeiro, Ivonizete
   Pires/0000-0003-0737-5430; Garkauskas Ramos, Daniel/0000-0002-7404-2209
FU "Programa Nacional de Pos-Doutorado (PNPD)" by the Coordenacao de
   Aperfeicoamento de Pessoal de Nivel Superior - Brazil (CAPES) [001];
   Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior - Brasil
   (CAPES)CAPES [001]; Conselho Nacional Desenvolvimento Cientifico e
   Tecnologico (CNPq)National Council for Scientific and Technological
   Development (CNPq) [309577/2013-6, 312446/2018-7]; Fundacao Carlos
   Chagas Filho de Amparo a Pesquisa do Estado do Rio de Janeiro
   [E-26/203.064/2016]; Institut Pasteur, Transversal Research Program
   (PTR) [528]; Coordenacao de Aperfeicoamento de Pessoal de Nivel
   SuperiorCAPES [COFECUB 799-14, AUXPE 1731/2014]; CNPq fellowship for
   Productivity in Technological Development and Innovative Extension
   [309471/2016-8]; Preventing and Combating the Zika Virus, MCTIC/FNDCT -
   CNPq/MEC-CAPES/MS-Decit [426767/2018-7, 88881.130684/2016-01];
   INOVA-Fiocruz [VPPIS-004-FIO18]
FX ED was financed by a Postdoctoral fellowship from the "Programa Nacional
   de Pos-Doutorado (PNPD)" by the Coordenacao de Aperfeicoamento de
   Pessoal de Nivel Superior -Brazil (CAPES) -Finance Code 001. MG and IR
   received a Postdoctoral fellowship from the Coordenacao de
   Aperfeicoamento de Pessoal de Nivel Superior -Brasil (CAPES) Finance
   Code 001. RL-d-O is funded by grants from Conselho Nacional
   Desenvolvimento Cientifico e Tecnologico (CNPq) (Grant Nos.
   309577/2013-6 and 312446/2018-7), Fundacao Carlos Chagas Filho de Amparo
   a Pesquisa do Estado do Rio de Janeiro (Grant E-26/203.064/2016),
   Institut Pasteur, Transversal Research Program (PTR Grant No. 528) and
   Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (Grant No.
   COFECUB 799-14, AUXPE 1731/2014). MB is a recipient of CNPq fellowship
   for Productivity in Technological Development and Innovative Extension
   (Grant 309471/2016-8) and is funded by grants from Preventing and
   Combating the Zika Virus, MCTIC/FNDCT - CNPq/MEC-CAPES/MS-Decit. (Grants
   426767/2018-7 and 88881.130684/2016-01) and INOVA-Fiocruz (Grant
   VPPIS-004-FIO18).
CR Agencia Nacional de Aguas [ANA], 2019, DIV HIDR BRAS
   Alencar J, 2018, J AM MOSQUITO CONTR, V34, P85, DOI 10.2987/18-6739.1
   Ayres DL, 2012, SYST BIOL, V61, P170, DOI 10.1093/sysbio/syr100
   Baele G, 2012, MOL BIOL EVOL, V29, P2157, DOI 10.1093/molbev/mss084
   Bielejec F, 2011, BIOINFORMATICS, V27, P2910, DOI 10.1093/bioinformatics/btr481
   Bonaldo MC, 2017, MEM I OSWALDO CRUZ, V112, P447, DOI 10.1590/0074-02760170134
   Carrington CVF, 2013, INFECT GENET EVOL, V13, P198, DOI 10.1016/j.meegid.2012.08.015
   CAUSEY OR, 1950, AM J TROP MED, V30, P301
   Vasconcelos PFD, 2010, REV SAUDE PUBL, V44, P1144, DOI 10.1590/S0034-89102010005000046
   Darriba D, 2012, NAT METHODS, V9, P772, DOI 10.1038/nmeth.2109
   de Rezende IM, 2018, PLOS NEGLECT TROP D, V12, DOI 10.1371/journal.pntd.0006538
   de Souza RP, 2010, J MED VIROL, V82, P175, DOI 10.1002/jmv.21606
   Drummond AJ, 2005, MOL BIOL EVOL, V22, P1185, DOI 10.1093/molbev/msi103
   Drummond AJ, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-214
   Drummond AJ, 2006, PLOS BIOL, V4, P699, DOI 10.1371/journal.pbio.0040088
   Drummond AJ, 2012, MOL BIOL EVOL, V29, P1969, DOI 10.1093/molbev/mss075
   Faria NR, 2018, SCIENCE, V361, P894, DOI 10.1126/science.aat7115
   Ferreira MAR, 2008, CAN J STAT, V36, P355, DOI 10.1002/cjs.5550360302
   Ferreira-de-Brito A, 2016, MEM I OSWALDO CRUZ, V111, P655, DOI 10.1590/0074-02760160332
   Fioravanti C, 2018, ALARME MACACOS
   Frost SDW, 2015, EPIDEMICS-NETH, V10, P88, DOI 10.1016/j.epidem.2014.09.001
   Gomez MM, 2018, J GEN VIROL, V99, P536, DOI 10.1099/jgv.0.001033
   Guindon S, 2010, SYST BIOL, V59, P307, DOI 10.1093/sysbio/syq010
   Hamrick PN, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0005897
   Jung L, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0129789
   Katoh K, 2013, MOL BIOL EVOL, V30, P772, DOI 10.1093/molbev/mst010
   Kumar S, 2016, MOL BIOL EVOL, V33, P1870, DOI [10.1093/molbev/msw054, 10.1093/molbev/msv279]
   Lemey P, 2010, MOL BIOL EVOL, V27, P1877, DOI 10.1093/molbev/msq067
   Lemey P, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000520
   Mir D, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-07873-7
   Monath TP, 2015, J CLIN VIROL, V64, P160, DOI 10.1016/j.jcv.2014.08.030
   Nunes MRT, 2012, J VIROL, V86, P13263, DOI 10.1128/JVI.00565-12
   Possas C, 2018, MEM I OSWALDO CRUZ, V113, DOI 10.1590/0074-02760180278
   Possas C, 2018, MEM I OSWALDO CRUZ, V113, P1, DOI 10.1590/0074-02760170361
   Rambaut A, 2018, SYST BIOL, V67, P901, DOI 10.1093/sysbio/syy032
   Rambaut A, 2016, VIRUS EVOL, V2, DOI 10.1093/ve/vew007
   de Abreu FVS, 2019, EMERG MICROBES INFEC, V8, P218, DOI 10.1080/22221751.2019.1568180
   Secretaria de Vigilancia em Saude, 2015, REEM FEBR AM SILV BR
   Secretaria de Vigilancia em Saude, 2017, EM EP FEBR AM BRAS P
   Secretaria de Vigilancia em Saude, 2019, MON PER SAZ FEBR AM
   Secretaria de Vigilancia em Saude, 2014, EP PRIM NAO HUM PNH
NR 41
TC 8
Z9 8
U1 1
U2 2
PU FRONTIERS MEDIA SA
PI LAUSANNE
PA AVENUE DU TRIBUNAL FEDERAL 34, LAUSANNE, CH-1015, SWITZERLAND
SN 1664-302X
J9 FRONT MICROBIOL
JI Front. Microbiol.
PD MAY 24
PY 2019
VL 10
AR 1079
DI 10.3389/fmicb.2019.01079
PG 12
WC Microbiology
SC Microbiology
GA HZ5RT
UT WOS:000468911000001
PM 31178835
OA DOAJ Gold, Green Published
DA 2020-12-01
ER

PT J
AU de Souza, YRM
   Manso, PPD
   de Oliveira, BCEPD
   Terra, MABL
   Paschoal, T
   Caminha, G
   Ribeiro, IP
   Raphael, LMS
   Bonaldo, MC
   Pelajo-Machado, M
AF Maia de Souza, Yuli Rodrigues
   de Abreu Manso, Pedro Paulo
   Dias de Oliveira, Barbara C. E. P.
   Barge Loucao Terra, Marcia Andreia
   Paschoal, Thalita
   Caminha, Giulia
   Ribeiro, Ieda Pereira
   Souza Raphael, Lidiane Menezes
   Bonaldo, Myrna Cristina
   Pelajo-Machado, Marcelo
TI Generation of Yellow Fever virus vaccine in skeletal muscle cells of
   chicken embryos
SO MEMORIAS DO INSTITUTO OSWALDO CRUZ
LA English
DT Article
DE Yellow Fever; vaccine; 17DD; chicken embryos; muscle cell; cell culture
ID DIFFERENTIATION; MYOBLASTS; CULTURE; FUSION
AB BACKGROUND The Yellow Fever (YF) vaccine is produced by the inoculation of embryonated chicken eggs with YF17DD virus on the ninth day of development. Full embryos are collected on the twelfth day of development for vaccine formulation. Skeletal muscle tissue is the main site where biosynthesis of viral particles occurs.
   OBJECTIVES This study aimed to analyse the experimental infection of skeletal muscle cells of chicken embryos by the 17DD Yellow Fever virus (YFV) in vivo and in vitro.
   METHODS Chicken embryos infected with YF17DD virus were analysed by immunofluorescence using confocal and super-resolution microscopes. Primary cultures of skeletal muscle cells of non-infected chicken embryos were evaluated for susceptibility and permissiveness to YF17DD virus using different protocols. This evaluation was performed based on morphological, viral titration, molecular biology, and colorimetric techniques.
   FINDINGS The present work phenotypically characterises embryonic chicken skeletal muscle cells as myogenic precursors expressing the Pax7 transcription factor in some cases. We demonstrated that these cells are susceptible to in vitro infection at different multiplicities of infection (MOIs), reproducing the same infection pattern observed in vivo. Furthermore, myogenic precursors and myoblasts are preferred infection targets, but establishment of infection does not depend on the presence of these cells. The peak of viral production occurred at 48 hpi, with decay occurring 72 hpi, when the cytopathic effect can be observed.
   MAIN CONCLUSIONS In conclusion, the primary culture of chicken skeletal muscle cells is a good model for studying muscle cells infected with YF17DD virus. This culture system displays satisfactory emulation of the in vitro phenomenon observed, contributing to our understanding of virus infection dynamics and leading to the development of alternative methods of vaccine production.
C1 [Maia de Souza, Yuli Rodrigues; de Abreu Manso, Pedro Paulo; Dias de Oliveira, Barbara C. E. P.; Barge Loucao Terra, Marcia Andreia; Paschoal, Thalita; Caminha, Giulia; Pelajo-Machado, Marcelo] Fundacao Oswaldo Cruz Fiocruz, Lab Patol, Inst Oswaldo Cruz, Rio De Janeiro, RJ, Brazil.
   [Ribeiro, Ieda Pereira; Souza Raphael, Lidiane Menezes; Bonaldo, Myrna Cristina] Fundacao Oswaldo Cruz Fiocruz, Lab Biol Mol Flavivirus, Inst Oswaldo Cruz, Rio De Janeiro, RJ, Brazil.
RP de Souza, YRM (corresponding author), Fundacao Oswaldo Cruz Fiocruz, Lab Patol, Inst Oswaldo Cruz, Rio De Janeiro, RJ, Brazil.
EM yuli.rmaia@gmail.com
OI Ribeiro, Ivonizete Pires/0000-0003-0737-5430; Rodrigues Maia de Souza,
   Yuli/0000-0002-6202-1961
CR Barrett ADT, 2009, CURR OPIN IMMUNOL, V21, P308, DOI 10.1016/j.coi.2009.05.018
   Bentzinger CF, 2012, CSH PERSPECT BIOL, V4, DOI 10.1101/cshperspect.a008342
   CARSON FL, 1973, AM J CLIN PATHOL, V59, P365
   Manso PPD, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0155041
   Manso PPD, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0004064
   Desdouits M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079628
   Freire MS, 2005, VACCINE, V23, P2501, DOI 10.1016/j.vaccine.2004.10.035
   Gaspar LP, 2008, J VIROL METHODS, V150, P57, DOI 10.1016/j.jviromet.2008.03.002
   INESTROSA NC, 1982, CELL STRUCT FUNCT, V7, P91, DOI 10.1247/csf.7.91
   Khromava AY, 2005, VACCINE, V23, P3256, DOI 10.1016/j.vaccine.2005.01.089
   KONIGSBERG IR, 1963, SCIENCE, V140, P1273, DOI 10.1126/science.140.3573.1273
   LIN ZX, 1994, CELL MOTIL CYTOSKEL, V29, P1, DOI 10.1002/cm.970290102
   Monath TP, 2011, NEW ENGL J MED, V364, P1326, DOI 10.1056/NEJMoa1009303
   Monath TP, 2005, EXPERT REV VACCINES, V4, P553, DOI 10.1586/14760584.4.4.553
   Monath TP, 2002, CLIN INFECT DIS, V34, P1369, DOI 10.1086/340104
   ONEILL MC, 1972, J CELL BIOL, V52, P52, DOI 10.1083/jcb.52.1.52
   Ozden S, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000527
   Pastorino B, 2010, ANTIVIR RES, V87, P281, DOI 10.1016/j.antiviral.2010.04.014
   Pereira RC, 2015, VACCINE, V33, P4261, DOI 10.1016/j.vaccine.2015.03.077
   SHIMADA Y, 1971, J CELL BIOL, V48, P128, DOI 10.1083/jcb.48.1.128
   TANAKA M, 1993, J VIROL METHODS, V41, P311, DOI 10.1016/0166-0934(93)90020-R
   WAKELAM MJO, 1985, BIOCHEM J, V228, P1
   WHO, 2015, VACCINE, V33, P76, DOI 10.1016/j.vaccine.2014.05.040
NR 23
TC 0
Z9 0
U1 0
U2 0
PU FUNDACO OSWALDO CRUZ
PI RIO DE JANEIRO, RJ
PA AV BRASIL 4365, 21045-900 RIO DE JANEIRO, RJ, BRAZIL
SN 0074-0276
EI 1678-8060
J9 MEM I OSWALDO CRUZ
JI Mem. Inst. Oswaldo Cruz
PY 2019
VL 114
AR e190187
DI 10.1590/0074-02760190187
PG 10
WC Parasitology; Tropical Medicine
SC Parasitology; Tropical Medicine
GA JV4CT
UT WOS:000502312900001
PM 31826129
OA DOAJ Gold, Green Published
DA 2020-12-01
ER

PT J
AU de Abreu, FVS
   Delatorre, E
   dos Santos, AAC
   Ferreira-de-Brito, A
   de Castro, MG
   Ribeiro, IP
   Furtado, ND
   Vargas, WP
   Ribeiro, MS
   Meneguete, P
   Bonaldo, MC
   Bello, G
   Lourenco-de-Oliveira, R
AF Santos de Abreu, Filipe Vieira
   Delatorre, Edson
   Cunha dos Santos, Alexandre Araujo
   Ferreira-de-Brito, Anielly
   de Castro, Marcia Goncalves
   Ribeiro, Ieda Pereira
   Furtado, Nathalia Dias
   Vargas, Waldemir Paixao
   Ribeiro, Mario Sergio
   Meneguete, Patricia
   Bonaldo, Myrna Cristina
   Bello, Gonzalo
   Lourenco-de-Oliveira, Ricardo
TI Combination of surveillance tools reveals that Yellow Fever virus can
   remain in the same Atlantic Forest area at least for three transmission
   seasons
SO MEMORIAS DO INSTITUTO OSWALDO CRUZ
LA English
DT Article
DE Yellow Fever; amino acid changes; phylogeography; Alouatta; mosquito
   vectors
AB BACKGROUND In Brazil, the Yellow Fever virus (YFV) is endemic in the Amazon, from where it eventually expands into epidemic waves. Coastal south-eastern (SE) Brazil, which has been a YFV-free region for eight decades, has reported a severe sylvatic outbreak since 2016. The virus spread from the north toward the south of the Rio de Janeiro (RJ) state, causing 307 human cases with 105 deaths during the 2016-2017 and 2017-2018 transmission seasons. It is unclear, however, whether the YFV would persist in the coastal Atlantic Forest of RJ during subsequent transmission seasons.
   OBJECTIVES To conduct a real-time surveillance and assess the potential persistence of YFV in the coastal Atlantic Forest of RJ during the 2018-2019 transmission season.
   METHODS We combined epizootic surveillance with fast diagnostic and molecular, phylogenetic, and evolutionary analyses.
   FINDINGS Using this integrative strategy, we detected the first evidence of YFV re-emergence in the third transmission season (2018-2019) in a dying howler monkey from the central region of the RJ state. The YFV detected in 2019 has the molecular signature associated with the current SE YFV outbreak and exhibited a close phylogenetic relationship with the YFV lineage that circulated in the same Atlantic Forest fragment during the past seasons. This lineage circulated along the coastal side of the Serra do Mar mountain chain, and its evolution seems to be mainly driven by genetic drift. The potential bridge vector Aedes albopictus was found probing on the recently dead howler monkey in the forest edge, very close to urban areas.
   MAIN CONCLUSIONS Collectively, our data revealed that YFV transmission persisted at the same Atlantic Forest area for at least three consecutive transmission seasons without the need of new introductions. Our real-time surveillance strategy permitted health authorities to take preventive actions within 48 h after the detection of the sick non-human primate. The local virus persistence and the proximity of the epizootic forest to urban areas reinforces the concern with regards to the risk of reurbanisation and seasonal re-emergence of YFV, stressing the need for continuous effective surveillance and high vaccination coverage in the SE region, particularly in RJ, an important tourist location.
C1 [Santos de Abreu, Filipe Vieira; Ferreira-de-Brito, Anielly; de Castro, Marcia Goncalves; Lourenco-de-Oliveira, Ricardo] Fundacao Oswaldo Cruz Fiocruz, Inst Oswaldo Cruz, Lab Mosquitos Transmissores Hematozoarios, Rio De Janeiro, RJ, Brazil.
   [Santos de Abreu, Filipe Vieira] Inst Fed Norte Minas Gerais, Salinas, MG, Brazil.
   [Delatorre, Edson] Fundacao Oswaldo Cruz Fiocruz, Inst Oswaldo Cruz, Lab Genet Mol Microorganismos, Rio De Janeiro, RJ, Brazil.
   [Cunha dos Santos, Alexandre Araujo; Ribeiro, Ieda Pereira; Furtado, Nathalia Dias; Bonaldo, Myrna Cristina] Fundacao Oswaldo Cruz Fiocruz, Inst Oswaldo Cruz, Lab Biol Mol Flavivirus, Rio De Janeiro, RJ, Brazil.
   [Vargas, Waldemir Paixao] Fundacao Oswaldo Cruz Fiocruz, Escola Nacl Saude Publ, Dept Endemias Samuel Pessoa, Rio De Janeiro, RJ, Brazil.
   [Ribeiro, Mario Sergio; Meneguete, Patricia] Secretaria Estado Saude Sao Paulo, Superintendencia Vigilancia Epidemiol & Ambiental, Rio De Janeiro, RJ, Brazil.
   [Bello, Gonzalo] Fundacao Oswaldo Cruz Fiocruz, Inst Oswaldo Cruz, Lab AIDS & Imunol Mol, Rio De Janeiro, RJ, Brazil.
RP Lourenco-de-Oliveira, R (corresponding author), Fundacao Oswaldo Cruz Fiocruz, Inst Oswaldo Cruz, Lab Mosquitos Transmissores Hematozoarios, Rio De Janeiro, RJ, Brazil.; Bonaldo, MC (corresponding author), Fundacao Oswaldo Cruz Fiocruz, Inst Oswaldo Cruz, Lab Biol Mol Flavivirus, Rio De Janeiro, RJ, Brazil.; Bello, G (corresponding author), Fundacao Oswaldo Cruz Fiocruz, Inst Oswaldo Cruz, Lab AIDS & Imunol Mol, Rio De Janeiro, RJ, Brazil.
EM mbonaldo@ioc.fiocruz.br; gbellobr@gmail.com; lourenco@loc.fiocruz.br
RI Delatorre, Edson/J-8330-2015
OI Delatorre, Edson/0000-0002-5746-0820; Ribeiro, Ivonizete
   Pires/0000-0003-0737-5430
FU CNPqNational Council for Scientific and Technological Development (CNPq)
   [309577/2013-6, 312446/2018-7, 309471/2016-8]; FAPERJCarlos Chagas Filho
   Foundation for Research Support of the State of Rio de Janeiro (FAPERJ)
   [E-26/203.064/2016]; Institut Pasteur, Transversal Research Program
   (PTR) [528]; CAPESCAPES [COFECUB 799-14, AUXPE 1731/2014, 001];
   Preventing and Combating the Zika Virus,
   MCTIC/FNDCT-CNPq/MEC-CAPES/MS-Decit [426767/2018-7,
   88881.130684/2016-01]; MCTI/FINEP/FNDCT 01/2016 - ZIKA [0240/16];
   INOVA-Fiocruz [VPPCB-007-FIO-18-2-69]; "Programa Nacional de
   Pos-Doutorado (PNPD)" by the CAPES [001]
FX RLO was funded by CNPq (Grants no. 309577/2013-6 and 312446/2018-7),
   FAPERJ (Grant E-26/203.064/2016), Institut Pasteur, Transversal Research
   Program (PTR Grant no. 528), CAPES (Grant no. COFECUB 799-14, AUXPE
   1731/2014). MCB is a recipient of the CNPq fellowship for Productivity
   in Technological Development and Innovative Extension (Grant
   309471/2016-8), and is funded by grants from Preventing and Combating
   the Zika Virus, MCTIC/FNDCT-CNPq/MEC-CAPES/MS-Decit (Grants
   426767/2018-7 and 88881.130684/2016-01), MCTI/FINEP/FNDCT 01/2016 - ZIKA
   Ref: 0240/16, and INOVA-Fiocruz (Grant VPPCB-007-FIO-18-2-69). IPR
   received a postdoctoral fellowship from the CAPES - Finance Code 001. ED
   was financed by a postdoctoral fellowship from the "Programa Nacional de
   Pos-Doutorado (PNPD)" by the CAPES - Finance Code 001.
CR Almeida MAB, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002741
   Bielejec F, 2011, BIOINFORMATICS, V27, P2910, DOI 10.1093/bioinformatics/btr481
   Bonaldo MC, 2017, MEM I OSWALDO CRUZ, V112, P447, DOI 10.1590/0074-02760170134
   Bugher JC, 1944, AM J HYG, V39, P16, DOI 10.1093/oxfordjournals.aje.a118895
   Causey OR, 1949, AM J TROP MED HYG  S, Vs1-29, P555, DOI [10.4269/ajtmh.1949.s1-29.555, DOI 10.4269/AJTMH.1949.S1-29.555]
   Vasconcelos PFD, 2010, REV SAUDE PUBL, V44, P1144, DOI 10.1590/S0034-89102010005000046
   Darriba D, 2012, NAT METHODS, V9, P772, DOI 10.1038/nmeth.2109
   de Almeida MAB, 2019, ECOHEALTH, V16, P95, DOI 10.1007/s10393-018-1388-4
   de Rezende IM, 2018, PLOS NEGLECT TROP D, V12, P1
   dos Santos TP, 2018, EMERG MICROBES INFEC, V7, DOI 10.1038/s41426-018-0194-y
   GALINDO PEDRO, 1955, ANN ENT SOC AMER, V48, P158
   Goenaga S, 2012, VECTOR-BORNE ZOONOT, V12, P986, DOI 10.1089/vbz.2011.0730
   Gomez MM, 2018, J GEN VIROL, V99, P536, DOI 10.1099/jgv.0.001033
   Hamer DH, 2018, MMWR-MORBID MORTAL W, V67, P340, DOI 10.15585/mmwr.mm6711e1
   Hamrick PN, 2017, PLOS NEGLECT TROP D, V11, P1, DOI DOI 10.1371/J0URNAL.PNTD.0005897
   LAEMMERT HW, 1946, AM J TROP MED, V26, P33
   Lafer C., 2002, JK PROGRAMA METAS 19
   Lemey P, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000520
   Romano APM, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002740
   Mascheretti M, 2013, REV SAUDE PUBL, V47, DOI 10.1590/S0034-8910.2013047004341
   Massad E, 2018, EPIDEMIOL INFECT, V146, P1219, DOI [10.1017/S0950268818001334, 10.1017/s0950268818001334]
   Mir D, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-07873-7
   MS/ SVS-Ministerio da Saude/ Secretaria de Vigilancia em Saude, 2018, MON PER SAZ FEBR AM
   MS/ SVS-Ministerio da Saude/ Secretaria de Vigilancia em Saude, 2017, MON CAS OB FEBR AM B
   MS/ SVS-Ministerio da Saude/ Secretaria de Vigilancia em Saude, 2018, MON PER SAZ FEBR AM
   MS/ SVS-Ministerio da Saude/ Secretaria de Vigilancia em Saude/ Departamento de Vigilancia das Doencas Transmissiveis, 2017, GUIA VIG EP PRIM NAO
   Murrell B, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002764
   Possas C, 2018, MEM I OSWALDO CRUZ, V113, P1, DOI 10.1590/0074-02760170361
   de Abreu FVS, 2019, EMERG MICROBES INFEC, V8, P218, DOI 10.1080/22221751.2019.1568180
   Secretaria de Estado de Saude do Rio de Janeiro. Vigilancia em Saude, 2018, INF EP 05 07 2018
   Secretaria de Saude de Estado do Rio de Janeiro. Vigilancia em Saude, 2017, INF EP 071 2017
   Secretaria de Saude de Estado do Rio de Janeiro. Vigiliancia em Saude, 2017, INF EP 001 2017
   SOPER F. L., 1938, TRAM ROY SOC TROP MED AND HYG, V32, P297, DOI 10.1016/S0035-9203(38)90045-8
   Strode G. K, 1951, YELLOW FEVER
   Taylor RM, 1946, AM J TROP MED HYG S2, Vs1-26, P1, DOI [10.4269/ajtmh.1946.s1-26.1, DOI 10.4269/AJTMH.1946.S1-26.1]
   2012, MOL BIOL EVOL, V29, P2157, DOI DOI 10.1093/MOLBEV/MSS084
   2002, MOL BIOL EVOL, V19, P2333
   2013, MOL BIOL EVOL, V30, P772, DOI DOI 10.1093/MOLBEV/MST010
   2010, J VIROL, V84, P765, DOI DOI 10.1128/JVI.01738-09
   2002, VECTOR BORNE ZOONOTI, V2, P47
   2012, MOL BIOL EVOL, V29, P1969, DOI DOI 10.1093/MOLBEV/MSS075
   2003, MEM I O CRUZ, V98, P191
   1993, MOL BIOL EVOL, V10, P271
   2005, BIOINFORMATICS, V21, P676, DOI DOI 10.1093/BIOINFORMATICS/BTI079
   2012, SYST BIOL, V61, P170, DOI DOI 10.1093/SYSBIO/SYR100
   2018, SCIENCE, V361, P894, DOI DOI 10.1126/SCIENCE.AAT7115
   2012, J VIROL, V86, P1326, DOI DOI 10.1128/JVI.00565-12
   1993, J MOL EVOL, V36, P96
   2010, MOL BIOL EVOL, V27, P1877, DOI DOI 10.1093/MOLBEV/MSQ067
   2008, ENTOMOL NEWS, V119, P239, DOI DOI 10.3157/0013-872X(2008)119[239:EOM-IOE]2.0.CO
   2012, J CLIN MICROBIOL, V50, P4054, DOI DOI 10.1128/JCM.01799-12
   2010, SYST BIOL, V59, P307, DOI DOI 10.1093/SYSBIO/SYQ010
NR 52
TC 7
Z9 7
U1 2
U2 2
PU FUNDACO OSWALDO CRUZ
PI RIO DE JANEIRO, RJ
PA AV BRASIL 4365, 21045-900 RIO DE JANEIRO, RJ, BRAZIL
SN 0074-0276
EI 1678-8060
J9 MEM I OSWALDO CRUZ
JI Mem. Inst. Oswaldo Cruz
PY 2019
VL 114
AR e190076
DI 10.1590/0074-02760190076
PG 10
WC Parasitology; Tropical Medicine
SC Parasitology; Tropical Medicine
GA HW3IF
UT WOS:000466583800001
PM 31038550
OA DOAJ Gold, Green Published
DA 2020-12-01
ER

PT J
AU Martins, MA
   Tully, DC
   Pedreno-Lopez, N
   von Bredow, B
   Pauthner, MG
   Shin, YC
   Yuan, ML
   Lima, NS
   Bean, DJ
   Gonzalez-Nieto, L
   Domingues, A
   Gutman, MJ
   Maxwell, HS
   Magnani, DM
   Ricciardi, MJ
   Bailey, VK
   Altman, JD
   Burton, DR
   Ejima, K
   Allison, DB
   Evans, DT
   Rakasz, EG
   Parks, CL
   Bonaldo, MC
   Capuano, S
   Lifson, JD
   Desrosiers, RC
   Allen, TM
   Watkins, DI
AF Martins, Mauricio A.
   Tully, Damien C.
   Pedreno-Lopez, Nuria
   von Bredow, Benjamin
   Pauthner, Matthias G.
   Shin, Young C.
   Yuan, Maoli
   Lima, Noemia S.
   Bean, David J.
   Gonzalez-Nieto, Lucas
   Domingues, Aline
   Gutman, Martin J.
   Maxwell, Helen S.
   Magnani, Diogo M.
   Ricciardi, Michael J.
   Bailey, Varian K.
   Altman, John D.
   Burton, Dennis R.
   Ejima, Keisuke
   Allison, David B.
   Evans, David T.
   Rakasz, Eva G.
   Parks, Christopher L.
   Bonaldo, Myrna C.
   Capuano, Saverio, III
   Lifson, Jeffrey D.
   Desrosiers, Ronald C.
   Allen, Todd M.
   Watkins, David I.
TI Mamu-B*17(+) Rhesus Macaques Vaccinated with env, vif, and nef Manifest
   Early Control of SIVmac239 Replication
SO JOURNAL OF VIROLOGY
LA English
DT Article
DE AIDS; human immunodeficiency virus; simian immunodeficiency virus;
   vaccines
ID SIMIAN-IMMUNODEFICIENCY-VIRUS; T-CELL RESPONSES; HIGHLY PATHOGENIC SIV;
   EFFICACY TRIAL; HIV-1 VACCINE; DOUBLE-BLIND; CLASS-I; ESCAPE VARIANTS;
   NEUTRALIZATION; ENVELOPE
AB Certain major histocompatibility complex class I (MHC-I) alleles are associated with spontaneous control of viral replication in human immunodeficiency virus (HIV)-infected people and simian immunodeficiency virus (SIV)infected rhesus macaques (RMs). These cases of "elite" control of HIV/SIV replication are often immune-mediated, thereby providing a framework for studying anti-lentiviral immunity. In this study, we examined how vaccination impacts SIV replication in RMs expressing the MHC-I allele Mamu-B*17. Approximately 21% of Mamu-B*17(+) and 50% of Mamu-B*08(+) RMs control chronic-phase viremia after SIVmac239 infection. Because CD8(+) T cells targeting Mamu-B*08-restricted SIV epitopes have been implicated in virologic suppression in Mamu-B*08(+) RMs, we investigated whether this might also be true for Mamu-B*17(+) RMs. Two groups of Mamu-B*17(+) RMs were vaccinated with genes encoding Mamu-B*17-restricted epitopes in Vif and Nef. These genes were delivered by themselves (group 1) or together with env (group 2). Group 3 included MHC-I-matched RMs and served as the control group. Surprisingly, the group 1 vaccine regimen had little effect on viral replication compared to group 3, suggesting that unlike Mamu-B*08(+) RMs, preexisting SIV-specific CD8(+) T cells alone do not facilitate long-term virologic suppression in Mamu-B*17(+) RMs. Remarkably, however, 5/8 group 2 vaccinees controlled viremia to <15 viral RNA copies/ml soon after infection. No serological neutralizing activity against SIVmac239 was detected in group 2, although vaccine-elicited gp140-binding antibodies correlated inversely with nadir viral loads. Collectively, these data shed new light on the unique mechanism of elite control in Mamu-B*17(+) RMs and implicate vaccine-induced, nonneutralizing antiEnv anti-bodies in the containment of immunodeficiency virus infection.
   IMPORTANCE A better understanding of the immune correlates of protection against HIV might facilitate the development of a prophylactic vaccine. Therefore, we investigated simian immunodeficiency virus (SIV) infection outcomes in rhesus macaques expressing the major histocompatibility complex class I allele Mamu-B*17. Approximately 21% of Mamu-B*17(+) macaques spontaneously controlled chronic phase viremia after SIV infection, an effect that may involve CD8(+) T cells targeting Mamu-B*17-restricted SIV epitopes. We vaccinated Mamu-B*17(+) macaques with genes encoding immunodominant epitopes in Vif and Nef alone (group 1) or together with env (group 2). Although neither vaccine regimen prevented SIV infection, 5/8 group 2 vaccinees controlled viremia to below detection limits shortly after infection. This outcome, which was not observed in group 1, was associated with vaccine-induced, nonneutralizing Env-binding antibodies. Together, these findings suggest a limited contribution of Vif-and Nefspecific CD8(+) T cells for virologic control in Mamu-B*17(+) macaques and implicate antiEnv antibodies in containment of SIV infection.
C1 [Martins, Mauricio A.; Pedreno-Lopez, Nuria; Shin, Young C.; Gonzalez-Nieto, Lucas; Domingues, Aline; Gutman, Martin J.; Maxwell, Helen S.; Magnani, Diogo M.; Ricciardi, Michael J.; Bailey, Varian K.; Desrosiers, Ronald C.; Watkins, David I.] Univ Miami, Dept Pathol, Miami, FL USA.
   [Tully, Damien C.; Bean, David J.; Burton, Dennis R.; Allen, Todd M.] Ragon Inst MGH MIT & Harvard, Cambridge, MA USA.
   [von Bredow, Benjamin; Evans, David T.] Univ Wisconsin, Dept Pathol & Lab Med, Madison, WI USA.
   [Pauthner, Matthias G.; Burton, Dennis R.] Scripps Res Inst, Dept Immunol & Microbiol, La Jolla, CA 92037 USA.
   [Pauthner, Matthias G.; Burton, Dennis R.] Scripps Res Inst, IAVI Neutralizing Antibody Ctr, La Jolla, CA 92037 USA.
   [Pauthner, Matthias G.; Burton, Dennis R.] Scripps Res Inst, Ctr HIV AIDS Vaccine Immunol & Immunogen Discover, La Jolla, CA 92037 USA.
   [Yuan, Maoli; Parks, Christopher L.] AIDS Vaccine Design & Dev Lab, Int AIDS Vaccine Initiat, Brooklyn, NY USA.
   [Lima, Noemia S.; Bonaldo, Myrna C.] Fiocruz MS, Inst Oswaldo Cruz, Lab Biol Mol Flavivirus, Rio De Janeiro, Brazil.
   [Altman, John D.] Emory Univ, Dept Microbiol & Immunol, Atlanta, GA 30322 USA.
   [Ejima, Keisuke; Allison, David B.] Indiana Univ, Sch Publ Hlth, Bloomington, IN USA.
   [Evans, David T.; Rakasz, Eva G.; Capuano, Saverio, III] Univ Wisconsin, Wisconsin Natl Primate Res Ctr, Madison, WI USA.
   [Lifson, Jeffrey D.] Leidos Biomed Res Inc, Frederick Natl Lab Canc Res, AIDS & Canc Virus Program, Frederick, MD USA.
RP Martins, MA (corresponding author), Univ Miami, Dept Pathol, Miami, FL USA.
EM mmartins@med.miami.edu
RI Martins, Mauricio/AAU-9226-2020; Rakasz, Eva G/H-9197-2019; Allen,
   Todd/F-5473-2011
OI Martins, Mauricio/0000-0001-8336-216X; Allen, Todd/0000-0002-6609-1318;
   Tully, Damien/0000-0002-7620-9340; Magnani, Diogo/0000-0002-1773-2406;
   Bean, David/0000-0001-7497-8026; Pauthner, Matthias
   G./0000-0001-9212-4307
FU Public Health Service (PHS) from the National Institute of Allergy and
   Infectious Diseases [R56 AI049120, R37 AI052056, P01 AI104715]; PHS
   grant [R01 AI121135]; Office of Research Infrastructure Programs [P51
   OD011106]; National Cancer Institute, National Institutes of
   HealthUnited States Department of Health & Human ServicesNational
   Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)
   [HHSN261200800001E]; Bill & Melinda Gates FoundationBill & Melinda Gates
   FoundationCGIAR; Ministry of Foreign Affairs of Denmark; Irish AidCGIAR;
   Ministry of Finance of Japan; Ministry of Foreign Affairs of the
   Netherlands; Norwegian Agency for Development Cooperation (NORAD)CGIAR;
   United Kingdom Department for International Development (DFID); United
   States Agency for International Development (USAID)United States Agency
   for International Development (USAID)CGIAR; NATIONAL INSTITUTE OF
   ALLERGY AND INFECTIOUS DISEASESUnited States Department of Health &
   Human ServicesNational Institutes of Health (NIH) - USANIH National
   Institute of Allergy & Infectious Diseases (NIAID) [R01AI098485,
   R56AI049120, P01AI104715, R37AI063928, R37AI052056, P01AI104715,
   P01AI104715, R01AI121135, R01AI121135, P01AI104715, R37AI063928,
   P01AI104715, P01AI104715, R37AI063928, P01AI104715, P01AI104715,
   R37AI063928, P01AI104715, R01AI095098, P01AI104715, R37AI052056,
   R01AI121135, P01AI104715, R01AI121135, R37AI052056, R37AI052056,
   R01AI108421, R37AI052056, R37AI052056, R37AI063928, R37AI063928,
   P01AI104715, P01AI104715, P01AI104715, R01AI108421, P01AI104715,
   P01AI104715, P01AI104715, R37AI052056, P01AI104715, R37AI063928,
   P01AI104715, P01AI104715, P01AI104715, P01AI104715, R01AI121135,
   P01AI104715, P01AI104715, R56AI049120, P01AI104715, R37AI052056,
   P01AI104715, P01AI104715, P01AI104715, R37AI052056, R37AI052056,
   P01AI104715, R37AI063928, P01AI104715, R37AI052056] Funding Source: NIH
   RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTHUnited
   States Department of Health & Human ServicesNational Institutes of
   Health (NIH) - USA [P51OD011106, P51OD011106, P51OD011106, P51OD011106,
   P51OD011106, P51OD011106, P51OD011106, P51OD011106, P51OD011106,
   P51OD011106, P51OD011106, P51OD011106, P51OD011106, P51OD011106,
   P51OD011106, P51OD011106, P51OD011106] Funding Source: NIH RePORTER
FX This work was funded by Public Health Service (PHS) grants R56 AI049120
   (D.I.W.), R37 AI052056 (D.I.W.), and P01 AI104715 (T.M.A.) from the
   National Institute of Allergy and Infectious Diseases. Partial support
   came from PHS grant R01 AI121135 (D.T.E.), federal funds from the Office
   of Research Infrastructure Programs (P51 OD011106), and the National
   Cancer Institute, National Institutes of Health, under contract no.
   HHSN261200800001E (J.D.L.). IAVI's work is made possible by generous
   support from many donors, including The Bill & Melinda Gates Foundation,
   the Ministry of Foreign Affairs of Denmark, Irish Aid, the Ministry of
   Finance of Japan, the Ministry of Foreign Affairs of the Netherlands,
   the Norwegian Agency for Development Cooperation (NORAD), the United
   Kingdom Department for International Development (DFID), and the United
   States Agency for International Development (USAID). The full list of
   IAVI donors is available at http://www.iavi.org. The contents are the
   responsibility of the International AIDS Vaccine Initiative and do not
   necessarily reflect the views of USAID or the U.S. government.; J.D.L.
   is employed by Leidos Biomedical Research, Inc., the Prime Contractor
   for the Operations and Technical Support Contract for the Frederick
   National Laboratory for Cancer Research (FNLCR), which exists solely to
   operate the FNLCR on behalf of the National Cancer Institute and
   National Institutes of Health. J.D.L.'s laboratory is supported by this
   contract (contract HHSN261200800001E) from the National Cancer
   Institute, National Institutes of Health. There are no competing
   interests or relevant declarations related to employment, consultancy,
   patents, products in development, or marketed products. T.M.A.'s spouse
   was an employee of Bristol-Myers Squibb (BMS), which has a focus in
   virology, specifically treatments for hepatitis B and C and HIV/AIDS.
   T.M.A.'s spouse no longer works for BMS and retained only a small stock
   interest in the public company. T.M.A.'s interests were reviewed and
   managed by Massachusetts General Hospital and Partners HealthCare in
   accordance with their conflict-of-interest policies.
CR Adnan S, 2016, PLOS PATHOG, V12, DOI 10.1371/journal.ppat.1006104
   Adnan S, 2015, PLOS PATHOG, V11, DOI 10.1371/journal.ppat.1004633
   Alpert MD, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002890
   Alpert MD, 2012, J VIROL, V86, P12039, DOI 10.1128/JVI.01650-12
   [Anonymous], 2016, GLOB AIDS UPD
   Barouch DH, 2015, SCIENCE, V349, P320, DOI 10.1126/science.aab3886
   Barouch DH, 2012, NATURE, V482, P89, DOI 10.1038/nature10766
   Bilello JP, 2011, J VIROL, V85, P12708, DOI 10.1128/JVI.00865-11
   Bolger AM, 2014, BIOINFORMATICS, V30, P2114, DOI 10.1093/bioinformatics/btu170
   Bonaldo MC, 2007, VIROL J, V4, DOI 10.1186/1743-422X-4-115
   Buchbinder SP, 2008, LANCET, V372, P1881, DOI 10.1016/S0140-6736(08)61591-3
   Chung AW, 2015, CELL, V163, P988, DOI 10.1016/j.cell.2015.10.027
   Cirelli KM, 2017, CURR OPIN IMMUNOL, V47, P64, DOI 10.1016/j.coi.2017.06.008
   Dang Q, 2008, ADV PHARMACOL, V56, P369, DOI 10.1016/S1054-3589(07)56012-6
   DANIEL MD, 1992, SCIENCE, V258, P1938, DOI 10.1126/science.1470917
   Desrosiers RC, 2017, J VIROL, V91, DOI 10.1128/JVI.00905-17
   Evans DT, 2005, J VIROL, V79, P7707, DOI 10.1128/JVI.79.12.7707-7720.2005
   Flynn MN, 2005, J INFECT DIS, V191, P654
   Fuchs JD, 2015, OPEN FORUM INFECT DI, V2, DOI 10.1093/ofid/ofv082
   Fukazawa Y, 2012, NAT MED, V18, P1673, DOI 10.1038/nm.2934
   Gilbert PB, 2011, J INFECT DIS, V203, P969, DOI 10.1093/infdis/jiq152
   Gonzalez-Nieto L, 2016, JOVE-J VIS EXP, DOI 10.3791/54881
   Goulder PJR, 2012, IMMUNITY, V37, P426, DOI 10.1016/j.immuni.2012.09.005
   Gray GE, 2011, LANCET INFECT DIS, V11, P507, DOI 10.1016/S1473-3099(11)70098-6
   Hammer SM, 2013, NEW ENGL J MED, V369, P2083, DOI 10.1056/NEJMoa1310566
   Hansen SG, 2013, NATURE, V502, P100, DOI 10.1038/nature12519
   Hansen SG, 2011, NATURE, V473, P523, DOI 10.1038/nature10003
   Henn MR, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002529
   Iwamoto N, 2014, J VIROL, V88, P425, DOI 10.1128/JVI.02634-13
   Johnson JE, 1997, J VIROL, V71, P5060, DOI 10.1128/JVI.71.7.5060-5068.1997
   Johnson WE, 2003, J VIROL, V77, P9993, DOI 10.1128/JVI.77.18.9993-10003.2003
   Johnson WE, 2002, J VIROL, V76, P2075, DOI 10.1128/JVI.76.5.2075-2086.2002
   Johnson WE, 2003, J VIROL, V77, P375, DOI 10.1128/JVI.77.1.375-381.2003
   Kiepiela P, 2007, NAT MED, V13, P46, DOI 10.1038/nm1520
   Kilgore KM, 2015, J VIROL, V89, P8130, DOI 10.1128/JVI.01221-14
   Li H, 2016, P NATL ACAD SCI USA, V113, pE3413, DOI 10.1073/pnas.1606636113
   Loffredo JT, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001152
   Loffredo JT, 2008, J VIROL, V82, P1723, DOI 10.1128/JVI.02084-07
   Loffredo JT, 2007, J VIROL, V81, P8827, DOI 10.1128/JVI.00895-07
   Loffredo JT, 2009, J IMMUNOL, V182, P7763, DOI 10.4049/jimmunol.0900111
   Lu WX, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0173929
   Maness NJ, 2008, J VIROL, V82, P5245, DOI 10.1128/JVI.00292-08
   Manrique J, 2013, J VIROL, V87, P7246, DOI 10.1128/JVI.00798-13
   Martin MP, 2007, NAT GENET, V39, P733, DOI 10.1038/ng2035
   Martins MA, 2017, AIDS RES HUM RETROV, V33, P843, DOI [10.1089/aid.2017.0046, 10.1089/AID.2017.0046]
   Martins MA, 2017, PLOS PATHOG, V13, DOI 10.1371/journal.ppat.1006529
   Martins MA, 2018, CSH PERSPECT BIOL, V10, DOI 10.1101/cshperspect.a029504
   Martins MA, 2015, J VIROL, V89, P10802, DOI 10.1128/JVI.01440-15
   Martins MA, 2014, J VIROL, V88, P7493, DOI 10.1128/JVI.00601-14
   Martins MA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054434
   Matano T, 2004, J EXP MED, V199, P1709, DOI 10.1084/jem.20040432
   Means RE, 1997, J VIROL, V71, P7895, DOI 10.1128/JVI.71.10.7895-7902.1997
   Migueles SA, 2010, JAMA-J AM MED ASSOC, V304, P194, DOI 10.1001/jama.2010.925
   Mothe BR, 2002, J IMMUNOL, V169, P210, DOI 10.4049/jimmunol.169.1.210
   Mudd PA, 2012, NATURE, V491, P129, DOI 10.1038/nature11443
   Mudd PA, 2012, J IMMUNOL, V188, P3364, DOI 10.4049/jimmunol.1102470
   National Research Council, 2011, GUIDE CARE USE LAB A
   Picker LJ, 2012, ANNU REV MED, V63, P95, DOI 10.1146/annurev-med-042010-085643
   Pitisuttithum P, 2006, J INFECT DIS, V194, P1661, DOI 10.1086/508748
   Rerks-Ngarm S, 2009, NEW ENGL J MED, V361, P2209, DOI 10.1056/NEJMoa0908492
   Reynolds MR, 2010, J VIROL, V84, P9190, DOI 10.1128/JVI.00041-10
   Rosati M, 2005, J VIROL, V79, P8480, DOI 10.1128/JVI.79.13.8480-8492.2005
   Sato S, 2008, J VIROL, V82, P9739, DOI 10.1128/JVI.00871-08
   Sok D, 2016, IMMUNITY, V45, P31, DOI 10.1016/j.immuni.2016.06.026
   Tully DC, 2016, PLOS PATHOG, V12, DOI 10.1371/journal.ppat.1005619
   Vaccari M, 2016, NAT MED, V22, P762, DOI 10.1038/nm.4105
   Walker BD, 2013, NAT REV IMMUNOL, V13, P487, DOI 10.1038/nri3478
   Weatherall DJ., 2006, USE NONHUMAN PRIMATE
   Winstone N, 2011, J VIROL, V85, P9578, DOI 10.1128/JVI.05060-11
   Xu HB, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052249
   Yang X, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-475
   Yant LJ, 2006, J VIROL, V80, P5074, DOI 10.1128/JVI.80.10.5074-5077.2006
NR 72
TC 5
Z9 5
U1 0
U2 5
PU AMER SOC MICROBIOLOGY
PI WASHINGTON
PA 1752 N ST NW, WASHINGTON, DC 20036-2904 USA
SN 0022-538X
EI 1098-5514
J9 J VIROL
JI J. Virol.
PD AUG
PY 2018
VL 92
IS 16
AR e00690-18
DI 10.1128/JVI.00690-18
PG 24
WC Virology
SC Virology
GA GO7XD
UT WOS:000440292200029
PM 29875239
OA Green Accepted, Green Published, Bronze
DA 2020-12-01
ER

PT J
AU Gomez, MM
   de Abreu, FVS
   dos Santos, AAC
   de Mello, IS
   Santos, MP
   Ribeiro, IP
   Ferreira-de-Brito, A
   de Miranda, RM
   de Castro, MG
   Ribeiro, MS
   Laterriere, RD
   Aguiar, SF
   Meira, GLS
   Antunes, D
   Torres, PHM
   Mir, D
   Vicente, ACP
   Guimaraes, ACR
   Caffarena, ER
   Bello, G
   Lourenco-de-Oliveira, R
   Bonaldo, MC
AF Gomez, Mariela Martinez
   Santos de Abreu, Filipe Vieira
   Cunha dos Santos, Alexandre Araujo
   de Mello, Iasmim Silva
   Santos, Marta Pereira
   Ribeiro, Ieda Pereira
   Ferreira-de-Brito, Anielly
   de Miranda, Rafaella Moraes
   de Castro, Marcia Goncalves
   Ribeiro, Mario Sergio
   Laterriere Junior, Roberto da Costa
   Aguiar, Shirlei Ferreira
   Silva Meira, Guilherme Louzada
   Antunes, Deborah
   Monteiro Torres, Pedro Henrique
   Mir, Daiana
   Paulo Vicente, Ana Carolina
   Ramos Guimaraes, Ana Carolina
   Caffarena, Ernesto Raul
   Bello, Gonzalo
   Lourenco-de-Oliveira, Ricardo
   Bonaldo, Myrna Cristina
TI Genomic and structural features of the yellow fever virus from the
   2016-2017 Brazilian outbreak
SO JOURNAL OF GENERAL VIROLOGY
LA English
DT Article
DE yellow fever virus; 2016-2017 Brazilian outbreak; amino acid changes;
   genetic diversity; evolution
ID NS2B-NS3 PROTEASE; MOSAIC STRUCTURE; ZIKA VIRUS; NS3; RECOMBINATION;
   EMERGENCE; PROTEINS; ELECTROSTATICS; EVOLUTIONARY; PROTECTION
AB Southeastern Brazil has been suffering a rapid expansion of a severe sylvatic yellow fever virus (YFV) outbreak since late 2016, which has reached one of the most populated zones in Brazil and South America, heretofore a yellow fever-free zone for more than 70 years. In the current study, we describe the complete genome of 12 YFV samples from mosquitoes, humans and non-human primates from the Brazilian 2017 epidemic. All of the YFV sequences belong to the modern lineage (sub-lineage 1E) of South American genotype I, having been circulating for several months prior to the December 2016 detection. Our data confirm that viral strains associated with the most severe YF epidemic in South America in the last 70 years display unique amino acid substitutions that are mainly located in highly conserved positions in non-structural proteins. Our data also corroborate that YFV has spread southward into Rio de Janeiro state following two main sylvatic dispersion routes that converged at the border of the great metropolitan area comprising nearly 12 million unvaccinated inhabitants. Our original results can help public health authorities to guide the surveillance, prophylaxis and control measures required to face such a severe epidemiological problem. Finally, it will also inspire other workers to further investigate the epidemiological and biological significance of the amino acid polymorphisms detected in the Brazilian 2017 YFV strains.
C1 [Gomez, Mariela Martinez; Cunha dos Santos, Alexandre Araujo; de Mello, Iasmim Silva; Santos, Marta Pereira; Ribeiro, Ieda Pereira; Bonaldo, Myrna Cristina] Fundacao Oswaldo Cruz, Inst Oswaldo Cruz, Lab Biol Mol Flavivirus, Rio De Janeiro, Brazil.
   [Santos de Abreu, Filipe Vieira; Ferreira-de-Brito, Anielly; de Miranda, Rafaella Moraes; de Castro, Marcia Goncalves; Lourenco-de-Oliveira, Ricardo] Fundacao Oswaldo Cruz, Inst Oswaldo Cruz, Lab Mosquitos Transmissores Hematozoarios, Rio De Janeiro, Brazil.
   [Santos de Abreu, Filipe Vieira] Inst Fed Norte Minas Gerais, Salinas, MG, Brazil.
   [Ribeiro, Mario Sergio] Secretaria Estadual Saude, Superintendencia Vigilancia Epidemiol & Ambiental, Rio De Janeiro, Brazil.
   [Laterriere Junior, Roberto da Costa] Secretaria Estadual Saude Espirito Santo, Nucleo Especial Vigilancia Ambiental, Vitoria, Brazil.
   [Aguiar, Shirlei Ferreira; Silva Meira, Guilherme Louzada] Lab Cent Saude Publ Noel Nutels LACEN RJ, Rio De Janeiro, Brazil.
   [Antunes, Deborah; Monteiro Torres, Pedro Henrique; Caffarena, Ernesto Raul] Fundacao Oswaldo Cruz, Programa Computacao Cient PROCC, Rio De Janeiro, Brazil.
   [Mir, Daiana; Bello, Gonzalo] Fundacao Oswaldo Cruz, Inst Oswaldo Cruz, Lab AIDS Imunol Mol, Rio De Janeiro, Brazil.
   [Paulo Vicente, Ana Carolina] Fundacao Oswaldo Cruz, Inst Oswaldo Cruz, Lab Genet Mol Microorganismos, Rio De Janeiro, Brazil.
   [Ramos Guimaraes, Ana Carolina] Fundacao Oswaldo Cruz, Inst Oswaldo Cruz, Lab Genom Func & Bioinformat, Rio De Janeiro, Brazil.
RP Bonaldo, MC (corresponding author), Fundacao Oswaldo Cruz, Inst Oswaldo Cruz, Lab Biol Mol Flavivirus, Rio De Janeiro, Brazil.; Lourenco-de-Oliveira, R (corresponding author), Fundacao Oswaldo Cruz, Inst Oswaldo Cruz, Lab Mosquitos Transmissores Hematozoarios, Rio De Janeiro, Brazil.
EM lourenco@ioc.fiocruz; mbonaldo@ioc.fiocruz.br
RI , daiana/J-5515-2019; Caffarena, Ernesto R/G-4467-2011; Torres, Pedro
   Henrique Monteiro/C-7657-2015; Guimaraes, Ana Carolina
   Ramos/P-7914-2018; Antunes, Deborah/O-2505-2019; Antunes,
   Deborah/P-5615-2018; Caffarena, Ernesto/O-5920-2019; Bello,
   Gonzalo/E-6842-2013
OI , daiana/0000-0002-3172-4867; Caffarena, Ernesto R/0000-0002-8353-3034;
   Torres, Pedro Henrique Monteiro/0000-0002-0945-1495; Guimaraes, Ana
   Carolina Ramos/0000-0003-1260-543X; Antunes,
   Deborah/0000-0002-2927-0800; Antunes, Deborah/0000-0002-2927-0800;
   Caffarena, Ernesto/0000-0002-8353-3034; Ribeiro, Ivonizete
   Pires/0000-0003-0737-5430
FU Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio de
   Janeiro [E-26/102.351/2013, E-26/201.335/2016]; Conselho Nacional
   Desenvolvimento Cientifico e TecnologicoNational Council for Scientific
   and Technological Development (CNPq) [309577/2013-6, 440865/2016-6];
   Coordenacao de Aperfeicoamento de Pessoal de Nivel SuperiorCAPES
   [88881130684/2016-00]; Institut Pasteur, Transversal Research Program
   (PTR) [528]
FX This work was funded by Fundacao Carlos Chagas Filho de Amparo a
   Pesquisa do Estado do Rio de Janeiro (grants nos E-26/102.351/2013 and
   E-26/201.335/2016 to R.L.O.), Conselho Nacional Desenvolvimento
   Cientifico e Tecnologico [grants nos 309577/2013-6 (to R.L.O.) and
   440865/2016-6 (to M.C.B.)], Coordenacao de Aperfeicoamento de Pessoal de
   Nivel Superior (grant no. 88881130684/2016-00 to M.C.B.) and the
   Institut Pasteur, Transversal Research Program (PTR grant no. 528 to
   R.L.O.). The funders had no role in study design, data collection and
   analysis, decision to publish, or preparation of the manuscript.
CR Abraham Mark James, 2015, SoftwareX, V1-2, P19, DOI 10.1016/j.softx.2015.06.001
   Baele G, 2012, MOL BIOL EVOL, V29, P2157, DOI 10.1093/molbev/mss084
   Baker NA, 2001, P NATL ACAD SCI USA, V98, P10037, DOI 10.1073/pnas.181342398
   Barnett ED, 2007, CLIN INFECT DIS, V44, P850, DOI 10.1086/511869
   Beasley DWC, 2015, ANTIVIR RES, V115, P48, DOI 10.1016/j.antiviral.2014.12.010
   Benkert P, 2009, NUCLEIC ACIDS RES, V37, pW510, DOI 10.1093/nar/gkp322
   Bonaldo MC, 2017, MEM I OSWALDO CRUZ, V112, P447, DOI 10.1590/0074-02760170134
   Bond CS, 2009, ACTA CRYSTALLOGR D, V65, P510, DOI 10.1107/S0907444909007835
   Boni MF, 2007, GENETICS, V176, P1035, DOI 10.1534/genetics.106.068874
   Bryant JE, 2007, PLOS PATHOG, V3, P668, DOI 10.1371/journal.ppat.0030075
   Carpp LN, 2011, MICROBES INFECT, V13, P85, DOI 10.1016/j.micinf.2010.10.010
   Carrington CVF, 2013, INFECT GENET EVOL, V13, P198, DOI 10.1016/j.meegid.2012.08.015
   CAUSEY OR, 1950, AM J TROP MED, V30, P301
   Coffey LL, 2013, FUTURE MICROBIOL, V8, P155, DOI [10.2217/FMB.12.139, 10.2217/fmb.12.139]
   Consoli RAGB, 1994, PRINCIPAIS MOSQUITOS
   Couto-Lima D, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-05186-3
   Cumberworth SL, 2017, CELL MICROBIOL, V19, DOI 10.1111/cmi.12737
   de Souza RP, 2010, J MED VIROL, V82, P175, DOI 10.1002/jmv.21606
   Tommaso P, 2011, NUCLEIC ACIDS RES, V39, pW13, DOI 10.1093/nar/gkr245
   Dolinsky TJ, 2004, NUCLEIC ACIDS RES, V32, pW665, DOI 10.1093/nar/gkh381
   Dorigatti I, 2017, EUROSURVEILLANCE, V22, P10, DOI 10.2807/1560-7917.ES.2017.22.28.30572
   Drummond AJ, 2005, MOL BIOL EVOL, V22, P1185, DOI 10.1093/molbev/msi103
   Drummond AJ, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-214
   Drummond AJ, 2006, PLOS BIOL, V4, P699, DOI 10.1371/journal.pbio.0040088
   Drummond AJ, 2012, MOL BIOL EVOL, V29, P1969, DOI 10.1093/molbev/mss075
   Environment BMot, 2017, MON BIOM
   FELSENSTEIN J, 1985, EVOLUTION, V39, P783, DOI 10.1111/j.1558-5646.1985.tb00420.x
   Ferreira-de-Brito A, 2016, MEM I OSWALDO CRUZ, V111, P655, DOI 10.1590/0074-02760160332
   Fioravanti C., 2018, REV PESQUISA FAPESP
   Gibbs MJ, 2000, BIOINFORMATICS, V16, P573, DOI 10.1093/bioinformatics/16.7.573
   Health BMo, 2017, EM EP FEBR AM NO BRA
   (IBGE) BIoGaS, 2017, MAPAS
   Jung L, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0129789
   KIMURA M, 1980, J MOL EVOL, V16, P111, DOI 10.1007/BF01731581
   Kong GH, 2015, PLOS PATHOG, V11, DOI 10.1371/journal.ppat.1005139
   Le Breton M, 2011, BMC MICROBIOL, V11, DOI 10.1186/1471-2180-11-234
   Lemey P, 2010, MOL BIOL EVOL, V27, P1877, DOI 10.1093/molbev/msq067
   Lim SP, 2013, J BIOL CHEM, V288, P31105, DOI 10.1074/jbc.M113.508606
   Lindorff-Larsen K, 2010, PROTEINS, V78, P1950, DOI 10.1002/prot.22711
   Lu GL, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003549
   Luo DH, 2015, ANTIVIR RES, V118, P148, DOI 10.1016/j.antiviral.2015.03.014
   Martin D, 2000, BIOINFORMATICS, V16, P562, DOI 10.1093/bioinformatics/16.6.562
   Martin DP, 2015, VIRUS EVOL, V1, DOI 10.1093/ve/vev003
   Martin DP, 2005, AIDS RES HUM RETROV, V21, P98, DOI 10.1089/aid.2005.21.98
   Romano APM, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002740
   Mathew A, 2014, FUTURE MICROBIOL, V9, P411, DOI 10.2217/fmb.13.171
   Mir D, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-07873-7
   Monath TP, 2015, J CLIN VIROL, V64, P160, DOI 10.1016/j.jcv.2014.08.030
   Mutebi JP, 2001, J VIROL, V75, P6999, DOI 10.1128/JVI.75.15.6999-7008.2001
   Nunes MRT, 2012, J VIROL, V86, P13263, DOI 10.1128/JVI.00565-12
   Padidam M, 1999, VIROLOGY, V265, P218, DOI 10.1006/viro.1999.0056
   Pan American Health Organization, 2017, EP UPD YELL FEV
   Patkar CG, 2008, J VIROL, V82, P3342, DOI 10.1128/JVI.02447-07
   Phoo WW, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms13410
   Posada D, 2001, P NATL ACAD SCI USA, V98, P13757, DOI 10.1073/pnas.241370698
   SAITOU N, 1987, MOL BIOL EVOL, V4, P406, DOI 10.1093/oxfordjournals.molbev.a040454
   SCHLESINGER JJ, 1993, VIROLOGY, V192, P132, DOI 10.1006/viro.1993.1015
   SMITH JM, 1992, J MOL EVOL, V34, P126
   Staples JE, 2008, JAMA-J AM MED ASSOC, V300, P960, DOI 10.1001/jama.300.8.960
   Suchard MA, 2009, BIOINFORMATICS, V25, P1370, DOI 10.1093/bioinformatics/btp244
   Teramoto T, 2017, J BIOL CHEM, V292, P9465, DOI [10.1074/jbc.M117.775643, 10.1074/jbc.m117.775643]
   Tsetsarkin KA, 2011, P NATL ACAD SCI USA, V108, P7872, DOI 10.1073/pnas.1018344108
   Vasconcelos PFC, 2016, VECTOR-BORNE ZOONOT, V16, P566, DOI 10.1089/vbz.2016.2031
   Vasconcelos PFC, 2004, EMERG INFECT DIS, V10, P1578, DOI 10.3201/eid1009.040197
   Weaver SC, 2010, ANTIVIR RES, V85, P328, DOI 10.1016/j.antiviral.2009.10.008
   Webb B, 2014, METHODS MOL BIOL, V1137, P1, DOI 10.1007/978-1-4939-0366-5_1
   Wu JH, 2005, J VIROL, V79, P10268, DOI 10.1128/JVI.79.16.10268-10277.2005
   Wu RH, 2017, J VIROL, V91, DOI [10.1128/JVI.01836-16, 10.1128/jvi.01836-16]
   Zou J, 2015, J VIROL, V89, P3471, DOI 10.1128/JVI.03454-14
NR 69
TC 17
Z9 17
U1 0
U2 3
PU MICROBIOLOGY SOC
PI LONDON
PA CHARLES DARWIN HOUSE, 12 ROGER ST, LONDON WC1N 2JU, ERKS, ENGLAND
SN 0022-1317
EI 1465-2099
J9 J GEN VIROL
JI J. Gen. Virol.
PD APR
PY 2018
VL 99
IS 4
BP 536
EP 548
DI 10.1099/jgv.0.001033
PG 13
WC Biotechnology & Applied Microbiology; Virology
SC Biotechnology & Applied Microbiology; Virology
GA GE2CH
UT WOS:000431022600011
PM 29469689
OA Bronze
DA 2020-12-01
ER

PT J
AU Martins, MA
   Tully, DC
   Shin, YC
   Gonzalez-Nieto, L
   Weisgrau, KL
   Bean, DJ
   Gadgil, R
   Gutman, MJ
   Domingues, A
   Maxwell, HS
   Magnani, DM
   Ricciardi, M
   Pedreno-Lopez, N
   Bailey, V
   Cruz, MA
   Lima, NS
   Bonaldo, MC
   Altman, JD
   Rakasz, E
   Capuano, S
   Reimann, KA
   Piatak, M
   Lifson, JD
   Desrosiers, RC
   Allen, TM
   Watkins, DI
AF Martins, Mauricio A.
   Tully, Damien C.
   Shin, Young C.
   Gonzalez-Nieto, Lucas
   Weisgrau, Kim L.
   Bean, David J.
   Gadgil, Rujuta
   Gutman, Martin J.
   Domingues, Aline
   Maxwell, Helen S.
   Magnani, Diogo M.
   Ricciardi, Michael
   Pedreno-Lopez, Nuria
   Bailey, Varian
   Cruz, Michael A.
   Lima, Noemia S.
   Bonaldo, Myrna C.
   Altman, John D.
   Rakasz, Eva
   Capuano, Saverio, III
   Reimann, Keith A.
   Piatak, Michael, Jr.
   Lifson, Jeffrey D.
   Desrosiers, Ronald C.
   Allen, Todd M.
   Watkins, David I.
TI Rare Control of SIVmac239 Infection in a Vaccinated Rhesus Macaque
SO AIDS RESEARCH AND HUMAN RETROVIRUSES
LA English
DT Article
DE SIV vaccine; lymphocyte depletion; nonhuman primate; HIV/AIDS
ID SIMIAN IMMUNODEFICIENCY VIRUS; T-CELL RESPONSES; NATURAL-KILLER-CELLS;
   HIGHLY PATHOGENIC SIV; LONG-TERM SURVIVOR; IN-VIVO; NEF GENE;
   MONOCLONAL-ANTIBODY; IMMUNE-RESPONSES; NONHUMAN PRIMATE
AB Effector memory T cell (T-EM) responses display potent antiviral properties and have been linked to stringent control of simian immunodeficiency virus (SIV) replication. Since recurrent antigen stimulation drives the differentiation of CD8(+) T cells toward the T-EM phenotype, in this study we incorporated a persistent herpesviral vector into a heterologous prime/boost/boost vaccine approach to maximize the induction of T-EM responses. This new regimen resulted in CD8(+) T-EM-biased responses in four rhesus macaques, three of which controlled viral replication to < 1,000 viral RNA copies/ml of plasma for more than 6 months after infection with SIV-mac239. Over the course of this study, we made a series of interesting observations in one of these successful controller animals. Indeed, in vivo elimination of CD8 alpha beta(+) T cells using a new CD8 beta-depleting antibody did not abrogate virologic control in this monkey. Only after its CD8 alpha(+) lymphocytes were depleted did SIV rebound, suggesting that CD8 alpha alpha(+) but not CD8 alpha beta(+) cells were controlling viral replication. By 2 weeks postinfection (PI), the only SIV sequences that could be detected in this animal harbored a small in-frame deletion in nef affecting six amino acids. Deep sequencing of the SIVmac239 challenge stock revealed no evidence of this polymorphism. However, sequencing of the rebound virus following CD8 alpha depletion at week 38.4 PI again revealed only the six-amino acid deletion in nef. While any role for immunological pressure on the selection of this deleted variant remains uncertain, our data provide anecdotal evidence that control of SIV replication can be maintained without an intact CD8 alpha beta(+) T cell compartment.
C1 [Martins, Mauricio A.; Shin, Young C.; Gonzalez-Nieto, Lucas; Gutman, Martin J.; Domingues, Aline; Maxwell, Helen S.; Magnani, Diogo M.; Ricciardi, Michael; Pedreno-Lopez, Nuria; Bailey, Varian; Cruz, Michael A.; Desrosiers, Ronald C.; Watkins, David I.] Univ Miami, Dept Pathol, Life Sci Tech Pk,1951 NW 7th Ave,Room 2340, Miami, FL 33136 USA.
   [Tully, Damien C.; Bean, David J.; Gadgil, Rujuta; Allen, Todd M.] Ragon Inst MGH MIT & Harvard, Cambridge, MA USA.
   [Weisgrau, Kim L.; Rakasz, Eva; Capuano, Saverio, III] Univ Wisconsin Madison, Wisconsin Natl Primate Res Ctr, Madison, WI USA.
   [Lima, Noemia S.; Bonaldo, Myrna C.] Fiocruz MS, Inst Oswaldo Cruz, Lab Biol Mol Flavivirus, Rio De Janeiro, Brazil.
   [Altman, John D.] Emory Univ, Dept Microbiol & Immunol, Atlanta, GA USA.
   [Reimann, Keith A.] Univ Massachusetts, Sch Med, MassBiol, Boston, MA USA.
   [Piatak, Michael, Jr.; Lifson, Jeffrey D.] Leidos Biomed Res Inc, AIDS & Canc Virus Program, Frederick Natl Lab Canc Res, Frederick, MD USA.
RP Watkins, DI (corresponding author), Univ Miami, Dept Pathol, Life Sci Tech Pk,1951 NW 7th Ave,Room 2340, Miami, FL 33136 USA.
EM dwatkins@med.miami.edu
RI Rakasz, Eva G/H-9197-2019; Martins, Mauricio/AAU-9226-2020
OI Martins, Mauricio/0000-0001-8336-216X; Magnani,
   Diogo/0000-0002-1773-2406; Bean, David/0000-0001-7497-8026; Allen,
   Todd/0000-0002-6609-1318; Tully, Damien/0000-0002-7620-9340
FU Public Health ServiceUnited States Public Health Service [R37AI052056];
   National Cancer Institute, National Institutes of HealthUnited States
   Department of Health & Human ServicesNational Institutes of Health (NIH)
   - USANIH National Cancer Institute (NCI) [HHSN261200800001E]; National
   Institute of Allergy and Infectious DiseasesUnited States Department of
   Health & Human ServicesNational Institutes of Health (NIH) - USANIH
   National Institute of Allergy & Infectious Diseases (NIAID) [P01
   AI074415]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASESUnited
   States Department of Health & Human ServicesNational Institutes of
   Health (NIH) - USANIH National Institute of Allergy & Infectious
   Diseases (NIAID) [P01AI074415, R37AI052056, R37AI063928, P01AI074415,
   P01AI074415, P01AI074415, P01AI074415, R37AI063928, R37AI063928,
   P01AI074415, R37AI052056, P01AI074415, P01AI074415, P01AI074415,
   P01AI074415, R37AI052056, R37AI052056, P01AI074415, P01AI074415,
   R37AI052056, P01AI074415, P01AI074415, P01AI074415, R37AI063928,
   P01AI074415, P01AI074415, P01AI074415, P01AI074415, P01AI074415,
   P01AI074415, P01AI074415, P01AI074415, P01AI074415, R37AI063928,
   P01AI074415, R37AI063928, P01AI074415, P01AI074415, P01AI074415,
   P01AI074415, P01AI074415, R37AI052056, P01AI074415, P01AI074415,
   P01AI074415, R37AI052056, R37AI063928, P01AI074415, P01AI074415,
   R37AI052056, R37AI052056, P01AI074415, R37AI052056, P01AI074415,
   P01AI074415, P01AI074415, R37AI052056, P01AI074415, P01AI074415,
   R37AI063928, P01AI074415, P01AI074415] Funding Source: NIH RePORTER;
   OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTHUnited States
   Department of Health & Human ServicesNational Institutes of Health (NIH)
   - USA [R24OD010976, P51OD011132, P51OD011132, R24OD010976, P51OD011132,
   P51OD011132, R24OD010976, R24OD010976, P51OD011132, R24OD010976,
   R24OD010976, P51OD011132, P51OD011132, P51OD011132, P51OD011132,
   P51OD011132, R24OD010976] Funding Source: NIH RePORTER
FX The authors are grateful to Brandon Keele for helpful comments on this
   article and to Dr. Elizabeth Connick for quantifying SIV-producing cells
   in lymph node biopsies by in situ hybridization. The authors also thank
   Rebecca Shoemaker, Nicholas Pomplun, Jessica Furlott, Randy Fast, Kelli
   Oswald, Marlon Veloso de Santana, and William Lauer for technical
   support. The authors also wish to acknowledge Eric Peterson, Kristin
   Crosno, and Kevin Brunner for providing excellent care of the rhesus
   macaques used in this experiment; Teresa Maidana Giret for confirming
   the MHC class I genotype of the monkeys in this study; Leydi Guzman for
   administrative assistance; and Christopher Parks for facilitating the
   electroporated rDNA vaccinations used in this study. This work was
   funded by Public Health Service grant R37AI052056 to D.I.W. and was
   supported, in part, by federal funds from the National Cancer Institute,
   National Institutes of Health, under contract no. HHSN261200800001E and
   from the National Institute of Allergy and Infectious Diseases through
   P01 AI074415 (T.M.A.). The funders had no role in study design, data
   collection, and interpretation or the decision to submit the work for
   publication. The mAbs used in the in vivo lymphocyte depletions were
   produced by the NIH Nonhuman Primate Reagent Resource (OD010976 and
   HHSN2722001300031C, K.A.R.).
CR Alexander L, 2000, J VIROL, V74, P4361, DOI 10.1128/JVI.74.9.4361-4376.2000
   Alexander L, 2002, J VIROL, V76, P10533, DOI 10.1128/JVI.76.20.10533-10539.2002
   Allen TM, 2005, J VIROL, V79, P13239, DOI 10.1128/JVI.79.21.13239-13249.2005
   Allen TM, 1998, J IMMUNOL, V160, P6062
   Alter G, 2011, NATURE, V476, P96, DOI 10.1038/nature10237
   Barouch DH, 2010, CURR OPIN HIV AIDS, V5, P386, DOI 10.1097/COH.0b013e32833cfe4c
   Bilello JP, 2011, J VIROL, V85, P12708, DOI 10.1128/JVI.00865-11
   Bilello JP, 2006, J VIROL, V80, P1549, DOI 10.1128/JVI.80.3.1549-1562.2006
   Bimber BN, 2010, J VIROL, V84, P12087, DOI 10.1128/JVI.01378-10
   Bosselut R, 2000, IMMUNITY, V12, P409, DOI 10.1016/S1074-7613(00)80193-4
   Buchbinder SP, 2008, LANCET, V372, P1881, DOI 10.1016/S0140-6736(08)61591-3
   Carl S, 1999, J VIROL, V73, P2790, DOI 10.1128/JVI.73.4.2790-2797.1999
   Carlson JM, 2012, J VIROL, V86, P13202, DOI 10.1128/JVI.01998-12
   Casimiro DR, 2005, J VIROL, V79, P15547, DOI 10.1128/JVI.79.24.15547-15555.2005
   Cheroutre H, 2004, ANNU REV IMMUNOL, V22, P217, DOI 10.1146/annurev.immunol.22.012703.104522
   Cheroutre H, 2011, NAT REV IMMUNOL, V11, P445, DOI 10.1038/nri3007
   Choi EI, 2008, IMMUNOLOGY, V124, P215, DOI 10.1111/j.1365-2567.2007.02757.x
   Choi EI, 2008, J VIROL, V82, P6758, DOI 10.1128/JVI.02277-07
   Cline AN, 2005, J MED PRIMATOL, V34, P303
   Cranage MP, 1998, J GEN VIROL, V79, P1935, DOI 10.1099/0022-1317-79-8-1935
   Cranage MP, 1997, VIROLOGY, V229, P143, DOI 10.1006/viro.1996.8419
   Damania B, 2001, PHILOS T ROY SOC B, V356, P535, DOI 10.1098/rstb.2000.0782
   DANIEL MD, 1992, SCIENCE, V258, P1938, DOI 10.1126/science.1470917
   DEACON NJ, 1995, SCIENCE, V270, P988, DOI 10.1126/science.270.5238.988
   Del Prete GQ, 2013, J VIROL, V87, P4584, DOI 10.1128/JVI.03507-12
   Desrosiers RC, 1997, J VIROL, V71, P9764, DOI 10.1128/JVI.71.12.9764-9769.1997
   Excler JL, 2010, BIOLOGICALS, V38, P511, DOI 10.1016/j.biologicals.2010.03.005
   Friedrich TC, 2007, J VIROL, V81, P3465, DOI 10.1128/JVI.02392-06
   Fukazawa Y, 2012, NAT MED, V18, P1673, DOI 10.1038/nm.2934
   Garcia KC, 1996, NATURE, V384, P577, DOI 10.1038/384577a0
   Gonzalez-Nieto L, 2016, JOVE-J VIS EXP, P118
   Gray GE, 2011, LANCET INFECT DIS, V11, P507, DOI 10.1016/S1473-3099(11)70098-6
   Hammer SM, 2013, NEW ENGL J MED, V369, P2083, DOI 10.1056/NEJMoa1310566
   Hansen SG, 2016, SCIENCE, V351, P714, DOI 10.1126/science.aac9475
   Hansen SG, 2013, NATURE, V502, P100, DOI 10.1038/nature12519
   Hansen SG, 2011, NATURE, V473, P523, DOI 10.1038/nature10003
   Hansen SG, 2009, NAT MED, V15, P293, DOI 10.1038/nm.1935
   Hansen SG, CYTOMEGALOVIRUS VECT
   Hel Z, 2006, J IMMUNOL, V176, P85, DOI 10.4049/jimmunol.176.1.85
   Hel Z, 2002, J IMMUNOL, V169, P4778, DOI 10.4049/jimmunol.169.9.4778
   Henn MR, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002529
   Holzemer A, 2015, PLOS MED, V12, DOI 10.1371/journal.pmed.1001900
   Jin X, 1999, J EXP MED, V189, P991, DOI 10.1084/jem.189.6.991
   Jost S, 2012, MICROBES INFECT, V14, P904, DOI 10.1016/j.micinf.2012.05.001
   Kern P, 1999, J BIOL CHEM, V274, P27237, DOI 10.1074/jbc.274.38.27237
   KESTLER HW, 1991, CELL, V65, P651, DOI 10.1016/0092-8674(91)90097-I
   Kiepiela P, 2007, NAT MED, V13, P46, DOI 10.1038/nm1520
   KIRCHHOFF F, 1994, J VIROL, V68, P2031, DOI 10.1128/JVI.68.3.2031-2037.1994
   KIRCHHOFF F, 1995, NEW ENGL J MED, V332, P228, DOI 10.1056/NEJM199501263320405
   Klein F, 2014, J EXP MED, V211, P2361, DOI 10.1084/jem.20141050
   KOUP RA, 1994, J VIROL, V68, P4650, DOI 10.1128/JVI.68.7.4650-4655.1994
   Lasaro MO, 2011, MOL THER, V19, P417, DOI 10.1038/mt.2010.238
   Liu JY, 2009, NATURE, V457, P87, DOI 10.1038/nature07469
   Loffredo JT, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001152
   Loffredo JT, 2007, J VIROL, V81, P8827, DOI 10.1128/JVI.00895-07
   Loffredo JT, 2006, HIV MOL IMMUNOL, P29
   Madakamutil LT, 2004, SCIENCE, V304, P590, DOI 10.1126/science.1092316
   Mariani R, 1996, J VIROL, V70, P7752, DOI 10.1128/JVI.70.11.7752-7764.1996
   Martins MA, 2015, J VIROL, V89, P10802, DOI 10.1128/JVI.01440-15
   Martins MA, 2014, J VIROL, V88, P7493, DOI 10.1128/JVI.00601-14
   Masopust D, 2006, J IMMUNOL, V177, P831, DOI 10.4049/jimmunol.177.2.831
   Masopust D, 2013, NAT REV IMMUNOL, V13, P309, DOI 10.1038/nri3442
   Masopust D, 2012, J IMMUNOL, V188, P5811, DOI 10.4049/jimmunol.1102695
   Matano T, 1998, J VIROL, V72, P164, DOI 10.1128/JVI.72.1.164-169.1998
   Mudd PA, 2012, NATURE, V491, P129, DOI 10.1038/nature11443
   Okoye A, 2009, J EXP MED, V206, P1575, DOI 10.1084/jem.20090356
   Pantaleo G, 2010, CURR OPIN HIV AIDS, V5, P391, DOI 10.1097/COH.0b013e32833d1e87
   Parham P, 2009, GARLAND SCI, P125
   PATHAK VK, 1990, P NATL ACAD SCI USA, V87, P6024, DOI 10.1073/pnas.87.16.6024
   Pellett P, 2013, FIELDS VIROLOGY, V2, P1802
   PULSINELLI GA, 1991, J VIROL, V65, P4786, DOI 10.1128/JVI.65.9.4786-4797.1991
   Reeves RK, 2010, BLOOD, V115, P4439, DOI 10.1182/blood-2010-01-265595
   RUD EW, 1994, J GEN VIROL, V75, P529, DOI 10.1099/0022-1317-75-3-529
   RUD EW, 1992, VACCINES 92 : MODERN APPROACHES TO NEW VACCINES INCLUDING PREVENTION OF AIDS, P229
   Sardesai NY, 2011, CURR OPIN IMMUNOL, V23, P421, DOI 10.1016/j.coi.2011.03.008
   Schmitz JE, 1998, BLOOD, V92, P198, DOI 10.1182/blood.V92.1.198.413k13_198_206
   Schmitz JE, 1999, SCIENCE, V283, P857, DOI 10.1126/science.283.5403.857
   Schmitz JE, 1999, AM J PATHOL, V154, P1923, DOI 10.1016/S0002-9440(10)65450-8
   Scully E, 2016, CURR HIV-AIDS REP, V13, P85, DOI 10.1007/s11904-016-0310-3
   Sharpe SA, 1997, J GEN VIROL, V78, P1923, DOI 10.1099/0022-1317-78-8-1923
   Thompson EA, 2016, J IMMUNOL, V196, P3054, DOI 10.4049/jimmunol.1501797
   Torti N, 2012, VIRUSES-BASEL, V4, P1116, DOI 10.3390/v4071116
   Webster RL, 2005, IMMUNOLOGY, V115, P206, DOI 10.1111/j.1365-2567.2005.02147.x
   Wyer JR, 1999, IMMUNITY, V10, P219, DOI 10.1016/S1074-7613(00)80022-9
   Yang X, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-674
   Yang X, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-475
   Zhu J, 2013, NATURE, V497, P494, DOI 10.1038/nature12110
NR 87
TC 7
Z9 7
U1 1
U2 6
PU MARY ANN LIEBERT, INC
PI NEW ROCHELLE
PA 140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA
SN 0889-2229
EI 1931-8405
J9 AIDS RES HUM RETROV
JI Aids Res. Hum. Retrovir.
PD AUG
PY 2017
VL 33
IS 8
SI SI
BP 843
EP 858
DI 10.1089/aid.2017.0046
PG 16
WC Immunology; Infectious Diseases; Virology
SC Immunology; Infectious Diseases; Virology
GA FD0DN
UT WOS:000407210100013
PM 28503929
OA Green Published
DA 2020-12-01
ER

PT J
AU Fernandes, RS
   Campos, SS
   Ribeiro, PS
   Raphael, LMS
   Bonaldo, MC
   Lourenco-de-Oliveira, R
AF Fernandes, Rosilainy Surubi
   Campos, Stephanie Silva
   Ribeiro, Paulino Siqueira
   Raphael, Lidiane M. S.
   Bonaldo, Myrna C.
   Lourenco-de-Oliveira, Ricardo
TI Culex quinquefasciatus from areas with the highest incidence of
   microcephaly associated with Zika virus infections in the Northeast
   Region of Brazil are refractory to the virus
SO MEMORIAS DO INSTITUTO OSWALDO CRUZ
LA English
DT Article
DE Culex quinquefasciatus; Zika virus; vector competence; Brazil
ID TRANSMISSION
AB Zika virus (ZIKV) is widely distributed in Brazil and the Northeast Region (NE) is the most affected zone, showing the highest incidence of microcephaly associated with ZIKV congenital infections worldwide. We report attempts to infect three populations of Culex quinquefasciatus from severely affected sites in the NE and Southeast Region (SE) of Brazil with three strains of ZIKV isolated from these localities. An Aedes aegypti population from the SE was used as a positive control. All tested Cx. quinquefasciatus populations were refractory to the ZIKV isolates. For these reasons, we believe Cx. quinquefasciatus should not be considered a potential vector of ZIKV in Brazil.
C1 [Fernandes, Rosilainy Surubi; Campos, Stephanie Silva; Ribeiro, Paulino Siqueira; Lourenco-de-Oliveira, Ricardo] Fundacao Oswaldo Cruz, Inst Oswaldo Cruz, Lab Mosquitos Transmissores Hematozoarios, Rio De Janeiro, RJ, Brazil.
   [Raphael, Lidiane M. S.; Bonaldo, Myrna C.] Fundacao Oswaldo Cruz, Inst Oswaldo Cruz, Lab Biol Mol Flavivirus, Rio De Janeiro, RJ, Brazil.
RP Lourenco-de-Oliveira, R (corresponding author), Fundacao Oswaldo Cruz, Inst Oswaldo Cruz, Lab Mosquitos Transmissores Hematozoarios, Rio De Janeiro, RJ, Brazil.
EM lourenco@ioc.fiocruz.br
FU European Union's Horizon 2020 Research and Innovation Programme
   (ZIKAlliance) [734548]; CAPES-COFECUBCAPES [799/14]; FAPERJCarlos Chagas
   Filho Foundation for Research Support of the State of Rio de Janeiro
   (FAPERJ) [E-26/102.351/2013, E-26/201.335/2016]; CNPqNational Council
   for Scientific and Technological Development (CNPq) [309577/2013-6];
   NIHUnited States Department of Health & Human ServicesNational
   Institutes of Health (NIH) - USA [1UO1 AI115595-01]; NATIONAL INSTITUTE
   OF ALLERGY AND INFECTIOUS DISEASESUnited States Department of Health &
   Human ServicesNational Institutes of Health (NIH) - USANIH National
   Institute of Allergy & Infectious Diseases (NIAID) [U01AI115595,
   U01AI115595, U01AI115595, U01AI115595, U01AI115595, U01AI115595] Funding
   Source: NIH RePORTER
FX European Union's Horizon 2020 Research and Innovation Programme
   (ZIKAlliance 734548), CAPES-COFECUB (799/14), FAPERJ (E-26/102.351/2013,
   E-26/201.335/2016), CNPq (309577/2013-6), NIH (1UO1 AI115595-01). The
   funders had no role in the study design, data collection, and analysis,
   decision to publish or preparation of the manuscript.
CR Amraoui F, 2016, EUROSURVEILLANCE, V21, P2, DOI 10.2807/1560-7917.ES.2016.21.35.30333
   Bonaldo MC, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004816
   Donald CL, 2016, PLOS NEGLECT TROP D, V10, P1, DOI DOI 10.1371/J0URNAL.PNTD.0005048
   Faria NR, 2016, SCIENCE, V352, P345, DOI 10.1126/science.aaf5036
   Fernandes RS, 2016, PLOS NEGLECT TROP D, V10, P1, DOI DOI 10.1371/J0URNAL.PNTD.0004993
   Ferreira-de-Brito A, 2016, MEM I OSWALDO CRUZ, V111, P655, DOI 10.1590/0074-02760160332
   Guo XX, 2016, EMERG MICROBES INFEC, V5, DOI 10.1038/emi.2016.102
   Hall-Mendelin S, 2016, PLOS NEGLECT TROP D, V10, P1
   Hart CE, 2017, EMERG INFECT DIS, V23, P559, DOI 10.3201/eid2303.161636
   Lambrechts L, 2011, TRENDS PARASITOL, V27, P111, DOI 10.1016/j.pt.2010.12.001
   Liu Z, 2017, EMERG INFECT DIS, V23
   Possas C, 2017, MEM I OSWALDO CRUZ, V112, P319, DOI 10.1590/0074-02760160510
   Tabachnick WJ, 2013, INT J ENV RES PUB HE, V10, P249, DOI 10.3390/ijerph10010249
   Weger-Lucarelli J, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0005101
   Zanluca C, 2015, MEM I OSWALDO CRUZ, V110, P569, DOI 10.1590/0074-02760150192
NR 15
TC 19
Z9 20
U1 0
U2 7
PU FUNDACO OSWALDO CRUZ
PI RIO DE JANEIRO, RJ
PA AV BRASIL 4365, 21045-900 RIO DE JANEIRO, RJ, BRAZIL
SN 0074-0276
EI 1678-8060
J9 MEM I OSWALDO CRUZ
JI Mem. Inst. Oswaldo Cruz
PD AUG
PY 2017
VL 112
IS 8
BP 577
EP 579
DI 10.1590/0074-02760170145
PG 3
WC Parasitology; Tropical Medicine
SC Parasitology; Tropical Medicine
GA FC4JY
UT WOS:000406807300009
PM 28767975
OA DOAJ Gold, Green Published
DA 2020-12-01
ER

PT J
AU Bonaldo, MC
   Gomez, MM
   dos Santos, AAC
   de Abreu, FVS
   Ferreira-de-Brito, A
   de Miranda, RM
   de Castro, MG
   Lourenco-de-Oliveira, R
AF Bonaldo, Myrna C.
   Gomez, Mariela Martinez
   dos Santos, Alexandre A. C.
   Santos de Abreu, Filipe Vieira
   Ferreira-de-Brito, Anielly
   de Miranda, Rafaella Moraes
   de Castro, Marcia Goncalves
   Lourenco-de-Oliveira, Ricardo
TI Genome analysis of yellow fever virus of the ongoing outbreak in Brazil
   reveals polymorphisms
SO MEMORIAS DO INSTITUTO OSWALDO CRUZ
LA English
DT Article
DE yellow fever virus; 2017 Brazil outbreak; amino acid changes
AB The current yellow fever outbreak in Brazil is the most severe one in the country in recent times. It has rapidly spread to areas where YF virus (YFV) activity has not been observed for more than 70 years and vaccine coverage is almost null. Here, we sequenced the whole YFV genome of two naturally infected howler-monkeys (Alouatta clamitans) obtained from the Municipality of Domingos Martins, state of Espirito Santo, Brazil. These two ongoing-outbreak genome sequences are identical. They clustered in the 1E sub-clade (South America genotype I) along with the Brazilian and Venezuelan strains recently characterised from infections in humans and non-human primates that have been described in the last 20 years. However, we detected eight unique amino acid changes in the viral proteins, including the structural capsid protein (one change), and the components of the viral replicase complex, the NS3 (two changes) and NS5 (five changes) proteins, that could impact the capacity of viral infection in vertebrate and/or invertebrate hosts and spreading of the ongoing outbreak.
C1 [Bonaldo, Myrna C.; Gomez, Mariela Martinez; dos Santos, Alexandre A. C.] Fundacao Oswaldo Cruz Fiocruz, Inst Oswaldo Cruz, Lab Biol Mol Flavivirus, Rio De Janeiro, RJ, Brazil.
   [Santos de Abreu, Filipe Vieira; Ferreira-de-Brito, Anielly; de Miranda, Rafaella Moraes; de Castro, Marcia Goncalves; Lourenco-de-Oliveira, Ricardo] Fundacao Oswaldo Cruz Fiocruz, Inst Oswaldo Cruz, Lab Mosquitos Transmissores Hematozoarios, Rio De Janeiro, RJ, Brazil.
   [Santos de Abreu, Filipe Vieira] Inst Fed Norte Minas Gerais, Montes Claros, MG, Brazil.
RP Bonaldo, MC (corresponding author), Fundacao Oswaldo Cruz Fiocruz, Inst Oswaldo Cruz, Lab Biol Mol Flavivirus, Rio De Janeiro, RJ, Brazil.
EM mbonaldo@ioc.fiocruz.br
FU FAPERJCarlos Chagas Filho Foundation for Research Support of the State
   of Rio de Janeiro (FAPERJ); CNPqNational Council for Scientific and
   Technological Development (CNPq); CAPESCAPES; FIOCRUZ
FX FAPERJ, CNPq, CAPES, FIOCRUZ
CR Auguste AJ, 2015, EMERG INFECT DIS, V21, P99, DOI 10.3201/eid2101.140814
   Bryant JE, 2007, PLOS PATHOG, V3, P668, DOI 10.1371/journal.ppat.0030075
   COES - Febre Amarela, 2017, 322017 COES
   de Souza RP, 2010, J MED VIROL, V82, P175, DOI 10.1002/jmv.21606
   FELSENSTEIN J, 1985, EVOLUTION, V39, P783, DOI 10.1111/j.1558-5646.1985.tb00420.x
   KIMURA M, 1980, J MOL EVOL, V16, P111, DOI 10.1007/BF01731581
   Kumar S, 2016, MOL BIOL EVOL, V33, P1870, DOI [10.1093/molbev/msw054, 10.1093/molbev/msv279]
   Monath TP, 2015, J CLIN VIROL, V64, P160, DOI 10.1016/j.jcv.2014.08.030
   Nunes MRT, 2012, J VIROL, V86, P13263, DOI 10.1128/JVI.00565-12
   SAITOU N, 1987, MOL BIOL EVOL, V4, P406, DOI 10.1093/oxfordjournals.molbev.a040454
   THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673
   Vasconcelos PFC, 2016, VECTOR-BORNE ZOONOT, V16, P566, DOI 10.1089/vbz.2016.2031
   Vasconcelos PFC, 2004, EMERG INFECT DIS, V10, P1578, DOI 10.3201/eid1009.040197
NR 13
TC 40
Z9 40
U1 0
U2 5
PU FUNDACO OSWALDO CRUZ
PI RIO DE JANEIRO, RJ
PA AV BRASIL 4365, 21045-900 RIO DE JANEIRO, RJ, BRAZIL
SN 0074-0276
EI 1678-8060
J9 MEM I OSWALDO CRUZ
JI Mem. Inst. Oswaldo Cruz
PD JUN
PY 2017
VL 112
IS 6
BP 447
EP 451
DI 10.1590/0074-02760170134
PG 5
WC Parasitology; Tropical Medicine
SC Parasitology; Tropical Medicine
GA EX5HH
UT WOS:000403269600008
PM 28591405
OA DOAJ Gold, Green Published
DA 2020-12-01
ER

PT J
AU Ferreira-de-Brito, A
   Ribeiro, IP
   de Miranda, RM
   Fernandes, RS
   Campos, SS
   da Silva, KAB
   de Castro, MG
   Bonaldo, MC
   Brasil, P
   Lourenco-de-Oliveira, R
AF Ferreira-de-Brito, Anielly
   Ribeiro, Ieda P.
   de Miranda, Rafaella Moraes
   Fernandes, Rosilainy Surubi
   Campos, Stephanie Silva
   Barbosa da Silva, Keli Antunes
   de Castro, Marcia Goncalves
   Bonaldo, Myrna C.
   Brasil, Patricia
   Lourenco-de-Oliveira, Ricardo
TI First detection of natural infection of Aedes aegypti with Zika virus in
   Brazil and throughout South America
SO MEMORIAS DO INSTITUTO OSWALDO CRUZ
LA English
DT Article
DE Zika; Aedes aegypti; natural infection; Culex quinquefasciatus; Aedes
   albopictus
ID MOSQUITOS; TRANSMISSION; ISOLATIONS; STATES; FEVER
AB Zika virus (ZIKV) has caused a major epidemic in Brazil and several other American countries. ZIKV is an arbovirus whose natural vectors during epidemics have been poorly determined. In this study, 1,683 mosquitoes collected in the vicinity of ZIKV suspected cases in Rio de Janeiro, Brazil, from June 2015 to May 2016 were screened for natural infection by using molecular methods. Three pools of Aedes aegypti were found with the ZIKV genome, one of which had only one male. This finding supports the occurrence of vertical and/or venereal transmission of ZIKV in Ae. aegypti in nature. None of the examined Ae. albopictus and Culex quinquefasciatus was positive. This is the first report of natural infection by ZIKV in mosquitoes in Brazil and other South American countries. So far, Ae. aegypti is the only confirmed vector of ZIKV during the ongoing Pan-American epidemics.
C1 [Ferreira-de-Brito, Anielly; de Miranda, Rafaella Moraes; Fernandes, Rosilainy Surubi; Campos, Stephanie Silva; Barbosa da Silva, Keli Antunes; de Castro, Marcia Goncalves; Lourenco-de-Oliveira, Ricardo] Fundacao Oswaldo Cruz, Inst Oswaldo Cruz, Lab Mosquitos Transmissores Hematozoarios, Rio De Janeiro, RJ, Brazil.
   [Ribeiro, Ieda P.; Bonaldo, Myrna C.] Fundacao Oswaldo Cruz, Inst Oswaldo Cruz, Lab Biol Mol Flavivirus, Rio De Janeiro, RJ, Brazil.
   [Brasil, Patricia] Inst Nacl Infectol, Lab Pesquisa Clin Doencas Febris Agudas, Rio De Janeiro, RJ, Brazil.
RP Lourenco-de-Oliveira, R (corresponding author), Fundacao Oswaldo Cruz, Inst Oswaldo Cruz, Lab Mosquitos Transmissores Hematozoarios, Rio De Janeiro, RJ, Brazil.
EM lourenco@ioc.fiocruz.br
OI Castro, Maria Graciela/0000-0003-2237-2756; Ribeiro, Ivonizete
   Pires/0000-0003-0737-5430
FU NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASESUnited States
   Department of Health & Human ServicesNational Institutes of Health (NIH)
   - USANIH National Institute of Allergy & Infectious Diseases (NIAID)
   [U01AI115595, U01AI115595, U01AI115595, U01AI115595, U01AI115595,
   U01AI115595] Funding Source: NIH RePORTER; NIAID NIH HHSUnited States
   Department of Health & Human ServicesNational Institutes of Health (NIH)
   - USANIH National Institute of Allergy & Infectious Diseases (NIAID)
   [U01 AI115595] Funding Source: Medline
CR Akoua-Koffi C, 2001, B SOC PATHOL EXOT, V94, P227
   Bonaldo MC, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004816
   BOORMAN J. P. T., 1956, TRANS ROY SOC TROP MED AND HYG, V50, P238, DOI 10.1016/0035-9203(56)90029-3
   Brasil P, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004636
   Dutra HLC, 2016, CELL HOST MICROBE, V19, P771, DOI 10.1016/j.chom.2016.04.021
   Carvalho RG, 2014, MEM I OSWALDO CRUZ, V109, P787, DOI 10.1590/0074-0276140304
   Chouin-Carneiro T, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004543
   Diagne CT, 2015, BMC INFECT DIS, V15, DOI 10.1186/s12879-015-1231-2
   Diallo D, 2014, PLOS ONE, V9
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P509, DOI 10.1016/0035-9203(52)90042-4
   Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715
   Faye O, 2013, VIROL J, V10, DOI 10.1186/1743-422X-10-311
   Fernandes RS, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004993
   Grard G, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002681
   Guerbois M, 2016, J INFECT DIS, V214, P1349, DOI 10.1093/infdis/jiw302
   HADDOW AJ, 1964, B WORLD HEALTH ORGAN, V31, P57
   Hills SL, 2016, MMWR-MORBID MORTAL W, V65, P215, DOI 10.15585/mmwr.mm6508e2
   Juliano SA, 2014, MEM I OSWALDO CRUZ, V109, P1070, DOI 10.1590/0074-02760140455
   Ledermann JP, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0003188
   Lourenco-de-Oliveira R, 2015, ORG DENGUE TEORIAS P, P127
   MARCHETTE NJ, 1969, AM J TROP MED HYG, V18, P411, DOI 10.4269/ajtmh.1969.18.411
   Musso D, 2014, CLIN MICROBIOL INFEC, V20, pO595, DOI 10.1111/1469-0691.12707
   Musso D, 2016, CLIN MICROBIOL REV, V29, P487, DOI 10.1128/CMR.00072-15
   OLSON JG, 1981, T ROY SOC TROP MED H, V75, P389, DOI 10.1016/0035-9203(81)90100-0
   PAHO/WHO - Pan American Health Organization/World Health Organization, 2016, ZIK VIR DET AED ALB
   WEINBREN M. P., 1958, TRANS ROY SOC TROP MED AND HYG, V52, P263, DOI 10.1016/0035-9203(58)90085-3
   Zanluca C, 2015, MEM I OSWALDO CRUZ, V110, P569, DOI 10.1590/0074-02760150192
NR 27
TC 98
Z9 103
U1 0
U2 19
PU FUNDACO OSWALDO CRUZ
PI RIO DE JANEIRO, RJ
PA AV BRASIL 4365, 21045-900 RIO DE JANEIRO, RJ, BRAZIL
SN 0074-0276
EI 1678-8060
J9 MEM I OSWALDO CRUZ
JI Mem. Inst. Oswaldo Cruz
PD OCT
PY 2016
VL 111
IS 10
BP 655
EP 658
DI 10.1590/0074-02760160332
PG 4
WC Parasitology; Tropical Medicine
SC Parasitology; Tropical Medicine
GA DZ0FY
UT WOS:000385514100009
PM 27706382
OA DOAJ Gold, Green Published
DA 2020-12-01
ER

PT J
AU Manso, PPD
   de Oliveira, BCEPD
   de Sequeira, PC
   de Souza, YRM
   Ferro, JMD
   da Silva, IJ
   Caputo, LFG
   Guedes, PT
   dos Santos, AAC
   Freire, MD
   Bonaldo, MC
   Machado, MP
AF de Abreu Manso, Pedro Paulo
   Dias de Oliveira, Barbara Cristina E. P.
   de Sequeira, Patricia Carvalho
   Maia de Souza, Yuli Rodrigues
   dos Santos Ferro, Jessica Maria
   da Silva, Igor Jose
   Goncalves Caputo, Luzia Fatima
   Guedes, Priscila Tavares
   Cunha dos Santos, Alexandre Araujo
   Freire, Marcos da Silva
   Bonaldo, Myrna Cristina
   Machado, Marcelo Pelajo
TI Kinetic Study of Yellow Fever 17DD Viral Infection in Gallus gallus
   domesticus Embryos
SO PLOS ONE
LA English
DT Article
ID VIRUS-INFECTION; CHICK-EMBRYO; PATHOGENESIS; VACCINATION; PATHOLOGY;
   CELLS; LIVER
AB Yellow fever continues to be an important epidemiological problem in Africa and South America even though the disease can be controlled by vaccination. The vaccine has been produced since 1937 and is based on YFV 17DD chicken embryo infection. However, little is known about the histopathological background of virus infection and replication in this model. Here we show by morphological and molecular methods (brightfield and confocal microscopies, immunofluorescence, nested-PCR and sequencing) the kinetics of YFV 17DD infection in chicken embryos with 9 days of development, encompassing 24 to 96 hours post infection. Our principal findings indicate that the main cells involved in virus production are myoblasts with a mesenchymal shape, which also are the first cells to express virus proteins in Gallus gallus embryos at 48 hours after infection. At 72 hours post infection, we observed an increase of infected cells in embryos. Many sites are thus affected in the infection sequence, especially the skeletal muscle. We were also able to confirm an increase of nervous system infection at 96 hours post infection. Our data contribute to the comprehension of the pathogenesis of YF 17DD virus infection in Gallus gallus embryos.
C1 [de Abreu Manso, Pedro Paulo; Dias de Oliveira, Barbara Cristina E. P.; Maia de Souza, Yuli Rodrigues; dos Santos Ferro, Jessica Maria; da Silva, Igor Jose; Goncalves Caputo, Luzia Fatima; Guedes, Priscila Tavares; Machado, Marcelo Pelajo] Fiocruz MS, Inst Oswaldo Cruz, Lab Patol, BR-21045900 Rio De Janeiro, Brazil.
   [de Sequeira, Patricia Carvalho; Cunha dos Santos, Alexandre Araujo; Bonaldo, Myrna Cristina] Fiocruz MS, Inst Oswaldo Cruz, Lab Biol Mol Flavivirus, BR-21045900 Rio De Janeiro, Brazil.
   [Guedes, Priscila Tavares] Univ Fed Estado Rio de Janeiro, UNIRIO, Rio De Janeiro, Brazil.
   [Freire, Marcos da Silva] Fundacao Oswaldo Cruz, Inst Tecnol Imunobiol, Lab Tecnol Virol, Rio De Janeiro, Brazil.
RP Manso, PPD (corresponding author), Fiocruz MS, Inst Oswaldo Cruz, Lab Patol, BR-21045900 Rio De Janeiro, Brazil.
EM mansoppa@gmail.com
RI de Abreu Manso, Pedro Paulo/M-7326-2018
OI de Abreu Manso, Pedro Paulo/0000-0002-7255-0429; Pelajo Machado,
   Marcelo/0000-0002-7295-7018; Rodrigues Maia de Souza,
   Yuli/0000-0002-6202-1961
FU Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio de
   Janeiro [E-26/010.001530/2014]; Coordenacao de Aperfeicoamento de
   Pessoal de Nivel SuperiorCAPES; Fundacao Oswaldo Cruz
FX This work was supported by Fundacao Carlos Chagas Filho de Amparo a
   Pesquisa do Estado do Rio de Janeiro (www.faperj.br)
   (E-26/010.001530/2014), Coordenacao de Aperfeicoamento de Pessoal de
   Nivel Superior (www.capes.gov.br), and Fundacao Oswaldo Cruz
   (WWW.fiocruz.br). The funders had no role in study design, data
   collection and analysis, decision to publish, or preparation of the
   manuscript.
CR Barrett ADT, 2009, CURR OPIN IMMUNOL, V21, P308, DOI 10.1016/j.coi.2009.05.018
   Beasley DWC, 2015, ANTIVIR RES, V115, P48, DOI 10.1016/j.antiviral.2014.12.010
   Beck A, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0001910
   BENCHIMOL JL, 2001, FEBRE AMARELA DOENCA
   CARSON FL, 1973, AM J CLIN PATHOL, V59, P365
   Manso PPD, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0004064
   FOX JP, 1947, AM J HYG, V46, P21, DOI 10.1093/oxfordjournals.aje.a119152
   Freire MS, 2005, VACCINE, V23, P2501, DOI 10.1016/j.vaccine.2004.10.035
   Guedes PT, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0090975
   Heinz FX, 2012, VACCINE, V30, P4301, DOI 10.1016/j.vaccine.2011.09.114
   Martins RdM, 2014, VACCINE
   Massad E, 2005, VACCINE, V23, P3908, DOI 10.1016/j.vaccine.2005.03.002
   MAURO A, 1961, J BIOPHYS BIOCHEM CY, V9, P493, DOI 10.1083/jcb.9.2.493
   Mayer P., 1903, Z WISSENSCHAFTLICHE, V20, P409
   McMahon AW, 2007, VACCINE, V25, P1727, DOI 10.1016/j.vaccine.2006.11.027
   McWilliam H, 2013, NUCLEIC ACIDS RES, V41, pW597, DOI 10.1093/nar/gkt376
   Monath T P, 2001, Lancet Infect Dis, V1, P11, DOI 10.1016/S1473-3099(01)00016-0
   Monath TP, 2003, ADV VIRUS RES, V60, P343, DOI 10.1016/S0065-3527(03)60009-6
   Monath TP CM, 2008, VACCINES
   Ozden S, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000527
   Penna H, 1956, YF VACCINATION MONOG, P67
   Post PR, 2001, MEM I OSWALDO CRUZ, V96, P849, DOI 10.1590/S0074-02762001000600019
   Quaresma JAS, 2006, VIRUS RES, V116, P91, DOI 10.1016/j.virusres.2005.08.019
   Quaresma JAS, 2006, VIROLOGY, V345, P22, DOI 10.1016/j.virol.2005.09.058
   Quaresma JAS, 2013, REV MED VIROL, V23, P305, DOI 10.1002/rmv.1752
   SEAY AR, 1981, NEUROLOGY, V31, P656, DOI 10.1212/WNL.31.6.656
   Shawn F., 2005, SOUTH MED J, V98, P484, DOI [10.1097/01.SMJ.0000145879.14102.F4, DOI 10.1097/01.SMJ.0000145879.14102.F4]
   Strode G. K, 1951, YELLOW FEVER
   TANAKA M, 1993, J VIROL METHODS, V41, P311, DOI 10.1016/0166-0934(93)90020-R
   TOKUYASU KT, 1984, J CELL BIOL, V98, P1961, DOI 10.1083/jcb.98.6.1961
   WAKAI S, 1978, CELL TISSUE RES, V195, P195
   Xiao SY, 2001, J INFECT DIS, V183, P1437, DOI 10.1086/320200
   Zhou ZE, 2012, BMC DEV BIOL, V12, DOI 10.1186/1471-213X-12-38
NR 33
TC 2
Z9 2
U1 0
U2 1
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD MAY 9
PY 2016
VL 11
IS 5
AR e0155041
DI 10.1371/journal.pone.0155041
PG 16
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA DM7YQ
UT WOS:000376576700032
PM 27158977
OA DOAJ Gold, Green Published
DA 2020-12-01
ER

PT J
AU Martins, MA
   Tully, DC
   Cruz, MA
   Power, KA
   de Santana, MGV
   Bean, DJ
   Ogilvie, CB
   Gadgil, R
   Lima, NS
   Magnani, DM
   Ejima, K
   Allison, DB
   Piatak, M
   Altman, JD
   Parks, CL
   Rakasz, EG
   Capuano, S
   Galler, R
   Bonaldo, MC
   Lifson, JD
   Allen, TM
   Watkins, DI
AF Martins, Mauricio A.
   Tully, Damien C.
   Cruz, Michael A.
   Power, Karen A.
   de Santana, Marlon G. Veloso
   Bean, David J.
   Ogilvie, Colin B.
   Gadgil, Rujuta
   Lima, Noemia S.
   Magnani, Diogo M.
   Ejima, Keisuke
   Allison, David B.
   Piatak, Michael, Jr.
   Altman, John D.
   Parks, Christopher L.
   Rakasz, Eva G.
   Capuano, Saverio, III
   Galler, Ricardo
   Bonaldo, Myrna C.
   Lifson, Jeffrey D.
   Allen, Todd M.
   Watkins, David I.
TI Vaccine-Induced Simian Immunodeficiency Virus-Specific CD8(+) T-Cell
   Responses Focused on a Single Nef Epitope Select for Escape Variants
   Shortly after Infection
SO JOURNAL OF VIROLOGY
LA English
DT Article
ID CLASS-I MOLECULES; HLA CLASS-I; MAMU-B-ASTERISK-08-POSITIVE MACAQUES;
   LYMPHOCYTE RESPONSE; HIV; REPLICATION; AIDS; DNA; PROGRESSION;
   MECHANISMS
AB Certain major histocompatibility complex class I (MHC-I) alleles (e.g., HLA-B*27) are enriched among human immunodeficiency virus type 1 (HIV-1)-infected individuals who suppress viremia without treatment (termed "elite controllers" [ECs]). Likewise, Mamu-B*08 expression also predisposes rhesus macaques to control simian immunodeficiency virus (SIV) replication. Given the similarities between Mamu-B*08 and HLA-B*27, SIV-infected Mamu-B*08(+) animals provide a model to investigate HLA-B* 27-mediated elite control. We have recently shown that vaccination with three immunodominant Mamu-B*08-restricted epitopes (Vif RL8, Vif RL9, and Nef RL10) increased the incidence of elite control in Mamu-B* 08(+) macaques after challenge with the pathogenic SIVmac239 clone. Furthermore, a correlate analysis revealed that CD8(+) T cells targeting Nef RL10 was correlated with improved outcome. Interestingly, this epitope is conserved between SIV and HIV-1 and exhibits a delayed and atypical escape pattern. These features led us to postulate that a monotypic vaccine-induced Nef RL10-specific CD8(+)T-cell response would facilitate the development of elite control in Mamu-B* 08(+) animals following repeated intrarectal challenges with SIVmac239. To test this, we vaccinated Mamu-B* 08(+) animals with nef inserts in which Nef RL10 was either left intact (group 1) or disrupted by mutations (group 2). Although monkeys in both groups mounted Nef-specific cellular responses, only those in group 1 developed Nef RL10-specific CD8(+) T cells. These vaccine-induced effector memory CD8(+)T cells did not prevent infection. Escape variants emerged rapidly in the group 1 vaccinees, and ultimately, the numbers of ECs were similar in groups 1 and 2. High-frequency vaccine-induced CD8(+)T cells focused on a single conserved epitope and therefore did not prevent infection or increase the incidence of elite control in Mamu-B* 08(+) macaques.
   IMPORTANCE
   Since elite control of chronic-phase viremia is a classic example of an effective immune response against HIV/SIV, elucidating the basis of this phenomenon may provide useful insights into how to elicit such responses by vaccination. We have previously established that vaccine-induced CD8(+)T-cell responses against three immunodominant epitopes can increase the incidence of elite control in SIV-infected Mamu-B* 08(+) rhesus macaques-a model of HLA-B* 27-mediated elite control. Here, we investigated whether a monotypic vaccine-induced CD8(+)T-cell response targeting the conserved "late-escaping" Nef RL10 epitope can increase the incidence of elite control in Mamu-B* 08(+) monkeys. Surprisingly, vaccine-induced Nef RL10-specific CD8(+)T cells selected for variants within days after infection and, ultimately, did not facilitate the development of elite control. Elite control is, therefore, likely to involve CD8(+)T-cell responses against more than one epitope. Together, these results underscore the complexity and multidimensional nature of virologic control of lentivirus infection.
C1 [Martins, Mauricio A.; Cruz, Michael A.; de Santana, Marlon G. Veloso; Magnani, Diogo M.; Watkins, David I.] Univ Miami, Dept Pathol, Miami, FL 33136 USA.
   [Tully, Damien C.; Power, Karen A.; Bean, David J.; Ogilvie, Colin B.; Gadgil, Rujuta; Allen, Todd M.] Ragon Inst MGH MIT & Harvard, Cambridge, MA USA.
   [Lima, Noemia S.; Bonaldo, Myrna C.] Inst Oswaldo Cruz FIOCRUZ, Lab Biol Mol Flavivirus, Rio De Janeiro, Brazil.
   [Ejima, Keisuke; Allison, David B.] Univ Alabama Birmingham, Dept Biostat, Sect Stat Genet, Birmingham, AL 35294 USA.
   [Piatak, Michael, Jr.; Lifson, Jeffrey D.] Leidos Biomedical Res Inc, Frederick Natl Lab, AIDS & Canc Virus Program, Frederick, MD USA.
   [Altman, John D.] Emory Univ, Dept Microbiol & Immunol, Atlanta, GA 30322 USA.
   [Parks, Christopher L.] Brooklyn Army Terminal, AIDS Vaccine Design & Dev Lab, Int AIDS Vaccine Initiat, Brooklyn, NY USA.
   [Rakasz, Eva G.; Capuano, Saverio, III] Univ Wisconsin, Wisconsin Natl Primate Res Ctr, Madison, WI USA.
   [Galler, Ricardo] Fundacao Oswaldo Cruz, Inst Tecnol Imunobiol, Rio De Janeiro, Brazil.
RP Martins, MA (corresponding author), Univ Miami, Dept Pathol, Miami, FL 33136 USA.
EM mmartins@med.miami.edu
RI Allen, Todd/F-5473-2011; Rakasz, Eva G/H-9197-2019; Martins,
   Mauricio/AAU-9226-2020
OI Allen, Todd/0000-0002-6609-1318; Martins, Mauricio/0000-0001-8336-216X;
   Magnani, Diogo/0000-0002-1773-2406; Ejima, Keisuke/0000-0002-1185-3987;
   Bean, David/0000-0001-7497-8026; Tully, Damien/0000-0002-7620-9340
FU Public Health ServiceUnited States Public Health Service [R37AI052056];
   National Cancer Institute, National Institutes of HealthUnited States
   Department of Health & Human ServicesNational Institutes of Health (NIH)
   - USANIH National Cancer Institute (NCI) [HHSN261200800001E]; National
   Institute of Allergy and Infectious DiseasesUnited States Department of
   Health & Human ServicesNational Institutes of Health (NIH) - USANIH
   National Institute of Allergy & Infectious Diseases (NIAID) [P01
   AI074415]; International AIDS Vaccine Initiative (IAVI); U.S. Agency for
   International Development (USAID)United States Agency for International
   Development (USAID); Bill and Melinda Gates FoundationBill & Melinda
   Gates Foundation; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS
   DISEASESUnited States Department of Health & Human ServicesNational
   Institutes of Health (NIH) - USANIH National Institute of Allergy &
   Infectious Diseases (NIAID) [R37AI052056, P01AI074415, P01AI074415,
   P01AI074415, P01AI074415, P01AI074415, P01AI074415, R37AI052056,
   P01AI074415, P01AI074415, P01AI074415, R37AI052056, P01AI074415,
   P01AI074415, R37AI052056, P01AI074415, R37AI052056, P01AI074415,
   P01AI074415, P01AI074415, P01AI074415, P01AI074415, P01AI074415,
   P01AI074415, P01AI074415, R37AI052056, R37AI052056, P01AI074415,
   P01AI074415, P01AI074415, P01AI074415, P01AI074415, P01AI074415,
   P01AI074415, P01AI074415, P01AI074415, P01AI074415, R37AI052056,
   P01AI074415, R37AI052056, P01AI074415, P01AI074415, P01AI074415,
   P01AI074415, P01AI074415, P01AI074415, P01AI074415, P01AI074415,
   P01AI074415, R37AI052056, P01AI074415, P01AI074415, P01AI074415,
   R37AI052056] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR,
   NATIONAL INSTITUTES OF HEALTHUnited States Department of Health & Human
   ServicesNational Institutes of Health (NIH) - USA [P51OD011106,
   P51OD011106, P51OD011106, P51OD011106, P51OD011106, P51OD011106,
   P51OD011106, P51OD011106, P51OD011106, P51OD011106, P51OD011106,
   P51OD011106, P51OD011106, P51OD011106, P51OD011106] Funding Source: NIH
   RePORTER
FX This work was funded by Public Health Service grant R37AI052056 to
   D.I.W. and was supported in part by federal funds from the National
   Cancer Institute, National Institutes of Health, under contract no.
   HHSN261200800001E and from the National Institute of Allergy and
   Infectious Diseases through P01 AI074415 (T.M.A.). This work was also
   partially funded by the International AIDS Vaccine Initiative (IAVI)
   with the generous support of the U.S. Agency for International
   Development (USAID) and the Bill and Melinda Gates Foundation. A full
   list of IAVI donors is available at http://www.iavi.org.
CR Adland E, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073117
   Allen TM, 2002, J VIROL, V76, P4108, DOI 10.1128/JVI.76.8.4108-4112.2002
   Allen TM, 2000, NATURE, V407, P386, DOI 10.1038/35030124
   Altfeld M, 2006, PLOS MED, V3, P1851, DOI 10.1371/journal.pmed.0030403
   Anderson RD, 2000, GENE THER, V7, P1034, DOI 10.1038/sj.gt.3301197
   Arts EJ, 2012, CSH PERSPECT MED, V2, DOI 10.1101/cshperspect.a007161
   Betts MR, 2006, BLOOD, V107, P4781, DOI 10.1182/blood-2005-12-4818
   Betts MR, 2005, P NATL ACAD SCI USA, V102, P4512, DOI 10.1073/pnas.0408773102
   Bonaldo MC, 2010, J VIROL, V84, P3699, DOI 10.1128/JVI.02255-09
   Bonaldo MC, 2007, VIROL J, V4, DOI 10.1186/1743-422X-4-115
   Carl S, 1999, J VIROL, V73, P2790, DOI 10.1128/JVI.73.4.2790-2797.1999
   Chen HB, 2012, NAT IMMUNOL, V13, P691, DOI 10.1038/ni.2342
   Cline AN, 2005, J MED PRIMATOL, V34, P303
   Dang Q, 2008, ADV PHARMACOL, V56, P369, DOI 10.1016/S1054-3589(07)56012-6
   Day CL, 2006, NATURE, V443, P350, DOI 10.1038/nature05115
   Deeks SG, 2007, IMMUNITY, V27, P406, DOI 10.1016/j.immuni.2007.08.010
   Draenert R, 2004, J EXP MED, V199, P905, DOI 10.1084/jem.20031982
   Feeney ME, 2004, J VIROL, V78, P8927, DOI 10.1128/JVI.78.16.8927-8930.2004
   Friedrich TC, 2004, NAT MED, V10, P275, DOI 10.1038/nm998
   Fujita T, 2014, J IMMUNOL, V193, P5576, DOI 10.4049/jimmunol.1400961
   Goulder PJR, 2012, IMMUNITY, V37, P426, DOI 10.1016/j.immuni.2012.09.005
   Goulder PJR, 1997, NAT MED, V3, P212, DOI 10.1038/nm0297-212
   Hansen SG, 2013, NATURE, V502, P100, DOI 10.1038/nature12519
   Hansen SG, 2013, SCIENCE, V340, P940, DOI 10.1126/science.1237874
   Henn MR, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002529
   Hersperger AR, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000917
   Jalah R, 2012, HUM VACC IMMUNOTHER, V8, P1620, DOI 10.4161/hv.21407
   Johnson S, 2015, J IMMUNOL, V194, P1755, DOI 10.4049/jimmunol.1401771
   Kawada M, 2006, J VIROL, V80, P1949, DOI 10.1128/JVI.80.4.1949-1958.2006
   Loffredo JT, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001152
   Loffredo JT, 2008, J VIROL, V82, P1723, DOI 10.1128/JVI.02084-07
   Loffredo JT, 2007, J VIROL, V81, P8827, DOI 10.1128/JVI.00895-07
   Loffredo JT, 2009, J IMMUNOL, V182, P7763, DOI 10.4049/jimmunol.0900111
   Macalalad AR, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002417
   Martins MA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054434
   Masopust D, 2006, J IMMUNOL, V177, P831, DOI 10.4049/jimmunol.177.2.831
   Matano T, 2004, J EXP MED, V199, P1709, DOI 10.1084/jem.20040432
   Migueles SA, 2002, NAT IMMUNOL, V3, P1061, DOI 10.1038/ni845
   Migueles SA, 2008, IMMUNITY, V29, P1009, DOI 10.1016/j.immuni.2008.10.010
   Mothe BR, 2002, J IMMUNOL, V169, P210, DOI 10.4049/jimmunol.169.1.210
   Mudd PA, 2012, NATURE, V491, P129, DOI 10.1038/nature11443
   Mudd PA, 2012, J IMMUNOL, V188, P3364, DOI 10.4049/jimmunol.1102470
   Mudd PA, 2011, J VIROL, V85, P12804, DOI 10.1128/JVI.05841-11
   Mudd PA, 2011, CURR OPIN HIV AIDS, V6, P197, DOI 10.1097/COH.0b013e3283453e16
   Mudd PA, 2010, IMMUNOGENETICS, V62, P593, DOI 10.1007/s00251-010-0461-0
   Price DA, 2004, IMMUNITY, V21, P793, DOI 10.1016/j.immuni.2004.10.010
   Rosati M, 2005, J VIROL, V79, P8480, DOI 10.1128/JVI.79.13.8480-8492.2005
   Sardesai NY, 2011, CURR OPIN IMMUNOL, V23, P421, DOI 10.1016/j.coi.2011.03.008
   Valentine LE, 2009, J VIROL, V83, P11514, DOI 10.1128/JVI.01298-09
   Vasan S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019252
   Vezys V, 2006, J EXP MED, V203, P2263, DOI 10.1084/jem.20060995
   Virgin HW, 2009, CELL, V138, P30, DOI 10.1016/j.cell.2009.06.036
   Vojnov L, 2010, J VIROL, V84, P753, DOI 10.1128/JVI.01596-09
   Walker BD, 2013, NAT REV IMMUNOL, V13, P487, DOI 10.1038/nri3478
   Wu H, 2014, HIV R4P C S 11 EM AR
   Yant LJ, 2006, J VIROL, V80, P5074, DOI 10.1128/JVI.80.10.5074-5077.2006
NR 56
TC 19
Z9 19
U1 0
U2 7
PU AMER SOC MICROBIOLOGY
PI WASHINGTON
PA 1752 N ST NW, WASHINGTON, DC 20036-2904 USA
SN 0022-538X
EI 1098-5514
J9 J VIROL
JI J. Virol.
PD NOV
PY 2015
VL 89
IS 21
BP 10802
EP 10820
DI 10.1128/JVI.01440-15
PG 19
WC Virology
SC Virology
GA CU3ZP
UT WOS:000363465900007
PM 26292326
OA Green Published, Bronze
DA 2020-12-01
ER

PT J
AU Manso, PPD
   de Oliveira, BCEPD
   de Sequeira, PC
   de Souza, YRM
   Ferro, JMD
   da Silva, IJ
   Caputo, LFG
   Guedes, PT
   dos Santos, AAC
   Freire, MD
   Bonaldo, MC
   Pelajo-Machado, M
AF de Abreu Manso, Pedro Paulo
   Dias de Oliveira, Barbara C. E. P.
   de Sequeira, Patricia Carvalho
   Maia de Souza, Yuli Rodrigues
   dos Santos Ferro, Jessica Maria
   da Silva, Igor Jose
   Goncalves Caputo, Luzia Fatima
   Guedes, Priscila Tavares
   Cunha dos Santos, Alexandre Araujo
   Freire, Marcos da Silva
   Bonaldo, Myrna Cristina
   Pelajo-Machado, Marcelo
TI Yellow Fever 17DD Vaccine Virus Infection Causes Detectable Changes in
   Chicken Embryos
SO PLOS NEGLECTED TROPICAL DISEASES
LA English
DT Article
ID HAMSTER MESOCRICETUS-AURATUS; MACACUS-RHESUS; IMMUNE-RESPONSE; LIVER;
   PATHOGENESIS; PATHOLOGY; CELLS; TARGETS; BRAZIL
AB The yellow fever (YF) 17D vaccine is one of the most effective human vaccines ever created. The YF vaccine has been produced since 1937 in embryonated chicken eggs inoculated with the YF 17D virus. Yet, little information is available about the infection mechanism of YF 17DD virus in this biological model. To better understand this mechanism, we infected embryos of Gallus gallus domesticus and analyzed their histopathology after 72 hours of YF infection. Some embryos showed few apoptotic bodies in infected tissues, suggesting mild focal infection processes. Confocal and super-resolution microscopic analysis allowed us to identify as targets of viral infection: skeletal muscle cells, cardiomyocytes, nervous system cells, renal tubular epithelium, lung parenchyma, and fibroblasts associated with connective tissue in the perichondrium and dermis. The virus replication was heaviest in muscle tissues. In all of these specimens, RT-PCR methods confirmed the presence of replicative intermediate and genomic YF RNA. This clearer characterization of cell targets in chicken embryos paves the way for future development of a new YF vaccine based on a new cell culture system.
C1 [de Abreu Manso, Pedro Paulo; Dias de Oliveira, Barbara C. E. P.; Maia de Souza, Yuli Rodrigues; dos Santos Ferro, Jessica Maria; da Silva, Igor Jose; Goncalves Caputo, Luzia Fatima; Guedes, Priscila Tavares; Pelajo-Machado, Marcelo] Fiocruz MS, Lab Patol, Inst Oswaldo Cruz, BR-21045900 Rio De Janeiro, Brazil.
   [de Sequeira, Patricia Carvalho; Cunha dos Santos, Alexandre Araujo; Bonaldo, Myrna Cristina] Fiocruz MS, Lab Biol Mol Flavivirus, Inst Oswaldo Cruz, BR-21045900 Rio De Janeiro, Brazil.
   [Guedes, Priscila Tavares] Univ Fed Rio de Janeiro, UNIRIO, Rio De Janeiro, Brazil.
   [Freire, Marcos da Silva] Fundacao Oswaldo Cruz, Inst Tecnol Imunobiol, Rio De Janeiro, Brazil.
RP Manso, PPD (corresponding author), Fiocruz MS, Lab Patol, Inst Oswaldo Cruz, BR-21045900 Rio De Janeiro, Brazil.
EM mansoppa@gmail.com
RI de Abreu Manso, Pedro Paulo/M-7326-2018
OI de Abreu Manso, Pedro Paulo/0000-0002-7255-0429; Rodrigues Maia de
   Souza, Yuli/0000-0002-6202-1961
FU Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio de
   Janeiro [E-26/010.001530/2014]; Coordenacao de Aperfeicoamento de
   Pessoal de Nivel SuperiorCAPES; Fundacao Oswaldo Cruz
FX This work was supported by Fundacao Carlos Chagas Filho de Amparo a
   Pesquisa do Estado do Rio de Janeiro (www.faperj.br)
   (E-26/010.001530/2014), Coordenacao de Aperfeicoamento de Pessoal de
   Nivel Superior (www.capes.gov.br), and Fundacao Oswaldo Cruz
   (WWW.fiocruz.br). The funders had no role in study design, data
   collection and analysis, decision to publish, or preparation of the
   manuscript.
CR Barba-Spaeth G, 2005, J EXP MED, V202, P1179, DOI 10.1084/jem.20051352
   Barrett ADT, 2009, CURR OPIN IMMUNOL, V21, P308, DOI 10.1016/j.coi.2009.05.018
   BEARCROFT WGC, 1957, J PATHOL BACTERIOL, V74, P295, DOI 10.1002/path.1700740207
   Bonaldo MC, 2014, HUMAN VACCINES IMMUN, V10, P0
   CARSON FL, 1973, AM J CLIN PATHOL, V59, P365
   Davison TF, 2003, BRIT POULTRY SCI, V44, P6, DOI 10.1080/0007166031000085364
   DEBRITO T, 1992, PATHOL RES PRACT, V188, P177, DOI 10.1016/S0344-0338(11)81176-3
   Domingo C, 2011, J CLIN MICROBIOL, V49, P760, DOI 10.1128/JCM.01775-10
   FOX JP, 1947, AM J HYG, V46, P21, DOI 10.1093/oxfordjournals.aje.a119152
   Freire MS, 2005, VACCINE, V23, P2501, DOI 10.1016/j.vaccine.2004.10.035
   Guedes PT, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0090975
   Guy B, 2010, VACCINE, V28, P632, DOI 10.1016/j.vaccine.2009.09.098
   Heinz FX, 2012, VACCINE, V30, P4301, DOI 10.1016/j.vaccine.2011.09.114
   Hudson NP, 1928, AM J PATHOL, V4, P419
   Hudson NP, 1928, AM J PATHOL, V4, P407
   Immunization V, 2015, VACC VACC YELL FEV W
   Kanai M, 2007, ANAT REC, V290, P862, DOI 10.1002/ar.20557
   Lindenbach BD, 2003, ADV VIRUS RES, V59, P23, DOI 10.1016/S0065-3527(03)59002-9
   LOWENTHAL JW, 1994, IMMUNOL CELL BIOL, V72, P115, DOI 10.1038/icb.1994.18
   Lown BA, 2012, CLIN INFECT DIS, V55, P837, DOI 10.1093/cid/cis520
   Marovich M, 2001, J INVEST DERM SYMP P, V6, P219, DOI 10.1046/j.0022-202x.2001.00037.x
   Mayer P., 1903, Z WISSENSCHAFTLICHE, V20, P409
   McWilliam H, 2013, NUCLEIC ACIDS RES, V41, pW597, DOI 10.1093/nar/gkt376
   Monath T P, 2001, Lancet Infect Dis, V1, P11, DOI 10.1016/S1473-3099(01)00016-0
   Monath TP, 2015, J CLIN VIROL, V64, P160, DOI 10.1016/j.jcv.2014.08.030
   Monath TP, 2003, ADV VIRUS RES, V60, P343, DOI 10.1016/S0065-3527(03)60009-6
   Monath TP CM, 2008, VACCINES
   Mukhopadhyay S, 2005, NAT REV MICROBIOL, V3, P13, DOI 10.1038/nrmicro1067
   Nogueira RT, 2011, VIROL J, V8, DOI 10.1186/1743-422X-8-127
   Ozden S, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000527
   Pastorino B, 2010, ANTIVIR RES, V87, P281, DOI 10.1016/j.antiviral.2010.04.014
   Penna H, 1956, YF VACCINATION MONOG, P67
   Post PR, 2001, MEM I OSWALDO CRUZ, V96, P849, DOI 10.1590/S0074-02762001000600019
   Pulendran B, 2009, NAT REV IMMUNOL, V9, P741, DOI 10.1038/nri2629
   Quaresma JAS, 2006, VIRUS RES, V116, P91, DOI 10.1016/j.virusres.2005.08.019
   Quaresma JAS, 2006, VIROLOGY, V345, P22, DOI 10.1016/j.virol.2005.09.058
   Quaresma JAS, 2007, T ROY SOC TROP MED H, V101, P161, DOI 10.1016/j.trstmh.2006.02.019
   Quaresma JAS, 2013, REV MED VIROL, V23, P305, DOI 10.1002/rmv.1752
   Robertson SE, 1996, JAMA-J AM MED ASSOC, V276, P1157, DOI 10.1001/jama.276.14.1157
   Rowland M, 2012, MIL MED, V177, P467, DOI 10.7205/MILMED-D-11-00304
   Rutkowski K, 2013, INT ARCH ALLERGY IMM, V161, P274, DOI 10.1159/000346350
   Sbrana E, 2006, AM J TROP MED HYG, V74, P1084, DOI 10.4269/ajtmh.2006.74.1084
   SEAY AR, 1981, NEUROLOGY, V31, P656, DOI 10.1212/WNL.31.6.656
   Staples J. Erin, 2010, Morbidity and Mortality Weekly Report, V59, P1
   Stokes A, 1928, J AMER MED ASSOC, V90, P253, DOI 10.1001/jama.1928.02690310005002
   TANAKA M, 1993, J VIROL METHODS, V41, P311, DOI 10.1016/0166-0934(93)90020-R
   Taylor SF, 2005, SOUTH MED J, V98, P484, DOI 10.1097/01.SMJ.0000145879.14102.F4
   Tesh RB, 2001, J INFECT DIS, V183, P1431, DOI 10.1086/320199
   Vargas A, 2007, ADV DRUG DELIVER REV, V59, P1162, DOI 10.1016/j.addr.2007.04.019
   Vasconcelos Pedro Fernando da Costa, 2003, Rev. Soc. Bras. Med. Trop., V36, P275, DOI 10.1590/S0037-86822003000200012
   Vasconcelos PFC, 2001, LANCET, V358, P91, DOI 10.1016/S0140-6736(01)05326-0
   WAKAI S, 1978, CELL TISSUE RES, V195, P195
   Xiao SY, 2001, J INFECT DIS, V183, P1437, DOI 10.1086/320200
NR 53
TC 4
Z9 4
U1 0
U2 3
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1935-2735
J9 PLOS NEGLECT TROP D
JI Plos Neglect. Trop. Dis.
PD SEP
PY 2015
VL 9
IS 9
AR e0004064
DI 10.1371/journal.pntd.0004064
PG 16
WC Infectious Diseases; Parasitology; Tropical Medicine
SC Infectious Diseases; Parasitology; Tropical Medicine
GA CT7YI
UT WOS:000363031200044
PM 26371874
OA DOAJ Gold, Green Published
DA 2020-12-01
ER

PT J
AU Martins, MA
   Wilson, NA
   Piaskowski, SM
   Weisgrau, KL
   Furlott, JR
   Bonaldo, MC
   de Santana, MGV
   Rudersdorf, RA
   Rakasz, EG
   Keating, KD
   Chiuchiolo, MJ
   Piatak, M
   Allison, DB
   Parks, CL
   Galler, R
   Lifson, JD
   Watkins, DI
AF Martins, Mauricio A.
   Wilson, Nancy A.
   Piaskowski, Shari M.
   Weisgrau, Kim L.
   Furlott, Jessica R.
   Bonaldo, Myrna C.
   de Santana, Marlon G. Veloso
   Rudersdorf, Richard A.
   Rakasz, Eva G.
   Keating, Karen D.
   Chiuchiolo, Maria J.
   Piatak, Michael, Jr.
   Allison, David B.
   Parks, Christopher L.
   Galler, Ricardo
   Lifson, Jeffrey D.
   Watkins, David I.
TI Vaccination with gag, vif, and nef Gene Fragments Affords Partial
   Control of Viral Replication after Mucosal Challenge with SIVmac239
SO JOURNAL OF VIROLOGY
LA English
DT Article
ID T-CELL RESPONSES; IMMUNODEFICIENCY VIRUS-REPLICATION; CLASS-I MOLECULE;
   HIV-1 VACCINE; IMMUNE-RESPONSES; RHESUS MACAQUES; DOUBLE-BLIND;
   DISCORDANT ASSOCIATIONS; SUBDOMINANT EPITOPE; DOSE CHALLENGE
AB Broadly targeted cellular immune responses are thought to be important for controlling replication of human and simian immunodeficiency viruses (HIV and SIV). However, eliciting such responses by vaccination is complicated by immunodominance, the preferential targeting of only a few of the many possible epitopes of a given antigen. This phenomenon may be due to the coexpression of dominant and subdominant epitopes by the same antigen-presenting cell and may be overcome by distributing these sequences among several different vaccine constructs. Accordingly, we tested whether vaccinating rhesus macaques with "minigenes" encoding fragments of Gag, Vif, and Nef resulted in broadened cellular responses capable of controlling SIV replication. Wedelivered these minigenes through combinations of recombinant Mycobacterium bovis BCG (rBCG), electroporated recombinant DNA (rDNA) along with an interleukin-12 (IL-12)-expressing plasmid (EP rDNA plus pIL-12), yellow fever vaccine virus 17D (rYF17D), and recombinant adenovirus serotype 5 (rAd5). Although priming with EP rDNA plus pIL-12 increased the breadth of vaccine-induced T-cell responses, this effect was likely due to the improved antigen delivery afforded by electroporation rather than modulation of immunodominance. Indeed, Mamu-A*01(+) vaccinees mounted CD8(+) T cells directed against only one subdominant epitope, regardless of the vaccination regimen. After challenge with SIVmac239, vaccine efficacy was limited to a modest reduction in set point in some of the groups and did not correlate with standard T-cell measurements. These findings suggest that broad T-cell responses elicited by conventional vectors may not be sufficient to substantially contain AIDS virus replication.
C1 [Martins, Mauricio A.; de Santana, Marlon G. Veloso; Watkins, David I.] Univ Miami, Miller Sch Med, Dept Pathol, Miami, FL 33136 USA.
   [Wilson, Nancy A.] Univ Wisconsin, Dept Med, Madison, WI USA.
   [Piaskowski, Shari M.; Weisgrau, Kim L.; Furlott, Jessica R.; Rudersdorf, Richard A.; Rakasz, Eva G.] Univ Wisconsin, Wisconsin Natl Primate Res Ctr, Madison, WI USA.
   [Bonaldo, Myrna C.] Inst Oswaldo Cruz, Lab Biol Mol Flavivirus, BR-20001 Rio De Janeiro, Brazil.
   [Keating, Karen D.; Allison, David B.] Univ Alabama Birmingham, Dept Biostat, Sect Stat Genet, Birmingham, AL 35294 USA.
   [Chiuchiolo, Maria J.; Parks, Christopher L.] AIDS Vaccine Design & Dev Lab, Int AIDS Vaccine Initiat, Brooklyn, NY USA.
   [Piatak, Michael, Jr.; Lifson, Jeffrey D.] Leidos Biomedical Res Inc, Frederick Natl Lab, AIDS & Canc Virus Program, Frederick, MD USA.
   [Galler, Ricardo] Fundacao Oswaldo Cruz, Inst Tecnol Imunobiol, Rio De Janeiro, Brazil.
RP Watkins, DI (corresponding author), Univ Miami, Miller Sch Med, Dept Pathol, Miami, FL 33136 USA.
EM dwatkins@med.miami.edu
RI de Santana, Marlon Gilsepp Veloso/H-8146-2017; Martins,
   Mauricio/AAU-9226-2020; Rakasz, Eva G/H-9197-2019
OI de Santana, Marlon Gilsepp Veloso/0000-0002-3427-841X; Martins,
   Mauricio/0000-0001-8336-216X; Allison, David/0000-0003-3566-9399
FU Public Health Service from the National Institute of Allergy and
   Infectious DiseasesUnited States Department of Health & Human
   ServicesNational Institutes of Health (NIH) - USANIH National Institute
   of Allergy & Infectious Diseases (NIAID) [R01 AI076114, R01 AI049120];
   Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior
   (CAPES)CAPES; FIOCRUZ; National Center for Research ResourcesUnited
   States Department of Health & Human ServicesNational Institutes of
   Health (NIH) - USANIH National Center for Research Resources (NCRR) [P51
   RR000167]; National Cancer Institute, National Institutes of
   HealthUnited States Department of Health & Human ServicesNational
   Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)
   [HHSN261200800001E]; International AIDS Vaccine Initiative (IAVI);
   United StatesAgency for International Development (USAID)United States
   Agency for International Development (USAID)CGIAR; Bill and Melinda
   Gates FoundationBill & Melinda Gates Foundation; Ministry of Foreign
   Affairs of Denmark; Ministry of Finance of Japan; Ministry of Foreign
   Affairs of the Netherlands; United Kingdom Department for International
   Development (DFID); Research Facilities Improvement ProgramUnited States
   Department of Health & Human ServicesNational Institutes of Health (NIH)
   - USANIH National Center for Research Resources (NCRR) [RR15459,
   RR020141]; Norwegian Agency for Development Cooperation (NORAD)CGIAR;
   Irish AidCGIAR; NATIONAL CENTER FOR RESEARCH RESOURCESUnited States
   Department of Health & Human ServicesNational Institutes of Health (NIH)
   - USANIH National Center for Research Resources (NCRR) [P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, C06RR020141, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, C06RR020141,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   C06RR020141, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, C06RR015459, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, C06RR020141,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, C06RR020141,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   C06RR020141, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167] Funding
   Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS
   DISEASESUnited States Department of Health & Human ServicesNational
   Institutes of Health (NIH) - USANIH National Institute of Allergy &
   Infectious Diseases (NIAID) [R01AI076114, R01AI049120, R01AI076114,
   R01AI049120, R01AI049120, R01AI049120, R01AI049120, R01AI076114,
   R01AI049120, R01AI076114, R01AI049120, R01AI076114, R01AI049120,
   R01AI049120] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR,
   NATIONAL INSTITUTES OF HEALTHUnited States Department of Health & Human
   ServicesNational Institutes of Health (NIH) - USA [P51OD011106,
   P51OD011106, P51OD011106, P51OD011106, P51OD011106, P51OD011106,
   P51OD011106, P51OD011106, P51OD011106, P51OD011106, P51OD011106,
   P51OD011106, P51OD011106, P51OD011106, P51OD011106] Funding Source: NIH
   RePORTER
FX This work was funded in part by Public Health Service grants R01
   AI076114 and R01 AI049120 from the National Institute of Allergy and
   Infectious Diseases awarded to D. I. W., Coordenacao de Aperfeicoamento
   de Pessoal de Nivel Superior (CAPES), and FIOCRUZ. In addition, this
   work was supported by grant P51 RR000167 from the National Center for
   Research Resources to the Wisconsin National Primate Research Center at
   the University of Wisconsin-Madison and in part with federal funds from
   the National Cancer Institute, National Institutes of Health, under
   contract number HHSN261200800001E. Additional support was provided by
   the International AIDS Vaccine Initiative (IAVI) and its generous
   supporters, including the United States Agency for International
   Development (USAID); the Bill and Melinda Gates Foundation; the Ministry
   of Foreign Affairs of Denmark; Irish Aid; the Ministry of Finance of
   Japan; the Ministry of Foreign Affairs of the Netherlands; the Norwegian
   Agency for Development Cooperation (NORAD); and the United Kingdom
   Department for International Development (DFID). This research was
   conducted in part at a facility constructed with support from Research
   Facilities Improvement Program grants RR15459 and RR020141.
CR Adland E, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073117
   Allen TM, 2005, J VIROL, V79, P13239, DOI 10.1128/JVI.79.21.13239-13249.2005
   Allen TM, 2001, J VIROL, V75, P738, DOI 10.1128/JVI.75.2.738-749.2001
   Anderson RD, 2000, GENE THER, V7, P1034, DOI 10.1038/sj.gt.3301197
   Barouch DH, 2008, NATURE, V455, P613, DOI 10.1038/nature07352
   Betts MR, 2005, P NATL ACAD SCI USA, V102, P4512, DOI 10.1073/pnas.0408773102
   Bonaldo MC, 2007, VIROL J, V4, DOI 10.1186/1743-422X-4-115
   Buchbinder SP, 2008, LANCET, V372, P1881, DOI 10.1016/S0140-6736(08)61591-3
   Burton DR, 2012, CELL HOST MICROBE, V12, P396, DOI 10.1016/j.chom.2012.09.008
   Burton DR, 2004, NAT IMMUNOL, V5, P233, DOI 10.1038/ni0304-233
   Casimiro DR, 2005, J VIROL, V79, P15547, DOI 10.1128/JVI.79.24.15547-15555.2005
   Cline AN, 2005, J MED PRIMATOL, V34, P303
   dos Santos PR, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019493
   Eberl G, 1996, EUR J IMMUNOL, V26, P2709, DOI 10.1002/eji.1830261124
   Flynn MN, 2005, J INFECT DIS, V191, P654
   Geldmacher C, 2010, J EXP MED, V207, P2869, DOI 10.1084/jem.20100090
   Giraldo-Vela JP, 2010, IMMUNOGENETICS, V62, P701, DOI 10.1007/s00251-010-0473-9
   Goulder PJR, 2004, NAT REV IMMUNOL, V4, P630, DOI 10.1038/nri1417
   Gray GE, 2011, LANCET INFECT DIS, V11, P507, DOI 10.1016/S1473-3099(11)70098-6
   Hammer SM, 2013, NEW ENGL J MED, V369, P2083, DOI 10.1056/NEJMoa1310566
   Hansen SG, 2011, NATURE, V473, P523, DOI 10.1038/nature10003
   Hirao LA, 2008, VACCINE, V26, P3112, DOI 10.1016/j.vaccine.2008.02.036
   Hirao LA, 2010, MOL THER, V18, P1568, DOI 10.1038/mt.2010.112
   Im EJ, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002041
   Iwamoto N, 2014, J VIROL, V88, P425, DOI 10.1128/JVI.02634-13
   Jalah R, 2012, HUM VACC IMMUNOTHER, V8, P1620, DOI 10.4161/hv.21407
   JENNINGS SR, 1991, CELL IMMUNOL, V133, P234, DOI 10.1016/0008-8749(91)90194-G
   Jin X, 1999, J EXP MED, V189, P991, DOI 10.1084/jem.189.6.991
   Joint United Nations Programme on HIV/AIDS, 2013, GLOB REP UNAIDS REP
   Kaizu M, 2007, IMMUNOGENETICS, V59, P693, DOI 10.1007/s00251-007-0233-7
   Kalams SA, 2013, J INFECT DIS, V208, P818, DOI 10.1093/infdis/jit236
   Kawada M, 2008, J VIROL, V82, P10199, DOI 10.1128/JVI.01103-08
   Kedl RM, 2000, J EXP MED, V192, P1105, DOI 10.1084/jem.192.8.1105
   Kiepiela P, 2007, NAT MED, V13, P46, DOI 10.1038/nm1520
   Kirmaier A, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000462
   KOUP RA, 1994, J VIROL, V68, P4650, DOI 10.1128/JVI.68.7.4650-4655.1994
   Koup RA, 2011, NAT REV IMMUNOL, V11, P65, DOI 10.1038/nri2890
   Liu JY, 2006, J VIROL, V80, P11991, DOI 10.1128/JVI.01348-06
   Liu JY, 2009, NATURE, V457, P87, DOI 10.1038/nature07469
   Liu Y, 2011, VACCINE, V29, P2582, DOI 10.1016/j.vaccine.2011.01.049
   Loffredo JT, 2007, J VIROL, V81, P8827, DOI 10.1128/JVI.00895-07
   Loffredo JT, 2006, HIV MOL IMMUNOL, P29
   Makedonas G, 2011, IMMUNOL REV, V239, P109, DOI 10.1111/j.1600-065X.2010.00968.x
   Martins MA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054434
   Martins MA, 2010, J VIROL, V84, P4352, DOI 10.1128/JVI.02365-09
   Masopust D, 2012, J IMMUNOL, V188, P5811, DOI 10.4049/jimmunol.1102695
   Matano T, 1998, J VIROL, V72, P164, DOI 10.1128/JVI.72.1.164-169.1998
   McDermott AB, 2004, J VIROL, V78, P3140, DOI 10.1128/JVI.78.6.3140-3144.2004
   McElrath MJ, 2008, LANCET, V372, P1894, DOI 10.1016/S0140-6736(08)61592-5
   McElrath MJ, 2010, IMMUNITY, V33, P542, DOI 10.1016/j.immuni.2010.09.011
   Mok H, 2008, VACCINE, V26, P4775, DOI 10.1016/j.vaccine.2008.07.012
   Mothe BR, 2003, J VIROL, V77, P2736, DOI 10.1128/JVI.77.4.2736-2740.2003
   Mothe BR, 2002, J VIROL, V76, P875, DOI 10.1128/JVI.76.2.875-884.2002
   Mudd PA, 2012, NATURE, V491, P129, DOI 10.1038/nature11443
   Nemes E, 2010, AIDS, V24, P947, DOI 10.1097/QAD.0b013e328337b144
   Pitisuttithum P, 2006, J INFECT DIS, V194, P1661, DOI 10.1086/508748
   Ranasinghe S, 2012, J VIROL, V86, P277, DOI 10.1128/JVI.05577-11
   Rerks-Ngarm S, 2009, NEW ENGL J MED, V361, P2209, DOI 10.1056/NEJMoa0908492
   Reynolds MR, 2012, VACCINE, V30, P4465, DOI 10.1016/j.vaccine.2012.04.082
   Reynolds MR, 2011, J VIROL, V85, P9637, DOI 10.1128/JVI.05074-11
   Robertson MJ, 1999, CLIN CANCER RES, V5, P9
   Rodriguez F, 2002, J VIROL, V76, P4251, DOI 10.1128/JVI.76.9.4251-4259.2002
   Rosati M, 2005, J VIROL, V79, P8480, DOI 10.1128/JVI.79.13.8480-8492.2005
   Saade F, 2012, EXPERT REV VACCINES, V11, P189, DOI [10.1586/erv.11.188, 10.1586/ERV.11.188]
   Sardesai NY, 2011, CURR OPIN IMMUNOL, V23, P421, DOI 10.1016/j.coi.2011.03.008
   Schoenberger SP, 1998, NATURE, V393, P480, DOI 10.1038/31002
   Shiver JW, 2004, ANNU REV MED, V55, P355, DOI 10.1146/annurev.med.55.091902.104344
   Singh RAK, 2004, J IMMUNOL, V173, P4387, DOI 10.4049/jimmunol.173.7.4387
   Soghoian DZ, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3003165
   Soghoian DZ, 2010, EXPERT REV VACCINES, V9, P1453, DOI 10.1586/ERV.10.132
   Stremlau M, 2006, P NATL ACAD SCI USA, V103, P5514, DOI 10.1073/pnas.0509996103
   Vasan S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019252
   Vojnov L, 2011, VACCINE, V29, P7483, DOI 10.1016/j.vaccine.2011.07.048
   Watkins DI, 2008, NAT MED, V14, P617, DOI 10.1038/nm.f.1759
   Williams MA, 2007, ANNU REV IMMUNOL, V25, P171, DOI 10.1146/annurev.immunol.25.022106.141548
   Willis RA, 2006, P NATL ACAD SCI USA, V103, P12063, DOI 10.1073/pnas.0605130103
   Wilson NA, 2006, J VIROL, V80, P5875, DOI 10.1128/JVI.00171-06
   Wilson NA, 2009, J VIROL, V83, P6508, DOI 10.1128/JVI.00272-09
   Winstone N, 2011, J VIROL, V85, P9578, DOI 10.1128/JVI.05060-11
   Yant LJ, 2006, J VIROL, V80, P5074, DOI 10.1128/JVI.80.10.5074-5077.2006
   Yewdell JW, 2006, IMMUNITY, V25, P533, DOI 10.1016/j.immuni.2006.09.005
   Zhang ZQ, 2002, J VIROL, V76, P12845, DOI 10.1128/JVI.76.24.12845-12854.2002
NR 82
TC 17
Z9 17
U1 0
U2 8
PU AMER SOC MICROBIOLOGY
PI WASHINGTON
PA 1752 N ST NW, WASHINGTON, DC 20036-2904 USA
SN 0022-538X
EI 1098-5514
J9 J VIROL
JI J. Virol.
PD JUL
PY 2014
VL 88
IS 13
BP 7493
EP 7516
DI 10.1128/JVI.00601-14
PG 24
WC Virology
SC Virology
GA AI9GN
UT WOS:000337240700034
PM 24741098
OA Green Published, Bronze
DA 2020-12-01
ER

PT J
AU Bonaldo, MC
   Sequeira, PC
   Galler, R
AF Bonaldo, Myrna C.
   Sequeira, Patricia C.
   Galler, Ricardo
TI The yellow fever 17D virus as a platform for new live attenuated
   vaccines
SO HUMAN VACCINES & IMMUNOTHERAPEUTICS
LA English
DT Review
DE Yellow Fever; 17D virus-vaccines-immune responses-expression;
   vector-insertion; sites-live; recombinant virus
ID TETRAVALENT DENGUE VACCINE; T-CELL RESPONSES; WEST-NILE-VIRUS; INDIAN
   RHESUS MACAQUES; HEALTHY-ADULTS; PHASE-II; FLAVIVIRUS INFECTIONS;
   ENDOPLASMIC-RETICULUM; PROTECTIVE EFFICACY; ENVELOPE PROTEIN
AB The live-attenuated yellow fever 17D virus is one of the most outstanding human vaccines ever developed. It induces efficacious immune responses at a low production cost with a well-established manufacture process. These advantages make the YF17D virus attractive as a vector for the development of new vaccines. At the beginning of vector development studies, YF17D was genetically manipulated to express other flavivirus prM and E proteins, components of the viral envelope. While these 17D recombinants are based on the substitution of equivalent YF17D genes, other antigens from unrelated pathogens have also been successfully expressed and delivered by recombinant YF17D viruses employing alternative strategies for genetic manipulation of the YF17D genome. Herein, we discuss these strategies in terms of possibilities of single epitope or larger sequence expression and the main properties of these replication-competent viral platforms.
C1 [Bonaldo, Myrna C.; Sequeira, Patricia C.] Fiocruz MS, IOC, Lab Biol Mol Flavivirus, Rio De Janeiro, Brazil.
   [Galler, Ricardo] Fiocruz MS, Inst Tecnol Imunobiol, Rio De Janeiro, Brazil.
RP Bonaldo, MC (corresponding author), Fiocruz MS, IOC, Lab Biol Mol Flavivirus, Rio De Janeiro, Brazil.
EM mbonaldo@ioc.fiocruz.br
CR Akondy RS, 2009, J IMMUNOL, V183, P7919, DOI 10.4049/jimmunol.0803903
   Andino R, 2001, RECOMBINANT BICISTRO, P28
   Arroyo J, 2004, J VIROL, V78, P12497, DOI 10.1128/JVI.78.22.12497-12507.2004
   Auclair SM, 2012, PROTEIN SCI, V21, P13, DOI 10.1002/pro.757
   Barba-Spaeth G, 2005, J EXP MED, V202, P1179, DOI 10.1084/jem.20051352
   Biedenbender R, 2011, J INFECT DIS, V203, P75, DOI 10.1093/infdis/jiq003
   Blom K, 2013, J IMMUNOL, V190, P2150, DOI 10.4049/jimmunol.1202234
   Bonaldo MC, 2006, CELL BIOCHEM BIOPHYS, V44, P313, DOI 10.1385/CBB:44:3:313
   Bonaldo MC, 2005, J VIROL, V79, P8602, DOI 10.1128/JVI.79.13.8602-8613.2005
   Bonaldo MC, 2002, J MOL BIOL, V315, P873, DOI 10.1006/jmbi.2001.5258
   Bonaldo MC, 2005, METHOD PRODUCTION RE, P93
   Bonaldo MC, 2010, J VIROL, V84, P3699, DOI 10.1128/JVI.02255-09
   Bonaldo MC, 2007, VIROL J, V4, DOI 10.1186/1743-422X-4-115
   BRANDRISS MW, 1990, J INFECT DIS, V161, P1134, DOI 10.1093/infdis/161.6.1134
   BRAY M, 1991, P NATL ACAD SCI USA, V88, P10342, DOI 10.1073/pnas.88.22.10342
   Bredenbeek PJ, 2006, VIROLOGY, V345, P299, DOI 10.1016/j.virol.2005.12.001
   Camacho LAB, 2005, REV SAUDE PUBL, V39, P413, DOI 10.1590/S0034-89102005000300012
   Camacho LAB, 2004, REV SAUDE PUBL, V38, P671, DOI 10.1590/S0034-89102004000500009
   Cao WP, 2008, NAT IMMUNOL, V9, P1157, DOI 10.1038/ni.1645
   Capeding RZ, 2011, VACCINE, V29, P3863, DOI 10.1016/j.vaccine.2011.03.057
   Caufour PS, 2001, VIRUS RES, V79, P1, DOI 10.1016/S0168-1702(01)00273-8
   Chambers TJ, 1999, J VIROL, V73, P3095, DOI 10.1128/JVI.73.4.3095-3101.1999
   Childs KS, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064202
   Chokephaibulkit K, 2010, PEDIATR INFECT DIS J, V29, P1111, DOI 10.1097/INF.0b013e3181f68e9c
   Co MDT, 2009, IMMUNOLOGY, V128, pe718, DOI 10.1111/j.1365-2567.2009.03070.x
   Corver J, 2003, J VIROL, V77, P2265, DOI 10.1128/JVI.77.3.2265-2270.2003
   Dayan GH, 2013, AM J TROP MED HYG, V89, P1058, DOI 10.4269/ajtmh.13-0304
   Dayan GH, 2013, VACCINE, V31, P5047, DOI 10.1016/j.vaccine.2013.08.088
   De Filette M, 2012, VET RES, V43, DOI 10.1186/1297-9716-43-16
   de Melo AB, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0001938
   Deas TS, 2005, J VIROL, V79, P4599, DOI 10.1128/JVI.79.8.4599-4609.2005
   Franco D, 2010, VACCINE, V28, P5676, DOI 10.1016/j.vaccine.2010.06.052
   Galler R, 1998, VACCINE, V16, P1024, DOI 10.1016/S0264-410X(97)00278-8
   Gaucher D, 2008, J EXP MED, V205, P3119, DOI 10.1084/jem.20082292
   Grant D, 2011, J VIROL, V85, P7775, DOI 10.1128/JVI.00665-11
   Guirakhoo F, 2001, J VIROL, V75, P7290, DOI 10.1128/JVI.75.16.7290-7304.2001
   Guirakhoo F, 2006, HUM VACCINES, V2, P60, DOI 10.4161/hv.2.2.2555
   Guy B, 2010, VACCINE, V28, P632, DOI 10.1016/j.vaccine.2009.09.098
   Jiang XH, 2011, VACCINE, V29, P1248, DOI 10.1016/j.vaccine.2010.11.079
   Julander JG, 2011, VACCINE, V29, P6008, DOI 10.1016/j.vaccine.2011.06.034
   Kaptein SJF, 2010, ANTIMICROB AGENTS CH, V54, P5269, DOI 10.1128/AAC.00686-10
   Kohler S, 2012, EUR J IMMUNOL, V42, P2363, DOI 10.1002/eji.201142306
   Lefeuvre Anabelle, 2004, Curr Infect Dis Rep, V6, P96, DOI 10.1007/s11908-996-0005-9
   LOBIGS M, 1987, VIROLOGY, V161, P474, DOI 10.1016/0042-6822(87)90141-3
   Mantel N, 2011, VACCINE, V29, P6629, DOI 10.1016/j.vaccine.2011.06.101
   Marchevsky RS, 2003, VIROLOGY, V316, P55, DOI 10.1016/S0042-6822(03)00583-X
   Martins MA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054434
   McAllister A, 2000, J VIROL, V74, P9197, DOI 10.1128/JVI.74.19.9197-9205.2000
   Miller JD, 2008, IMMUNITY, V28, P710, DOI 10.1016/j.immuni.2008.02.020
   Monath TP, 2003, ADV VIRUS RES, V60, P343, DOI 10.1016/S0065-3527(03)60009-6
   Monath TP, 2003, J INFECT DIS, V188, P1213, DOI 10.1086/378356
   Monath TP, 2002, VACCINE, V20, P1004, DOI 10.1016/S0264-410X(01)00457-1
   Mudd PA, 2012, NATURE, V491, P129, DOI 10.1038/nature11443
   Mudd PA, 2010, IMMUNOGENETICS, V62, P593, DOI 10.1007/s00251-010-0461-0
   Mutebi JP, 2004, J VIROL, V78, P9652, DOI 10.1128/JVI.78.18.9652-9665.2004
   Nasveld PE, 2010, HUM VACCINES, V6, P1038, DOI 10.4161/hv.6.12.13057
   Neves PCC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081953
   Neves PCC, 2010, VACCINE, V28, P8183, DOI 10.1016/j.vaccine.2010.09.090
   Nogueira RT, 2011, VIROL J, V8, DOI 10.1186/1743-422X-8-127
   Nogueira RT, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059347
   Pierson TC, 2005, VIROLOGY, V334, P28, DOI 10.1016/j.virol.2005.01.021
   POLAND JD, 1981, B WORLD HEALTH ORGAN, V59, P895
   Pugachev KV, 2004, J VIROL, V78, P1032, DOI 10.1128/JVI.78.2.1032-1038.2004
   Pulendran B, 2013, IMMUNOL REV, V255, P243, DOI 10.1111/imr.12099
   Pulendran B, 2009, NAT REV IMMUNOL, V9, P741, DOI 10.1038/nri2629
   Qiao M, 2011, AM J TROP MED HYG, V85, P724, DOI 10.4269/ajtmh.2011.10-0436
   Querec T, 2006, J EXP MED, V203, P413, DOI 10.1084/jem.20051720
   Reinhardt B, 1998, J MED VIROL, V56, P159, DOI 10.1002/(SICI)1096-9071(199810)56:2&lt;159::AID-JMV10&gt;3.0.CO;2-B
   RICE C M, 1989, New Biologist, V1, P285
   Richter JD, 2005, NATURE, V433, P477, DOI 10.1038/nature03205
   Ron D, 2007, NAT REV MOL CELL BIO, V8, P519, DOI 10.1038/nrm2199
   Rumyantsev AA, 2010, VIROLOGY, V396, P329, DOI 10.1016/j.virol.2009.10.033
   Sabchareon A, 2012, LANCET, V380, P1559, DOI 10.1016/S0140-6736(12)61428-7
   Santana MGV, VIROLOGY IN PRESS
   Schoggins JW, 2012, P NATL ACAD SCI USA, V109, P14610, DOI 10.1073/pnas.1212379109
   Silva ML, 2011, VACCINE, V29, P583, DOI 10.1016/j.vaccine.2010.08.046
   Stoyanov CT, 2010, VACCINE, V28, P4644, DOI 10.1016/j.vaccine.2010.04.071
   Strode G. K, 1951, YELLOW FEVER
   Tao D, 2005, J EXP MED, V201, P201, DOI 10.1084/jem.20041526
   Trindade GF, 2012, MEM I OSWALDO CRUZ, V107, P262, DOI 10.1590/S0074-02762012000200017
   van der Most RG, 2002, VIROLOGY, V296, P117, DOI 10.1006/viro.2002.1432
   Villar LA, 2013, PEDIATR INFECT DIS J, V32, P1102, DOI 10.1097/INF.0b013e31829b8022
   Weill L, 2010, NUCLEIC ACIDS RES, V38, P1367, DOI 10.1093/nar/gkp1109
   Yun SI, 2003, J VIROL, V77, P6450, DOI 10.1128/JVI.77.11.6450-6465.2003
   Zou G, 2011, ANTIVIR RES, V91, P11, DOI 10.1016/j.antiviral.2011.05.001
NR 85
TC 14
Z9 14
U1 0
U2 9
PU LANDES BIOSCIENCE
PI AUSTIN
PA 1806 RIO GRANDE ST, AUSTIN, TX 78702 USA
SN 2164-5515
EI 2164-554X
J9 HUM VACC IMMUNOTHER
JI Human Vaccines Immunother.
PD MAY
PY 2014
VL 10
IS 5
BP 1256
EP 1265
DI 10.4161/hv.28117
PG 10
WC Biotechnology & Applied Microbiology; Immunology
SC Biotechnology & Applied Microbiology; Immunology
GA AI2AA
UT WOS:000336656700025
PM 24553128
OA Green Published, Bronze
DA 2020-12-01
ER

PT J
AU de Santana, MGV
   Neves, PCC
   dos Santos, JR
   Lima, NS
   dos Santos, AAC
   Watkins, DI
   Galler, R
   Bonaldo, MC
AF Veloso de Santana, Marlon G.
   Neves, Patricia C. C.
   dos Santos, Juliana Ribeiro
   Lima, Noemia S.
   dos Santos, Alexandre A. C.
   Watkins, David I.
   Galler, Ricardo
   Bonaldo, Myrna C.
TI Improved genetic stability of recombinant yellow fever 17D virus
   expressing a lentiviral Gag gene fragment
SO VIROLOGY
LA English
DT Article
DE Yellow Fever 17D virus; Viral vector; Genetic stability; SIV gag IRES;
   SIV Gag; Recombinant virus
ID SIMIAN IMMUNODEFICIENCY VIRUS; I MOLECULE MAMU-A-ASTERISK-01; RIBOSOME
   ENTRY SITE; HIV-2 GENOMIC RNA; T-CELL RESPONSES; ENDOPLASMIC-RETICULUM;
   RHESUS MACAQUES; VACCINE VIRUS; FLAVIVIRUS VACCINES; DENGUE VIRUS
AB We have previously designed a method to construct viable recombinant Yellow Fever (YF) 17D viruses expressing heterologous polypeptides including part of the Simian Immunodeficiency Virus (SIV) Gag protein. However, the expressed region, encompassing amino acid residues from 45 to 269, was genetically unstable. In this study, we improved the genetic stability of this recombinant YF 17D virus by introducing mutations in the IRES element localized at the 5' end of the SIV gag gene. The new stable recombinant virus elicited adaptive immune responses similar to those induced by the original recombinant virus. It is, therefore, possible to increase recombinant stability by removing functional motifs from the insert that may have deleterious effects on recombinant YF viral fitness. (C) 2014 Elsevier Inc. All rights reserved.
C1 [Veloso de Santana, Marlon G.; Neves, Patricia C. C.; dos Santos, Juliana Ribeiro; Lima, Noemia S.; dos Santos, Alexandre A. C.; Bonaldo, Myrna C.] Fiocruz MS, Inst Oswaldo Cruz, Lab Biol Mol Flavivirus, BR-21045900 Rio De Janeiro, Brazil.
   [Galler, Ricardo] Fundacao Oswaldo Cruz, Inst Tecnol Imunobiol, Rio De Janeiro, Brazil.
   [Veloso de Santana, Marlon G.; Watkins, David I.] Univ Miami, Miller Sch Med, Dept Pathol, Coral Gables, FL 33124 USA.
RP Bonaldo, MC (corresponding author), Inst Oswaldo Cruz FIOCRUZ, Lab Biol Mol Flavivirus, Sala 317,Av Brasil,4365 Manguinhos, BR-21040900 Rio De Janeiro, RJ, Brazil.
EM mbonaldo@ioc.fiocruz.br
RI de Santana, Marlon Gilsepp Veloso/H-8146-2017
OI de Santana, Marlon Gilsepp Veloso/0000-0002-3427-841X
FU Fundacao de Amparo Pesquisa do Estado de Rio de Janeiro (Faperj);
   National Institute for Vaccine Science and Technology (INCTV); National
   Institute for Vaccine Science and Technology (MCT/CNPq); Conselho
   Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq)National
   Council for Scientific and Technological Development (CNPq); Fiocruz;
   National Institutes of Health (NIH) HIVRAD [1P01AI094420-01A1]; NATIONAL
   INSTITUTE OF ALLERGY AND INFECTIOUS DISEASESUnited States Department of
   Health & Human ServicesNational Institutes of Health (NIH) - USANIH
   National Institute of Allergy & Infectious Diseases (NIAID)
   [P01AI094420, P01AI094420, P01AI094420, P01AI094420, P01AI094420,
   P01AI094420, P01AI094420, P01AI094420, P01AI094420, P01AI094420,
   P01AI094420, P01AI094420, P01AI094420, P01AI094420, P01AI094420,
   P01AI094420, P01AI094420, P01AI094420, P01AI094420, P01AI094420,
   P01AI094420, P01AI094420, P01AI094420, P01AI094420, P01AI094420,
   P01AI094420, P01AI094420, P01AI094420] Funding Source: NIH RePORTER
FX The authors are in debt to PDTIS-FIOCRUZ for supporting the sequencing,
   ELISpot and confocal microscopy studies through the Genomics, ELISpot
   and Confocal Microscopy Facilities. We are also grateful to Heloisa
   Diniz of Servico de Producao e Tratamento de Imagem - IOC/FIOCRUZ and
   Marcia de Souza Santana for technical support with the figures presented
   in this work and to Richard Rudersdorf for technical assistance. This
   work was supported by Grants from Fundacao de Amparo Pesquisa do Estado
   de Rio de Janeiro (Faperj), The National Institute for Vaccine Science
   and Technology (INCTV, MCT/CNPq), Conselho Nacional de Desenvolvimento
   Cientifico e Tecnologico (CNPq), Fiocruz and National Institutes of
   Health (NIH) HIVRAD Grant 1P01AI094420-01A1.
CR Allen TM, 1998, J IMMUNOL, V160, P6062
   Allen TM, 2001, J VIROL, V75, P738, DOI 10.1128/JVI.75.2.738-749.2001
   Barba-Spaeth G, 2005, J EXP MED, V202, P1179, DOI 10.1084/jem.20051352
   Bonaldo MC, 2005, J VIROL, V79, P8602, DOI 10.1128/JVI.79.13.8602-8613.2005
   Bonaldo MC, 2002, J MOL BIOL, V315, P873, DOI 10.1006/jmbi.2001.5258
   Bonaldo MC, 2000, MEM I OSWALDO CRUZ, V95, P215, DOI 10.1590/S0074-02762000000700037
   Bonaldo MC, 2010, J VIROL, V84, P3699, DOI 10.1128/JVI.02255-09
   Bonaldo MC, 2007, VIROL J, V4, DOI 10.1186/1743-422X-4-115
   Buck CB, 2001, J VIROL, V75, P181, DOI 10.1128/JVI.75.1.181-191.2001
   Castellino F, 2006, ANNU REV IMMUNOL, V24, P519, DOI 10.1146/annurev.immunol.23.021704.115825
   CHAMBERS TJ, 1990, ANNU REV MICROBIOL, V44, P649, DOI 10.1146/annurev.mi.44.100190.003245
   Ciczora Y, 2010, J GEN VIROL, V91, P404, DOI 10.1099/vir.0.015339-0
   Darty K, 2009, BIOINFORMATICS, V25, P1974, DOI 10.1093/bioinformatics/btp250
   Deas TS, 2005, J VIROL, V79, P4599, DOI 10.1128/JVI.79.8.4599-4609.2005
   Fang Y, 2009, AM J TROP MED HYG, V80, P862, DOI 10.4269/ajtmh.2009.80.862
   Franco D, 2010, VACCINE, V28, P5676, DOI 10.1016/j.vaccine.2010.06.052
   Friebe P, 2010, J VIROL, V84, P6103, DOI 10.1128/JVI.02042-09
   Gebhard LG, 2011, VIRUSES-BASEL, V3, P1739, DOI 10.3390/v3091739
   Giraldo-Vela JP, 2008, J VIROL, V82, P859, DOI 10.1128/JVI.01816-07
   Green DR, 2009, NAT REV IMMUNOL, V9, P353, DOI 10.1038/nri2545
   Herbreteau CH, 2005, NAT STRUCT MOL BIOL, V12, P1001, DOI 10.1038/nsmb1011
   Hsieh SC, 2010, J VIROL, V84, P4782, DOI 10.1128/JVI.01963-09
   Loffredo JT, 2004, J IMMUNOL, V173, P5064, DOI 10.4049/jimmunol.173.8.5064
   Loffredo JT, 2007, HIV MOL IMMUNOLOGY 2, P29
   Maciel M, 2008, VIROLOGY, V378, P105, DOI 10.1016/j.virol.2008.04.043
   McAllister A, 2000, J VIROL, V74, P9197, DOI 10.1128/JVI.74.19.9197-9205.2000
   Miller J. D., 2005, Current Drug Targets - Infectious Disorders, V5, P121, DOI 10.2174/1568005054201544
   Monath T. P, 2004, VACCINES, P1095
   Neves PCC, 2010, VACCINE, V28, P8183, DOI 10.1016/j.vaccine.2010.09.090
   Nicholson MG, 2006, VIROLOGY, V349, P325, DOI 10.1016/j.virol.2006.01.034
   Nogueira RT, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059347
   Palmer DR, 2007, J GEN VIROL, V88, P148, DOI 10.1099/vir.0.82272-0
   Pierson TC, 2005, VIROLOGY, V334, P28, DOI 10.1016/j.virol.2005.01.021
   Pugachev KV, 2005, CURR OPIN INFECT DIS, V18, P387, DOI 10.1097/01.qco.0000178823.28585.ad
   Querec T, 2006, J EXP MED, V203, P413, DOI 10.1084/jem.20051720
   RICE C M, 1989, New Biologist, V1, P285
   Santos AP, 2008, CYTOKINE, V42, P152, DOI 10.1016/j.cyto.2008.02.007
   Song HS, 2010, VIROL J, V7, DOI 10.1186/1743-422X-7-40
   Stefano I, 1999, VACCINE, V17, P1042, DOI 10.1016/S0264-410X(98)00320-X
   Tao D, 2005, J EXP MED, V201, P201, DOI 10.1084/jem.20041526
   Todd DJ, 2008, NAT REV IMMUNOL, V8, P663, DOI 10.1038/nri2359
   Trindade GF, 2012, MEM I OSWALDO CRUZ, V107, P262, DOI 10.1590/S0074-02762012000200017
   Weill L, 2010, NUCLEIC ACIDS RES, V38, P1367, DOI 10.1093/nar/gkp1109
   Zou G, 2011, ANTIVIR RES, V91, P11, DOI 10.1016/j.antiviral.2011.05.001
NR 44
TC 6
Z9 6
U1 0
U2 2
PU ACADEMIC PRESS INC ELSEVIER SCIENCE
PI SAN DIEGO
PA 525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA
SN 0042-6822
J9 VIROLOGY
JI Virology
PD MAR
PY 2014
VL 452
BP 202
EP 211
DI 10.1016/j.virol.2014.01.017
PG 10
WC Virology
SC Virology
GA AD1NJ
UT WOS:000333000400022
PM 24606697
OA Green Accepted, Bronze, Green Published
DA 2020-12-01
ER

PT J
AU Neves, PCC
   Santos, JR
   Tubarao, LN
   Bonaldo, MC
   Galler, R
AF Neves, Patricia C. C.
   Santos, Juliana R.
   Tubarao, Luciana N.
   Bonaldo, Myrna C.
   Galler, Ricardo
TI Early IFN-Gamma Production after YF 17D Vaccine Virus Immunization in
   Mice and Its Association with Adaptive Immune Responses
SO PLOS ONE
LA English
DT Article
ID DELTA-T-CELLS; YELLOW-FEVER VACCINE; DENDRITIC CELLS; NK CELLS; INNATE
   IMMUNITY; LISTERIA-MONOCYTOGENES; TRYPANOSOMA-CRUZI; INTERFERON-GAMMA;
   RHESUS MACAQUES; TNF-ALPHA
AB Yellow Fever vaccine is one of the most efficacious human vaccines ever made. The vaccine (YF 17D) virus induces polyvalent immune responses, with a mixed T(H)1/T(H)2 CD4(+) cell profile, which results in robust T CD8(+) responses and high titers of neutralizing antibody. In recent years, it has been suggested that early events after yellow fever vaccination are crucial to the development of adequate acquired immunity. We have previously shown that primary immunization of humans and monkeys with YF 17D virus vaccine resulted in the early synthesis of IFN-gamma. Herein we have demonstrated, for the first time that early IFN-gamma production after yellow fever vaccination is a feature also of murine infection and is much more pronounced in the C57BL/6 strain compared to the BALB/c strain. Likewise, in C57BL/6 strain, we have observed the highest CD8(+) T cells responses as well as higher titers of neutralizing antibodies and total anti-YF IgG. Regardless of this intense IFN-. response in mice, it was not possible to see higher titers of IgG2a in relation to IgG1 in both mice lineages. However, IgG2a titers were positively correlated to neutralizing antibodies levels, pointing to an important role of IFN-gamma in eliciting high quality responses against YF 17D, therefore influencing the immunogenicity of this vaccine.
C1 [Neves, Patricia C. C.; Galler, Ricardo] Fundacao Oswaldo Cruz, Inst Tecnol Imunobiol, Rio De Janeiro, Brazil.
   [Santos, Juliana R.; Tubarao, Luciana N.; Bonaldo, Myrna C.] Fundacao Oswaldo Cruz, Inst Oswaldo Cruz, Lab Biol Mol Flavivirus, Rio De Janeiro, Brazil.
RP Galler, R (corresponding author), Fundacao Oswaldo Cruz, Inst Tecnol Imunobiol, Rio De Janeiro, Brazil.
EM rgaller@bio.fiocruz.br
RI Galler, Ricardo/B-3280-2014
FU CNPqNational Council for Scientific and Technological Development
   (CNPq); PDTIS/FIOCRUZ [RVR03]; Instituto Nacional de Ciencia e
   Tecnologia em Vacinas (INCTV-CNPq/MCT); National Institutes of Health
   (NIH)United States Department of Health & Human ServicesNational
   Institutes of Health (NIH) - USA [1 P01 AI094420-01A1]; NATIONAL
   INSTITUTE OF ALLERGY AND INFECTIOUS DISEASESUnited States Department of
   Health & Human ServicesNational Institutes of Health (NIH) - USANIH
   National Institute of Allergy & Infectious Diseases (NIAID)
   [P01AI094420, P01AI094420, P01AI094420, P01AI094420, P01AI094420,
   P01AI094420, P01AI094420, P01AI094420, P01AI094420, P01AI094420,
   P01AI094420, P01AI094420, P01AI094420, P01AI094420, P01AI094420,
   P01AI094420, P01AI094420, P01AI094420, P01AI094420, P01AI094420,
   P01AI094420, P01AI094420, P01AI094420, P01AI094420, P01AI094420,
   P01AI094420, P01AI094420, P01AI094420] Funding Source: NIH RePORTER
FX This work was supported by grants from CNPq, PDTIS/FIOCRUZ (RVR03),
   Instituto Nacional de Ciencia e Tecnologia em Vacinas (INCTV-CNPq/MCT)
   and the National Institutes of Health (NIH grant: 1 P01 AI094420-01A1).
   The funders had no role in study design, data collection and analysis,
   decision to publish, or preparation of the manuscript.
CR Antunez MI, 2001, IMMUNOL LETT, V79, P189, DOI 10.1016/S0165-2478(01)00283-8
   Bachmann MF, 2010, NAT REV IMMUNOL, V10, P787, DOI 10.1038/nri2868
   Barba-Spaeth G, 2005, J EXP MED, V202, P1179, DOI 10.1084/jem.20051352
   Barrett ADT, 2009, CURR OPIN IMMUNOL, V21, P308, DOI 10.1016/j.coi.2009.05.018
   Beetz S, 2008, IMMUNOBIOLOGY, V213, P173, DOI 10.1016/j.imbio.2007.10.006
   Berg RE, 2003, J EXP MED, V198, P1583, DOI 10.1084/jem.20031051
   Billiau A, 2009, CYTOKINE GROWTH F R, V20, P97, DOI 10.1016/j.cytogfr.2009.02.004
   Bonaldo MC, 2000, MEM I OSWALDO CRUZ, V95, P215, DOI 10.1590/S0074-02762000000700037
   Bonaldo MC, 2010, J VIROL, V84, P3699, DOI 10.1128/JVI.02255-09
   Bonaldo MC, 2007, VIROL J, V4, DOI 10.1186/1743-422X-4-115
   Burton DR, 2002, NAT REV IMMUNOL, V2, P706, DOI 10.1038/nri891
   Casetti R, 2008, CELL MOL IMMUNOL, V5, P161, DOI 10.1038/cmi.2008.20
   Chan RC, 2001, LANCET, V358, P121, DOI 10.1016/S0140-6736(01)05341-7
   Conti L, 2005, J IMMUNOL, V174, P252, DOI 10.4049/jimmunol.174.1.252
   D'Orazio SEF, 2006, J IMMUNOL, V177, P7146, DOI 10.4049/jimmunol.177.10.7146
   Neves PCD, 2009, VACCINE, V27, P5543, DOI 10.1016/j.vaccine.2009.07.028
   Devilder MC, 2009, J IMMUNOL, V183, P3625, DOI 10.4049/jimmunol.0901571
   Dittmer U, 2001, J VIROL, V75, P654, DOI 10.1128/JVI.75.2.654-660.2001
   Dowd KA, 2011, VIROLOGY, V411, P306, DOI 10.1016/j.virol.2010.12.020
   Fagundes CT, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0001449
   Fang H, 2010, FEMS IMMUNOL MED MIC, V59, P71, DOI 10.1111/j.1574-695X.2010.00663.x
   Gandini M, 2011, MEM I OSWALDO CRUZ, V106, P594, DOI 10.1590/S0074-02762011000500012
   Gaucher D, 2008, J EXP MED, V205, P3119, DOI 10.1084/jem.20082292
   Ghanem ENB, 2011, J IMMUNOL, V186, P1703, DOI 10.4049/jimmunol.1001960
   Gunther VJ, 2011, VACCINE, V29, P3895, DOI 10.1016/j.vaccine.2011.03.038
   HOFT DF, 1993, J IMMUNOL, V151, P7038
   Ismaili J, 2002, CLIN IMMUNOL, V103, P296, DOI 10.1006/clim.2002.5218
   Julander JG, 2011, VACCINE, V29, P6008, DOI 10.1016/j.vaccine.2011.06.034
   Kasturi SP, 2011, NATURE, V470, P543, DOI 10.1038/nature09737
   Kohler S, 2012, EUR J IMMUNOL, V42, P2363, DOI 10.1002/eji.201142306
   Lauzon NM, 2006, CELL IMMUNOL, V241, P102, DOI 10.1016/j.cellimm.2006.08.004
   LIBLAU RS, 1995, IMMUNOL TODAY, V16, P34, DOI 10.1016/0167-5699(95)80068-9
   Lieberman LA, 2002, MICROBES INFECT, V4, P1531, DOI 10.1016/S1286-4579(02)00036-9
   Liu SY, 2012, P NATL ACAD SCI USA, V109, P4239, DOI 10.1073/pnas.1114981109
   Liu T, 2001, J VIROL, V75, P2107, DOI 10.1128/JVI.75.5.2107-2118.2001
   Liu T, 2000, CELL IMMUNOL, V202, P31, DOI 10.1006/cimm.2000.1644
   Maciel M, 2008, VIROLOGY, V378, P105, DOI 10.1016/j.virol.2008.04.043
   Martin-Fontecha A, 2004, NAT IMMUNOL, V5, P1260, DOI 10.1038/ni1138
   Martino A, 2007, CURR MOL MED, V7, P658, DOI 10.2174/156652407782564345
   Martins MA, 2008, VACCINE, V26, P1173, DOI 10.1016/j.vaccine.2007.12.035
   Miller JD, 2008, IMMUNITY, V28, P710, DOI 10.1016/j.immuni.2008.02.020
   Mills CD, 2000, J IMMUNOL, V164, P6166, DOI 10.4049/jimmunol.164.12.6166
   Munoz-Jordan JL, 2005, J VIROL, V79, P8004, DOI 10.1128/JVI.79.13.8004-8013.2005
   Munz C, 2005, J EXP MED, V202, P203, DOI 10.1084/jem.20050810
   Neves PCC, 2010, VACCINE, V28, P8183, DOI 10.1016/j.vaccine.2010.09.090
   Neves-Souza PCF, 2005, BMC INFECT DIS, V5, DOI 10.1186/1471-2334-5-64
   Nimmerjahn F, 2008, NAT REV IMMUNOL, V8, P34, DOI 10.1038/nri2206
   Nogueira RT, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059347
   Park SJ, 2009, J IMMUNOL, V182, P4306, DOI 10.4049/jimmunol.0803462
   Pulendran B, 2009, NAT REV IMMUNOL, V9, P741, DOI 10.1038/nri2629
   Qin G, 2009, J INFECT DIS, V200, P858, DOI 10.1086/605413
   Quaresma JAS, 2006, VIROLOGY, V345, P22, DOI 10.1016/j.virol.2005.09.058
   Querec T, 2006, J EXP MED, V203, P413, DOI 10.1084/jem.20051720
   Querec TD, 2009, NAT IMMUNOL, V10, P116, DOI 10.1038/ni.1688
   Ryan EJ, 2007, VACCINE, V25, P3380, DOI 10.1016/j.vaccine.2006.12.048
   Santos AP, 2008, CYTOKINE, V42, P152, DOI 10.1016/j.cyto.2008.02.007
   SCHLESINGER JJ, 1993, VIROLOGY, V192, P132, DOI 10.1006/viro.1993.1015
   SCHLESINGER JJ, 1995, J GEN VIROL, V76, P217, DOI 10.1099/0022-1317-76-1-217
   Schoenborn JR, 2007, ADV IMMUNOL, V96, P41, DOI 10.1016/S0065-2776(07)96002-2
   Schoggins JW, 2011, NATURE, V472, P481, DOI 10.1038/nature09907
   Siegers GM, 2011, CYTOTHERAPY, V13, P753, DOI 10.3109/14653249.2011.553595
   Singh R, 2010, J INFECT DIS, V202, P223, DOI 10.1086/653486
   Sivori S, 2004, P NATL ACAD SCI USA, V101, P10116, DOI 10.1073/pnas.0403744101
   Soulard V, 2009, MALARIA J, V8, DOI 10.1186/1475-2875-8-128
   Stefano I, 1999, VACCINE, V17, P1042, DOI 10.1016/S0264-410X(98)00320-X
   Tu WW, 2011, J EXP MED, V208, P1511, DOI 10.1084/jem.20110226
   Verhoeven D, 2008, VIRAL IMMUNOL, V21, P99, DOI 10.1089/vim.2007.0002
   Wang T, 2003, J IMMUNOL, V171, P2524, DOI 10.4049/jimmunol.171.5.2524
   Watanabe H, 2004, SHOCK, V22, P460, DOI 10.1097/01.shk.0000142249.08135.e9
   Wehner R, 2011, J INNATE IMMUN, V3, P258, DOI 10.1159/000323923
   Weill L, 2010, NUCLEIC ACIDS RES, V38, P1367, DOI 10.1093/nar/gkp1109
   Wiesel M, 2012, EUR J IMMUNOL, V42, P1080, DOI 10.1002/eji.201142205
   Zhou L, 2009, IMMUNITY, V30, P646, DOI 10.1016/j.immuni.2009.05.001
NR 73
TC 19
Z9 19
U1 0
U2 0
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD DEC 6
PY 2013
VL 8
IS 12
AR e81953
DI 10.1371/journal.pone.0081953
PG 16
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA 273WJ
UT WOS:000328566700055
PM 24324734
OA DOAJ Gold, Green Published
DA 2020-12-01
ER

PT J
AU Nogueira, RT
   Nogueira, AR
   Pereira, MCS
   Rodrigues, MM
   Neves, PCD
   Galler, R
   Bonaldo, MC
AF Nogueira, Raquel Tayar
   Nogueira, Alanderson Rocha
   Souza Pereira, Mirian Claudia
   Rodrigues, Mauricio Martins
   da Costa Neves, Patricia Cristina
   Galler, Ricardo
   Bonaldo, Myrna Cristina
TI Recombinant Yellow Fever Viruses Elicit CD8(+) T Cell Responses and
   Protective Immunity against Trypanosoma cruzi
SO PLOS ONE
LA English
DT Article
ID AMASTIGOTE SURFACE PROTEIN-2; SUSCEPTIBLE MOUSE STRAIN; INDIAN RHESUS
   MACAQUES; GENETIC IMMUNIZATION; DISEASE SEVERITY; NITRIC-OXIDE;
   INFECTION; VACCINE; ANTIGEN; MICE
AB Chagas' disease is a major public health problem affecting nearly 10 million in Latin America. Despite several experimental vaccines have shown to be immunogenic and protective in mouse models, there is not a current vaccine being licensed for humans or in clinical trial against T. cruzi infection. Towards this goal, we used the backbone of Yellow Fever (YF) 17D virus, one of the most effective and well-established human vaccines, to express an immunogenic fragment derived from T. cruzi Amastigote Surface Protein 2 (ASP-2). The cDNA sequence of an ASP-2 fragment was inserted between E and NS1 genes of YF 17D virus through the construction of a recombinant heterologous cassette. The replication ability and genetic stability of recombinant YF virus (YF17D/ENS1/Tc) was confirmed for at least six passages in Vero cells. Immunogenicity studies showed that YF17D/ENS1/Tc virus elicited neutralizing antibodies and gamma interferon (IFN-gamma) producing-cells against the YF virus. Also, it was able to prime a CD8(+) T cell directed against the transgenic T. cruzi epitope (TEWETGQI) which expanded significantly as measured by T cell-specific production of IFN-gamma before and after T. cruzi challenge. However, most important for the purposes of vaccine development was the fact that a more efficient protective response could be seen in mice challenged after vaccination with the YF viral formulation consisting of YF17D/ENS1/Tc and a YF17D recombinant virus expressing the TEWETGQI epitope at the NS2B-3 junction. The superior protective immunity observed might be due to an earlier priming of epitope-specific IFN-gamma-producing T CD8(+) cells induced by vaccination with this viral formulation. Our results suggest that the use of viral formulations consisting of a mixture of recombinant YF 17D viruses may be a promising strategy to elicit protective immune responses against pathogens, in general.
C1 [Nogueira, Raquel Tayar; da Costa Neves, Patricia Cristina; Bonaldo, Myrna Cristina] Fundacao Oswaldo Cruz, Inst Oswaldo Cruz, Lab Biol Mol Flavivirus, Rio De Janeiro, Brazil.
   [Galler, Ricardo] Fundacao Oswaldo Cruz, Inst Tecnol & Imunobiol, Rio De Janeiro, Brazil.
   [Nogueira, Alanderson Rocha; Souza Pereira, Mirian Claudia] Fundacao Oswaldo Cruz, Inst Oswaldo Cruz, Lab Ultra Estrutura Celular, Rio De Janeiro, Brazil.
   [Rodrigues, Mauricio Martins] Univ Fed Sao Paulo, Escola Paulista Med, Dept Microbiol Imunol & Parasitol, Ctr Terapia Celular & Mol, Sao Paulo, Brazil.
   [da Costa Neves, Patricia Cristina] Fundacao Oswaldo Cruz, Inst Tecnol & Imunobiol, Lab Tecnol Imunol, Rio De Janeiro, Brazil.
RP Bonaldo, MC (corresponding author), Fundacao Oswaldo Cruz, Inst Oswaldo Cruz, Lab Biol Mol Flavivirus, Rio De Janeiro, Brazil.
EM mbonaldo@ioc.fiocruz.br
RI Rodrigues, Mauricio M./B-8512-2012; Nogueira, Raquel Tayar/F-6475-2019;
   Galler, Ricardo/B-3280-2014
OI Nogueira, Raquel Tayar/0000-0002-0581-763X; Pereira, Mirian
   Claudia/0000-0003-2223-3289
FU Fundacao de Amparo a Pesquisa do Estado de Rio de Janeiro; National
   Institute for Vaccine Science and Technology; Conselho Nacional de
   Desenvolvimento Cientifico e Tecnologico (CNPq)National Council for
   Scientific and Technological Development (CNPq); FIOCRUZ; CNPqNational
   Council for Scientific and Technological Development (CNPq)
FX This work was supported by grants from Fundacao de Amparo a Pesquisa do
   Estado de Rio de Janeiro, The National Institute for Vaccine Science and
   Technology, Conselho Nacional de Desenvolvimento Cientifico e
   Tecnologico (CNPq) and FIOCRUZ. RTN, MMR, MCB and RG are recipients of
   fellowships from CNPq. The funders had no role in study design, data
   collection and analysis, decision to publish, or preparation of the
   manuscript.
CR Akondy RS, 2009, J IMMUNOL, V183, P7919, DOI 10.4049/jimmunol.0803903
   Albajar-Vinas P, 2011, EUROSURVEILLANCE, P16
   Aliberti JCS, 2001, AM J PATHOL, V158, P1433, DOI 10.1016/S0002-9440(10)64094-1
   Amigorena S, 2010, CURR OPIN IMMUNOL, V22, P109, DOI 10.1016/j.coi.2010.01.022
   Araujo AFS, 2005, INFECT IMMUN, V73, P6017, DOI 10.1128/IAI.73.9.6017-6025.2005
   Bachmann MF, 2010, NAT REV IMMUNOL, V10, P787, DOI 10.1038/nri2868
   Bonaldo MC, 2002, J MOL BIOL, V315, P873, DOI 10.1006/jmbi.2001.5258
   Bonaldo MC, 2010, J VIROL, V84, P3699, DOI 10.1128/JVI.02255-09
   Bonaldo MC, 2007, VIROL J, V4, DOI 10.1186/1743-422X-4-115
   Boscardin SB, 2003, INFECT IMMUN, V71, P2744, DOI 10.1128/IAI.71.5.2744-2757.2003
   BRENER Z, 1969, ANN TROP MED PARASIT, V63, P215, DOI 10.1080/00034983.1969.11686622
   Cazorla SI, 2008, VACCINE, V26, P1999, DOI 10.1016/j.vaccine.2008.02.011
   Cazorla SI, 2010, J INFECT DIS, V202, P136, DOI 10.1086/652872
   Cazorla SI, 2009, EXPERT REV VACCINES, V8, P921, DOI [10.1586/erv.09.45, 10.1586/ERV.09.45]
   Claser C, 2007, MICROBES INFECT, V9, P1011, DOI 10.1016/j.micinf.2007.04.006
   Co MDT, 2002, VIROLOGY, V293, P151, DOI 10.1006/viro.2001.1255
   de Alencar BCG, 2007, VACCINE, V25, P6018, DOI 10.1016/j.vaccine.2007.05.022
   de Alencar BCG, 2009, INFECT IMMUN, V77, P4383, DOI 10.1128/IAI.01459-08
   Dominguez MR, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022011
   Duan XF, 2009, VACCINE, V27, P6154, DOI 10.1016/j.vaccine.2009.08.026
   Dumonteil E, 2009, INFECT GENET EVOL, V9, P1075, DOI 10.1016/j.meegid.2009.02.009
   Dutra WO, 2009, MEM I OSWALDO CRUZ, V104, P208, DOI 10.1590/S0074-02762009000900027
   Egui A, 2012, MOL IMMUNOL, V52, P289, DOI 10.1016/j.molimm.2012.05.021
   Eickhoff CS, 2010, MEM I OSWALDO CRUZ, V105, P687, DOI 10.1590/S0074-02762010000500015
   Franco D, 2010, VACCINE, V28, P5676, DOI 10.1016/j.vaccine.2010.06.052
   Garg N, 2002, INFECT IMMUN, V70, P5547, DOI 10.1128/IAI.70.10.5547-5555.2002
   Goonetilleke N, 2006, J VIROL, V80, P4717, DOI 10.1128/JVI.80.10.4717-4728.2006
   Green DR, 2009, NAT REV IMMUNOL, V9, P353, DOI 10.1038/nri2545
   Gulland A, 2012, BRIT MED J, V344, DOI 10.1136/bmj.e3771
   Gutierrez FRS, 2009, MEM I OSWALDO CRUZ, V104, P236, DOI 10.1590/S0074-02762009000900030
   Heath WR, 2001, NAT REV IMMUNOL, V1, P126, DOI 10.1038/35100512
   Hoft DF, 2007, J IMMUNOL, V179, P6889, DOI 10.4049/jimmunol.179.10.6889
   Hoft DF, 2005, INFECT IMMUN, V73, P4934, DOI 10.1128/IAI.73.8.4934-4940.2005
   Junqueira C, 2010, EXPERT REV MOL MED, V12, DOI 10.1017/S1462399410001560
   Laucella SA, 2004, J INFECT DIS, V189, P909, DOI 10.1086/381682
   Lee BY, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000916
   Lefeuvre Anabelle, 2004, Curr Infect Dis Rep, V6, P96, DOI 10.1007/s11908-996-0005-9
   Lima-Junior JC, 2008, VACCINE, V26, P6645, DOI 10.1016/j.vaccine.2008.09.029
   Liniger M, 2007, EXPERT REV VACCINES, V6, P255, DOI 10.1586/14760584.6.2.255
   Low HP, 1997, MOL BIOCHEM PARASIT, V88, P137, DOI 10.1016/S0166-6851(97)00088-1
   Low WP, 1998, J IMMUNOL, V160, P1817
   Machado AV, 2006, HUM GENE THER, V17, P898, DOI 10.1089/hum.2006.17.898
   Martin D, 2004, IMMUNOL REV, V201, P304, DOI 10.1111/j.0105-2896.2004.00183.x
   Martin DL, 2006, PLOS PATHOG, V2, P731, DOI 10.1371/journal.ppat.0020077
   Martin DL, 2005, J IMMUNOL, V174, P1594, DOI 10.4049/jimmunol.174.3.1594
   Miller JD, 2008, IMMUNITY, V28, P710, DOI 10.1016/j.immuni.2008.02.020
   Miyahira Y, 2005, INFECT IMMUN, V73, P7356, DOI 10.1128/IAI.73.11.7356-7365.2005
   Miyahira Y, 2008, PARASITOL INT, V57, P38, DOI 10.1016/j.parint.2007.07.005
   Monath TP, 2003, ADV VIRUS RES, V60, P343, DOI 10.1016/S0065-3527(03)60009-6
   Morell M, 2006, VACCINE, V24, P7046, DOI 10.1016/j.vaccine.2006.07.006
   Mudd PA, 2010, IMMUNOGENETICS, V62, P593, DOI 10.1007/s00251-010-0461-0
   Neves PCC, 2010, VACCINE, V28, P8183, DOI 10.1016/j.vaccine.2010.09.090
   Nogueira RT, 2011, VIROL J, V8, DOI 10.1186/1743-422X-8-127
   Perez Brandan C, 2012, BIOENGINEERED, P3
   Planelles L, 2001, INFECT IMMUN, V69, P6558, DOI 10.1128/IAI.69.10.6558-6563.2001
   POLAND JD, 1981, B WORLD HEALTH ORGAN, V59, P895
   Querec T, 2006, J EXP MED, V203, P413, DOI 10.1084/jem.20051720
   Quijano-Hernandez I, 2011, HUM VACCINES, V7, P1184, DOI 10.4161/hv.7.11.17016
   Rassi A, 2012, INFECT DIS CLIN N AM, V26, P275, DOI 10.1016/j.idc.2012.03.002
   Reyes-Sandoval A, 2012, MOL THER
   RICE C M, 1989, New Biologist, V1, P285
   Rigato PO, 2011, INFECT IMMUN, V79, P2120, DOI 10.1128/IAI.01190-10
   Rodrigues MM, 2009, MEM I OSWALDO CRUZ, V104, P281, DOI 10.1590/S0074-02762009000900037
   Rodrigues MM, 2003, AN ACAD BRAS CIENC, V75, P443, DOI 10.1590/S0001-37652003000400005
   Sanchez-Burgos G, 2007, FEMS IMMUNOL MED MIC, V50, P333, DOI 10.1111/j.1574-695X.2007.00251.x
   Schmunis GA, 2010, ACTA TROP, V115, P14, DOI 10.1016/j.actatropica.2009.11.003
   Seder RA, 2008, NAT REV IMMUNOL, V8, P247, DOI 10.1038/nri2274
   SILVA JS, 1995, INFECT IMMUN, V63, P4862, DOI 10.1128/IAI.63.12.4862-4867.1995
   Silveira ELV, 2008, CLIN VACCINE IMMUNOL, V15, P1292, DOI 10.1128/CVI.00142-08
   Stoyanov CT, 2010, VACCINE, V28, P4644, DOI 10.1016/j.vaccine.2010.04.071
   TAIBI A, 1993, J IMMUNOL, V151, P2676
   Takayama E, 2010, INT J PARASITOL, V40, P1549, DOI 10.1016/j.ijpara.2010.05.011
   Theiler M, 1937, J EXP MED, V65, P787, DOI 10.1084/jem.65.6.787
   Todd DJ, 2008, NAT REV IMMUNOL, V8, P663, DOI 10.1038/nri2359
   Trindade GF, 2012, MEM I OSWALDO CRUZ, V107, P262, DOI 10.1590/S0074-02762012000200017
   Tzelepis F, 2006, INFECT IMMUN, V74, P2477, DOI 10.1128/IAI.74.4.2477-2481.2006
   Tzelepis F, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000393
   van der Most RG, 2002, VIROLOGY, V296, P117, DOI 10.1006/viro.2002.1432
   Vasconcelos JR, 2004, HUM GENE THER, V15, P878, DOI 10.1089/hum.2004.15.878
   Wizel B, 1998, J CLIN INVEST, V102, P1062, DOI 10.1172/JCI3835
   Limon-Flores AY, 2010, VACCINE, V28, P7414, DOI 10.1016/j.vaccine.2010.08.104
NR 81
TC 13
Z9 14
U1 0
U2 7
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD MAR 19
PY 2013
VL 8
IS 3
AR e59347
DI 10.1371/journal.pone.0059347
PG 13
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA 125SR
UT WOS:000317562100113
PM 23527169
OA DOAJ Gold, Green Published
DA 2020-12-01
ER

PT J
AU Martins, MA
   Bonaldo, MC
   Rudersdorf, RA
   Piaskowski, SM
   Rakasz, EG
   Weisgrau, KL
   Furlott, JR
   Eernisse, CM
   de Santana, MGV
   Hidalgo, B
   Friedrich, TC
   Chiuchiolo, MJ
   Parks, CL
   Wilson, NA
   Allison, DB
   Galler, R
   Watkins, DI
AF Martins, Mauricio A.
   Bonaldo, Myrna C.
   Rudersdorf, Richard A.
   Piaskowski, Shari M.
   Rakasz, Eva G.
   Weisgrau, Kim L.
   Furlott, Jessica R.
   Eernisse, Christopher M.
   Veloso de Santana, Marlon G.
   Hidalgo, Bertha
   Friedrich, Thomas C.
   Chiuchiolo, Maria J.
   Parks, Christopher L.
   Wilson, Nancy A.
   Allison, David B.
   Galler, Ricardo
   Watkins, David I.
TI Immunogenicity of Seven New Recombinant Yellow Fever Viruses 17D
   Expressing Fragments of SIVmac239 Gag, Nef, and Vif in Indian Rhesus
   Macaques
SO PLOS ONE
LA English
DT Article
ID T-CELL RESPONSES; TETRAVALENT DENGUE VACCINE; CLASS-I MOLECULE;
   IMMUNODEFICIENCY-VIRUS; HIV-1 VACCINE; VIRAL LOAD; ATTENUATED VACCINE;
   INNATE IMMUNITY; EPITOPES; VECTOR
AB An effective vaccine remains the best solution to stop the spread of human immunodeficiency virus (HIV). Cellular immune responses have been repeatedly associated with control of viral replication and thus may be an important element of the immune response that must be evoked by an efficacious vaccine. Recombinant viral vectors can induce potent T-cell responses. Although several viral vectors have been developed to deliver HIV genes, only a few have been advanced for clinical trials. The live-attenuated yellow fever vaccine virus 17D (YF17D) has many properties that make it an attractive vector for AIDS vaccine regimens. YF17D is well tolerated in humans and vaccination induces robust T-cell responses that persist for years. Additionally, methods to manipulate the YF17D genome have been established, enabling the generation of recombinant (r)YF17D vectors carrying genes from unrelated pathogens. Here, we report the generation of seven new rYF17D viruses expressing fragments of simian immunodeficiency virus (SIV)mac239 Gag, Nef, and Vif. Studies in Indian rhesus macaques demonstrated that these live-attenuated vectors replicated in vivo, but only elicited low levels of SIV-specific cellular responses. Boosting with recombinant Adenovirus type-5 (rAd5) vectors resulted in robust expansion of SIV-specific CD8(+) T-cell responses, particularly those targeting Vif. Priming with rYF17D also increased the frequency of CD4(+) cellular responses in rYF17D/ rAd5-immunized macaques compared to animals that received rAd5 only. The effect of the rYF17D prime on the breadth of SIV-specific T-cell responses was limited and we also found evidence that some rYF17D vectors were more effective than others at priming SIV-specific T-cell responses. Together, our data suggest that YF17D - a clinically relevant vaccine vector - can be used to prime AIDS virus-specific T-cell responses in heterologous prime boost regimens. However, it will be important to optimize rYF17D-based vaccine regimens to ensure maximum delivery of all immunogens in a multivalent vaccine.
C1 [Martins, Mauricio A.; Watkins, David I.] Univ Miami, Miller Sch Med, Dept Pathol, Miami, FL 33136 USA.
   [Bonaldo, Myrna C.; Veloso de Santana, Marlon G.; Galler, Ricardo] Inst Oswaldo Cruz, FIOCRUZ, Lab Biol Mol Flavivirus, BR-20001 Rio De Janeiro, Brazil.
   [Rudersdorf, Richard A.; Piaskowski, Shari M.; Rakasz, Eva G.; Weisgrau, Kim L.; Furlott, Jessica R.; Eernisse, Christopher M.; Friedrich, Thomas C.; Wilson, Nancy A.] Univ Wisconsin, Wisconsin Natl Primate Res Ctr, Madison, WI USA.
   [Friedrich, Thomas C.] Univ Wisconsin, Dept Pathobiol Sci, Madison, WI 53706 USA.
   [Chiuchiolo, Maria J.; Parks, Christopher L.] Brooklyn Army Terminal, Int AIDS Vaccine Initiat, AIDS Vaccine Design & Dev Lab, Brooklyn, NY USA.
   [Wilson, Nancy A.] Univ Wisconsin, Dept Med, Madison, WI USA.
   [Hidalgo, Bertha; Allison, David B.] Univ Alabama Birmingham, Dept Biostat, Sect Stat Genet, Birmingham, AL 35294 USA.
RP Watkins, DI (corresponding author), Univ Miami, Miller Sch Med, Dept Pathol, Miami, FL 33136 USA.
EM dwatkins@med.miami.edu
RI Galler, Ricardo/B-3280-2014; Rakasz, Eva G/H-9197-2019; Bonaldo, Myrna
   C/D-9494-2013; de Santana, Marlon Gilsepp Veloso/H-8146-2017; Martins,
   Mauricio/AAU-9226-2020
OI de Santana, Marlon Gilsepp Veloso/0000-0002-3427-841X; Martins,
   Mauricio/0000-0001-8336-216X; Friedrich, Thomas/0000-0001-9831-6895;
   Allison, David/0000-0003-3566-9399
FU National Institutes of Health (NIH)/National Institute of Allergy and
   Infectious Disease (NIAID)United States Department of Health & Human
   ServicesNational Institutes of Health (NIH) - USANIH National Institute
   of Allergy & Infectious Diseases (NIAID) [R01 AI076114, R01 AI049120];
   Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior
   (CAPES)CAPES; FIOCRUZ in Brazil; National Institute for Vaccine
   Technology (INCTV/CNPq); NCRRUnited States Department of Health & Human
   ServicesNational Institutes of Health (NIH) - USANIH National Center for
   Research Resources (NCRR) [P51 RR000167]; Research Facilities
   Improvement ProgramUnited States Department of Health & Human
   ServicesNational Institutes of Health (NIH) - USANIH National Center for
   Research Resources (NCRR) [RR15459, RR020141]; NATIONAL CENTER FOR
   RESEARCH RESOURCESUnited States Department of Health & Human
   ServicesNational Institutes of Health (NIH) - USANIH National Center for
   Research Resources (NCRR) [P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, C06RR020141, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   C06RR020141, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, C06RR020141,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, C06RR015459,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, C06RR020141, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   C06RR020141, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, C06RR020141,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167] Funding Source: NIH RePORTER; NATIONAL HEART,
   LUNG, AND BLOOD INSTITUTEUnited States Department of Health & Human
   ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung
   & Blood Institute (NHLBI) [T32HL072757, T32HL072757, T32HL072757,
   T32HL072757, T32HL072757, T32HL072757, T32HL072757, T32HL072757,
   T32HL072757, T32HL072757, T32HL072757, T32HL072757, T32HL072757,
   T32HL072757] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY
   AND INFECTIOUS DISEASESUnited States Department of Health & Human
   ServicesNational Institutes of Health (NIH) - USANIH National Institute
   of Allergy & Infectious Diseases (NIAID) [R01AI076114, R01AI076114,
   R01AI076114, R01AI076114, R01AI049120, R01AI049120, R01AI049120,
   R01AI049120, R01AI049120, R01AI049120, R01AI049120, R01AI049120,
   R01AI076114, R01AI049120] Funding Source: NIH RePORTER; OFFICE OF THE
   DIRECTOR, NATIONAL INSTITUTES OF HEALTHUnited States Department of
   Health & Human ServicesNational Institutes of Health (NIH) - USA
   [P51OD011106, P51OD011106, P51OD011106, P51OD011106, P51OD011106,
   P51OD011106, P51OD011106, P51OD011106, P51OD011106, P51OD011106,
   P51OD011106, P51OD011106, P51OD011106, P51OD011106, P51OD011106] Funding
   Source: NIH RePORTER
FX This research was supported by National Institutes of Health
   (NIH)/National Institute of Allergy and Infectious Disease (NIAID)
   grants R01 AI076114 and R01 AI049120 awarded to DIW. Funding also came
   from Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)
   and FIOCRUZ in Brazil. Part of the work done in FIOCRUZ was supported by
   the National Institute for Vaccine Technology (INCTV/CNPq). In addition,
   this work was supported by NCRR grant P51 RR000167 to the Wisconsin
   National Primate Research Center, University of Wisconsin-Madison. This
   research was conducted in part at a facility constructed with support
   from Research Facilities Improvement Program grant numbers RR15459 and
   RR020141. The funders had no role in study design, data collection and
   analysis, decision to publish, or preparation of the manuscript.
CR Abbink P, 2007, J VIROL, V81, P4654, DOI 10.1128/JVI.02696-06
   Allen TM, 2000, NATURE, V407, P386, DOI 10.1038/35030124
   Allen TM, 2005, J VIROL, V79, P13239, DOI 10.1128/JVI.79.21.13239-13249.2005
   Appaiahgari MB, 2010, EXPERT REV VACCINES, V9, P1371, DOI [10.1586/erv.10.139, 10.1586/ERV.10.139]
   Arroyo J, 2004, J VIROL, V78, P12497, DOI 10.1128/JVI.78.22.12497-12507.2004
   Barnett ED, 2007, CLIN INFECT DIS, V44, P850, DOI 10.1086/511869
   Barouch DH, 2010, CURR OPIN HIV AIDS, V5, P386, DOI 10.1097/COH.0b013e32833cfe4c
   Barrett ADT, 2009, CURR OPIN IMMUNOL, V21, P308, DOI 10.1016/j.coi.2009.05.018
   Betts MR, 2006, BLOOD, V107, P4781, DOI 10.1182/blood-2005-12-4818
   Boaz MJ, 2002, J IMMUNOL, V169, P6376, DOI 10.4049/jimmunol.169.11.6376
   Bonaldo MC, 2006, CELL BIOCHEM BIOPHYS, V44, P313, DOI 10.1385/CBB:44:3:313
   Bonaldo MC, 2002, J MOL BIOL, V315, P873, DOI 10.1006/jmbi.2001.5258
   Bonaldo MC, 2010, J VIROL, V84, P3699, DOI 10.1128/JVI.02255-09
   Bonaldo MC, 2007, VIROL J, V4, DOI 10.1186/1743-422X-4-115
   Buchbinder SP, 2008, LANCET, V372, P1881, DOI 10.1016/S0140-6736(08)61591-3
   Carrington M, 2003, ANNU REV MED, V54, P535, DOI 10.1146/annurev.med.54.101601.152346
   Caufour PS, 2001, VIRUS RES, V79, P1, DOI 10.1016/S0168-1702(01)00273-8
   Centers for Disease Control (CDC), 1981, MMWR Morb Mortal Wkly Rep, V30, P250
   Cline AN, 2005, J MED PRIMATOL, V34, P303
   dos Santos AP, 2005, MEM I OSWALDO CRUZ, V100, P331, DOI 10.1590/S0074-02762005000300021
   Edwards BH, 2002, J VIROL, V76, P2298, DOI 10.1128/JVI.76.5.2298-2305.2002
   Franco D, 2010, VACCINE, V28, P5676, DOI 10.1016/j.vaccine.2010.06.052
   Friedrich TC, 2007, J VIROL, V81, P3465, DOI 10.1128/JVI.02392-06
   Giraldo-Vela JP, 2008, J VIROL, V82, P859, DOI 10.1128/JVI.01816-07
   Goulder PJR, 2008, NAT REV IMMUNOL, V8, P619, DOI 10.1038/nri2357
   Guirakhoo F, 2004, J VIROL, V78, P4761, DOI 10.1128/JVI.78.9.4761-4775.2004
   Guy B, 2008, VACCINE, V26, P5712, DOI 10.1016/j.vaccine.2008.08.019
   Guy B, 2011, VACCINE, V29, P7229, DOI 10.1016/j.vaccine.2011.06.094
   Guy B, 2010, VACCINE, V28, P632, DOI 10.1016/j.vaccine.2009.09.098
   Hanke T, 2007, J GEN VIROL, V88, P1, DOI 10.1099/vir.0.82493-0
   HIV/ AIDS JUNPo, 2010, GLOB REP UNAIDS REP
   Im EJ, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002041
   Jin X, 1999, J EXP MED, V189, P991, DOI 10.1084/jem.189.6.991
   Kaizu M, 2007, IMMUNOGENETICS, V59, P693, DOI 10.1007/s00251-007-0233-7
   Kiepiela P, 2007, NAT MED, V13, P46, DOI 10.1038/nm1520
   Liu JY, 2006, J VIROL, V80, P11991, DOI 10.1128/JVI.01348-06
   Liu MA, 2010, IMMUNITY, V33, P504, DOI 10.1016/j.immuni.2010.10.004
   Liu Y, 2011, VACCINE, V29, P2582, DOI 10.1016/j.vaccine.2011.01.049
   Loffredo JT, 2007, J VIROL, V81, P8827, DOI 10.1128/JVI.00895-07
   Loffredo JT, 2004, J IMMUNOL, V173, P5064, DOI 10.4049/jimmunol.173.8.5064
   Martins MA, 2010, J VIROL, V84, P4352, DOI 10.1128/JVI.02365-09
   Matano T, 1998, J VIROL, V72, P164, DOI 10.1128/JVI.72.1.164-169.1998
   McAllister A, 2000, J VIROL, V74, P9197, DOI 10.1128/JVI.74.19.9197-9205.2000
   McElrath MJ, 2008, LANCET, V372, P1894, DOI 10.1016/S0140-6736(08)61592-5
   McElrath MJ, 2010, IMMUNITY, V33, P542, DOI 10.1016/j.immuni.2010.09.011
   Mittereder N, 1996, J VIROL, V70, P7498, DOI 10.1128/JVI.70.11.7498-7509.1996
   Monath TP, 2006, P NATL ACAD SCI USA, V103, P6694, DOI 10.1073/pnas.0601932103
   Monath TP, 2005, EXPERT REV VACCINES, V4, P553, DOI 10.1586/14760584.4.4.553
   Monath TP, 2003, J INFECT DIS, V188, P1213, DOI 10.1086/378356
   Mothe BR, 2002, J VIROL, V76, P875, DOI 10.1128/JVI.76.2.875-884.2002
   Neves PCC, 2010, VACCINE, V28, P8183, DOI 10.1016/j.vaccine.2010.09.090
   Nitayaphan S, 2004, J INFECT DIS, V190, P702, DOI 10.1086/422258
   Pantaleo G, 2010, CURR OPIN HIV AIDS, V5, P391, DOI 10.1097/COH.0b013e32833d1e87
   Pereyra FP, 2010, SCIENCE, V330, P1551, DOI 10.1126/science.1195271
   Peters B, 2005, VACCINE, V23, P5212, DOI 10.1016/j.vaccine.2005.07.086
   Pulendran B, 2009, NAT REV IMMUNOL, V9, P741, DOI 10.1038/nri2629
   Querec T, 2006, J EXP MED, V203, P413, DOI 10.1084/jem.20051720
   Querec TD, 2007, ADV EXP MED BIOL, V590, P43
   Robert-Guroff M, 2007, CURR OPIN BIOTECH, V18, P546, DOI 10.1016/j.copbio.2007.10.010
   Rodriguez F, 2002, J VIROL, V76, P4251, DOI 10.1128/JVI.76.9.4251-4259.2002
   Roederer M, 2011, CYTOM PART A, V79A, P167, DOI 10.1002/cyto.a.21015
   Rolland M, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001424
   Rosenberg ES, 1997, SCIENCE, V278, P1447, DOI 10.1126/science.278.5342.1447
   Russell ND, 2007, JAIDS-J ACQ IMM DEF, V44, P203, DOI 10.1097/01.qai.0000248356.48501.ff
   Sacha JB, 2007, J IMMUNOL, V178, P2746, DOI 10.4049/jimmunol.178.5.2746
   Smith HL, 2011, J INFECT DIS, V203, P513, DOI 10.1093/infdis/jiq074
   Tao D, 2005, J EXP MED, V201, P201, DOI 10.1084/jem.20041526
   Thorner AR, 2006, J CLIN MICROBIOL, V44, P3781, DOI 10.1128/JCM.01249-06
   Vogel TU, 2002, J VIROL, V76, P11623, DOI 10.1128/JVI.76.22.11623-11636.2002
   Weatherall DJ., 2006, USE NONHUMAN PRIMATE
   Winstone N, 2011, J VIROL, V85, P9578, DOI 10.1128/JVI.05060-11
   World Health Organization, 2009, WHO VACC PREV DIS MO
NR 72
TC 13
Z9 13
U1 0
U2 5
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD JAN 15
PY 2013
VL 8
IS 1
AR e54434
DI 10.1371/journal.pone.0054434
PG 16
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA 086SQ
UT WOS:000314707700058
PM 23336000
OA DOAJ Gold, Green Published
DA 2020-12-01
ER

PT J
AU Mudd, PA
   Martins, MA
   Ericsen, AJ
   Tully, DC
   Power, KA
   Bean, AT
   Piaskowski, SM
   Duan, LJ
   Seese, A
   Gladden, AD
   Weisgrau, KL
   Furlott, JR
   Kim, YI
   de Santana, MGV
   Rakasz, E
   Capuano, S
   Wilson, NA
   Bonaldo, MC
   Galler, R
   Allison, DB
   Piatak, M
   Haase, AT
   Lifson, JD
   Allen, TM
   Watkins, DI
AF Mudd, Philip A.
   Martins, Mauricio A.
   Ericsen, Adam J.
   Tully, Damien C.
   Power, Karen A.
   Bean, Alex T.
   Piaskowski, Shari M.
   Duan, Lijie
   Seese, Aaron
   Gladden, Adrianne D.
   Weisgrau, Kim L.
   Furlott, Jessica R.
   Kim, Young-il
   Veloso de Santana, Marlon G.
   Rakasz, Eva
   Capuano, Saverio, III
   Wilson, Nancy A.
   Bonaldo, Myrna C.
   Galler, Ricardo
   Allison, David B.
   Piatak, Michael, Jr.
   Haase, Ashley T.
   Lifson, Jeffrey D.
   Allen, Todd M.
   Watkins, David I.
TI Vaccine-induced CD8(+) T cells control AIDS virus replication
SO NATURE
LA English
DT Article
ID MAMU-B-ASTERISK-08-POSITIVE MACAQUES; IMMUNODEFICIENCY; SIV; RESPONSES;
   HIV; INFECTION; DISEASE; ESCAPE; HOST
AB Developing a vaccine for human immunodeficiency virus(HIV) may be aided by a complete understanding of those rare cases in which some HIV-infected individuals control replication of the virus(1-3). Most of these elite controllers express the histocompatibility alleles HLA-B*57 or HLA-B*27 (ref. 3). These alleles remain by far the most robust associations with low concentrations of plasma virus(4,5), yet the mechanism of control in these individuals is not entirely clear. Here we vaccinate Indian rhesus macaques that express Mamu-B*08, an animal model for HLA-B*27-mediated elite control(6), with three Mamu-B*08-restricted CD8(+) T-cell epitopes, and demonstrate that these vaccinated animals control replication of the highly pathogenic clonal simian immunodeficiency virus (SIV) mac239 virus. High frequencies of CD8(+) T cells against these Vif and Nef epitopes in the blood, lymph nodes and colon were associated with viral control. Moreover, the frequency of the CD8(+) T-cell response against the Nef RL10 epitope (Nef amino acids 137-146) correlated significantly with reduced acute phase viraemia. Finally, two of the eight vaccinees lost control of viral replication in the chronic phase, concomitant with escape in all three targeted epitopes, further implicating these three CD8(+) T-cell responses in the control of viral replication. Our findings indicate that narrowly targeted vaccine-induced virus-specific CD8(+) T-cell responses can control replication of the AIDS virus.
C1 [Martins, Mauricio A.; Watkins, David I.] Univ Miami, Miller Sch Med, Dept Pathol, Miami, FL 33136 USA.
   [Mudd, Philip A.; Ericsen, Adam J.; Bean, Alex T.; Piaskowski, Shari M.; Weisgrau, Kim L.; Furlott, Jessica R.; Wilson, Nancy A.] Univ Wisconsin Madison, Dept Pathol & Lab Med, Madison, WI 53711 USA.
   [Mudd, Philip A.] Univ Wisconsin Madison, Med Scientist Training Program, Madison, WI 53705 USA.
   [Tully, Damien C.; Power, Karen A.; Seese, Aaron; Gladden, Adrianne D.; Allen, Todd M.] Ragon Inst MGH MIT & Harvard, Boston, MA 02129 USA.
   [Duan, Lijie; Haase, Ashley T.] Univ Minnesota, Dept Microbiol, Minneapolis, MN 55455 USA.
   [Kim, Young-il] Univ Alabama Birmingham, Dept Med, Div Prevent Med, Birmingham, AL 35294 USA.
   [Veloso de Santana, Marlon G.; Bonaldo, Myrna C.] Fiocruz MS, Inst Oswaldo Cruz, Lab Biol Mol Flavivirus, BR-21045900 Rio De Janeiro, Brazil.
   [Rakasz, Eva; Capuano, Saverio, III; Wilson, Nancy A.] Univ Wisconsin Madison, Wisconsin Natl Primate Res Ctr, Madison, WI 53711 USA.
   [Galler, Ricardo] Fundacao Oswaldo Cruz, Inst Tecnol Imunobiol, Rio De Janeiro, Brazil.
   [Allison, David B.] Univ Alabama Birmingham, Dept Biostat, Sect Stat Genet, Birmingham, AL 35294 USA.
   [Piatak, Michael, Jr.; Lifson, Jeffrey D.] NCI, AIDS & Canc Virus Program, SAIC Frederick Inc, Frederick, MD 21702 USA.
RP Watkins, DI (corresponding author), Univ Miami, Miller Sch Med, Dept Pathol, Miami, FL 33136 USA.
EM dwatkins@med.miami.edu
RI de Santana, Marlon Gilsepp Veloso/H-8146-2017; Allen, Todd/F-5473-2011;
   Rakasz, Eva G/H-9197-2019; Bonaldo, Myrna C/D-9494-2013; Ericsen,
   Adam/AAW-1187-2020; Galler, Ricardo/B-3280-2014; Martins,
   Mauricio/AAU-9226-2020
OI de Santana, Marlon Gilsepp Veloso/0000-0002-3427-841X; Allen,
   Todd/0000-0002-6609-1318; Ericsen, Adam/0000-0003-4176-8270; Martins,
   Mauricio/0000-0001-8336-216X; Allison, David/0000-0003-3566-9399; Mudd,
   Philip/0000-0002-3860-5473; Tully, Damien/0000-0002-7620-9340
FU National Institutes of Health (NIH)United States Department of Health &
   Human ServicesNational Institutes of Health (NIH) - USA [R37 AI052056,
   RO1 AI076114, RR015371, HHSN261200800001E]; FAPERJCarlos Chagas Filho
   Foundation for Research Support of the State of Rio de Janeiro (FAPERJ);
   INCTV; CNPqNational Council for Scientific and Technological Development
   (CNPq); MCT; FIOCRUZ; NATIONAL CENTER FOR RESEARCH RESOURCESUnited
   States Department of Health & Human ServicesNational Institutes of
   Health (NIH) - USANIH National Center for Research Resources (NCRR)
   [P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, R24RR015371, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, R24RR015371, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, R24RR015371, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, R24RR015371, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, R24RR015371, P51RR000167, P51RR000167, P51RR000167,
   R24RR015371, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, R24RR015371,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, R24RR015371, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, R24RR015371,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, R24RR015371,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, R24RR015371, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, R24RR015371, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, R24RR015371, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167] Funding Source: NIH RePORTER; NATIONAL
   INSTITUTE OF ALLERGY AND INFECTIOUS DISEASESUnited States Department of
   Health & Human ServicesNational Institutes of Health (NIH) - USANIH
   National Institute of Allergy & Infectious Diseases (NIAID)
   [T32AI078985, R01AI076114, R37AI052056, T32AI078985, T32AI078985,
   T32AI078985, R37AI052056, R01AI076114, R37AI052056, T32AI078985,
   R37AI052056, R37AI052056, T32AI078985, R37AI052056, T32AI078985,
   T32AI078985, R01AI076114, R01AI076114, R37AI052056, R01AI076114,
   R37AI052056, T32AI078985, T32AI078985, R37AI052056, T32AI078985,
   R37AI052056, R37AI052056] Funding Source: NIH RePORTER; NATIONAL
   INSTITUTE OF GENERAL MEDICAL SCIENCESUnited States Department of Health
   & Human ServicesNational Institutes of Health (NIH) - USANIH National
   Institute of General Medical Sciences (NIGMS) [T32GM008692, T32GM008692,
   T32GM008692, T32GM008692, T32GM008692, T32GM008692, T32GM008692,
   T32GM008692, T32GM008692, T32GM008692, T32GM008692, T32GM008692,
   T32GM008692, T32GM008692, T32GM008692, T32GM008692, T32GM008692,
   T32GM008692, T32GM008692, T32GM008692, T32GM008692, T32GM008692,
   T32GM008692, T32GM008692, T32GM008692, T32GM008692, T32GM008692] Funding
   Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF
   HEALTHUnited States Department of Health & Human ServicesNational
   Institutes of Health (NIH) - USA [P51OD011106, P51OD011106, P51OD011106,
   P51OD011106, P51OD011106, P51OD011106, P51OD011106, P51OD011106,
   P51OD011106, P51OD011106, P51OD011106, P51OD011106, P51OD011106,
   P51OD011106, P51OD011106] Funding Source: NIH RePORTER
FX We would like to thank M. Stevenson, M. Reynolds, N. Maness and J. Sacha
   for discussions and suggestions. We also thank D. Evans, L. Heyer and Z.
   R. Bergman for facilitating the experiments. This work was funded in
   part by National Institutes of Health (NIH) grants R37 AI052056, RO1
   AI076114, RR015371, contract number HHSN261200800001E and FAPERJ, INCTV,
   CNPq, MCT and FIOCRUZ.
CR Bonaldo MC, 2010, J VIROL, V84, P3699, DOI 10.1128/JVI.02255-09
   Bonaldo MC, 2007, VIROL J, V4, DOI 10.1186/1743-422X-4-115
   Cline AN, 2005, J MED PRIMATOL, V34, P303
   Dang Q, 2008, ADV PHARMACOL, V56, P369, DOI 10.1016/S1054-3589(07)56012-6
   Deeks SG, 2007, IMMUNITY, V27, P406, DOI 10.1016/j.immuni.2007.08.010
   Fellay J, 2007, SCIENCE, V317, P944, DOI 10.1126/science.1143767
   Goulder PJR, 2004, NAT REV IMMUNOL, V4, P630, DOI 10.1038/nri1417
   Hansen SG, 2011, NATURE, V473, P523, DOI 10.1038/nature10003
   Hansen SG, 2009, NAT MED, V15, P293, DOI 10.1038/nm.1935
   Henn MR, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002529
   Johnston MI, 2008, NEW ENGL J MED, V359, P888, DOI 10.1056/NEJMp0806162
   Kawada M, 2008, J VIROL, V82, P10199, DOI 10.1128/JVI.01103-08
   Li QS, 2009, NATURE, V458, P1034, DOI 10.1038/nature07831
   Li QS, 2005, NATURE, V434, P1148, DOI 10.1038/nature03513
   Loffredo JT, 2008, J VIROL, V82, P1723, DOI 10.1128/JVI.02084-07
   Loffredo JT, 2007, J VIROL, V81, P8827, DOI 10.1128/JVI.00895-07
   Loffredo JT, 2009, J IMMUNOL, V182, P7763, DOI 10.4049/jimmunol.0900111
   Macalalad AR, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002417
   Migueles SA, 2010, JAMA-J AM MED ASSOC, V304, P194, DOI 10.1001/jama.2010.925
   Mudd PA, 2012, J IMMUNOL, V188, P3364, DOI 10.4049/jimmunol.1102470
   Mudd PA, 2011, CURR OPIN HIV AIDS, V6, P197, DOI 10.1097/COH.0b013e3283453e16
   Pereyra FP, 2010, SCIENCE, V330, P1551, DOI 10.1126/science.1195271
   Tsukamoto T, 2009, J VIROL, V83, P9339, DOI 10.1128/JVI.01120-09
   Valentine LE, 2009, J VIROL, V83, P11514, DOI 10.1128/JVI.01298-09
NR 24
TC 131
Z9 134
U1 0
U2 34
PU NATURE PUBLISHING GROUP
PI LONDON
PA MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
SN 0028-0836
EI 1476-4687
J9 NATURE
JI Nature
PD NOV 1
PY 2012
VL 491
IS 7422
BP 129
EP U152
DI 10.1038/nature11443
PG 7
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA 028PM
UT WOS:000310434500044
PM 23023123
OA Green Accepted
DA 2020-12-01
ER

PT J
AU Vojnov, L
   Martins, M
   Bean, A
   de Santana, MV
   Sacha, J
   Wilson, N
   Bonaldo, M
   Galler, R
   Stevenson, M
   Watkins, D
AF Vojnov, L.
   Martins, M.
   Bean, A.
   de Santana, M. Veloso
   Sacha, J.
   Wilson, N.
   Bonaldo, M.
   Galler, R.
   Stevenson, M.
   Watkins, D.
TI The majority of freshly sorted SIV-specific CD8(+) T cells cannot
   suppress viral replication in SIV-infected macrophages
SO JOURNAL OF THE INTERNATIONAL AIDS SOCIETY
LA English
DT Meeting Abstract
C1 [Vojnov, L.; Martins, M.; Bean, A.; Wilson, N.] Univ Wisconsin Madison, Madison, WI USA.
   [de Santana, M. Veloso] Inst Oswaldo Cruz FIOCRUZ, Rio De Janeiro, Brazil.
   [Sacha, J.] Oregon Hlth & Sci Univ, Beaverton, OR USA.
   [Bonaldo, M.; Galler, R.] Fundacao Oswaldo Cruz, Rio De Janeiro, Brazil.
   [Stevenson, M.; Watkins, D.] Univ Miami, Miller Sch Med, Miami, FL 33136 USA.
EM laravojnov@gmail.com
RI Bonaldo, Myrna C/D-9494-2013
NR 0
TC 0
Z9 0
U1 0
U2 0
PU JOHN WILEY & SONS LTD
PI CHICHESTER
PA THE ATRIUM, SOUTHERN GATE, CHICHESTER PO19 8SQ, W SUSSEX, ENGLAND
EI 1758-2652
J9 J INT AIDS SOC
JI J. Int. AIDS Soc.
PD OCT
PY 2012
VL 15
SU 3
BP 2
EP 3
PG 2
WC Immunology; Infectious Diseases
SC Immunology; Infectious Diseases
GA 030RQ
UT WOS:000310588200005
OA DOAJ Gold
DA 2020-12-01
ER

PT J
AU Vojnov, L
   Martins, MA
   Bean, AT
   de Santana, MGV
   Sacha, JB
   Wilson, NA
   Bonaldo, MC
   Galler, R
   Stevenson, M
   Watkins, DI
AF Vojnov, Lara
   Martins, Mauricio A.
   Bean, Alexander T.
   de Santana, Marlon G. Veloso
   Sacha, Jonah B.
   Wilson, Nancy A.
   Bonaldo, Myrna C.
   Galler, Ricardo
   Stevenson, Mario
   Watkins, David I.
TI The Majority of Freshly Sorted Simian Immunodeficiency Virus
   (SIV)-Specific CD8(+) T Cells Cannot Suppress Viral Replication in
   SIV-Infected Macrophages
SO JOURNAL OF VIROLOGY
LA English
DT Article
ID PERIPHERAL-BLOOD LYMPHOCYTES; RHESUS MACAQUES; HIV-INFECTION;
   AIDS-VIRUS; HIV-1-SPECIFIC CTL; VIREMIA; DEPLETION; TISSUE; RECOGNIZE;
   RESPONSES
AB Human immunodeficiency virus (HIV) and simian immunodeficiency virus (SIV) primarily infect activated CD4(+) T cells but can infect macrophages. Surprisingly, ex vivo tetramer-sorted SIV-specific CD8(+) T cells that eliminated and suppressed viral replication in SIV-infected CD4(+) T cells failed to do so in SIV-infected macrophages. It is possible, therefore, that while AIDS virus-infected macrophages constitute only a small percentage of all virus-infected cells, they may be relatively resistant to CD8(+) T cell-mediated lysis and continue to produce virus over long periods of time.
C1 [Vojnov, Lara; Martins, Mauricio A.; Bean, Alexander T.; Wilson, Nancy A.; Watkins, David I.] Univ Wisconsin Madison, Dept Pathol & Lab Med, Madison, WI USA.
   [de Santana, Marlon G. Veloso; Bonaldo, Myrna C.] Inst Oswaldo Cruz FIOCRUZ, Lab Biol Mol Flavivirus, Rio De Janeiro, Brazil.
   [Sacha, Jonah B.] Oregon Hlth & Sci Univ, Oregon Natl Primate Res Ctr, Vaccine & Gene Therapy Inst, Beaverton, OR USA.
   [Galler, Ricardo] Fundacao Oswaldo Cruz, Inst Tecnol Imunobiol, Rio De Janeiro, Brazil.
   [Stevenson, Mario] Univ Miami, Leonard M Miller Sch Med, Miami, FL USA.
   [Watkins, David I.] Wisconsin Natl Primate Res Ctr, Madison, WI USA.
RP Watkins, DI (corresponding author), Univ Wisconsin Madison, Dept Pathol & Lab Med, Madison, WI USA.
EM DWatkins@med.miami.edu
RI Bonaldo, Myrna C/D-9494-2013; Martins, Mauricio/AAU-9226-2020; Galler,
   Ricardo/B-3280-2014; de Santana, Marlon Gilsepp Veloso/H-8146-2017
OI Martins, Mauricio/0000-0001-8336-216X; de Santana, Marlon Gilsepp
   Veloso/0000-0002-3427-841X; Vojnov, Lara/0000-0003-0488-1012
FU National Institutes of Health (NIH)/National Institute of Allergy and
   Infectious DiseaseUnited States Department of Health & Human
   ServicesNational Institutes of Health (NIH) - USANIH National Institute
   of Allergy & Infectious Diseases (NIAID) [R01 AI076114, R01 AI049120,
   R24 RR015371, R24 RR016038]; National Center for Research Resources
   (NCRR)United States Department of Health & Human ServicesNational
   Institutes of Health (NIH) - USANIH National Center for Research
   Resources (NCRR) [R51 RR000167];  [RR000168]; NATIONAL CENTER FOR
   RESEARCH RESOURCESUnited States Department of Health & Human
   ServicesNational Institutes of Health (NIH) - USANIH National Center for
   Research Resources (NCRR) [P51RR000167, P51RR000168, P51RR000168,
   P51RR000168, P51RR000167, P51RR000168, P51RR000168, P51RR000168,
   P51RR000168, P51RR000167, P51RR000168, P51RR000167, P51RR000168,
   P51RR000168, P51RR000168, P51RR000168, P51RR000168, P51RR000168,
   P51RR000167, P51RR000168, P51RR000168, P51RR000167, P51RR000168,
   P51RR000168, P51RR000168, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000168, P51RR000168, P51RR000167,
   P51RR000167, P51RR000168, P51RR000167, P51RR000168, P51RR000168,
   P51RR000167, P51RR000168, P51RR000168, P51RR000168, P51RR000168,
   P51RR000168, P51RR000167, P51RR000167, P51RR000168, P51RR000167,
   P51RR000168, P51RR000167, P51RR000168, P51RR000167, P51RR000167,
   P51RR000168, P51RR000167, P51RR000168, P51RR000168, P51RR000167,
   P51RR000168, P51RR000167, P51RR000168, P51RR000168, P51RR000168,
   P51RR000168, P51RR000167, P51RR000168, P51RR000167, P51RR000167,
   P51RR000168, P51RR000167, P51RR000168, P51RR000168, P51RR000168,
   P51RR000168, P51RR000168, P51RR000168, P51RR000168, P51RR000168,
   K26RR000168, P51RR000167, P51RR000168, P51RR000168, P51RR000168,
   P51RR000167, P51RR000167, P51RR000168, P51RR000167, R24RR016038,
   P51RR000168, P51RR000168, P51RR000168, P51RR000168, P51RR000168,
   P51RR000168, P51RR000168, P51RR000168, P51RR000168, P51RR000167,
   P51RR000168, P51RR000168, P51RR000167, P51RR000167, P51RR000167,
   P51RR000168, P51RR000167, P51RR000167, P51RR000168, P51RR000167,
   P51RR000167, P51RR000167, P51RR000168, P51RR000168, P51RR000168,
   P51RR000167, P51RR000167, P51RR000167, P51RR000168, P51RR000168,
   P51RR000168, P51RR000168, P51RR000168, P51RR000168, P51RR000167,
   P51RR000168, R24RR016038, P51RR000167, P51RR000167, P51RR000167,
   P51RR000168, P51RR000168, R24RR016038, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000168, P51RR000167, P51RR000167,
   P51RR000168, P51RR000168, P51RR000168, P51RR000167, P51RR000167,
   P51RR000168, P51RR000168, P51RR000168, P51RR000167, P51RR000167,
   P51RR000168, P51RR000167, P51RR000168, P51RR000167, P51RR000168,
   P51RR000168, P51RR000168, P51RR000168, P51RR000167, P51RR000168,
   P51RR000168, P51RR000167, P51RR000167, P51RR000167, P51RR000168,
   P51RR000168, P51RR000168, P51RR000167, P51RR000168, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000168, P51RR000168,
   P51RR000167, P51RR000168, P51RR000168, P51RR000168, P51RR000168,
   P51RR000167, P51RR000168, P51RR000167, P51RR000168, P51RR000167,
   P51RR000167, P51RR000168, P51RR000168, P51RR000168, P51RR000167,
   P51RR000167, P51RR000168, P51RR000167, P51RR000167, P51RR000167,
   P51RR000168, P51RR000167, P51RR000168, P51RR000168, P51RR000168,
   P51RR000167, P51RR000168, P51RR000168, P51RR000168, P51RR000168,
   P51RR000167, P51RR000168, P51RR000168, P51RR000167, P51RR000168,
   P51RR000168, P51RR000167, P51RR000168, P51RR000168, P51RR000168,
   P51RR000168, P51RR000168, P51RR000168, P51RR000168, P51RR000168,
   P51RR000168, P51RR000167, P51RR000167, P51RR000168, P51RR000167,
   P51RR000168, P51RR000168, P51RR000167, P51RR000168, P51RR000168,
   P51RR000167, P51RR000168, P51RR000168, P51RR000167, P51RR000167,
   P51RR000168, P51RR000168, P51RR000167, P51RR000167, P51RR000168,
   P51RR000168, P51RR000167, P51RR000168, P51RR000167, P51RR000168,
   P51RR000168, P51RR000168, P51RR000167, P51RR000168, P51RR000168,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000168,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000168,
   P51RR000167, P51RR000167, P51RR000167, P51RR000168, P51RR000167,
   P51RR000168, P51RR000168, P51RR000168, P51RR000167, P51RR000167,
   P51RR000167, P51RR000168, R24RR015371, P51RR000168, P51RR000167,
   P51RR000168, P51RR000168, P51RR000168, P51RR000168, P51RR000167,
   P51RR000168, P51RR000168, P51RR000168, P51RR000168, P51RR000167,
   P51RR000168, P51RR000167, P51RR000167, P51RR000168, P51RR000168,
   P51RR000167, P51RR000168, P51RR000167, P51RR000167, P51RR000168,
   P51RR000167, P51RR000168, P51RR000168, P51RR000168, P51RR000168,
   P51RR000167, P51RR000168, P51RR000168, P51RR000167, P51RR000167,
   P51RR000167, P51RR000168, P51RR000168, P51RR000168, P51RR000168,
   P51RR000168, P51RR000167, P51RR000168, P51RR000168, P51RR000168,
   P51RR000168, P51RR000167, P51RR000168, P51RR000168, P51RR000168,
   P51RR000168, P51RR000168, P51RR000168, P51RR000168, P51RR000167,
   P51RR000168, P51RR000168, P51RR000167, P51RR000167, P51RR000167,
   P51RR000168, P51RR000168, P51RR000167, P51RR000167, P51RR000168,
   P51RR000167, P51RR000168, P51RR000168, P51RR000167, P51RR000167,
   P51RR000168, P51RR000168, P51RR000168, P51RR000167, P51RR000167,
   P51RR000168, P51RR000168, P51RR000168, P51RR000168, P51RR000168,
   P51RR000168, P51RR000168, P51RR000167, P51RR000167, P51RR000168,
   R24RR015371, P51RR000168, P51RR000168, P51RR000168, P51RR000167,
   P51RR000168, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000168, P51RR000167, P51RR000168, P51RR000167,
   P51RR000168, P51RR000168, P51RR000168, P51RR000168, P51RR000167,
   P51RR000168, P51RR000168, P51RR000168, P51RR000167, P51RR000168,
   P51RR000167, P51RR000167, P51RR000168, P51RR000167, P51RR000167,
   P51RR000167, P51RR000168, P51RR000168, P51RR000167, P51RR000167,
   P51RR000168, P51RR000168, P51RR000167, P51RR000168, P51RR000168,
   R24RR015371, P51RR000167, P51RR000168, P51RR000168, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000168, P51RR000168,
   P51RR000168, P51RR000167, P51RR000167, P51RR000167, P51RR000168,
   P51RR000168, P51RR000167, P51RR000168, P51RR000167, P51RR000168,
   P51RR000168, P51RR000168, P51RR000167, P51RR000167, P51RR000167,
   P51RR000168, P51RR000168, P51RR000167, P51RR000168, P51RR000167,
   P51RR000168, P51RR000168, P51RR000168, P51RR000168, P51RR000168,
   P51RR000168, P51RR000167, P51RR000167, P51RR000168, P51RR000167,
   P51RR000168, P51RR000167, P51RR000168, P51RR000168, P51RR000168,
   P51RR000168, P51RR000168, P51RR000168, P51RR000167, P51RR000167,
   P51RR000167, P51RR000168, P51RR000167, P51RR000167, P51RR000168,
   P51RR000168, P51RR000168, P51RR000168, P51RR000168, P51RR000168,
   P51RR000167, P51RR000168, P51RR000167, P51RR000167, P51RR000167,
   P51RR000168, P51RR000168, P51RR000167, P51RR000167, P51RR000167,
   P51RR000168, P51RR000167, P51RR000167, P51RR000168, P51RR000167,
   P51RR000168, P51RR000168, P51RR000167, P51RR000167, P51RR000168,
   P51RR000167, P51RR000167, P51RR000168, P51RR000168, P51RR000167,
   P51RR000168, P51RR000168, P51RR000168, P51RR000167, P51RR000167,
   P51RR000168, P51RR000168, P51RR000168, P51RR000168, P51RR000168,
   P51RR000168, P51RR000167, P51RR000167, P51RR000167, P51RR000168,
   P51RR000167, P51RR000168, P51RR000168, P51RR000167, P51RR000167,
   P51RR000168, P51RR000167, P51RR000168, P51RR000167, P51RR000167,
   P51RR000168, P51RR000168, P51RR000167, P51RR000168, P51RR000168,
   P51RR000168, P51RR000168, P51RR000168, P51RR000167, P51RR000168,
   P51RR000168, P51RR000167, P51RR000168, P51RR000168, P51RR000167,
   P51RR000168, P51RR000168, P51RR000168, P51RR000167, P51RR000168,
   P51RR000168, P51RR000167, P51RR000168, P51RR000168, P51RR000168,
   P51RR000167, P51RR000168, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000168, P51RR000167, P51RR000168, P51RR000168,
   P51RR000168, P51RR000168, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000168,
   P51RR000168, P51RR000167, P51RR000167, P51RR000168, R24RR015371,
   P51RR000167, P51RR000167, P51RR000167, P51RR000168, P51RR000168,
   P51RR000167, P51RR000168, P51RR000168, P51RR000167, P51RR000168,
   P51RR000168, P51RR000167, P51RR000167, P51RR000168, P51RR000167,
   P51RR000167, P51RR000168, P51RR000168, P51RR000167, P51RR000167,
   P51RR000168, P51RR000168, P51RR000168, P51RR000168, P51RR000167,
   P51RR000167, P51RR000167, P51RR000168, P51RR000168, P51RR000168,
   P51RR000168, P51RR000168, P51RR000168, P51RR000168, P51RR000168,
   P51RR000167, P51RR000168, P51RR000167, P51RR000168, P51RR000167,
   P51RR000167, P51RR000168, P51RR000168, P51RR000168, P51RR000167,
   P51RR000167, P51RR000168, P51RR000167, P51RR000168, P51RR000168,
   P51RR000167, P51RR000168, P51RR000167, P51RR000167, P51RR000167,
   P51RR000168, P51RR000167, P51RR000168, P51RR000167, P51RR000167,
   P51RR000167, P51RR000168, P51RR000167, P51RR000168, P51RR000167,
   P51RR000168, P51RR000168, P51RR000168, P51RR000168, P51RR000168,
   P51RR000168, P51RR000168, P51RR000168, P51RR000167, P51RR000168,
   P51RR000167, P51RR000167, P51RR000168, P51RR000168, P51RR000167,
   P51RR000167, P51RR000168, P51RR000167, P51RR000168, P51RR000168,
   P51RR000167, P51RR000167, P51RR000168, P51RR000168, P51RR000168,
   P51RR000168, P51RR000167, P51RR000168, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000168, P51RR000168, P51RR000167,
   R24RR016038, P51RR000168, P51RR000168, P51RR000168, P51RR000168,
   P51RR000168, P51RR000168, P51RR000168, P51RR000168, P51RR000168,
   P51RR000168, P51RR000167, P51RR000167, P51RR000168, P51RR000167,
   P51RR000168, P51RR000167, P51RR000167, P51RR000168, P51RR000167,
   P51RR000167, P51RR000167, P51RR000168, P51RR000168, P51RR000168,
   P51RR000168, P51RR000167, P51RR000168, P51RR000168, P51RR000167,
   P51RR000168, P51RR000168, P51RR000168, P51RR000167, P51RR000168,
   P51RR000168, P51RR000167, P51RR000168, P51RR000168, P51RR000167,
   P51RR000168, P51RR000167, P51RR000168, P51RR000168, P51RR000168,
   P51RR000168, P51RR000167, P51RR000168, P51RR000168, P51RR000168,
   P51RR000168, P51RR000168, P51RR000167, P51RR000168, R24RR015371,
   P51RR000168, P51RR000168, P51RR000168, P51RR000168, P51RR000168,
   P51RR000167, P51RR000168, P51RR000167, P51RR000168, P51RR000168,
   P51RR000168, P51RR000167, P51RR000168, P51RR000167, P51RR000168,
   P51RR000167, P51RR000168, R24RR016038, P51RR000168, P51RR000168,
   P51RR000168, P51RR000167, P51RR000168, P51RR000167, P51RR000167,
   P51RR000168, P51RR000168, P51RR000167, P51RR000168, P51RR000168,
   P51RR000168, P51RR000168, P51RR000167, P51RR000168, P51RR000167,
   P51RR000168, P51RR000168, P51RR000167, P51RR000167, P51RR000168,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000168, P51RR000168, P51RR000167, P51RR000168,
   P51RR000168, P51RR000167, P51RR000168, P51RR000167, P51RR000168,
   P51RR000167, P51RR000168, P51RR000167, P51RR000167, P51RR000168,
   P51RR000168, P51RR000168, P51RR000168, P51RR000168, P51RR000168,
   P51RR000167, P51RR000167, P51RR000168, P51RR000168, P51RR000167,
   P51RR000168, P51RR000168, P51RR000167, P51RR000168, P51RR000168,
   P51RR000167, P51RR000168, P51RR000168, P51RR000167, P51RR000167,
   P51RR000167, P51RR000168, P51RR000167, P51RR000168, P51RR000168,
   P51RR000167, P51RR000167, P51RR000167, P51RR000168, P51RR000168,
   P51RR000168, P51RR000168, P51RR000168, P51RR000168, P51RR000168,
   P51RR000168, P51RR000167, P51RR000168, P51RR000167, P51RR000167,
   P51RR000167, P51RR000168, P51RR000168, P51RR000168, P51RR000168,
   P51RR000168, P51RR000168, P51RR000167, P51RR000168, P51RR000168,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000168, P51RR000168, P51RR000168, P51RR000167, P51RR000168,
   P51RR000168, P51RR000167, P51RR000168, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000168, P51RR000168,
   P51RR000167, P51RR000167, P51RR000168, P51RR000168, P51RR000168,
   P51RR000167, P51RR000168, P51RR000167, P51RR000168, P51RR000167,
   P51RR000168, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000168, P51RR000167, P51RR000168,
   P51RR000167, P51RR000167, P51RR000168, P51RR000168, P51RR000168,
   P51RR000168, P51RR000168, P51RR000168, P51RR000168, P51RR000168,
   P51RR000168, P51RR000167, P51RR000168, P51RR000168, P51RR000168,
   P51RR000168, P51RR000168, P51RR000168, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000168, P51RR000168, P51RR000168, P51RR000167, P51RR000168,
   P51RR000168, P51RR000168, P51RR000168, P51RR000168, P51RR000168,
   P51RR000168, P51RR000168, P51RR000167, P51RR000168, P51RR000168,
   P51RR000167, P51RR000167, P51RR000168, P51RR000167, P51RR000168,
   P51RR000168, P51RR000168, P51RR000168, P51RR000167, P51RR000167,
   P51RR000167, P51RR000168, P51RR000167, P51RR000167, P51RR000167,
   P51RR000168, P51RR000167, P51RR000167, P51RR000168, P51RR000167,
   P51RR000168, P51RR000167, P51RR000168, P51RR000168, P51RR000168,
   P51RR000168, P51RR000168, P51RR000167, P51RR000167, P51RR000167,
   P51RR000168, P51RR000168, P51RR000167, P51RR000168, P51RR000168,
   P51RR000168, P51RR000167, P51RR000167, P51RR000168, P51RR000168,
   P51RR000167, P51RR000168, P51RR000168, P51RR000168, P51RR000167,
   P51RR000168, P51RR000168, P51RR000167, P51RR000168, P51RR000167,
   P51RR000168, P51RR000168, P51RR000168, P51RR000168, P51RR000168,
   P51RR000168, P51RR000168, P51RR000167, P51RR000168, P51RR000168,
   P51RR000168, P51RR000168, P51RR000168, P51RR000168, P51RR000168,
   P51RR000168, P51RR000168, P51RR000168, R24RR015371, P51RR000167,
   P51RR000167, P51RR000168, P51RR000167, P51RR000167, P51RR000167,
   P51RR000168, P51RR000168, P51RR000167, P51RR000168, P51RR000168,
   P51RR000168, P51RR000167, P51RR000168, P51RR000167, P51RR000167,
   P51RR000168, P51RR000168, P51RR000168, P51RR000167, P51RR000167,
   P51RR000168, P51RR000168, P51RR000168, P51RR000168, P51RR000168,
   P51RR000167, P51RR000167, P51RR000168, P51RR000168, P51RR000168,
   P51RR000168, P51RR000168, P51RR000168, P51RR000167, P51RR000168,
   P51RR000167, P51RR000168, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000168, P51RR000168, P51RR000168, P51RR000168,
   P51RR000168, P51RR000167, P51RR000167, P51RR000168, P51RR000168,
   P51RR000168, P51RR000167, P51RR000167, P51RR000167, P51RR000168,
   P51RR000167, P51RR000168, P51RR000168, P51RR000167, P51RR000168,
   P51RR000168, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000168, P51RR000167, P51RR000167, P51RR000168, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000168, P51RR000167,
   P51RR000168, P51RR000167, P51RR000168, P51RR000168, P51RR000167,
   P51RR000167, P51RR000168, P51RR000168, P51RR000168, P51RR000168,
   P51RR000168, P51RR000167, P51RR000168, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000168, P51RR000167, P51RR000167,
   P51RR000168, P51RR000167, P51RR000167, P51RR000168, P51RR000167,
   P51RR000168, P51RR000167, P51RR000167, P51RR000168, P51RR000168,
   P51RR000168, P51RR000167, P51RR000167, P51RR000167, P51RR000168,
   P51RR000168, P51RR000167, P51RR000168, P51RR000167, P51RR000168,
   P51RR000168, P51RR000167, P51RR000168, P51RR000168, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000168, P51RR000168,
   P51RR000168, P51RR000168, P51RR000167, P51RR000167, P51RR000167,
   P51RR000168, P51RR000167, P51RR000168, P51RR000168, P51RR000167,
   P51RR000168, P51RR000167, P51RR000167, P51RR000167, P51RR000168,
   P51RR000167, P51RR000167, P51RR000168, P51RR000167, P51RR000167,
   P51RR000168, P51RR000167, P51RR000168, P51RR000167, P51RR000168,
   P51RR000168, P51RR000168, P51RR000167, P51RR000168, P51RR000168,
   P51RR000167, P51RR000167, P51RR000167, P51RR000168, P51RR000167,
   P51RR000167, P51RR000168, P51RR000168, P51RR000168, P51RR000168,
   P51RR000168, P51RR000167, P51RR000167, P51RR000168, P51RR000167,
   P51RR000167, P51RR000168, P51RR000167, P51RR000168, P51RR000167,
   P51RR000168, P51RR000167, P51RR000168, P51RR000168, P51RR000167,
   P51RR000168, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000168, P51RR000167, P51RR000168, P51RR000168, P51RR000168,
   P51RR000168, P51RR000168, P51RR000167, P51RR000168, P51RR000167,
   P51RR000168, P51RR000168, P51RR000168, P51RR000168, P51RR000167,
   P51RR000167, P51RR000167, P51RR000168, K26RR000168, P51RR000168,
   P51RR000168, P51RR000168, P51RR000168, P51RR000168, P51RR000168,
   P51RR000168, P51RR000167, P51RR000168, P51RR000168, P51RR000167,
   P51RR000168, P51RR000168, P51RR000168, P51RR000168, P51RR000168,
   P51RR000168, P51RR000167, P51RR000167, P51RR000167, P51RR000168,
   P51RR000168, P51RR000168, P51RR000168, P51RR000168, P51RR000168,
   P51RR000168, P51RR000168, P51RR000168, P51RR000167, P51RR000168,
   P51RR000167, P51RR000167, P51RR000168, P51RR000168, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000168, P51RR000168,
   P51RR000168, P51RR000168, P51RR000168, P51RR000167, P51RR000168,
   P51RR000167, P51RR000167, P51RR000167, P51RR000168, P51RR000167,
   P51RR000168, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   R24RR016038, P51RR000167, P51RR000168, P51RR000168, P51RR000167,
   P51RR000167, P51RR000168, P51RR000168, P51RR000168, P51RR000167,
   P51RR000167, P51RR000168, P51RR000168, P51RR000167, P51RR000168,
   P51RR000167, P51RR000168, P51RR000167, P51RR000168, P51RR000167,
   P51RR000168, P51RR000168, P51RR000168, P51RR000168, P51RR000167,
   P51RR000167, P51RR000167, P51RR000168, P51RR000168, P51RR000167,
   P51RR000167, P51RR000167, P51RR000168, P51RR000168, P51RR000168,
   P51RR000168, P51RR000168, P51RR000168, P51RR000168, P51RR000167,
   P51RR000167, P51RR000168, P51RR000168, P51RR000168, P51RR000168,
   P51RR000168, P51RR000167, P51RR000168, P51RR000167, P51RR000167,
   P51RR000168, P51RR000168, P51RR000168, P51RR000167, P51RR000167,
   P51RR000167, P51RR000168, P51RR000167, P51RR000167, P51RR000168,
   P51RR000168, P51RR000167, P51RR000167, P51RR000167, P51RR000168,
   P51RR000168, P51RR000168, P51RR000168, P51RR000167, P51RR000168,
   P51RR000168, P51RR000167, P51RR000168, P51RR000167, P51RR000167,
   P51RR000168, P51RR000168, P51RR000168, P51RR000168, P51RR000168,
   P51RR000168, P51RR000168, P51RR000168, P51RR000168, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000168, P51RR000168,
   P51RR000168, P51RR000168, P51RR000168, P51RR000167, P51RR000168,
   P51RR000168, P51RR000168, P51RR000168, P51RR000167, P51RR000168,
   P51RR000168, P51RR000168, P51RR000168, P51RR000168, P51RR000167,
   P51RR000168, P51RR000168, P51RR000167, P51RR000168, P51RR000168,
   P51RR000168, P51RR000167, P51RR000167, P51RR000167, P51RR000168,
   P51RR000168, P51RR000168, P51RR000167, P51RR000168, P51RR000168,
   P51RR000168, P51RR000167, P51RR000168, P51RR000168, P51RR000167,
   P51RR000168, P51RR000168, P51RR000167, P51RR000168, P51RR000167,
   P51RR000168, P51RR000167, P51RR000168, P51RR000168, K26RR000168,
   P51RR000168, P51RR000167, P51RR000168, P51RR000167, P51RR000168,
   P51RR000168, P51RR000167, P51RR000167, P51RR000168, P51RR000168,
   P51RR000167, P51RR000168, P51RR000167, P51RR000167, P51RR000167,
   P51RR000168, P51RR000167, P51RR000168, P51RR000168, P51RR000168,
   P51RR000168, P51RR000167, P51RR000167, P51RR000168, P51RR000168,
   P51RR000168, P51RR000168, P51RR000167, P51RR000168, P51RR000167,
   P51RR000168, P51RR000168, P51RR000167, P51RR000167, P51RR000168,
   P51RR000167, P51RR000168, P51RR000167, P51RR000168, P51RR000168,
   P51RR000168, P51RR000167, P51RR000168, P51RR000167, P51RR000167,
   P51RR000168, P51RR000168, P51RR000168, P51RR000167, P51RR000168,
   P51RR000168, P51RR000167, P51RR000168, P51RR000168, P51RR000168,
   P51RR000168, P51RR000168, P51RR000168, P51RR000167, P51RR000168,
   P51RR000167, P51RR000168, P51RR000168, P51RR000167, P51RR000168,
   P51RR000168, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000168, P51RR000167,
   P51RR000167, P51RR000168, P51RR000167, P51RR000168, P51RR000168,
   P51RR000167, P51RR000167, P51RR000167, P51RR000168, P51RR000168,
   P51RR000168, P51RR000167, P51RR000168, P51RR000167, P51RR000168,
   P51RR000168, P51RR000168, P51RR000168, P51RR000167, P51RR000168,
   P51RR000168, P51RR000167, P51RR000168, P51RR000168, P51RR000168,
   P51RR000168, P51RR000167, P51RR000168, P51RR000168, P51RR000168,
   P51RR000167, P51RR000168, P51RR000168, P51RR000168, P51RR000167,
   P51RR000168, P51RR000167, P51RR000168, P51RR000167, P51RR000167,
   P51RR000168, P51RR000167, P51RR000168, P51RR000168, P51RR000167,
   P51RR000168, P51RR000168, P51RR000168, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000168, P51RR000168, P51RR000167,
   P51RR000168, P51RR000168, P51RR000167, P51RR000168, P51RR000168,
   P51RR000167, P51RR000167, P51RR000168, P51RR000168, P51RR000168,
   P51RR000168, P51RR000167, P51RR000168, P51RR000168, P51RR000167,
   P51RR000168, P51RR000168, P51RR000168, P51RR000167, P51RR000167,
   P51RR000168, P51RR000168, P51RR000168, P51RR000168, P51RR000168,
   P51RR000168, P51RR000168, P51RR000167, P51RR000168, P51RR000168,
   P51RR000167, P51RR000168, P51RR000168, P51RR000167, P51RR000167,
   P51RR000168, P51RR000167, P51RR000167, P51RR000167, P51RR000168,
   P51RR000168, P51RR000168, P51RR000168, P51RR000167, P51RR000168,
   P51RR000168, P51RR000168, P51RR000167, P51RR000168, P51RR000168,
   P51RR000168, P51RR000168, P51RR000167, P51RR000168, P51RR000168,
   P51RR000167, P51RR000168, P51RR000168, P51RR000167, P51RR000167,
   P51RR000168, P51RR000168, P51RR000167, P51RR000168, P51RR000168,
   P51RR000168, P51RR000168, P51RR000168, P51RR000168, P51RR000167,
   P51RR000168, P51RR000167, P51RR000168, P51RR000168, P51RR000168,
   P51RR000168, P51RR000167, P51RR000167, P51RR000168, P51RR000168,
   P51RR000167, P51RR000167, P51RR000168, P51RR000167, P51RR000168,
   P51RR000167, P51RR000168, P51RR000168, P51RR000167, P51RR000168,
   P51RR000168, P51RR000168, P51RR000167, P51RR000168, P51RR000167,
   P51RR000167, P51RR000167, P51RR000168, P51RR000167, P51RR000168,
   R24RR015371, P51RR000168, P51RR000167, P51RR000168, P51RR000167,
   P51RR000168, P51RR000168, P51RR000168, P51RR000168, P51RR000167,
   P51RR000168, P51RR000167, P51RR000167, P51RR000168, P51RR000168,
   P51RR000167, P51RR000168, P51RR000168, P51RR000168, P51RR000168,
   P51RR000167, P51RR000168, P51RR000167, P51RR000167, P51RR000168,
   P51RR000168, P51RR000168, P51RR000168, P51RR000167, P51RR000168,
   P51RR000168, P51RR000168, P51RR000167, P51RR000168, P51RR000168,
   P51RR000167, P51RR000168, P51RR000168, P51RR000168, P51RR000167,
   P51RR000168, P51RR000167, P51RR000168, P51RR000168, P51RR000167,
   P51RR000168, P51RR000167, P51RR000167, P51RR000168, P51RR000168,
   P51RR000167, P51RR000168, P51RR000168, P51RR000167, P51RR000168,
   P51RR000168, P51RR000168, P51RR000167, P51RR000167, P51RR000168,
   P51RR000168, P51RR000168, P51RR000168, P51RR000167, P51RR000167,
   P51RR000168, P51RR000168, P51RR000168, P51RR000167, P51RR000168,
   P51RR000167, P51RR000167, P51RR000167, R24RR015371, P51RR000168,
   P51RR000167, P51RR000167, P51RR000168, P51RR000168, P51RR000168,
   P51RR000168, P51RR000168, P51RR000168, P51RR000167, P51RR000167,
   P51RR000168, P51RR000168, P51RR000167, P51RR000168, P51RR000167,
   P51RR000167, P51RR000167, P51RR000168, P51RR000168, P51RR000168,
   P51RR000168, P51RR000168, P51RR000167, P51RR000167, P51RR000168,
   R24RR015371, P51RR000168, P51RR000167, P51RR000167, P51RR000168,
   P51RR000168, P51RR000168, P51RR000167, P51RR000167, P51RR000168,
   P51RR000168, P51RR000168, P51RR000167, P51RR000167, P51RR000168,
   P51RR000167, P51RR000167, P51RR000168, P51RR000168, P51RR000167,
   P51RR000167, P51RR000168, P51RR000168, P51RR000167, P51RR000168,
   P51RR000167, P51RR000167, P51RR000167, P51RR000168, P51RR000167,
   P51RR000167, P51RR000168, P51RR000168, P51RR000168, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000168,
   P51RR000167, P51RR000168, P51RR000167, P51RR000168, P51RR000168,
   P51RR000168, P51RR000168, P51RR000168, P51RR000167, P51RR000167,
   P51RR000168, P51RR000167, P51RR000168, P51RR000167, P51RR000167,
   P51RR000168, P51RR000168, P51RR000168, P51RR000168, P51RR000168,
   P51RR000167, P51RR000168, P51RR000167, P51RR000168, P51RR000168,
   P51RR000168, P51RR000167, P51RR000167, P51RR000168, P51RR000168,
   P51RR000167, P51RR000168, P51RR000168, P51RR000168, P51RR000167,
   P51RR000168, P51RR000167, P51RR000168, P51RR000168, P51RR000167,
   P51RR000167, P51RR000167, P51RR000168, P51RR000167, P51RR000168,
   P51RR000168, P51RR000168, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000168, P51RR000168, P51RR000168, P51RR000168,
   P51RR000167, P51RR000168, P51RR000168, P51RR000168, P51RR000167,
   P51RR000167, P51RR000167, P51RR000168, P51RR000168, P51RR000167,
   P51RR000168, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000168, P51RR000168,
   P51RR000168, P51RR000167, P51RR000168, P51RR000167, P51RR000167,
   P51RR000168, P51RR000168, P51RR000168, P51RR000167, P51RR000167,
   P51RR000167, P51RR000168, P51RR000168, P51RR000167, P51RR000168,
   P51RR000167, P51RR000167, P51RR000168, P51RR000168, P51RR000167,
   P51RR000168, P51RR000168, P51RR000168, P51RR000167, P51RR000168,
   P51RR000168, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000168, P51RR000168, P51RR000168, P51RR000168, P51RR000167,
   P51RR000168, P51RR000168, P51RR000168, P51RR000167, P51RR000168,
   P51RR000167, P51RR000168, P51RR000167, P51RR000168, P51RR000168,
   P51RR000167, P51RR000167, P51RR000168, P51RR000168, P51RR000167,
   P51RR000167, P51RR000167, P51RR000168, P51RR000168, P51RR000168,
   P51RR000168, P51RR000167, P51RR000168, P51RR000168, P51RR000168,
   P51RR000168, P51RR000167, P51RR000167, P51RR000168, P51RR000167,
   P51RR000168, P51RR000168, P51RR000168, P51RR000167, P51RR000167,
   P51RR000168, P51RR000168, P51RR000167, P51RR000168, P51RR000167,
   P51RR000168, P51RR000167, P51RR000167, P51RR000168, P51RR000167,
   P51RR000168, P51RR000167, P51RR000168, P51RR000167, P51RR000167,
   P51RR000168, P51RR000168, P51RR000168, P51RR000167, P51RR000168,
   P51RR000168, P51RR000168, P51RR000167, P51RR000167, P51RR000168,
   P51RR000168, P51RR000167, P51RR000167, P51RR000168, P51RR000167,
   P51RR000168, P51RR000167, P51RR000168, P51RR000168, P51RR000168,
   P51RR000168, P51RR000168, P51RR000168, P51RR000167, P51RR000167,
   P51RR000168, P51RR000168, P51RR000168, P51RR000168, P51RR000168,
   P51RR000168, P51RR000167, P51RR000168, P51RR000167, P51RR000168,
   P51RR000168, P51RR000167, P51RR000167, P51RR000168, P51RR000167,
   P51RR000168, P51RR000168, P51RR000167, P51RR000167, P51RR000168,
   P51RR000168, P51RR000168, P51RR000168, P51RR000167, P51RR000168,
   P51RR000167, P51RR000168, P51RR000168, P51RR000168, P51RR000168,
   P51RR000168, P51RR000167, P51RR000167, P51RR000167, P51RR000168,
   P51RR000168, P51RR000167, P51RR000167, P51RR000168, P51RR000168,
   P51RR000168, P51RR000168, P51RR000168, P51RR000168, P51RR000167,
   P51RR000167, P51RR000167, P51RR000168, P51RR000167, P51RR000168,
   P51RR000168, P51RR000168, P51RR000168, P51RR000167, P51RR000168,
   P51RR000168, P51RR000167, P51RR000168, P51RR000168, P51RR000168,
   P51RR000168, P51RR000167, P51RR000168, P51RR000168, P51RR000168,
   P51RR000167, P51RR000168, P51RR000168, P51RR000167, P51RR000168,
   P51RR000168, P51RR000168, P51RR000168, P51RR000168, P51RR000167,
   P51RR000168, P51RR000167, P51RR000168, P51RR000168, P51RR000168,
   P51RR000168, P51RR000167, P51RR000168, P51RR000168, P51RR000167,
   P51RR000168, P51RR000167, P51RR000167, P51RR000168, P51RR000168,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000168, R24RR016038, P51RR000168, P51RR000168,
   P51RR000168, P51RR000168, P51RR000168, P51RR000168, P51RR000168,
   P51RR000168, P51RR000167, P51RR000168, P51RR000168, P51RR000168,
   P51RR000168, P51RR000168, P51RR000168, P51RR000168, P51RR000168,
   P51RR000168, P51RR000168, P51RR000167, P51RR000167, P51RR000168,
   P51RR000168, P51RR000168, P51RR000168, P51RR000167, P51RR000168,
   P51RR000167, P51RR000168, P51RR000168, P51RR000168, P51RR000168,
   P51RR000167, P51RR000168, P51RR000167, P51RR000167, P51RR000168,
   P51RR000167, P51RR000168, P51RR000168, P51RR000168, P51RR000167,
   P51RR000167, P51RR000168, P51RR000168, P51RR000167, P51RR000168,
   P51RR000168, P51RR000168, P51RR000168, P51RR000168, P51RR000168,
   P51RR000168, P51RR000167, P51RR000168, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000168, P51RR000168,
   P51RR000168, P51RR000167, P51RR000168, P51RR000167, P51RR000167,
   P51RR000168, P51RR000168, P51RR000168, P51RR000168, P51RR000168,
   P51RR000168, P51RR000167, P51RR000167, P51RR000168, P51RR000167,
   P51RR000167, P51RR000168, P51RR000168, P51RR000167, P51RR000168,
   P51RR000168, P51RR000168, P51RR000168, P51RR000167, P51RR000168,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000168,
   P51RR000168, P51RR000168, P51RR000168, P51RR000168, P51RR000168,
   P51RR000168, P51RR000168, P51RR000168, P51RR000167, P51RR000167,
   P51RR000167, P51RR000168, P51RR000168, P51RR000168, P51RR000168,
   P51RR000167, P51RR000167, P51RR000168, P51RR000168, P51RR000167,
   P51RR000167, P51RR000167, P51RR000168, P51RR000167, P51RR000167,
   P51RR000168, P51RR000168, P51RR000168, P51RR000168, P51RR000168,
   P51RR000167, P51RR000168, P51RR000167, P51RR000168, P51RR000168,
   P51RR000168, P51RR000167, P51RR000168, P51RR000167, P51RR000167,
   P51RR000168, P51RR000167, P51RR000168, P51RR000168, P51RR000167,
   P51RR000168, P51RR000167, P51RR000167, P51RR000168, P51RR000168,
   P51RR000168, P51RR000168, P51RR000168, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000168, P51RR000168, P51RR000167,
   P51RR000168, P51RR000167, P51RR000167, P51RR000168, P51RR000167,
   P51RR000168, P51RR000168, P51RR000168, P51RR000168, P51RR000168,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000168,
   P51RR000168, P51RR000167, P51RR000168, P51RR000168, P51RR000168,
   P51RR000168, P51RR000168, P51RR000168, P51RR000168, P51RR000168,
   P51RR000167, P51RR000168, P51RR000167, P51RR000168, P51RR000167,
   P51RR000167, P51RR000168, P51RR000167, P51RR000168, P51RR000168,
   P51RR000167, P51RR000168, P51RR000168, P51RR000167, P51RR000167,
   P51RR000168, P51RR000168, P51RR000168, P51RR000167, P51RR000168,
   P51RR000167, P51RR000168, P51RR000168, P51RR000168, P51RR000168,
   P51RR000168, P51RR000168, P51RR000168, P51RR000168, P51RR000167,
   P51RR000168, P51RR000168, P51RR000167, P51RR000167, P51RR000168,
   P51RR000168, P51RR000167, P51RR000167, P51RR000168, P51RR000168,
   P51RR000168, P51RR000168, P51RR000168, P51RR000168, P51RR000168,
   P51RR000167, P51RR000168, P51RR000168, P51RR000168, P51RR000168,
   P51RR000168, P51RR000168, P51RR000168, P51RR000167, P51RR000168,
   P51RR000167, P51RR000168, P51RR000167, P51RR000168, P51RR000168,
   P51RR000167, P51RR000168, P51RR000168, P51RR000168, P51RR000167,
   P51RR000168, P51RR000168, R24RR015371, P51RR000167, P51RR000168,
   P51RR000168, P51RR000168, P51RR000168, P51RR000168, P51RR000168,
   P51RR000167, P51RR000168, P51RR000167, P51RR000168, P51RR000168,
   P51RR000168, P51RR000168, P51RR000167, P51RR000167, P51RR000168,
   P51RR000168, P51RR000167, P51RR000168, P51RR000168, P51RR000167,
   R24RR016038, P51RR000167, P51RR000168, P51RR000168, P51RR000168,
   P51RR000168, P51RR000168, P51RR000168, P51RR000168, P51RR000168,
   P51RR000168, P51RR000167, P51RR000168, P51RR000168, P51RR000167,
   P51RR000168, P51RR000167, P51RR000167, P51RR000167, P51RR000168,
   P51RR000167, P51RR000167, P51RR000168, P51RR000168, P51RR000168,
   P51RR000168, P51RR000167, K26RR000168, P51RR000168, P51RR000167,
   P51RR000167, P51RR000167, P51RR000168, P51RR000168, P51RR000168,
   P51RR000167, P51RR000167, P51RR000167, P51RR000168, P51RR000167,
   R24RR015371, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000168, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000168, P51RR000167, P51RR000167, P51RR000168,
   P51RR000168, P51RR000168, P51RR000168, P51RR000168, P51RR000168,
   P51RR000168, P51RR000167, P51RR000168, P51RR000167, P51RR000168,
   P51RR000167, P51RR000167, P51RR000168, P51RR000168, P51RR000167,
   P51RR000168, P51RR000167, P51RR000168, P51RR000167, P51RR000168,
   P51RR000168, P51RR000167, P51RR000168, P51RR000167, P51RR000167,
   P51RR000168, P51RR000168, P51RR000167, P51RR000167, P51RR000167,
   P51RR000168, P51RR000168, P51RR000167, P51RR000168, P51RR000168,
   P51RR000168, P51RR000167, P51RR000167, P51RR000167, P51RR000168,
   P51RR000167, P51RR000168, P51RR000167, P51RR000167, P51RR000167,
   P51RR000168, P51RR000168, P51RR000168, P51RR000167, P51RR000168,
   P51RR000168, P51RR000167, P51RR000167, P51RR000168, P51RR000167,
   P51RR000168, P51RR000168, P51RR000167, P51RR000168, P51RR000168,
   P51RR000167, P51RR000168, P51RR000168, P51RR000167, P51RR000167,
   P51RR000168, P51RR000167, P51RR000167, P51RR000168, P51RR000167,
   P51RR000168, P51RR000167, P51RR000167, P51RR000168, P51RR000168,
   P51RR000167, P51RR000168, P51RR000167, P51RR000167, P51RR000168,
   P51RR000168, P51RR000167, P51RR000168, P51RR000168, P51RR000168,
   P51RR000168, P51RR000168, P51RR000167, P51RR000168, P51RR000167,
   P51RR000168, P51RR000167, P51RR000168, P51RR000168, P51RR000168,
   P51RR000167, P51RR000168, P51RR000168, P51RR000168, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000168, P51RR000168, P51RR000167, P51RR000167,
   P51RR000168, P51RR000167, P51RR000167, P51RR000168, P51RR000168,
   P51RR000167, P51RR000167, P51RR000168, P51RR000167, P51RR000168,
   P51RR000167, P51RR000167, P51RR000167, P51RR000168, P51RR000167,
   P51RR000168, P51RR000167, P51RR000168, P51RR000168, P51RR000168,
   P51RR000167, P51RR000168, P51RR000167, P51RR000167, P51RR000168,
   P51RR000168, P51RR000168, P51RR000167, P51RR000168, P51RR000168,
   P51RR000168, P51RR000168, P51RR000168, P51RR000167, P51RR000168,
   P51RR000167, P51RR000168, P51RR000167, P51RR000167, P51RR000167,
   P51RR000168, P51RR000168, P51RR000168, P51RR000168, P51RR000168,
   P51RR000167, P51RR000168, P51RR000167, P51RR000168, P51RR000168,
   P51RR000167, P51RR000168, P51RR000168, P51RR000168, P51RR000167,
   P51RR000167, P51RR000168, P51RR000168, P51RR000167, P51RR000168,
   P51RR000168, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000168, P51RR000167, P51RR000168, P51RR000168, P51RR000168,
   P51RR000168, P51RR000167, P51RR000167, P51RR000168, P51RR000168,
   P51RR000168, P51RR000168, P51RR000168, P51RR000167, P51RR000168,
   P51RR000167, P51RR000167, P51RR000168, P51RR000168, P51RR000167,
   P51RR000167, P51RR000168, P51RR000167, P51RR000168, P51RR000167,
   P51RR000168, P51RR000167, P51RR000168, P51RR000168, P51RR000168,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000168, P51RR000168, P51RR000167, P51RR000168, P51RR000168,
   P51RR000168, P51RR000168, P51RR000167, P51RR000168, P51RR000168,
   P51RR000168, P51RR000167, P51RR000167, P51RR000168, P51RR000167,
   P51RR000167, P51RR000168, P51RR000167, P51RR000168, P51RR000168,
   P51RR000167, P51RR000168, P51RR000167, P51RR000168, P51RR000168,
   P51RR000167, P51RR000168, R24RR016038, P51RR000167, P51RR000168,
   P51RR000167, P51RR000167, P51RR000168, P51RR000167, P51RR000167,
   P51RR000168, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000168, P51RR000168, R24RR015371, P51RR000167,
   P51RR000168, P51RR000167, P51RR000167, P51RR000168, P51RR000168,
   P51RR000167, P51RR000168, P51RR000167, P51RR000168, P51RR000168,
   P51RR000167, P51RR000168, P51RR000167, P51RR000168, P51RR000167,
   P51RR000168, P51RR000168, P51RR000167, P51RR000168, P51RR000168,
   P51RR000167, P51RR000168, P51RR000168, P51RR000167, P51RR000168,
   P51RR000167, P51RR000168, P51RR000167, P51RR000167, P51RR000168,
   P51RR000168, P51RR000167, P51RR000168, P51RR000168, P51RR000168,
   P51RR000168, P51RR000168, P51RR000167, P51RR000167, R24RR016038,
   P51RR000167, P51RR000167, P51RR000168, P51RR000168, P51RR000168,
   P51RR000168, P51RR000167, P51RR000168, P51RR000167, P51RR000168,
   P51RR000168, P51RR000168, P51RR000167, P51RR000168, P51RR000167,
   P51RR000168, P51RR000168, P51RR000167, P51RR000168, P51RR000168,
   P51RR000168, P51RR000168, P51RR000168, P51RR000167, P51RR000168,
   P51RR000167, P51RR000168, P51RR000168, P51RR000168, P51RR000168,
   P51RR000168, P51RR000167, P51RR000168, P51RR000167, P51RR000168,
   P51RR000167, P51RR000168, P51RR000167, P51RR000168, P51RR000167,
   P51RR000168, P51RR000168, P51RR000168, P51RR000167, P51RR000167,
   P51RR000167, P51RR000168, P51RR000167, P51RR000168, P51RR000168,
   P51RR000168, P51RR000168, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000168, P51RR000168, P51RR000168,
   P51RR000167, P51RR000167, P51RR000168, P51RR000167, P51RR000168,
   P51RR000168, P51RR000168, P51RR000167, P51RR000168, P51RR000167,
   P51RR000167, P51RR000168, P51RR000168, P51RR000167, P51RR000168,
   P51RR000167, P51RR000168, P51RR000167, P51RR000168, P51RR000167,
   P51RR000167, R24RR015371, P51RR000167, P51RR000167, P51RR000168,
   P51RR000168, P51RR000167, P51RR000168, P51RR000167, P51RR000167,
   P51RR000168, P51RR000168, P51RR000167, P51RR000168, P51RR000168,
   P51RR000167, P51RR000168, P51RR000167, P51RR000168, P51RR000167,
   P51RR000168, P51RR000168, P51RR000168, P51RR000167, P51RR000168,
   P51RR000168, P51RR000168, P51RR000168, P51RR000167, P51RR000167,
   P51RR000168, P51RR000168, P51RR000167, P51RR000168, P51RR000168,
   P51RR000167, P51RR000167, P51RR000167, P51RR000168, P51RR000167,
   P51RR000167, P51RR000168, P51RR000168, P51RR000167, P51RR000167,
   P51RR000168, P51RR000168, P51RR000168, P51RR000168, P51RR000168,
   P51RR000168, P51RR000168, P51RR000168, P51RR000168, P51RR000167,
   P51RR000168, P51RR000168, P51RR000168, P51RR000167, P51RR000167,
   P51RR000168, P51RR000168, P51RR000168, P51RR000168, P51RR000167,
   P51RR000167, P51RR000168, P51RR000167, P51RR000168, P51RR000168,
   P51RR000168, P51RR000168, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000168, P51RR000168, P51RR000168, P51RR000167,
   P51RR000168, P51RR000168, P51RR000167, P51RR000167, P51RR000167,
   P51RR000168, P51RR000168, P51RR000168, P51RR000168, P51RR000168,
   P51RR000168, P51RR000168, P51RR000168, P51RR000168, P51RR000168,
   P51RR000168, P51RR000168, P51RR000168, P51RR000168, P51RR000167,
   P51RR000167, P51RR000167, P51RR000168, P51RR000167, P51RR000168,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000168,
   P51RR000168, P51RR000167, P51RR000167, P51RR000168, P51RR000168,
   P51RR000168, P51RR000168, P51RR000167, P51RR000167, P51RR000168,
   P51RR000168, P51RR000168, P51RR000168, P51RR000168, P51RR000168,
   P51RR000168, P51RR000167, P51RR000168, P51RR000168, P51RR000168,
   P51RR000167, P51RR000167, P51RR000168, P51RR000167, P51RR000168,
   P51RR000168, P51RR000167, P51RR000168, P51RR000168, P51RR000168,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000168, P51RR000168, P51RR000168, P51RR000168, P51RR000167,
   P51RR000167, P51RR000167, P51RR000168, P51RR000168, P51RR000168,
   P51RR000167, P51RR000168, P51RR000168, P51RR000167, P51RR000168,
   P51RR000168, P51RR000168, P51RR000168, P51RR000168, P51RR000168,
   P51RR000168, P51RR000168, P51RR000167, P51RR000168, P51RR000167,
   P51RR000168, P51RR000167, P51RR000168, P51RR000168, P51RR000167,
   P51RR000168, P51RR000168, P51RR000167, P51RR000168, P51RR000168,
   P51RR000168, P51RR000167, P51RR000168, P51RR000168, P51RR000167,
   P51RR000168, P51RR000168, P51RR000167, P51RR000168, P51RR000168,
   P51RR000168, P51RR000168, P51RR000168, P51RR000168, P51RR000168,
   P51RR000168, P51RR000167, P51RR000167, P51RR000167, P51RR000168,
   P51RR000168, P51RR000167, P51RR000167, P51RR000168, P51RR000167,
   P51RR000167, P51RR000167, P51RR000168, P51RR000167, P51RR000168,
   P51RR000167, P51RR000167, P51RR000168, P51RR000167, P51RR000167,
   P51RR000167, P51RR000168, P51RR000168, P51RR000167, P51RR000167,
   P51RR000168, P51RR000167, P51RR000168, P51RR000167, P51RR000167,
   P51RR000167, P51RR000168, P51RR000168, P51RR000168, P51RR000167,
   P51RR000167, P51RR000168, P51RR000167, P51RR000168, P51RR000168,
   P51RR000168, P51RR000168, P51RR000168, P51RR000168, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000168, P51RR000167,
   P51RR000167, P51RR000168, P51RR000168, P51RR000168, P51RR000168,
   P51RR000167, P51RR000168, P51RR000168, P51RR000168, P51RR000168,
   P51RR000167, P51RR000168, P51RR000168, P51RR000168, P51RR000168,
   P51RR000168, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000168, P51RR000168, P51RR000167, P51RR000168, P51RR000168,
   P51RR000168, P51RR000167, P51RR000167, P51RR000168, P51RR000168,
   P51RR000168, P51RR000168, P51RR000168, P51RR000168, P51RR000168,
   P51RR000167, P51RR000167, P51RR000168, P51RR000167, P51RR000167,
   P51RR000167, P51RR000168, P51RR000168, P51RR000168, P51RR000167,
   P51RR000168, P51RR000167, P51RR000167, P51RR000168, P51RR000167,
   P51RR000167, P51RR000168, P51RR000167, P51RR000168, P51RR000168,
   P51RR000168, P51RR000168, P51RR000167, P51RR000167, P51RR000168,
   P51RR000168, P51RR000167, P51RR000168, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000168,
   P51RR000167, P51RR000168, P51RR000167, P51RR000168, P51RR000167,
   P51RR000168, P51RR000168, P51RR000167, P51RR000168, P51RR000168,
   P51RR000167, P51RR000168, P51RR000167, P51RR000168, P51RR000168,
   P51RR000167, P51RR000167, P51RR000168, P51RR000168, P51RR000168,
   P51RR000167, P51RR000168, P51RR000168, P51RR000167, P51RR000168,
   P51RR000167, P51RR000167, P51RR000168, P51RR000168, P51RR000168,
   P51RR000168, P51RR000167, K26RR000168, P51RR000167, P51RR000168,
   P51RR000168, P51RR000168, P51RR000167, P51RR000168, P51RR000168,
   P51RR000168, P51RR000168, P51RR000168, P51RR000168, P51RR000167,
   P51RR000167, P51RR000168, P51RR000168, P51RR000168, P51RR000168,
   P51RR000168, P51RR000168, P51RR000167, P51RR000168, P51RR000167,
   P51RR000168, P51RR000167, P51RR000168, P51RR000168, P51RR000167,
   P51RR000168, P51RR000168, P51RR000167, P51RR000167, P51RR000168,
   P51RR000168, P51RR000167, P51RR000168, P51RR000168, P51RR000167,
   P51RR000168, P51RR000167, P51RR000167, P51RR000168, P51RR000167,
   P51RR000167, P51RR000168, P51RR000167, P51RR000168, P51RR000168,
   P51RR000167, P51RR000167, P51RR000167, P51RR000168, P51RR000167,
   P51RR000167, P51RR000168, P51RR000168, P51RR000168, P51RR000168,
   P51RR000168, P51RR000168, P51RR000167, P51RR000168, P51RR000167,
   P51RR000168, P51RR000167, P51RR000168, P51RR000168, P51RR000168,
   P51RR000168, P51RR000168, P51RR000168, P51RR000168, P51RR000168,
   P51RR000167, P51RR000168, P51RR000168, P51RR000167, P51RR000167,
   P51RR000168, P51RR000168, P51RR000167, P51RR000167, P51RR000168,
   P51RR000167, P51RR000168, P51RR000167, P51RR000168, P51RR000168,
   P51RR000167, P51RR000168, P51RR000168, P51RR000168, P51RR000167,
   P51RR000167, P51RR000167, P51RR000168, P51RR000168, P51RR000168,
   P51RR000167, P51RR000168, P51RR000167, P51RR000167, P51RR000168,
   P51RR000167, P51RR000168, P51RR000168, P51RR000167, P51RR000168,
   P51RR000167, P51RR000168, P51RR000167, P51RR000167, P51RR000168,
   P51RR000168, P51RR000168, P51RR000167, P51RR000168, P51RR000168,
   P51RR000168, P51RR000168, P51RR000168, P51RR000167, P51RR000168,
   P51RR000167, P51RR000167, P51RR000168, P51RR000168, P51RR000167,
   P51RR000168, P51RR000167, P51RR000168, P51RR000168, P51RR000168,
   P51RR000168, P51RR000168, P51RR000168, P51RR000168, P51RR000168,
   P51RR000167, P51RR000168, P51RR000168, P51RR000167, P51RR000167,
   P51RR000168, P51RR000167, P51RR000168, P51RR000167, P51RR000168,
   P51RR000168, P51RR000168, P51RR000168, P51RR000168, P51RR000168,
   P51RR000168, P51RR000168, P51RR000168, P51RR000167, P51RR000167,
   P51RR000167, P51RR000168, P51RR000168, P51RR000167, P51RR000167,
   P51RR000167, P51RR000168, P51RR000167, P51RR000168, P51RR000168,
   P51RR000167, P51RR000168, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000168, P51RR000168, P51RR000167, P51RR000167,
   P51RR000168, P51RR000168, P51RR000168, P51RR000168, P51RR000168,
   P51RR000167, P51RR000167, P51RR000168, P51RR000168, P51RR000168,
   P51RR000167, P51RR000168, P51RR000168, P51RR000168, P51RR000168,
   P51RR000167, P51RR000168, P51RR000168, P51RR000167, P51RR000167,
   P51RR000168, P51RR000167, P51RR000167, P51RR000168, P51RR000168,
   P51RR000167, P51RR000167, P51RR000167, P51RR000168, P51RR000167,
   P51RR000168, P51RR000167, P51RR000168, P51RR000168, P51RR000168,
   P51RR000168, P51RR000167, P51RR000167, P51RR000167, P51RR000168,
   P51RR000168, P51RR000167, P51RR000167, P51RR000168, P51RR000168,
   P51RR000167, P51RR000168, P51RR000168, P51RR000167, P51RR000168,
   P51RR000168, P51RR000168, P51RR000168, P51RR000167, P51RR000167,
   P51RR000168, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000168, P51RR000167, P51RR000168,
   P51RR000168, P51RR000168, P51RR000168, P51RR000168, P51RR000168,
   P51RR000167, P51RR000167, P51RR000168, P51RR000168, P51RR000168,
   P51RR000168, P51RR000167, P51RR000168, P51RR000168, P51RR000167,
   P51RR000167, P51RR000167, P51RR000168, P51RR000168, P51RR000168,
   P51RR000168, P51RR000168, P51RR000168, P51RR000168, P51RR000167,
   P51RR000168, P51RR000167, P51RR000168, P51RR000168, P51RR000167,
   P51RR000168, P51RR000167, P51RR000168, P51RR000168, P51RR000167,
   P51RR000168, P51RR000167, P51RR000168, P51RR000168, P51RR000167,
   P51RR000168, P51RR000168, P51RR000168, P51RR000167, P51RR000167,
   P51RR000168, P51RR000168, P51RR000168, P51RR000168, P51RR000168,
   P51RR000168, P51RR000168, P51RR000167, P51RR000168, P51RR000167,
   P51RR000168, P51RR000167, P51RR000168, P51RR000168, P51RR000168,
   P51RR000168, P51RR000167, P51RR000167, P51RR000167, P51RR000168,
   P51RR000167, P51RR000167, P51RR000168, P51RR000168, P51RR000167,
   P51RR000168, P51RR000168, P51RR000168, P51RR000167, P51RR000168,
   P51RR000168, P51RR000168, P51RR000168, P51RR000167, P51RR000168,
   P51RR000168, P51RR000167, P51RR000167, P51RR000168, P51RR000167,
   P51RR000168, P51RR000167, P51RR000168, P51RR000168, P51RR000168,
   P51RR000168, P51RR000167, P51RR000168, P51RR000168, P51RR000168,
   P51RR000167, P51RR000168, P51RR000168, P51RR000167, P51RR000168,
   P51RR000168, P51RR000168, P51RR000168, P51RR000167, P51RR000168,
   P51RR000167, P51RR000168, P51RR000168, R24RR016038, P51RR000167,
   P51RR000168, P51RR000167, P51RR000168, P51RR000167, P51RR000167,
   P51RR000167, P51RR000168, P51RR000168, P51RR000167, P51RR000167,
   P51RR000168, P51RR000167, P51RR000167, P51RR000168, P51RR000167,
   P51RR000168, P51RR000168, P51RR000168, P51RR000168, P51RR000168,
   P51RR000168, P51RR000168, P51RR000167, P51RR000168, P51RR000167,
   P51RR000168, P51RR000167, P51RR000168, P51RR000168, P51RR000167,
   P51RR000168, P51RR000167, P51RR000168, P51RR000167, P51RR000167,
   P51RR000168, P51RR000167, P51RR000167, P51RR000167, P51RR000168,
   P51RR000167, P51RR000168, P51RR000168, P51RR000168, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000168, P51RR000167,
   P51RR000167, P51RR000168, P51RR000167, P51RR000167, P51RR000167,
   P51RR000168, P51RR000168, P51RR000167, P51RR000168, P51RR000168,
   P51RR000168, P51RR000167, P51RR000168, P51RR000168, P51RR000168,
   P51RR000167, P51RR000168, P51RR000168, P51RR000167, P51RR000167,
   P51RR000168, P51RR000167, P51RR000168, P51RR000168, P51RR000168,
   P51RR000168, P51RR000168, P51RR000167, P51RR000167, P51RR000168,
   P51RR000168, P51RR000168, P51RR000168, P51RR000168, P51RR000167,
   P51RR000168, P51RR000167, P51RR000168, P51RR000168, P51RR000167,
   P51RR000168] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY
   AND INFECTIOUS DISEASESUnited States Department of Health & Human
   ServicesNational Institutes of Health (NIH) - USANIH National Institute
   of Allergy & Infectious Diseases (NIAID) [U19AI096109, U19AI096109,
   U19AI096109, U19AI096109, R01AI049120, U19AI096109, U19AI096109,
   U19AI096109, R01AI049120, R01AI049120, U19AI096109, U19AI096109,
   R01AI049120, R01AI076114, U19AI096109, U19AI096109, U19AI096109,
   U19AI096109, R01AI049120, R01AI049120, U19AI096109, U19AI096109,
   U19AI096109, R01AI049120, U19AI096109, U19AI096109, U19AI096109,
   U19AI096109, R01AI076114, U19AI096109, U19AI096109, U19AI096109,
   U19AI096109, U19AI096109, U19AI096109, U19AI096109, U19AI096109,
   U19AI096109, U19AI096109, U19AI096109, U19AI096109, U19AI096109,
   U19AI096109, U19AI096109, R01AI049120, R01AI076114, U19AI096109,
   U19AI096109, U19AI096109, U19AI096109, U19AI096109, U19AI096109,
   U19AI096109, R01AI049120, U19AI096109, R01AI076114, U19AI096109,
   U19AI096109, U19AI096109, U19AI096109, U19AI096109, U19AI096109,
   U19AI096109, U19AI096109, R01AI076114, U19AI096109, U19AI096109] Funding
   Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF
   HEALTHUnited States Department of Health & Human ServicesNational
   Institutes of Health (NIH) - USA [P51OD011106, P51OD011106, P51OD011106,
   P51OD011106, P51OD011106, P51OD011106, P51OD011106, P51OD011106,
   P51OD011106, P51OD011106, P51OD011106, P51OD011106, P51OD011106,
   P51OD011106, P51OD011106] Funding Source: NIH RePORTER
FX This research was supported by National Institutes of Health
   (NIH)/National Institute of Allergy and Infectious Disease grants R01
   AI076114, R01 AI049120, R24 RR015371, and R24 RR016038 and in part by
   grant R51 RR000167 from the National Center for Research Resources
   (NCRR) awarded to the WNPRC, University of Wisconsin-Madison, and by
   grant RR000168 awarded to the New England Primate Research Center. The
   following reagents were obtained through the NIH AIDS Reagent and
   Reference Reagent Program, Division of AIDS, NIAID, NIH: IL-2, human
   (item no. 136), from Hoffman-La Roche; SIVmac p27 hybridoma (55-2F12,
   item no. 1547) from Niels Pedersen.
CR Adnan S, 2006, BLOOD, V108, P3414, DOI 10.1182/blood-2006-06-030668
   Borda JT, 2004, AM J PATHOL, V165, P2111, DOI 10.1016/S0002-9440(10)63261-0
   BORROW P, 1994, J VIROL, V68, P6103, DOI 10.1128/JVI.68.9.6103-6110.1994
   CAMERON PU, 1992, SCIENCE, V257, P383, DOI 10.1126/science.1352913
   Chung C, 2007, J VIROL, V81, P1517, DOI 10.1128/JVI.01780-06
   Collman RG, 2003, J LEUKOCYTE BIOL, V74, P631, DOI 10.1189/jlb.0703357
   CROWE SM, 1994, J LEUKOCYTE BIOL, V56, P318
   DESROSIERS RC, 1991, AM J PATHOL, V139, P29
   Douek DC, 2003, ANNU REV IMMUNOL, V21, P265, DOI 10.1146/annurev.immunol.21.120601.141053
   Douek DC, 2002, NATURE, V417, P95, DOI 10.1038/417095a
   Eckstein DA, 2001, J EXP MED, V194, P1407, DOI 10.1084/jem.194.10.1407
   EMBRETSON J, 1993, P NATL ACAD SCI USA, V90, P357, DOI 10.1073/pnas.90.1.357
   Friedrich TC, 2007, J VIROL, V81, P3465, DOI 10.1128/JVI.02392-06
   Fujiwara M, 2007, BLOOD, V109, P4832, DOI 10.1182/blood-2006-07-037481
   GARTNER S, 1986, SCIENCE, V233, P215, DOI 10.1126/science.3014648
   Geijtenbeek TBH, 2000, CELL, V100, P587, DOI 10.1016/S0092-8674(00)80694-7
   Greene JM, 2010, J VIROL, V84, P3362, DOI 10.1128/JVI.02028-09
   Igarashi T, 2003, J LEUKOCYTE BIOL, V74, P772, DOI 10.1189/jlb.0503196
   Igarashi T, 2001, P NATL ACAD SCI USA, V98, P658, DOI 10.1073/pnas.021551798
   Jin X, 1999, J EXP MED, V189, P991, DOI 10.1084/jem.189.6.991
   Kiepiela P, 2007, NAT MED, V13, P46, DOI 10.1038/nm1520
   KOENIG S, 1986, SCIENCE, V233, P1089, DOI 10.1126/science.3016903
   KOUP RA, 1994, J VIROL, V68, P4650, DOI 10.1128/JVI.68.7.4650-4655.1994
   Kuroda MJ, 1999, J IMMUNOL, V162, P5127
   LEVY JA, 1993, MICROBIOL REV, V57, P183, DOI 10.1128/MMBR.57.1.183-289.1993
   Loffredo JT, 2007, J VIROL, V81, P2624, DOI 10.1128/JVI.01912-06
   Loffredo JT, 2005, J VIROL, V79, P14986, DOI 10.1128/JVI.79.23.14986-14991.2005
   Martins MA, 2010, J VIROL, V84, P4352, DOI 10.1128/JVI.02365-09
   Matano T, 1998, J VIROL, V72, P164, DOI 10.1128/JVI.72.1.164-169.1998
   MELTZER MS, 1990, AIDS RES HUM RETROV, V6, P967, DOI 10.1089/aid.1990.6.967
   Ortiz AM, 2011, J CLIN INVEST, V121, P4433, DOI 10.1172/JCI46023
   Price RW, 1996, LANCET, V348, P445, DOI 10.1016/S0140-6736(95)11035-6
   RASHEED S, 1986, VIROLOGY, V154, P395, DOI 10.1016/0042-6822(86)90465-4
   REIMANN KA, 1994, J VIROL, V68, P2362, DOI 10.1128/JVI.68.4.2362-2370.1994
   Reinhart TA, 1997, J INFECT DIS, V176, P1198, DOI 10.1086/514113
   Sacha JB, 2007, J VIROL, V81, P11703, DOI 10.1128/JVI.00926-07
   Sacha JB, 2007, J IMMUNOL, V178, P2746, DOI 10.4049/jimmunol.178.5.2746
   Sacha JB, 2009, P NATL ACAD SCI USA, V106, P9791, DOI 10.1073/pnas.0813106106
   Schacker T, 2001, J INFECT DIS, V183, P555, DOI 10.1086/318524
   Schmitz JE, 1998, BLOOD, V92, P198, DOI 10.1182/blood.V92.1.198.413k13_198_206
   Schmitz JE, 1999, SCIENCE, V283, P857, DOI 10.1126/science.283.5403.857
   Sharova N, 2005, EMBO J, V24, P2481, DOI 10.1038/sj.emboj.7600707
   TSUBOTA H, 1989, J EXP MED, V169, P1421, DOI 10.1084/jem.169.4.1421
   Veazey RS, 1998, SCIENCE, V280, P427, DOI 10.1126/science.280.5362.427
   Vojnov L, 2010, J VIROL, V84, P753, DOI 10.1128/JVI.01596-09
   Webster RL, 2005, IMMUNOLOGY, V115, P206, DOI 10.1111/j.1365-2567.2005.02147.x
   Williams KC, 2001, J EXP MED, V193, P905, DOI 10.1084/jem.193.8.905
   Wykrzykowska JJ, 1998, J EXP MED, V187, P1767, DOI 10.1084/jem.187.11.1767
   Yang OO, 1997, J VIROL, V71, P3120, DOI 10.1128/JVI.71.4.3120-3128.1997
   Yang OO, 2003, J IMMUNOL, V171, P3718, DOI 10.4049/jimmunol.171.7.3718
   Zhang ZQ, 1999, SCIENCE, V286, P1353, DOI 10.1126/science.286.5443.1353
NR 51
TC 27
Z9 27
U1 0
U2 5
PU AMER SOC MICROBIOLOGY
PI WASHINGTON
PA 1752 N ST NW, WASHINGTON, DC 20036-2904 USA
SN 0022-538X
J9 J VIROL
JI J. Virol.
PD APR
PY 2012
VL 86
IS 8
BP 4682
EP 4687
DI 10.1128/JVI.06324-11
PG 6
WC Virology
SC Virology
GA 917NU
UT WOS:000302185400061
PM 22318140
OA Green Published, Bronze
DA 2020-12-01
ER

PT J
AU Trindade, GF
   de Santana, MGV
   dos Santos, JR
   Galler, R
   Bonaldo, MC
AF Trindade, Gisela Freitas
   Veloso de Santana, Marlon Gilsepp
   dos Santos, Juliana Ribeiro
   Galler, Ricardo
   Bonaldo, Myrna Cristina
TI Retention of a recombinant GFP protein expressed by the yellow fever 17D
   virus in the E/NS1 intergenic region in the endoplasmic reticulum
SO MEMORIAS DO INSTITUTO OSWALDO CRUZ
LA English
DT Article
DE recombinant yellow fever 17D virus; GFP expression; ER retention;
   deletion and insertion mutants
ID BORNE ENCEPHALITIS-VIRUS; STEM-ANCHOR REGION; DENGUE VIRUS; CELL
   EPITOPE; GLYCOPROTEIN; REPLICATION; DOMAINS; SIGNAL
AB The flaviviral envelope proteins, E protein and precursor membrane protein, are mainly associated with the endoplasmic reticulum (ER) through two transmembrane (TM) domains that are exposed to the luminal face of this compartment. Their retention is associated with the viral assembly process. ER-retrieval motifs were mapped at the carboxy terminus of these envelope proteins. A recombinant yellow fever (YF) 17D virus expressing the reporter green fluorescent protein (GFP) with the stem-anchor (SA) region of E protein fused to its carboxy terminus was subjected to distinct genetic mutations in the SA sequence to investigate their effect on ER retention. Initially, we introduced progressive deletions of the stem elements (H1, CS and H2). In a second set of mutants, the effect of a length increase for the first TM anchor region was evaluated either by replacing it with the longer TM of human LAMP-1 or by the insertion of the VALLLVA sequence into its carboxy terminus. We did not detect any effect on the GFP localisation in the cell, which remained associated with the ER. Further studies should be undertaken to elucidate the causes of the ER retention of recombinant proteins expressed at the intergenic E/NS1 region of the YF 17D virus polyprotein.
C1 [Trindade, Gisela Freitas; Veloso de Santana, Marlon Gilsepp; dos Santos, Juliana Ribeiro; Bonaldo, Myrna Cristina] Inst Oswaldo Cruz, Lab Biol Mol Flavivirus, BR-21045900 Rio De Janeiro, RJ, Brazil.
   [Galler, Ricardo] Inst Tecnol Imunobiol Fiocruz, BR-21045900 Rio De Janeiro, RJ, Brazil.
RP Bonaldo, MC (corresponding author), Inst Oswaldo Cruz, Lab Biol Mol Flavivirus, Av Brasil 4365, BR-21045900 Rio De Janeiro, RJ, Brazil.
EM mbonaldo@ioc.fiocruz.br
RI Bonaldo, Myrna C/D-9494-2013; Galler, Ricardo/B-3280-2014; de Santana,
   Marlon Gilsepp Veloso/H-8146-2017
OI de Santana, Marlon Gilsepp Veloso/0000-0002-3427-841X; Trindade,
   Gisela/0000-0002-1630-4143
FU PDTIS/FIOCRUZ (RVR03); CNPqNational Council for Scientific and
   Technological Development (CNPq); INCTVCNPq/MCT
FX Fianancial support: PDTIS/FIOCRUZ (RVR03), CNPq, INCTVCNPq/MCT
CR Allison SL, 1999, J VIROL, V73, P5605, DOI 10.1128/JVI.73.7.5605-5612.1999
   Bonaldo MC, 2005, J VIROL, V79, P8602, DOI 10.1128/JVI.79.13.8602-8613.2005
   Bonaldo MC, 2002, J MOL BIOL, V315, P873, DOI 10.1006/jmbi.2001.5258
   Bonaldo MC, 2010, J VIROL, V84, P3699, DOI 10.1128/JVI.02255-09
   Bonaldo MC, 2007, VIROL J, V4, DOI 10.1186/1743-422X-4-115
   BRETSCHER MS, 1993, SCIENCE, V261, P1280, DOI 10.1126/science.8362242
   Carpp LN, 2011, MICROBES INFECT, V13, P85, DOI 10.1016/j.micinf.2010.10.010
   CHEN JW, 1988, J BIOL CHEM, V263, P8754
   Ciczora Y, 2010, J GEN VIROL, V91, P404, DOI 10.1099/vir.0.015339-0
   De Beeck AO, 2004, J VIROL, V78, P12591, DOI 10.1128/JVI.78.22.12591-12602.2004
   Franco D, 2010, VACCINE, V28, P5676, DOI 10.1016/j.vaccine.2010.06.052
   Gillespie LK, 2010, J VIROL, V84, P10438, DOI 10.1128/JVI.00986-10
   Guy B, 2010, VACCINE, V28, P632, DOI 10.1016/j.vaccine.2009.09.098
   Hsieh SC, 2008, VIROLOGY, V374, P338, DOI 10.1016/j.virol.2007.12.041
   Hsieh SC, 2010, J VIROL, V84, P4782, DOI 10.1128/JVI.01963-09
   Levine TP, 2000, MOL BIOL CELL, V11, P2267, DOI 10.1091/mbc.11.7.2267
   Lin SR, 2011, J VIROL, V85, P5159, DOI 10.1128/JVI.02099-10
   Lorenz IC, 2003, J VIROL, V77, P4370, DOI 10.1128/JVI.77.7.4370-4382.2003
   Lorenz IC, 2002, J VIROL, V76, P5480, DOI 10.1128/JVI.76.11.5480-5491.2002
   Mackenzie J, 2005, TRAFFIC, V6, P967, DOI 10.1111/j.1600-0854.2005.00339.x
   McAllister A, 2000, J VIROL, V74, P9197, DOI 10.1128/JVI.74.19.9197-9205.2000
   Nogueira RT, 2011, VIROL J, V8, DOI 10.1186/1743-422X-8-127
   RICE C M, 1989, New Biologist, V1, P285
   Schmidt AG, 2010, J VIROL, V84, P12549, DOI 10.1128/JVI.01440-10
   Schmidt AG, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000851
   Sharpe HJ, 2010, CELL, V142, P158, DOI 10.1016/j.cell.2010.05.037
   Stadler K, 1997, J VIROL, V71, P8475, DOI 10.1128/JVI.71.11.8475-8481.1997
   Tsien RY, 1998, ANNU REV BIOCHEM, V67, P509, DOI 10.1146/annurev.biochem.67.1.509
   Welsch S, 2009, CELL HOST MICROBE, V5, P365, DOI 10.1016/j.chom.2009.03.007
   Yu IM, 2008, SCIENCE, V319, P1834, DOI 10.1126/science.1153264
   Zhang W, 2003, NAT STRUCT BIOL, V10, P907, DOI 10.1038/nsb990
NR 31
TC 4
Z9 4
U1 0
U2 0
PU FUNDACO OSWALDO CRUZ
PI RIO DE JANEIRO, RJ
PA AV BRASIL 4365, 21045-900 RIO DE JANEIRO, RJ, BRAZIL
SN 0074-0276
EI 1678-8060
J9 MEM I OSWALDO CRUZ
JI Mem. Inst. Oswaldo Cruz
PD MAR
PY 2012
VL 107
IS 2
BP 262
EP 272
DI 10.1590/S0074-02762012000200017
PG 11
WC Parasitology; Tropical Medicine
SC Parasitology; Tropical Medicine
GA 908AV
UT WOS:000301463500017
PM 22415267
OA DOAJ Gold, Green Published
DA 2020-12-01
ER

PT J
AU Galler, R
   Bonaldo, MC
   Alves, AMD
AF Galler, Ricardo
   Bonaldo, Myrna Cristina
   de Barcelos Alves, Ada Maria
TI Dengue vaccines: closer but not there yet
SO MEMORIAS DO INSTITUTO OSWALDO CRUZ
LA English
DT Editorial Material
ID DEMAND
C1 [Galler, Ricardo] Inst Tecnol Imunobiol Fiocruz, Rio De Janeiro, RJ, Brazil.
   [Bonaldo, Myrna Cristina; de Barcelos Alves, Ada Maria] Inst Oswaldo Cruz Fiocruz, Rio De Janeiro, RJ, Brazil.
RP Galler, R (corresponding author), Inst Tecnol Imunobiol Fiocruz, Rio De Janeiro, RJ, Brazil.
RI Galler, Ricardo/B-3280-2014; Bonaldo, Myrna C/D-9494-2013
CR Amarasinghe A, 2011, HUM VACCINES, V7, P776, DOI 10.4161/hv.7.7.16255
   Amarasinghe A, 2010, HUM VACCINES, V6, P745, DOI 10.4161/hv.6.9.12587
   BRANDT WE, 1990, J INFECT DIS, V162, P577, DOI 10.1093/infdis/162.3.577
   Gubler DJ, 2011, EXPERT REV VACCINES, V10, P563, DOI [10.1586/ERV.11.35, 10.1586/erv.11.35]
NR 4
TC 2
Z9 2
U1 0
U2 1
PU FUNDACO OSWALDO CRUZ
PI RIO DE JANEIRO, RJ
PA AV BRASIL 4365, 21045-900 RIO DE JANEIRO, RJ, BRAZIL
SN 0074-0276
J9 MEM I OSWALDO CRUZ
JI Mem. Inst. Oswaldo Cruz
PD DEC
PY 2011
VL 106
IS 8
BP 905
EP 906
DI 10.1590/S0074-02762011000800001
PG 2
WC Parasitology; Tropical Medicine
SC Parasitology; Tropical Medicine
GA 875XP
UT WOS:000299068800001
PM 22241108
OA DOAJ Gold
DA 2020-12-01
ER

PT J
AU Vojnov, L
   Martins, MA
   Almeida, JR
   Ende, Z
   Rakasz, EG
   Reynolds, MR
   Leon, EJ
   Weisgrau, KL
   Burwitz, BJ
   Folkvord, JM
   de Santana, MGV
   Neves, PCC
   Connick, E
   Skinner, PJ
   Gostick, E
   O'Connor, DH
   Wilson, NA
   Bonaldo, MC
   Galler, R
   Price, DA
   Douek, DC
   Watkins, DI
AF Vojnov, Lara
   Martins, Mauricio A.
   Almeida, Jorge R.
   Ende, Zachary
   Rakasz, Eva G.
   Reynolds, Matthew R.
   Leon, Enrique J.
   Weisgrau, Kim L.
   Burwitz, Benjamin J.
   Folkvord, Joy M.
   Veloso de Santana, Marlon G.
   Costa Neves, Patricia C.
   Connick, Elizabeth
   Skinner, Pamela J.
   Gostick, Emma
   O'Connor, David H.
   Wilson, Nancy A.
   Bonaldo, Myrna C.
   Galler, Ricardo
   Price, David A.
   Douek, Danny C.
   Watkins, David I.
TI GagCM9-Specific CD8(+) T Cells Expressing Limited Public TCR Clonotypes
   Do Not Suppress SIV Replication In Vivo
SO PLOS ONE
LA English
DT Article
ID SIMIAN-IMMUNODEFICIENCY-VIRUS; CELLULAR IMMUNE-RESPONSES;
   RHESUS-MONKEYS; LYMPHOCYTE RESPONSE; HIV-1 INFECTION;
   MAMU-B-ASTERISK-08-POSITIVE MACAQUES; GASTROINTESTINAL-TRACT; SIVMAC239
   REPLICATION; VIRAL REPLICATION; ESCAPE MUTATIONS
AB Several lines of evidence suggest that HIV/SIV-specific CD8(+) T cells play a critical role in the control of viral replication. Recently we observed high levels of viremia in Indian rhesus macaques vaccinated with a segment of SIVmac239 Gag (Gag(45-269)) that were subsequently infected with SIVsmE660. These seven Mamu-A*01(+) animals developed CD8(+) T cell responses against an immunodominant epitope in Gag, GagCM9, yet failed to control virus replication. We carried out a series of immunological and virological assays to understand why these Gag-specific CD8(+) T cells could not control virus replication in vivo. GagCM9-specific CD8(+) T cells from all of the animals were multifunctional and were found in the colonic mucosa. Additionally, GagCM9-specific CD8(+) T cells accessed B cell follicles, the primary residence of SIV-infected cells in lymph nodes, with effector to target ratios between 20-250 GagCM9-specific CD8(+) T cells per SIV-producing cell. Interestingly, vaccinated animals had few public TCR clonotypes within the GagCM9-specific CD8(+) T cell population pre- and post-infection. The number of public TCR clonotypes expressed by GagCM9-specific CD8(+) T cells post-infection significantly inversely correlated with chronic phase viral load. It is possible that these seven animals failed to control viral replication because of the narrow TCR repertoire expressed by the GagCM9-specific CD8(+) T cell population elicited by vaccination and infection.
C1 [Vojnov, Lara; Martins, Mauricio A.; Rakasz, Eva G.; Reynolds, Matthew R.; Burwitz, Benjamin J.; O'Connor, David H.; Wilson, Nancy A.; Watkins, David I.] Univ Wisconsin, Dept Pathol & Lab Med, Madison, WI 53706 USA.
   [Almeida, Jorge R.; Ende, Zachary; Douek, Danny C.] NIAID, Human Immunol Sect, Vaccine Res Ctr, NIH, Bethesda, MD 20892 USA.
   [Rakasz, Eva G.; Leon, Enrique J.; Weisgrau, Kim L.; Watkins, David I.] Wisconsin Natl Primate Res Ctr, Madison, WI USA.
   [Folkvord, Joy M.; Connick, Elizabeth] Univ Colorado, Sch Med, Denver, CO USA.
   [Veloso de Santana, Marlon G.; Costa Neves, Patricia C.; Bonaldo, Myrna C.] Inst Oswaldo Cruz FIOCRUZ, Lab Biol Mol Flavivirus, Rio De Janeiro, Brazil.
   [Skinner, Pamela J.] Univ Minnesota, Dept Vet & Biomed Sci, St Paul, MN 55108 USA.
   [Galler, Ricardo] Fundacao Oswaldo Cruz, Inst Tecnol Imunobiol, Rio De Janeiro, Brazil.
   [Gostick, Emma; Price, David A.] Cardiff Univ, Dept Infect Immun & Biochem, Cardiff, S Glam, Wales.
RP Vojnov, L (corresponding author), Univ Wisconsin, Dept Pathol & Lab Med, Madison, WI 53706 USA.
EM Watkins@primate.wisc.edu
RI de Santana, Marlon Gilsepp Veloso/H-8146-2017; Martins,
   Mauricio/AAU-9226-2020; Bonaldo, Myrna C/D-9494-2013; Ende,
   Zachary/AAD-3800-2019; Price, David A/C-7876-2013; Rakasz, Eva
   G/H-9197-2019; Galler, Ricardo/B-3280-2014
OI de Santana, Marlon Gilsepp Veloso/0000-0002-3427-841X; Martins,
   Mauricio/0000-0001-8336-216X; Price, David A/0000-0001-9416-2737;
   Skinner, Pamela/0000-0003-3388-1687; Ramos de Almeida,
   Jorge/0000-0002-5009-8478; o'connor, david/0000-0003-2139-470X; Vojnov,
   Lara/0000-0003-0488-1012
FU National Institutes of Health (NIH)/National Institute of Allergy and
   Infectious DiseaseUnited States Department of Health & Human
   ServicesNational Institutes of Health (NIH) - USANIH National Institute
   of Allergy & Infectious Diseases (NIAID) [R01 AI076114, R01 AI049120,
   R24 RR015371, R24 RR016038]; National Center for Research Resources
   (NCRR)United States Department of Health & Human ServicesNational
   Institutes of Health (NIH) - USANIH National Center for Research
   Resources (NCRR) [R51 RR000167]; NATIONAL CENTER FOR RESEARCH
   RESOURCESUnited States Department of Health & Human ServicesNational
   Institutes of Health (NIH) - USANIH National Center for Research
   Resources (NCRR) [P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, R24RR015371, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, R24RR015371, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, R24RR016038, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, R24RR016038, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, R24RR015371, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   R24RR016038, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, R24RR015371, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, R24RR016038, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, R24RR015371, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, R24RR015371, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, R24RR016038,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, R24RR016038, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, R24RR015371, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   R24RR015371, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, R24RR016038, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, R24RR016038, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, R24RR016038, P51RR000167, P51RR000167,
   P51RR000167, R24RR016038, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, R24RR015371,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, R24RR015371,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, R24RR015371,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, R24RR015371, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, R24RR016038, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, R24RR015371, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167] Funding Source: NIH
   RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASESUnited
   States Department of Health & Human ServicesNational Institutes of
   Health (NIH) - USANIH National Institute of Allergy & Infectious
   Diseases (NIAID) [R01AI049120, R01AI049120, R01AI049120, R01AI049120,
   R01AI076114, R01AI049120, R01AI076114, R01AI049120, R01AI049120,
   R01AI076114, R01AI076114, R01AI049120, R01AI049120, R01AI076114] Funding
   Source: NIH RePORTER; Medical Research CouncilMedical Research Council
   UK (MRC) [G0501963] Funding Source: researchfish
FX This research was supported by National Institutes of Health
   (NIH)/National Institute of Allergy and Infectious Disease grants R01
   AI076114, R01 AI049120, R24 RR015371, and R24 RR016038 and in part by
   grant R51 RR000167 from the National Center for Research Resources
   (NCRR) awarded to the WNPRC, University of Wisconsin-Madison. The
   funders had no role in study design, data collection and analysis,
   decision to publish, or preparation of the manuscript.
CR Allen TM, 2000, NATURE, V407, P386, DOI 10.1038/35030124
   Allen TM, 2002, J VIROL, V76, P10507, DOI 10.1128/JVI.76.20.10507-10511.2002
   Allen TM, 2001, J VIROL, V75, P738, DOI 10.1128/JVI.75.2.738-749.2001
   Barouch DH, 2003, J VIROL, V77, P7367, DOI 10.1128/JVI.77.13.7367-7375.2003
   Barouch DH, 2002, NATURE, V415, P335, DOI 10.1038/415335a
   Betts MR, 2006, BLOOD, V107, P4781, DOI 10.1182/blood-2005-12-4818
   Bimber BN, 2009, J VIROL, V83, P8247, DOI 10.1128/JVI.00897-09
   Bonaldo MC, 2010, J VIROL, V84, P3699, DOI 10.1128/JVI.02255-09
   Borrow P, 1997, NAT MED, V3, P205, DOI 10.1038/nm0297-205
   BORROW P, 1994, J VIROL, V68, P6103, DOI 10.1128/JVI.68.9.6103-6110.1994
   Brenchley JM, 2004, J EXP MED, V200, P749, DOI 10.1084/jem.20040874
   Brodie SJ, 1999, NAT MED, V5, P34, DOI 10.1038/4716
   Cline AN, 2005, J MED PRIMATOL, V34, P303
   Folkvord JM, 2005, AIDS RES HUM RETROV, V21, P363, DOI 10.1089/aid.2005.21.363
   Folkvord JM, 2003, JAIDS-J ACQ IMM DEF, V32, P469, DOI 10.1097/00126334-200304150-00001
   Friedrich TC, 2004, J VIROL, V78, P10064, DOI 10.1128/JVI.78.18.10064-10073.2004
   Friedrich TC, 2004, NAT MED, V10, P275, DOI 10.1038/nm998
   Friedrich TC, 2004, J VIROL, V78, P2581, DOI 10.1128/JVI.78.5.2581-2585.2004
   Friedrich TC, 2007, J VIROL, V81, P3465, DOI 10.1128/JVI.02392-06
   Goulder PJR, 1997, NAT MED, V3, P212, DOI 10.1038/nm0297-212
   Goulder PJR, 2001, NATURE, V412, P334, DOI 10.1038/35085576
   Horton H, 2006, J IMMUNOL, V177, P7406, DOI 10.4049/jimmunol.177.10.7406
   Jin X, 1999, J EXP MED, V189, P991, DOI 10.1084/jem.189.6.991
   Kaizu M, 2007, IMMUNOGENETICS, V59, P693, DOI 10.1007/s00251-007-0233-7
   Kaslow RA, 1996, NAT MED, V2, P405, DOI 10.1038/nm0496-405
   Kawada M, 2008, J VIROL, V82, P10199, DOI 10.1128/JVI.01103-08
   Kiepiela P, 2004, NATURE, V432, P769, DOI 10.1038/nature03113
   Kiepiela P, 2007, NAT MED, V13, P46, DOI 10.1038/nm1520
   KOENIG S, 1995, NAT MED, V1, P330, DOI 10.1038/nm0495-330
   KOUP RA, 1994, J VIROL, V68, P4650, DOI 10.1128/JVI.68.7.4650-4655.1994
   Kuroda MJ, 1999, J IMMUNOL, V162, P5127
   Liang XP, 2005, J VIROL, V79, P12321, DOI 10.1128/JVI.79.19.12321-12331.2005
   Lichterfeld M, 2004, J EXP MED, V200, P701, DOI 10.1084/jem.20041270
   Liu JY, 2009, NATURE, V457, P87, DOI 10.1038/nature07469
   Loffredo JT, 2008, J VIROL, V82, P1723, DOI 10.1128/JVI.02084-07
   Loffredo JT, 2007, J VIROL, V81, P8827, DOI 10.1128/JVI.00895-07
   Martins MA, 2010, J VIROL, V84, P4352, DOI 10.1128/JVI.02365-09
   Matano T, 1998, J VIROL, V72, P164, DOI 10.1128/JVI.72.1.164-169.1998
   Migueles SA, 2000, P NATL ACAD SCI USA, V97, P2709, DOI 10.1073/pnas.050567397
   Migueles SA, 2008, IMMUNITY, V29, P1009, DOI 10.1016/j.immuni.2008.10.010
   O'Connor DH, 2002, NAT MED, V8, P493, DOI 10.1038/nm0502-493
   PHILLIPS RE, 1991, NATURE, V354, P453, DOI 10.1038/354453a0
   Price DA, 2009, J EXP MED, V206, P923, DOI 10.1084/jem.20081127
   REIMANN KA, 1994, J VIROL, V68, P2362, DOI 10.1128/JVI.68.4.2362-2370.1994
   Reynolds MR, 2008, J EXP MED, V205, P2537, DOI 10.1084/jem.20081524
   Reynolds MR, 2005, J VIROL, V79, P9228, DOI 10.1128/JVI.79.14.9228-9235.2005
   Roederer M, 2011, CYTOM PART A, V79A, P167, DOI 10.1002/cyto.a.21015
   Sacha JB, 2007, J VIROL, V81, P11703, DOI 10.1128/JVI.00926-07
   Sacha JB, 2007, J IMMUNOL, V178, P2746, DOI 10.4049/jimmunol.178.5.2746
   Schmitz JE, 1999, SCIENCE, V283, P857, DOI 10.1126/science.283.5403.857
   Seder RA, 2008, NAT REV IMMUNOL, V8, P247, DOI 10.1038/nri2274
   Skinner PJ, 2000, J IMMUNOL, V165, P613, DOI 10.4049/jimmunol.165.2.613
   Vanderford TH, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002048
   Veazey RS, 1998, SCIENCE, V280, P427, DOI 10.1126/science.280.5362.427
   Venturi V, 2008, J IMMUNOL, V181, P2597, DOI 10.4049/jimmunol.181.4.2597
   Venturi V, 2008, NAT REV IMMUNOL, V8, P231, DOI 10.1038/nri2260
   Vogel TU, 2003, J VIROL, V77, P13348, DOI 10.1128/JVI.77.24.13348-13360.2003
   Wilson NA, 2006, J VIROL, V80, P5875, DOI 10.1128/JVI.00171-06
   Wolinsky SM, 1996, SCIENCE, V272, P537, DOI 10.1126/science.272.5261.537
   Yant LJ, 2006, J VIROL, V80, P5074, DOI 10.1128/JVI.80.10.5074-5077.2006
NR 60
TC 9
Z9 9
U1 0
U2 3
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD AUG 26
PY 2011
VL 6
IS 8
AR e23515
DI 10.1371/journal.pone.0023515
PG 12
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA 812MY
UT WOS:000294298800011
PM 21887264
OA DOAJ Gold, Green Published, Green Accepted
DA 2020-12-01
ER

PT J
AU Azevedo, AS
   Yamamura, AMY
   Freire, MS
   Trindade, GF
   Bonaldo, M
   Galler, R
   Alves, AMB
AF Azevedo, Adriana S.
   Yamamura, Anna M. Y.
   Freire, Marcos S.
   Trindade, Gisela F.
   Bonaldo, Myrna
   Galler, Ricardo
   Alves, Ada M. B.
TI DNA Vaccines against Dengue Virus Type 2 Based on Truncate Envelope
   Protein or Its Domain III
SO PLOS ONE
LA English
DT Article
ID NEUTRALIZING ANTIBODY-RESPONSE; JAPANESE ENCEPHALITIS; PROTECTIVE
   IMMUNITY; SIGNAL SEQUENCES; NS1 GENE; T-CELLS; MICE; CHALLENGE;
   IMMUNIZATION; FLAVIVIRUS
AB Two DNA vaccines were constructed encoding the ectodomain (domains I, II and III) of the DENV2 envelope protein (pE1D2) or only its domain III (pE2D2), fused to the human tissue plasminogen activator signal peptide (t-PA). The expression and secretion of recombinant proteins was confirmed in vitro in BHK cells transfected with the two plasmids, detected by immunofluorescence or immunoprecipitation of metabolically labeled gene products, using polyclonal and monoclonal antibodies against DENV2. Besides, results reveal that the ectodomain of the E protein can be efficiently expressed in vivo, in a mammalian system, without the prM protein that is hypothesized to act as a chaperonin during dengue infection. Balb/c mice were immunized with the DNA vaccines and challenged with a lethal dose of DENV2. All pE1D2-vaccinated mice survived challenge, while 45% of animals immunized with the pE2D2 died after infection. Furthermore, only 10% of pE1D2-immunized mice presented some clinical signs of infection after challenge, whereas most of animals inoculated with the pE2D2 showed effects of the disease with high morbidity degrees. Levels of neutralizing antibodies were significantly higher in pE1D2-vaccinated mice than in pE2D2-immunized animals, also suggesting that the pE1D2 vaccine was more protective than the pE2D2.
C1 [Azevedo, Adriana S.; Alves, Ada M. B.] Fundacao Oswaldo Cruz, Inst Oswaldo Cruz, Lab Biotecnol & Fisiol Infeccoes Virais, Rio De Janeiro, Brazil.
   [Yamamura, Anna M. Y.; Freire, Marcos S.; Galler, Ricardo] Fundacao Oswaldo Cruz, Inst Tecnol Imunobiol, Lab Tecnol Virol, Rio De Janeiro, Brazil.
   [Trindade, Gisela F.; Bonaldo, Myrna] Fundacao Oswaldo Cruz, Inst Oswaldo Cruz, Lab Biol Mol Flavivirus, Rio De Janeiro, Brazil.
RP Alves, AMB (corresponding author), Fundacao Oswaldo Cruz, Inst Oswaldo Cruz, Lab Biotecnol & Fisiol Infeccoes Virais, Rio De Janeiro, Brazil.
EM ada@ioc.fiocruz.br
RI Galler, Ricardo/B-3280-2014; Bonaldo, Myrna C/D-9494-2013
OI Trindade, Gisela/0000-0002-1630-4143; Souza Azevedo,
   Adriana/0000-0001-7401-5107
FU PDTIS-FIOCRUZ; IOC-FIOCRUZ; FAPERJCarlos Chagas Filho Foundation for
   Research Support of the State of Rio de Janeiro (FAPERJ); CNPqNational
   Council for Scientific and Technological Development (CNPq);
   CNPq-PRONEXNational Council for Scientific and Technological Development
   (CNPq)
FX This work was supported by PDTIS-FIOCRUZ, IOC-FIOCRUZ, FAPERJ, CNPq and
   CNPq-PRONEX grants. The funders had no role in study design, data
   collection and analysis, decision to publish, or preparation of the
   manuscript.
CR Allison SL, 1999, J VIROL, V73, P5605, DOI 10.1128/JVI.73.7.5605-5612.1999
   Ashok MS, 2002, VACCINE, V20, P1563, DOI 10.1016/S0264-410X(01)00492-3
   BONALDO MC, 2007, J VIROL, V30, P115
   Boyle JS, 1997, INT IMMUNOL, V9, P1897, DOI 10.1093/intimm/9.12.1897
   Caufour PS, 2001, VIRUS RES, V79, P1, DOI 10.1016/S0168-1702(01)00273-8
   Chambers TJ, 2003, J VIROL, V77, P3655, DOI 10.1128/JVI.77.6.3655-3668.2003
   Chang GJJ, 2000, J VIROL, V74, P4244, DOI 10.1128/JVI.74.9.4244-4252.2000
   Chang GJJ, 2001, ANN NY ACAD SCI, V951, P272
   Chen L, 2007, J VIROL, V81, P11634, DOI 10.1128/JVI.00996-07
   Clements DE, 2010, VACCINE, V28, P2705, DOI 10.1016/j.vaccine.2010.01.022
   COELHO GE, 2010, SECRETARIA VIGILANCI
   Colombage G, 1998, VIROLOGY, V250, P151, DOI 10.1006/viro.1998.9357
   Costa SM, 2007, VIROLOGY, V358, P413, DOI 10.1016/j.virol.2006.08.052
   Costa SM, 2006, VACCINE, V24, P4562, DOI 10.1016/j.vaccine.2005.08.022
   Costa SM, 2006, VACCINE, V24, P195, DOI 10.1016/j.vaccine.2005.07.059
   Davis BS, 2001, J VIROL, V75, P4040, DOI 10.1128/JVI.75.9.4040-4047.2001
   De Paula SO, 2008, ARCH VIROL, V153, P2215, DOI 10.1007/s00705-008-0250-3
   Dejnirattisai W, 2010, SCIENCE, V328, P745, DOI 10.1126/science.1185181
   Edelman R, 2005, J INFECT DIS, V191, P650, DOI 10.1086/427784
   Edelman R, 2007, CLIN INFECT DIS, V45, pS56, DOI 10.1086/518148
   ERHARDT W, 1984, RES EXP MED, V184, P159, DOI 10.1007/BF01852390
   Gubler DJ, 2002, ARCH MED RES, V33, P330, DOI 10.1016/S0188-4409(02)00378-8
   Guzman MG, 2002, LANCET INFECT DIS, V2, P33, DOI 10.1016/S1473-3099(01)00171-2
   HENCHAL EA, 1985, AM J TROP MED HYG, V34, P162, DOI 10.4269/ajtmh.1985.34.162
   HENCHAL EA, 1982, AM J TROP MED HYG, V31, P830, DOI 10.4269/ajtmh.1982.31.830
   Inchauspe G, 1997, DNA CELL BIOL, V16, P185, DOI 10.1089/dna.1997.16.185
   IRIE K, 1989, GENE, V75, P197, DOI 10.1016/0378-1119(89)90266-7
   Jaiswal S, 2004, PROTEIN EXPRES PURIF, V33, P80, DOI 10.1016/j.pep.2003.09.009
   Jimenez RO, 2000, VACCINE, V19, P648, DOI 10.1016/S0264-410X(00)00247-4
   Kinney RM, 2001, INTERVIROLOGY, V44, P176, DOI 10.1159/000050045
   Kochel T, 1997, VACCINE, V15, P547, DOI 10.1016/S0264-410X(97)00215-6
   Kochel TJ, 2000, VACCINE, V18, P3166, DOI 10.1016/S0264-410X(00)00105-5
   Konishi E, 1999, J VIROL, V73, P5527, DOI 10.1128/JVI.73.7.5527-5534.1999
   Konishi E, 2000, VACCINE, V18, P1133, DOI 10.1016/S0264-410X(99)00376-X
   Kuhn RJ, 2002, CELL, V108, P717, DOI 10.1016/S0092-8674(02)00660-8
   KURANE I, 1990, ARCH VIROL, V110, P91, DOI 10.1007/BF01310705
   Linderbach BD, 2001, FIELDS VIROLOGY, P991
   Lu Y, 2003, VACCINE, V21, P2178, DOI 10.1016/S0264-410X(03)00009-4
   Miller N, 2010, CURR OPIN MOL THER, V12, P31
   Modis Y, 2003, P NATL ACAD SCI USA, V100, P6986, DOI 10.1073/pnas.0832193100
   MONATH TP, 1997, CLIN VIROLOGY, P1133
   Mota J, 2005, VACCINE, V23, P3469, DOI 10.1016/j.vaccine.2004.12.028
   Phillpotts RJ, 1996, ARCH VIROL, V141, P743, DOI 10.1007/BF01718332
   Porter KR, 1998, ARCH VIROL, V143, P997, DOI 10.1007/s007050050348
   Putnak R, 2003, AM J TROP MED HYG, V68, P469, DOI 10.4269/ajtmh.2003.68.469
   Ramanathan MP, 2009, VACCINE, V27, P6444, DOI 10.1016/j.vaccine.2009.06.061
   Raviprakash K, 2000, VACCINE, V18, P2426, DOI 10.1016/S0264-410X(99)00570-8
   Raviprakash K, 2000, J GEN VIROL, V81, P1659, DOI 10.1099/0022-1317-81-7-1659
   Raviprakash K, 2001, VIROLOGY, V290, P74, DOI 10.1006/viro.2001.1136
   Nogueira RMR, 2007, REV PANAM SALUD PUBL, V22, P358, DOI 10.1590/S1020-49892007001000009
   Roehrig JT, 1998, VIROLOGY, V246, P317, DOI 10.1006/viro.1998.9200
   Shrestha B, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000823
   Simmons M, 2001, AM J TROP MED HYG, V65, P420, DOI 10.4269/ajtmh.2001.65.420
   Stefano I, 1999, VACCINE, V17, P1042, DOI 10.1016/S0264-410X(98)00320-X
   Suksanpaisan L, 2009, J BIOMED SCI, V16, DOI 10.1186/1423-0127-16-17
   Teixeira MG, 2009, CAD SAUDE PUBLICA, V25, pS7, DOI 10.1590/S0102-311X2009001300002
   Valdes I, 2009, VIROLOGY, V394, P249, DOI 10.1016/j.virol.2009.08.029
   Van Der Most RG, 2000, J VIROL, V74, P8094, DOI 10.1128/JVI.74.17.8094-8101.2000
   van der Most RG, 2003, INT IMMUNOL, V15, P119
   Wahala WMPB, 2009, VIROLOGY, V392, P103, DOI 10.1016/j.virol.2009.06.037
   Whitehead SS, 2007, NAT REV MICROBIOL, V5, P518, DOI 10.1038/nrmicro1690
   Yauch LE, 2010, J IMMUNOL, V185, P5405, DOI 10.4049/jimmunol.1001709
NR 62
TC 31
Z9 33
U1 0
U2 2
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD JUL 11
PY 2011
VL 6
IS 7
AR e20528
DI 10.1371/journal.pone.0020528
PG 8
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA 791QY
UT WOS:000292680900001
PM 21779317
OA DOAJ Gold, Green Published
DA 2020-12-01
ER

PT J
AU Nogueira, RT
   Nogueira, AR
   Pereira, MCS
   Rodrigues, MM
   Galler, R
   Bonaldo, MC
AF Nogueira, Raquel T.
   Nogueira, Alanderson R.
   Pereira, Mirian C. S.
   Rodrigues, Maurico M.
   Galler, Ricardo
   Bonaldo, Myrna C.
TI Biological and immunological characterization of recombinant Yellow
   Fever 17D Viruses expressing a Trypanosoma cruzi Amastigote Surface
   Protein-2 CD8(+) T cell epitope at two distinct regions of the genome
SO VIROLOGY JOURNAL
LA English
DT Article
ID SUSCEPTIBLE MOUSE STRAIN; PROTECTIVE IMMUNITY; LYMPHOCYTE RESPONSES;
   RHESUS MACAQUES; FOREIGN PROTEIN; CHAGAS-DISEASE; CTL EPITOPES; VACCINE;
   INFECTION; IMMUNIZATION
AB Background: The attenuated Yellow fever (YF) 17D vaccine virus is one of the safest and most effective viral vaccines administered to humans, in which it elicits a polyvalent immune response. Herein, we used the YF 17D backbone to express a Trypanosoma cruzi CD8(+) T cell epitope from the Amastigote Surface Protein 2 (ASP-2) to provide further evidence for the potential of this virus to express foreign epitopes. The TEWETGQI CD8(+) T cell epitope was cloned and expressed based on two different genomic insertion sites: in the fg loop of the viral Envelope protein and the protease cleavage site between the NS2B and NS3. We investigated whether the site of expression had any influence on immunogenicity of this model epitope.
   Results: Recombinant viruses replicated similarly to vaccine virus YF 17D in cell culture and remained genetically stable after several serial passages in Vero cells. Immunogenicity studies revealed that both recombinant viruses elicited neutralizing antibodies to the YF virus as well as generated an antigen-specific gamma interferon mediated T-cell response in immunized mice. The recombinant viruses displayed a more attenuated phenotype than the YF 17DD vaccine counterpart in mice. Vaccination of a mouse lineage highly susceptible to infection by T. cruzi with a homologous prime-boost regimen of recombinant YF viruses elicited TEWETGQI specific CD8(+) T cells which might be correlated with a delay in mouse mortality after a challenge with a lethal dose of T. cruzi.
   Conclusions: We conclude that the YF 17D platform is useful to express T. cruzi (Protozoan) antigens at different functional regions of its genome with minimal reduction of vector fitness. In addition, the model T. cruzi epitope expressed at different regions of the YF 17D genome elicited a similar T cell-based immune response, suggesting that both expression sites are useful. However, the epitope as such is not protective and it remains to be seen whether expression of larger domains of ASP-2, which include the TEWETGQI epitope, will elicit better T-CD8+ responses to the latter. It is likely that additional antigens and recombinant virus formulations will be necessary to generate a protective response.
C1 [Nogueira, Raquel T.; Bonaldo, Myrna C.] Fundacao Oswaldo Cruz, Inst Oswaldo Cruz, Lab Biol Mol Flavivirus, BR-21045900 Rio De Janeiro, Brazil.
   [Galler, Ricardo] Fundacao Oswaldo Cruz, Inst Tecnol Imunobiol, BR-21045900 Rio De Janeiro, Brazil.
   [Nogueira, Alanderson R.; Pereira, Mirian C. S.] Fundacao Oswaldo Cruz, Inst Oswaldo Cruz, Lab Ultraestrutura Celular, BR-21045900 Rio De Janeiro, Brazil.
   [Rodrigues, Maurico M.] Univ Fed Sao Paulo, Escola Paulista Med, Ctr Terapia Celular Mol CTCMol, BR-04044010 Sao Paulo, Brazil.
RP Bonaldo, MC (corresponding author), Fundacao Oswaldo Cruz, Inst Oswaldo Cruz, Lab Biol Mol Flavivirus, Ave Brasil 4365, BR-21045900 Rio De Janeiro, Brazil.
EM mbonaldo@ioc.fiocruz.br
RI Galler, Ricardo/B-3280-2014; Rodrigues, Mauricio M./B-8512-2012;
   Nogueira, Raquel Tayar/F-6475-2019; Bonaldo, Myrna C/D-9494-2013
OI Nogueira, Raquel Tayar/0000-0002-0581-763X; Pereira, Mirian
   Claudia/0000-0003-2223-3289
FU Fundacao de Amparo a Pesquisa do Estado de Sao PauloFundacao de Amparo a
   Pesquisa do Estado de Sao Paulo (FAPESP); National Institute for Vaccine
   Technology (INCTV-CNPq); Millennium Institute for Vaccine Development
   and Technology [CNPq - 420067/2005-1]; Millennium Institute for Gene
   Therapy (Brazil); CNPqNational Council for Scientific and Technological
   Development (CNPq)
FX We thank Fernanda Rimolli, Luiz da Silva and Isabel Freire from
   Laboratorio de Experimentacao Animal - Bio-Manguinhos for technical
   assistance on mice experimental studies. We also thank Gisela Freitas
   for fluorescence microscopy assay and images, Heloisa Diniz for image
   editing, Patricia Neves and Josue da Lima Costa Junior for ELISPOT
   analyzes support and PDTIS/FIOCRUZ for use of its technical platforms.
   English review and revision by Mitchell Raymond Lishon, Native of
   Chicago, Illinois, U. S. A., U. C. L. A. 1969. This work was supported
   by grants from Fundacao de Amparo a Pesquisa do Estado de Sao Paulo, The
   National Institute for Vaccine Technology (INCTV-CNPq), The Millennium
   Institute for Vaccine Development and Technology (CNPq - 420067/2005-1)
   and The Millennium Institute for Gene Therapy (Brazil). RTN, MMR, MCB
   and RG are recipients of fellowships from CNPq.
CR Akondy RS, 2009, J IMMUNOL, V183, P7919, DOI 10.4049/jimmunol.0803903
   de Noya BA, 2010, J INFECT DIS, V201, P1308, DOI 10.1086/651608
   Amigorena S, 2010, CURR OPIN IMMUNOL, V22, P109, DOI 10.1016/j.coi.2010.01.022
   Araujo AFS, 2005, INFECT IMMUN, V73, P6017, DOI 10.1128/IAI.73.9.6017-6025.2005
   Barba-Spaeth G, 2005, J EXP MED, V202, P1179, DOI 10.1084/jem.20051352
   Bonaldo MC, 2006, CELL BIOCHEM BIOPHYS, V44, P313, DOI 10.1385/CBB:44:3:313
   Bonaldo MC, 2005, J VIROL, V79, P8602, DOI 10.1128/JVI.79.13.8602-8613.2005
   Bonaldo MC, 2002, J MOL BIOL, V315, P873, DOI 10.1006/jmbi.2001.5258
   Bonaldo MC, 2010, J VIROL, V84, P3699, DOI 10.1128/JVI.02255-09
   Bonaldo MC, 2007, VIROL J, V4, DOI 10.1186/1743-422X-4-115
   Boscardin SB, 2003, INFECT IMMUN, V71, P2744, DOI 10.1128/IAI.71.5.2744-2757.2003
   Cazorla SI, 2008, INFECT IMMUN, V76, P324, DOI 10.1128/IAI.01163-07
   Claser C, 2007, MICROBES INFECT, V9, P1011, DOI 10.1016/j.micinf.2007.04.006
   Co MDT, 2002, VIROLOGY, V293, P151, DOI 10.1006/viro.2001.1255
   de Alencar BCG, 2007, VACCINE, V25, P6018, DOI 10.1016/j.vaccine.2007.05.022
   de Alencar BCG, 2009, INFECT IMMUN, V77, P4383, DOI 10.1128/IAI.01459-08
   Franco D, 2010, VACCINE, V28, P5676, DOI 10.1016/j.vaccine.2010.06.052
   Galler R, 1998, VACCINE, V16, P1024, DOI 10.1016/S0264-410X(97)00278-8
   Garg N, 2002, INFECT IMMUN, V70, P5547, DOI 10.1128/IAI.70.10.5547-5555.2002
   Gaucher D, 2008, J EXP MED, V205, P3119, DOI 10.1084/jem.20082292
   Guy B, 2010, VACCINE, V28, P632, DOI 10.1016/j.vaccine.2009.09.098
   Lindenbach BD, 2007, FIELDS VIROLOGY, P1101
   Low WP, 1998, J IMMUNOL, V160, P1817
   Maciel M, 2008, VIROLOGY, V378, P105, DOI 10.1016/j.virol.2008.04.043
   Marchevsky RS, 2006, BIOLOGICALS, V34, P191, DOI 10.1016/j.biologicals.2005.09.005
   Martin D, 2004, IMMUNOL REV, V201, P304, DOI 10.1111/j.0105-2896.2004.00183.x
   McAllister A, 2000, J VIROL, V74, P9197, DOI 10.1128/JVI.74.19.9197-9205.2000
   Miller JD, 2008, IMMUNITY, V28, P710, DOI 10.1016/j.immuni.2008.02.020
   Monath T. P, 2004, VACCINES, P1095
   Monath TP, 1999, VACCINES, P815
   Mudd PA, 2010, IMMUNOGENETICS, V62, P593, DOI 10.1007/s00251-010-0461-0
   MURRAY HW, 1988, ANN INTERN MED, V108, P595, DOI 10.7326/0003-4819-108-4-595
   POLAND JD, 1981, B WORLD HEALTH ORGAN, V59, P895
   Querec T, 2006, J EXP MED, V203, P413, DOI 10.1084/jem.20051720
   Querec TD, 2009, NAT IMMUNOL, V10, P116, DOI 10.1038/ni.1688
   Reinhardt B, 1998, J MED VIROL, V56, P159, DOI 10.1002/(SICI)1096-9071(199810)56:2&lt;159::AID-JMV10&gt;3.0.CO;2-B
   Rodrigues MM, 2003, AN ACAD BRAS CIENC, V75, P443, DOI 10.1590/S0001-37652003000400005
   Rumyantsev AA, 2010, VIROLOGY, V396, P329, DOI 10.1016/j.virol.2009.10.033
   Silveira ELV, 2008, CLIN VACCINE IMMUNOL, V15, P1292, DOI 10.1128/CVI.00142-08
   Stoyanov CT, 2010, VACCINE, V28, P4644, DOI 10.1016/j.vaccine.2010.04.071
   Tao D, 2005, J EXP MED, V201, P201, DOI 10.1084/jem.20041526
   Tzelepis F, 2006, INFECT IMMUN, V74, P2477, DOI 10.1128/IAI.74.4.2477-2481.2006
   Tzelepis F, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000393
   Vasconcelos JR, 2004, HUM GENE THER, V15, P878, DOI 10.1089/hum.2004.15.878
   Vasconcelos JRC, 2003, IMMUNOL CELL BIOL, V81, P121, DOI 10.1046/j.0818-9641.2002.01136.x
   *WHO, 2005, BOOK TROP DIS RES PR
   Wizel B, 1998, J CLIN INVEST, V102, P1062, DOI 10.1172/JCI3835
NR 47
TC 13
Z9 14
U1 0
U2 1
PU BMC
PI LONDON
PA CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
SN 1743-422X
J9 VIROL J
JI Virol. J.
PD MAR 18
PY 2011
VL 8
AR 127
DI 10.1186/1743-422X-8-127
PG 13
WC Virology
SC Virology
GA 742BH
UT WOS:000288912600001
PM 21418577
OA DOAJ Gold, Green Published
DA 2020-12-01
ER

PT J
AU Carpp, LN
   Galler, R
   Bonaldo, MC
AF Carpp, Lindsay N.
   Galler, Ricardo
   Bonaldo, Myrna C.
TI Interaction between the yellow fever virus nonstructural protein NS3 and
   the host protein Alix contributes to the release of infectious particles
SO MICROBES AND INFECTION
LA English
DT Article
DE Yellow fever virus; Flavivirus; Alix protein; Viral nonstructural
   proteins
ID ESCRT-III; MEMBRANE CURVATURE; CRYSTAL-STRUCTURE; HUMAN HOMOLOG; DOMAIN;
   COMPLEX; AIP1/ALIX; HELICASE; PATHWAY; TSG101
AB The ESCRT (endosomal sorting complex required for transport) machinery normally executes cargo sorting and internalization during multivesicular body biogenesis, but is also utilized by several enveloped viruses to facilitate their budding from cellular membranes. Although the mechanisms of flavivirus infectious particle assembly and release are poorly understood, the nonstructural protein NS3 has been reported to have an essential role via an undescribed mechanism. Here, we shed light on the role of NS3 by connecting it to the host factor Alix, a protein intimately connected with the ESCRT machinery. We demonstrate that NS3 and Alix interact and show that dominant negative versions of Alix inhibit YFV release. Furthermore, we show that NS3 supplied in trans rescues this effect. We propose that the interaction between NS3 and Alix contributes to YFV release. (C) 2010 Institut Pasteur. Published by Elsevier Masson SAS. All rights reserved.
C1 [Carpp, Lindsay N.; Bonaldo, Myrna C.] Fiocruz MS, Inst Oswaldo Cruz, Lab Biol Mol Flavivirus, Fdn Oswaldo Cruz, BR-21045900 Manguinho, RJ, Brazil.
   [Galler, Ricardo] Biomanguinhos, BR-21045900 Manguinho, RJ, Brazil.
RP Carpp, LN (corresponding author), Fiocruz MS, Inst Oswaldo Cruz, Lab Biol Mol Flavivirus, Fdn Oswaldo Cruz, Ave Brasil 4365, BR-21045900 Manguinho, RJ, Brazil.
EM learpp@systemsbiology.org
RI Bonaldo, Myrna C/D-9494-2013; Galler, Ricardo/B-3280-2014
FU FIOCRUZ; Instituto de Ciencia e Tecnologia de Vacina (INCTV - CNPq/MCT);
   FAPERJCarlos Chagas Filho Foundation for Research Support of the State
   of Rio de Janeiro (FAPERJ) [E-26/100.015/2009]
FX We are grateful to Prof. Wes Sundquist, Dr. Fadila Bouamr, and Prof.
   Remy Sadoul for generously providing plasmids. We thank Igor dos Santos
   Cestari for critical reading of the manuscript and Juliana Ribeira dos
   Santos for technical assistance. We acknowledge Regiane Burger for
   obtaining the alpha-NS3 antibodies and the Plataforma de Sequenciamento
   de DNA PDTIS/FIOCRUZ for DNA sequencing. This work was supported by
   FIOCRUZ, the Instituto de Ciencia e Tecnologia de Vacina (INCTV -
   CNPq/MCT), and a postdoctoral fellowship (E-26/100.015/2009) from FAPERJ
   to LNC.
CR Amberg SM, 1999, J VIROL, V73, P8083, DOI 10.1128/JVI.73.10.8083-8094.1999
   Babst M, 1998, EMBO J, V17, P2982, DOI 10.1093/emboj/17.11.2982
   Babst M, 2002, DEV CELL, V3, P271, DOI 10.1016/S1534-5807(02)00220-4
   Bonaldo MC, 2002, J MOL BIOL, V315, P873, DOI 10.1006/jmbi.2001.5258
   CHAMBERS TJ, 1991, J VIROL, V65, P6042, DOI 10.1128/JVI.65.11.6042-6050.1991
   CHAMBERS TJ, 1990, P NATL ACAD SCI USA, V87, P8898, DOI 10.1073/pnas.87.22.8898
   Chatellard-Causse C, 2002, J BIOL CHEM, V277, P29108, DOI 10.1074/jbc.M204019200
   Chen CP, 2005, J BIOL CHEM, V280, P40474, DOI 10.1074/jbc.M509317200
   Chiou CT, 2003, J GEN VIROL, V84, P2795, DOI 10.1099/vir.0.19201-0
   Demirov DG, 2004, VIRUS RES, V106, P87, DOI 10.1016/j.virusres.2004.08.007
   Dussupt V, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000339
   Fisher RD, 2007, CELL, V128, P841, DOI 10.1016/j.cell.2007.01.035
   Gallop JL, 2006, EMBO J, V25, P2898, DOI 10.1038/sj.emboj.7601174
   Garrus JE, 2001, CELL, V107, P55, DOI 10.1016/S0092-8674(01)00506-2
   Hanson PI, 2008, J CELL BIOL, V180, P389, DOI 10.1083/jcb.200707031
   Hanson PI, 2009, CURR OPIN CELL BIOL, V21, P568, DOI 10.1016/j.ceb.2009.06.002
   HOCHULI E, 1988, J CHROMATOGR, V444, P293, DOI 10.1016/S0021-9673(01)94032-4
   Hurley JH, 2006, ANNU REV BIOPH BIOM, V35, P277, DOI 10.1146/annurev.biophys.35.040405.102126
   Katoh K, 2003, J BIOL CHEM, V278, P39104, DOI 10.1074/jbc.M301604200
   Katzmann DJ, 2001, CELL, V106, P145, DOI 10.1016/S0092-8674(01)00434-2
   Katzmann DJ, 2003, J CELL BIOL, V162, P413, DOI 10.1083/jcb.200302136
   Kim JL, 1998, STRUCTURE, V6, P89, DOI 10.1016/S0969-2126(98)00010-0
   Kummerer BM, 2002, J VIROL, V76, P4773, DOI 10.1128/JVI.76.10.4773-4784.2002
   Lindenbach BD, 2007, FIELDS VIROLOGY, P1101
   Luo DH, 2008, EMBO J, V27, P3209, DOI 10.1038/emboj.2008.232
   Martin-Serrano J, 2003, P NATL ACAD SCI USA, V100, P12414, DOI 10.1073/pnas.2133846100
   Masuda M, 2006, EMBO J, V25, P2889, DOI 10.1038/sj.emboj.7601176
   Matusan AE, 2001, J VIROL, V75, P9633, DOI 10.1128/JVI.75.20.9633-9643.2001
   McCullough J, 2008, P NATL ACAD SCI USA, V105, P7687, DOI 10.1073/pnas.0801567105
   Murray CL, 2008, NAT REV MICROBIOL, V6, P699, DOI 10.1038/nrmicro1928
   Notredame C, 2000, J MOL BIOL, V302, P205, DOI 10.1006/jmbi.2000.4042
   Patkar CG, 2008, J VIROL, V82, P3342, DOI 10.1128/JVI.02447-07
   Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45
   RICE C M, 1989, New Biologist, V1, P285
   Stocks CE, 1998, J VIROL, V72, P2141, DOI 10.1128/JVI.72.3.2141-2149.1998
   Strack B, 2003, CELL, V114, P689, DOI 10.1016/S0092-8674(03)00653-6
   Teo H, 2004, DEV CELL, V7, P559, DOI 10.1016/j.devcel.2004.09.003
   Teo HL, 2006, CELL, V125, P99, DOI 10.1016/j.cell.2006.01.047
   Vincent O, 2003, MOL CELL BIOL, V23, P1647, DOI 10.1128/MCB.23.5.1647-1655.2003
   von Schwedler UK, 2003, CELL, V114, P701, DOI 10.1016/S0092-8674(03)00714-1
   Watanabe T, 2007, P NATL ACAD SCI USA, V104, P10205, DOI 10.1073/pnas.0704000104
   Wirblich C, 2006, J VIROL, V80, P460, DOI 10.1128/JVI.80.1.460-473.2006
   Wollert T, 2009, NATURE, V458, P172, DOI 10.1038/nature07836
   Wu JH, 2005, J VIROL, V79, P10268, DOI 10.1128/JVI.79.16.10268-10277.2005
NR 44
TC 26
Z9 27
U1 1
U2 3
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 1286-4579
J9 MICROBES INFECT
JI Microbes Infect.
PD JAN
PY 2011
VL 13
IS 1
BP 85
EP 95
DI 10.1016/j.micinf.2010.10.010
PG 11
WC Immunology; Infectious Diseases; Microbiology
SC Immunology; Infectious Diseases; Microbiology
GA 734DB
UT WOS:000288312300011
PM 21044891
DA 2020-12-01
ER

PT J
AU Neves, PCC
   Rudersdorf, RA
   Galler, R
   Bonaldo, MC
   de Santana, MGV
   Mudd, PA
   Martins, MA
   Rakasz, EG
   Wilson, NA
   Watkins, DI
AF Neves, Patricia C. C.
   Rudersdorf, Richard A.
   Galler, Ricardo
   Bonaldo, Myrna C.
   Veloso de Santana, Marlon Gilsepp
   Mudd, Philip A.
   Martins, Mauricio A.
   Rakasz, Eva G.
   Wilson, Nancy A.
   Watkins, David I.
TI CD8(+) gamma-delta TCR+ and CD4(+) T cells produce IFN-gamma at 5-7 days
   after yellow fever vaccination in Indian rhesus macaques, before the
   induction of classical antigen-specific T cell responses
SO VACCINE
LA English
DT Article
DE Yellow fever vaccine; IFN-gamma; Rhesus model
ID NILE-VIRUS-INFECTION; 1ST-TIME VACCINATION; YF ENCEPHALITIS; DENDRITIC
   CELLS; INNATE IMMUNITY; ACTIVATION; PROTECTION; MICE
AB The yellow fever 17D (YF-17D) vaccine is one of the most efficacious vaccines developed to date. Interestingly, vaccination with YF-17D induces IFN-gamma production early after vaccination (days 5-7) before the development of classical antigen-specific CD8(+) and CD4(+) T cell responses. Here we investigated the cellular source of this early IFN-gamma production. At days 5 and 7 post-vaccination activated CD8(+) gamma-delta TCR T cells produced IFN-gamma and TNF-alpha. Activated CD4(+) T cells produced IFN-gamma and TNF-alpha at day 7 post-vaccination. This early IFN-gamma production was also induced after vaccination with recombinant YF-17D (rYF-17D), but was not observed after recombinant Adenovirus type 5 (rAd5) vaccination. Early IFN-gamma production, therefore, might be an important aspect of yellow fever vaccination. Published by Elsevier Ltd.
C1 [Rudersdorf, Richard A.; Mudd, Philip A.; Martins, Mauricio A.; Rakasz, Eva G.; Wilson, Nancy A.; Watkins, David I.] Univ Wisconsin, Dept Pathol & Lab Med, Madison, WI 53706 USA.
   [Bonaldo, Myrna C.; Veloso de Santana, Marlon Gilsepp] Fundacao Oswaldo Cruz, Lab Biol Mol Flavivirus, IOC, BR-21040360 Manguinho, RJ, Brazil.
RP Watkins, DI (corresponding author), Univ Wisconsin, Dept Pathol & Lab Med, Madison, WI 53706 USA.
EM watkins@prirnate.wisc.edu
RI de Santana, Marlon Gilsepp Veloso/H-8146-2017; Galler,
   Ricardo/B-3280-2014; Martins, Mauricio/AAU-9226-2020; Bonaldo, Myrna
   C/D-9494-2013; Rakasz, Eva G/H-9197-2019
OI de Santana, Marlon Gilsepp Veloso/0000-0002-3427-841X; Martins,
   Mauricio/0000-0001-8336-216X; Mudd, Philip/0000-0002-3860-5473
FU National Institutes of HealthUnited States Department of Health & Human
   ServicesNational Institutes of Health (NIH) - USA [R01 AI076114];
   National Center for Research ResourcesUnited States Department of Health
   & Human ServicesNational Institutes of Health (NIH) - USANIH National
   Center for Research Resources (NCRR) [P51 RR000167]; Research Facilities
   Improvement ProgramUnited States Department of Health & Human
   ServicesNational Institutes of Health (NIH) - USANIH National Center for
   Research Resources (NCRR) [RR15459-01, RR020141-01]; NATIONAL CENTER FOR
   RESEARCH RESOURCESUnited States Department of Health & Human
   ServicesNational Institutes of Health (NIH) - USANIH National Center for
   Research Resources (NCRR) [P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, C06RR020141, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   C06RR020141, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, C06RR020141,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, C06RR015459, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, C06RR020141, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, C06RR020141, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, C06RR020141, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167] Funding Source: NIH RePORTER;
   NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASESUnited States
   Department of Health & Human ServicesNational Institutes of Health (NIH)
   - USANIH National Institute of Allergy & Infectious Diseases (NIAID)
   [R37AI052056, R01AI076114, R01AI076114, R01AI076114, R37AI052056,
   R37AI052056, R37AI052056, R37AI052056, R37AI052056, R37AI052056,
   R01AI076114, R37AI052056, R37AI052056, R01AI076114, R37AI052056,
   R37AI052056] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL
   MEDICAL SCIENCESUnited States Department of Health & Human
   ServicesNational Institutes of Health (NIH) - USANIH National Institute
   of General Medical Sciences (NIGMS) [T32GM008692, T32GM008692,
   T32GM008692, T32GM008692, T32GM008692, T32GM008692, T32GM008692,
   T32GM008692, T32GM008692, T32GM008692, T32GM008692, T32GM008692,
   T32GM008692, T32GM008692, T32GM008692, T32GM008692, T32GM008692,
   T32GM008692, T32GM008692, T32GM008692, T32GM008692, T32GM008692,
   T32GM008692, T32GM008692, T32GM008692, T32GM008692, T32GM008692] Funding
   Source: NIH RePORTER
FX This work was supported by National Institutes of Health grant R01
   AI076114 (to D.I.W.) and Grant P51 RR000167 from the National Center for
   Research Resources, a component of the National Institutes of Health (to
   the Wisconsin National Primate Research Center). This research was
   conducted in part at a facility constructed with support from Research
   Facilities Improvement Program grants RR15459-01 and RR020141-01.
CR Barba-Spaeth G, 2005, J EXP MED, V202, P1179, DOI 10.1084/jem.20051352
   Billiau A, 2009, CYTOKINE GROWTH F R, V20, P97, DOI 10.1016/j.cytogfr.2009.02.004
   Bonaldo MC, 2010, J VIROL, V84, P3699, DOI 10.1128/JVI.02255-09
   Bonaldo MC, 2007, VIROL J, V4, DOI 10.1186/1743-422X-4-115
   Neves PCD, 2009, VACCINE, V27, P5543, DOI 10.1016/j.vaccine.2009.07.028
   Devilder MC, 2009, J IMMUNOL, V183, P3625, DOI 10.4049/jimmunol.0901571
   Fang H, 2010, FEMS IMMUNOL MED MIC, V59, P71, DOI 10.1111/j.1574-695X.2010.00663.x
   Franco D, 2010, VACCINE, V28, P5676, DOI 10.1016/j.vaccine.2010.06.052
   Gaucher D, 2008, J EXP MED, V205, P3119, DOI 10.1084/jem.20082292
   Martins MA, 2007, CLIN EXP IMMUNOL, V148, P90, DOI 10.1111/j.1365-2249.2006.03317.x
   Martins MA, 2008, VACCINE, V26, P1173, DOI 10.1016/j.vaccine.2007.12.035
   Miller JD, 2008, IMMUNITY, V28, P710, DOI 10.1016/j.immuni.2008.02.020
   Poccia F, 2005, MICROBES INFECT, V7, P518, DOI 10.1016/j.micinf.2004.12.009
   Pulendran B, 2009, NAT REV IMMUNOL, V9, P741, DOI 10.1038/nri2629
   Querec T, 2006, J EXP MED, V203, P413, DOI 10.1084/jem.20051720
   Querec TD, 2009, NAT IMMUNOL, V10, P116, DOI 10.1038/ni.1688
   Santos AP, 2008, CYTOKINE, V42, P152, DOI 10.1016/j.cyto.2008.02.007
   SCHLESINGER JJ, 1993, VIROLOGY, V192, P132, DOI 10.1006/viro.1993.1015
   SCHLESINGER JJ, 1995, J GEN VIROL, V76, P217, DOI 10.1099/0022-1317-76-1-217
   Shrestha B, 2006, J VIROL, V80, P5338, DOI 10.1128/JVI.00274-06
   *WHO, 2007, WEEKLY EPIDEMIOLOGIC, V18, P153
   Zhou L, 2009, IMMUNITY, V30, P646, DOI 10.1016/j.immuni.2009.05.001
NR 22
TC 20
Z9 20
U1 0
U2 4
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0264-410X
J9 VACCINE
JI Vaccine
PD NOV 29
PY 2010
VL 28
IS 51
BP 8183
EP 8188
DI 10.1016/j.vaccine.2010.09.090
PG 6
WC Immunology; Medicine, Research & Experimental
SC Immunology; Research & Experimental Medicine
GA 707LS
UT WOS:000286288700020
PM 20939995
OA Green Accepted
DA 2020-12-01
ER

PT J
AU Mudd, PA
   Piaskowski, SM
   Neves, PCC
   Rudersdorf, R
   Kolar, HL
   Eernisse, CM
   Weisgrau, KL
   de Santana, MGV
   Wilson, NA
   Bonaldo, MC
   Galler, R
   Rakasz, EG
   Watkins, DI
AF Mudd, Philip A.
   Piaskowski, Shari M.
   Costa Neves, Patricia C.
   Rudersdorf, Richard
   Kolar, Holly L.
   Eernisse, Christopher M.
   Weisgrau, Kim L.
   Veloso de Santana, Marlon G.
   Wilson, Nancy A.
   Bonaldo, Myrna C.
   Galler, Ricardo
   Rakasz, Eva G.
   Watkins, David I.
TI The live-attenuated yellow fever vaccine 17D induces broad and potent T
   cell responses against several viral proteins in Indian rhesus
   macaques-implications for recombinant vaccine design
SO IMMUNOGENETICS
LA English
DT Article
DE Yellow fever 17D; Vaccine; Cytotoxic T lymphocyte; Indian rhesus macaque
ID CLASS-I MOLECULES; HIGH-FREQUENCY; VIRUS; EPITOPES; IMMUNOGENICITY;
   CONSTRUCTION; EFFICACY; SURFACE; ESCAPE; GENES
AB The yellow fever vaccine 17D (YF17D) is one of the most effective vaccines. Its wide use and favorable safety profile make it a prime candidate for recombinant vaccines. It is believed that neutralizing antibodies account for a large measure of the protection afforded to YF17D-vaccinated individuals, however cytotoxic T lymphocyte (CTL) responses have been described in the setting of YF17D vaccination. YF17D is an ssRNA flavivirus that is translated as a full-length polyprotein, several domains of which pass into the lumen of the endoplasmic reticulum (ER). The processing and presentation machinery for MHC class I-restricted CTL responses favor cytoplasmic peptides that are transported into the ER by the transporter associated with antigen presentation proteins. In order to inform recombinant vaccine design, we sought to determine if YF17D-induced CTL responses preferentially targeted viral domains that remain within the cytoplasm. We performed whole YF17D proteome mapping of CTL responses in six Indian rhesus macaques vaccinated with YF17D using overlapping YF17D peptides. We found that the ER luminal E protein was the most immunogenic viral protein followed closely by the cytoplasmic NS3 and NS5 proteins. These results suggest that antigen processing and presentation in this model system is not preferentially affected by the subcellular location of the viral proteins that are the source of CTL epitopes. The data also suggest potential immunogenic regions of YF17D that could serve as the focus of recombinant T cell vaccine development.
C1 [Mudd, Philip A.; Piaskowski, Shari M.; Rudersdorf, Richard; Kolar, Holly L.; Eernisse, Christopher M.; Weisgrau, Kim L.; Wilson, Nancy A.; Rakasz, Eva G.; Watkins, David I.] Univ Wisconsin, Dept Pathol & Lab Med, Madison, WI 53711 USA.
   [Costa Neves, Patricia C.; Veloso de Santana, Marlon G.; Bonaldo, Myrna C.] Fiocruz MS, Inst Oswaldo Cruz, Lab Biol Mol Flavivirus, BR-21045900 Rio De Janeiro, Brazil.
   [Galler, Ricardo] Fundacao Oswaldo Cruz, Inst Tecnol Imunobiol, Rio De Janeiro, Brazil.
   [Rakasz, Eva G.; Watkins, David I.] Univ Wisconsin, Wisconsin Natl Primate Res Ctr, Madison, WI 53711 USA.
RP Watkins, DI (corresponding author), Univ Wisconsin, Dept Pathol & Lab Med, 555 Sci Dr, Madison, WI 53711 USA.
EM watkins@primate.wisc.edu
RI Bonaldo, Myrna C/D-9494-2013; de Santana, Marlon Gilsepp
   Veloso/H-8146-2017; Galler, Ricardo/B-3280-2014; Rakasz, Eva
   G/H-9197-2019
OI de Santana, Marlon Gilsepp Veloso/0000-0002-3427-841X; Mudd,
   Philip/0000-0002-3860-5473
FU National Institutes of Health (NIH)United States Department of Health &
   Human ServicesNational Institutes of Health (NIH) - USA [R37 AI052056,
   R01 AI049120, R01 AI076114, R24 RR015371, R24 RR016038, R21 PRJ27JP];
   National Center for Research Resources (NCRR), NIHUnited States
   Department of Health & Human ServicesNational Institutes of Health (NIH)
   - USANIH National Center for Research Resources (NCRR) [P51 RR000167];
   Research Facilities Improvement ProgramUnited States Department of
   Health & Human ServicesNational Institutes of Health (NIH) - USANIH
   National Center for Research Resources (NCRR) [RR15459-01, RR020141-01];
   NATIONAL CENTER FOR RESEARCH RESOURCESUnited States Department of Health
   & Human ServicesNational Institutes of Health (NIH) - USANIH National
   Center for Research Resources (NCRR) [P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, R24RR016038, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, C06RR020141,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, R24RR015371, P51RR000167, P51RR000167, R24RR015371,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, R24RR015371, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, R24RR015371, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, C06RR020141, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, R24RR016038, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, R24RR016038, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, R24RR015371, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, C06RR015459, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, R24RR016038,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, R24RR016038,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, R24RR015371,
   P51RR000167, P51RR000167, C06RR020141, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, C06RR020141, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   R24RR016038, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   R24RR015371, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, R24RR015371,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, R24RR015371,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, R24RR015371, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, C06RR020141, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, C06RR020141, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, R24RR015371, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, R24RR016038, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, R24RR015371, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, R24RR016038, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   R24RR016038, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, R24RR015371, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, R24RR016038, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, R24RR016038, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167] Funding Source: NIH RePORTER;
   NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASESUnited States
   Department of Health & Human ServicesNational Institutes of Health (NIH)
   - USANIH National Institute of Allergy & Infectious Diseases (NIAID)
   [R01AI076114, R37AI052056, R01AI049120, R01AI049120, R01AI049120,
   R37AI052056, R37AI052056, R01AI049120, R37AI052056, R01AI049120,
   R37AI052056, R37AI052056, R37AI052056, R01AI049120, R37AI052056,
   R01AI076114, R37AI052056, R01AI049120, R37AI052056, R01AI049120,
   R01AI076114, R01AI076114, R01AI076114, R37AI052056, R01AI049120] Funding
   Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL
   SCIENCESUnited States Department of Health & Human ServicesNational
   Institutes of Health (NIH) - USANIH National Institute of General
   Medical Sciences (NIGMS) [T32GM008692, T32GM008692, T32GM008692,
   T32GM008692, T32GM008692, T32GM008692, T32GM008692, T32GM008692,
   T32GM008692, T32GM008692, T32GM008692, T32GM008692, T32GM008692,
   T32GM008692, T32GM008692, T32GM008692, T32GM008692, T32GM008692,
   T32GM008692, T32GM008692, T32GM008692, T32GM008692, T32GM008692,
   T32GM008692, T32GM008692, T32GM008692, T32GM008692] Funding Source: NIH
   RePORTER
FX The authors would like to thank Mauricio Martins for helpful
   discussions. This work was supported by National Institutes of Health
   (NIH) grants R37 AI052056, R01 AI049120, R01 AI076114, R24 RR015371, R24
   RR016038, and R21 PRJ27JP to DIW. This publication was made possible in
   part by Grant Number P51 RR000167 from the National Center for Research
   Resources (NCRR), a component of the NIH, to the Wisconsin National
   Primate Research Center, University of Wisconsin-Madison. This research
   was conducted in part at a facility constructed with support from
   Research Facilities Improvement Program grant numbers RR15459-01 and
   RR020141-01. This publication's contents are solely the responsibility
   of the authors and do not necessarily represent the official views of
   NCRR or NIH.
CR Akondy RS, 2009, J IMMUNOL, V183, P7919, DOI 10.4049/jimmunol.0803903
   Bonaldo MC, 2005, J VIROL, V79, P8602, DOI 10.1128/JVI.79.13.8602-8613.2005
   Bonaldo MC, 2002, J MOL BIOL, V315, P873, DOI 10.1006/jmbi.2001.5258
   Bonaldo MC, 2010, J VIROL, V84, P3699, DOI 10.1128/JVI.02255-09
   Bonaldo MC, 2007, VIROL J, V4, DOI 10.1186/1743-422X-4-115
   Fields BN, 2001, FIELDS VIROLOGY
   Galler R, 1998, VACCINE, V16, P1024, DOI 10.1016/S0264-410X(97)00278-8
   HAHN CS, 1987, P NATL ACAD SCI USA, V84, P2019, DOI 10.1073/pnas.84.7.2019
   Knapp LA, 1997, TISSUE ANTIGENS, V50, P657, DOI 10.1111/j.1399-0039.1997.tb02927.x
   Lai Ching-Juh, 2003, Adv Virus Res, V61, P469, DOI 10.1016/S0065-3527(03)61013-4
   Lev A, 2010, P NATL ACAD SCI USA, V107, P6964, DOI 10.1073/pnas.0910997107
   Loffredo JT, 2007, J VIROL, V81, P2624, DOI 10.1128/JVI.01912-06
   Loffredo JT, 2004, J IMMUNOL, V173, P5064, DOI 10.4049/jimmunol.173.8.5064
   Mateu GP, 2007, T ROY SOC TROP MED H, V101, P289, DOI 10.1016/j.trstmh.2006.08.006
   McAllister A, 2000, J VIROL, V74, P9197, DOI 10.1128/JVI.74.19.9197-9205.2000
   Peters B, 2005, VACCINE, V23, P5212, DOI 10.1016/j.vaccine.2005.07.086
   POLAND JD, 1981, B WORLD HEALTH ORGAN, V59, P895
   Pugachev KV, 2005, CURR OPIN INFECT DIS, V18, P387, DOI 10.1097/01.qco.0000178823.28585.ad
   Pulendran B, 2008, J INFECT DIS, V198, P500, DOI 10.1086/590187
   Querec TD, 2009, NAT IMMUNOL, V10, P116, DOI 10.1038/ni.1688
   Stoyanov CT, 2010, VACCINE, V28, P4644, DOI 10.1016/j.vaccine.2010.04.071
   Tao D, 2005, J EXP MED, V201, P201, DOI 10.1084/jem.20041526
   Van Der Most RG, 2000, J VIROL, V74, P8094, DOI 10.1128/JVI.74.17.8094-8101.2000
   Yewdell JW, 1996, J IMMUNOL, V157, P1823
   Yusim K., 2009, HIV MOL IMMUNOLOGY 2
NR 25
TC 12
Z9 12
U1 0
U2 2
PU SPRINGER
PI NEW YORK
PA 233 SPRING ST, NEW YORK, NY 10013 USA
SN 0093-7711
J9 IMMUNOGENETICS
JI Immunogenetics
PD SEP
PY 2010
VL 62
IS 9
BP 593
EP 600
DI 10.1007/s00251-010-0461-0
PG 8
WC Genetics & Heredity; Immunology
SC Genetics & Heredity; Immunology
GA 644RF
UT WOS:000281396500003
PM 20607226
OA Green Accepted
DA 2020-12-01
ER

PT J
AU Bonaldo, MC
   Martins, MA
   Rudersdorf, R
   Mudd, PA
   Sacha, JB
   Piaskowski, SM
   Neves, PCC
   de Santana, MGV
   Vojnov, L
   Capuano, S
   Rakasz, EG
   Wilson, NA
   Fulkerson, J
   Sadoff, JC
   Watkins, DI
   Galler, R
AF Bonaldo, Myrna C.
   Martins, Mauricio A.
   Rudersdorf, Richard
   Mudd, Philip A.
   Sacha, Jonah B.
   Piaskowski, Shari M.
   Costa Neves, Patricia C.
   Veloso de Santana, Marlon G.
   Vojnov, Lara
   Capuano, Saverio, III
   Rakasz, Eva G.
   Wilson, Nancy A.
   Fulkerson, John
   Sadoff, Jerald C.
   Watkins, David I.
   Galler, Ricardo
TI Recombinant Yellow Fever Vaccine Virus 17D Expressing Simian
   Immunodeficiency Virus SIVmac239 Gag Induces SIV-Specific CD8(+) T-Cell
   Responses in Rhesus Macaques
SO JOURNAL OF VIROLOGY
LA English
DT Article
ID ANKARA BOOST REGIMEN; HIV-1 VACCINE; DISEASE PROGRESSION; VIRAL
   REPLICATION; CHALLENGE; IMMUNITY; MONKEYS; LYMPHOCYTES; PROTECTION;
   VECTORS
AB Here we describe a novel vaccine vector for expressing human immunodeficiency virus (HIV) antigens. We show that recombinant attenuated yellow fever vaccine virus 17D expressing simian immunodeficiency virus SIVmac239 Gag sequences can be used as a vector to generate SIV-specific CD8(+) T-cell responses in the rhesus macaque. Priming with recombinant BCG expressing SIV antigens increased the frequency of these SIV-specific CD8(+) T-cell responses after recombinant YF17D boosting. These recombinant YF17D-induced SIVspecific CD8(+) T cells secreted several cytokines, were largely effector memory T cells, and suppressed viral replication in CD4(+) T cells.
C1 [Martins, Mauricio A.; Rudersdorf, Richard; Mudd, Philip A.; Sacha, Jonah B.; Piaskowski, Shari M.; Vojnov, Lara; Rakasz, Eva G.; Wilson, Nancy A.; Watkins, David I.] Univ Wisconsin, Dept Pathol & Lab Med, Madison, WI 53711 USA.
   [Capuano, Saverio, III; Rakasz, Eva G.; Wilson, Nancy A.; Watkins, David I.] Univ Wisconsin, Wisconsin Natl Primate Res Ctr, Madison, WI 53711 USA.
   [Fulkerson, John; Sadoff, Jerald C.] Aeras Global TB Vaccine Fdn, Rockville, MD USA.
   [Galler, Ricardo] Inst Tecnol Imunobiol, Fundacao Oswaldo Cruz, Rio De Janeiro, Brazil.
   [Bonaldo, Myrna C.; Costa Neves, Patricia C.; Veloso de Santana, Marlon G.] Inst Oswaldo Cruz FIOCRUZ, Lab Biol Mol Flavivirus, Rio De Janeiro, Brazil.
RP Watkins, DI (corresponding author), Univ Wisconsin, Dept Pathol & Lab Med, 555 Sci Dr, Madison, WI 53711 USA.
EM watkins@primate.wisc.edu
RI Martins, Mauricio/AAU-9226-2020; de Santana, Marlon Gilsepp
   Veloso/H-8146-2017; Rakasz, Eva G/H-9197-2019; Galler,
   Ricardo/B-3280-2014; Bonaldo, Myrna C/D-9494-2013
OI Martins, Mauricio/0000-0001-8336-216X; de Santana, Marlon Gilsepp
   Veloso/0000-0002-3427-841X; Vojnov, Lara/0000-0003-0488-1012; Mudd,
   Philip/0000-0002-3860-5473
FU NIHUnited States Department of Health & Human ServicesNational
   Institutes of Health (NIH) - USA [R01 AI076114, R01 AI049120];
   Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior
   (CAPES)CAPES; FIOCRUZ; NCRRUnited States Department of Health & Human
   ServicesNational Institutes of Health (NIH) - USANIH National Center for
   Research Resources (NCRR) [P51 RR000167]; Research Facilities
   Improvement ProgramUnited States Department of Health & Human
   ServicesNational Institutes of Health (NIH) - USANIH National Center for
   Research Resources (NCRR) [RR15459, RR020141]; NATIONAL CENTER FOR
   RESEARCH RESOURCESUnited States Department of Health & Human
   ServicesNational Institutes of Health (NIH) - USANIH National Center for
   Research Resources (NCRR) [P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, C06RR020141, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, C06RR020141,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   C06RR015459, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, C06RR020141, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, C06RR020141, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, C06RR020141, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, C06RR020141, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167, P51RR000167, P51RR000167,
   P51RR000167, P51RR000167, P51RR000167] Funding Source: NIH RePORTER;
   NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASESUnited States
   Department of Health & Human ServicesNational Institutes of Health (NIH)
   - USANIH National Institute of Allergy & Infectious Diseases (NIAID)
   [R01AI076114, R01AI049120, R01AI049120, R01AI076114, R01AI049120,
   R01AI076114, R01AI076114, R01AI076114, R01AI049120, R01AI049120,
   R01AI049120, R01AI049120, R01AI049120, R01AI049120] Funding Source: NIH
   RePORTER
FX This work was funded by NIH grants R01 AI076114 and R01 AI049120 to D.
   I. W., Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior
   (CAPES), and FIOCRUZ. In addition, this work was supported by NCRR grant
   P51 RR000167 to the Wisconsin National Primate Research Center,
   University of Wisconsin -Madison. This research was conducted in part at
   a facility constructed with support from Research Facilities Improvement
   Program grants RR15459 and RR020141.
CR Abbink P, 2007, J VIROL, V81, P4654, DOI 10.1128/JVI.02696-06
   Allen TM, 2002, J VIROL, V76, P4108, DOI 10.1128/JVI.76.8.4108-4112.2002
   Allen TM, 2000, J IMMUNOL, V164, P4968, DOI 10.4049/jimmunol.164.9.4968
   Allen TM, 2002, J VIROL, V76, P10507, DOI 10.1128/JVI.76.20.10507-10511.2002
   Barker LF, 2009, CURR OPIN IMMUNOL, V21, P331, DOI 10.1016/j.coi.2009.05.017
   Benson J, 1998, J VIROL, V72, P4170, DOI 10.1128/JVI.72.5.4170-4182.1998
   Bonaldo MC, 2002, J MOL BIOL, V315, P873, DOI 10.1006/jmbi.2001.5258
   Bonaldo MC, 2007, VIROL J, V4, DOI 10.1186/1743-422X-4-115
   Buchbinder SP, 2008, LANCET, V372, P1881, DOI 10.1016/S0140-6736(08)61591-3
   Burton DR, 2004, NAT IMMUNOL, V5, P233, DOI 10.1038/ni0304-233
   Cayabyab MJ, 2009, J VIROL, V83, P5505, DOI 10.1128/JVI.02544-08
   Davis NL, 2000, J VIROL, V74, P371, DOI 10.1128/JVI.74.1.371-378.2000
   Engram JC, 2009, J IMMUNOL, V183, P706, DOI 10.4049/jimmunol.0803746
   Guy B, 2008, VACCINE, V26, P5712, DOI 10.1016/j.vaccine.2008.08.019
   Hanke T, 1999, J VIROL, V73, P7524, DOI 10.1128/JVI.73.9.7524-7532.1999
   Hansen SG, 2009, NAT MED, V15, P293, DOI 10.1038/nm.1935
   Hoft DF, 2008, J INFECT DIS, V198, P1491, DOI 10.1086/592450
   Horton H, 2002, J VIROL, V76, P7187, DOI 10.1128/JVI.76.14.7187-7202.2002
   Johnson PR, 2005, J VIROL, V79, P955, DOI 10.1128/JVI.79.2.955-965.2005
   Johnston RE, 2005, VACCINE, V23, P4969, DOI 10.1016/j.vaccine.2005.05.034
   Liu JY, 2008, J VIROL, V82, P4844, DOI 10.1128/JVI.02616-07
   Liu JY, 2009, NATURE, V457, P87, DOI 10.1038/nature07469
   Masopust D, 2006, J IMMUNOL, V177, P831, DOI 10.4049/jimmunol.177.2.831
   McAllister A, 2000, J VIROL, V74, P9197, DOI 10.1128/JVI.74.19.9197-9205.2000
   McElrath MJ, 2008, LANCET, V372, P1894, DOI 10.1016/S0140-6736(08)61592-5
   Miller JD, 2008, IMMUNITY, V28, P710, DOI 10.1016/j.immuni.2008.02.020
   Monath TP, 2006, P NATL ACAD SCI USA, V103, P6694, DOI 10.1073/pnas.0601932103
   Monath TP, 2003, J INFECT DIS, V188, P1213, DOI 10.1086/378356
   Monath TP, 2003, VACCINES, P1095
   Patterson LJ, 2008, EXPERT OPIN BIOL TH, V8, P1347, DOI [10.1517/14712598.8.9.1347, 10.1517/14712598.8.9.1347 ]
   Peters B, 2005, VACCINE, V23, P5212, DOI 10.1016/j.vaccine.2005.07.086
   Reynolds MR, 2008, J EXP MED, V205, P2537, DOI 10.1084/jem.20081524
   Skeiky YAW, 2006, NAT REV MICROBIOL, V4, P469, DOI 10.1038/nrmicro1419
   STOVER CK, 1994, DEV BIOL STAND, V82, P163
   Tao D, 2005, J EXP MED, V201, P201, DOI 10.1084/jem.20041526
   Trindade GF, 2008, AN ACAD BRAS CIENC, V80, P311, DOI 10.1590/S0001-37652008000200009
   Valentine LE, 2009, J VIROL, V83, P11514, DOI 10.1128/JVI.01298-09
   Vogel TU, 2003, J VIROL, V77, P13348, DOI 10.1128/JVI.77.24.13348-13360.2003
   Vojnov L, 2010, J VIROL, V84, P753, DOI 10.1128/JVI.01596-09
   Watkins DI, 2008, NAT MED, V14, P617, DOI 10.1038/nm.f.1759
   Wilson NA, 2006, J VIROL, V80, P5875, DOI 10.1128/JVI.00171-06
   Wilson NA, 2009, J VIROL, V83, P6508, DOI 10.1128/JVI.00272-09
NR 42
TC 39
Z9 42
U1 0
U2 1
PU AMER SOC MICROBIOLOGY
PI WASHINGTON
PA 1752 N ST NW, WASHINGTON, DC 20036-2904 USA
SN 0022-538X
EI 1098-5514
J9 J VIROL
JI J. Virol.
PD APR
PY 2010
VL 84
IS 7
BP 3699
EP 3706
DI 10.1128/JVI.02255-09
PG 8
WC Virology
SC Virology
GA 565PV
UT WOS:000275307400054
PM 20089645
OA Bronze, Green Published
DA 2020-12-01
ER

PT J
AU Oliveira, RC
   Teixeira, BR
   Mello, FCA
   Pereira, AP
   Duarte, AS
   Bonaldo, MC
   Bonvicino, CR
   D'Andrea, PS
   Lemos, ERS
AF Oliveira, R. C.
   Teixeira, B. R.
   Mello, F. C. A.
   Pereira, A. P.
   Duarte, A. S.
   Bonaldo, M. C.
   Bonvicino, C. R.
   D'Andrea, P. S.
   Lemos, E. R. S.
TI Genetic characterization of a Juquitiba-like viral lineage in
   Oligoryzomys nigripes in Rio de Janeiro, Brazil
SO ACTA TROPICA
LA English
DT Article
DE Hantaviruses; Rodents; Oligoryzomys nigripes; Rio de Janeiro; Brazil
ID HANTAVIRUS PULMONARY SYNDROME; WILD RODENTS; S-SEGMENT; VIRUS;
   IDENTIFICATION; HANTAAN; RESERVOIRS; DIVERSITY; PARANA; HPS
AB Hantaviruses, family Bunyaviridae, are rodent-borne RNA viruses that have caused cases of hantavirus cardiopulmonary syndrome (HCPS) in various regions of the Americas. There are five hantaviral lineages associated with HCPS in Brazil: Juquitiba virus (JUQV), Araraquara virus (ARAV), Laguna Negra-like virus (LNV), Castelo dos Sonhos virus (CASV), and Anajatuba virus (ANAJV). Three additional hantaviruses have been described in rodents alone: Rio Mearim virus, Jabora virus, and a hantavirus lineage related to Seoul virus. This study describes the genetic detection and characterization of a Juquitiba-like hantavirus in Oligoryzomys nigripes, or the black-footed pygmy rice rat, in the Serra dos Orgaos National Park, Rio de Janeiro State, where so far no cases of HCPS have been reported. (C) 2009 Elsevier B.V. All rights reserved.
C1 [Oliveira, R. C.; Pereira, A. P.; Lemos, E. R. S.] Fundacao Oswaldo Cruz, Inst Oswaldo Cruz, Lab Hantaviroses & Rickettsioses, Rio De Janeiro, Brazil.
   [Teixeira, B. R.; Bonvicino, C. R.; D'Andrea, P. S.] Fundacao Oswaldo Cruz, Inst Oswaldo Cruz, Lab Biol Parasitol Mamiferos Silvestres Reservato, Rio De Janeiro, Brazil.
   [Mello, F. C. A.] Fundacao Oswaldo Cruz, Inst Oswaldo Cruz, Mol Virol Lab, Rio De Janeiro, Brazil.
   [Duarte, A. S.; Bonaldo, M. C.] Fundacao Oswaldo Cruz, Inst Oswaldo Cruz, Lab Biol Mol Flavivirus, Rio De Janeiro, Brazil.
   [Bonvicino, C. R.] Minist Saude, Inst Nacl Canc, Programa Genet, Rio De Janeiro, Brazil.
RP Oliveira, RC (corresponding author), Fundacao Oswaldo Cruz, Inst Oswaldo Cruz, Lab Hantaviroses & Rickettsioses, Rio De Janeiro, Brazil.
EM reoliveira@ioc.fiocruz.br
RI Oliveira, Renata/C-1124-2014; Bonvicino, Cibele/O-3390-2014; Bonaldo,
   Myrna C/D-9494-2013; D'Andrea, Paulo S./G-6820-2011; Teixeira, Bernardo
   R/D-7664-2013
OI Teixeira, Bernardo R/0000-0001-9013-9492; D'Andrea, Paulo
   Sergio/0000-0001-7880-8761; Lemos, Elba/0000-0003-3761-0200
FU Brazilian National Research Council (CNPq)National Council for
   Scientific and Technological Development (CNPq) [403050/2004-9,
   39/2004A]; Rio de Janeiro State Research Foundation (FAPERJ)Carlos
   Chagas Filho Foundation for Research Support of the State of Rio de
   Janeiro (FAPERJ) [E-26/170.985/2004]; Koln-FMER [690145/2001-2];
   IOC/FIOCRUZ; Brazilian Institute for the Environment and Renewable
   Natural Resources (IBAMA)
FX We are especially grateful to the field team of the Laboratory of
   Biology and Parasitology of Wild Mammal Reservoirs, IOC/FIOCRUZ, who
   participated in the Teresopolis expeditions, and to the administration
   of the Serra dos Orgaos National Park and farmers from Teresopolis
   Municipality for permission to work in these areas. Special thanks to Dr
   Gonzalo Jose Bello Bentancor of the Laboratory of SIDA and Molecular
   Immunology, IOC/FIOCRUZ. We also thank Jose Luis Passos Cordeiro for
   helping with the map image and Raphael Gomes for technical assistance,
   IOC/FIOCRUZ. This study had financial support of the Brazilian National
   Research Council (CNPq) (Call for Projects: CNPq/ITT/FH Brazil-Germany
   Cooperation, and Grant No. 403050/2004-9, Call for Projects 39/2004A),
   Rio de Janeiro State Research Foundation (FAPERJ) (Grant No.
   E-26/170.985/2004, Call for Projects APQ1), Koln-FMER (No.
   690145/2001-2), and IOC/FIOCRUZ. The study was authorized by the
   Brazilian Institute for the Environment and Renewable Natural Resources
   (IBAMA) (License numbers 02001.003618/03-06 and 02001.006721/2004).; The
   voucher numbers of infected rodents are MN 71983 (Oln6468_GenBank
   accession no. GQ259904), MN 71984 (Oln6469_GenBank accession no.
   GQ259905) and MN 71985 (Oln6470_GenBank accession no. GQ259906).
CR Andrades-Miranda J, 2001, J MAMMAL, V82, P1080, DOI 10.1644/1545-1542(2001)082<1080:CSOSSO>2.0.CO;2
   Bonvicino CR, 2008, GUIA ROEDORES BRASIL, P1
   *BRAZ MIN HLTH BRA, 2009, REP HANT PULM SYNDR
   CHILDS JE, 1994, J INFECT DIS, V169, P1271, DOI 10.1093/infdis/169.6.1271
   Chu YK, 2006, AM J TROP MED HYG, V75, P1127, DOI 10.4269/ajtmh.2006.75.1127
   Delfraro A, 2008, EMERG INFECT DIS, V14, P1447, DOI 10.3201/eid1409.080455
   Della Valle MG, 2002, AM J TROP MED HYG, V66, P713, DOI 10.4269/ajtmh.2002.66.713
   Doyle TJ, 1998, INFECT DIS CLIN N AM, V12, P95, DOI 10.1016/S0891-5520(05)70411-6
   Hjelle B, 2001, CURR TOP MICROBIOL, V256, P77
   Iversson L B, 1994, Rev Assoc Med Bras (1992), V40, P85
   Johnson AM, 1999, J MED VIROL, V59, P527, DOI 10.1002/(SICI)1096-9071(199912)59:4&lt;527::AID-JMV17&gt;3.0.CO;2-Y
   LEDUC JW, 1987, LAB ANIM SCI, V37, P413
   LEDUC JW, 1986, B WORLD HEALTH ORGAN, V64, P139
   LEDUC JW, 1985, AM J TROP MED HYG, V34, P810, DOI 10.4269/ajtmh.1985.34.810
   LEE HW, 1978, J INFECT DIS, V137, P298, DOI 10.1093/infdis/137.3.298
   LI DX, 1995, VIROLOGY, V206, P973, DOI 10.1006/viro.1995.1020
   Mills JN, 1998, EMERG INFECT DIS, V4, P529, DOI 10.3201/eid0404.980403
   Mills JN, 1995, METHODS TRAPPING SAM
   Monroe MC, 1999, EMERG INFECT DIS, V5, P75, DOI 10.3201/eid0501.990109
   Musser GG, 2005, MAMMAL SPECIES WORLD, P955
   NICHOL ST, 1993, SCIENCE, V262, P914, DOI 10.1126/science.8235615
   Padula PJ, 2000, J MED MICROBIOL, V49, P149, DOI 10.1099/0022-1317-49-2-149
   Plyusnin A, 2001, CURR TOP MICROBIOL, V256, P47
   Posada D, 1998, BIOINFORMATICS, V14, P817, DOI 10.1093/bioinformatics/14.9.817
   Raboni SM, 2005, J MED VIROL, V76, P553, DOI 10.1002/jmv.20398
   Raboni SM, 2009, J GEN VIROL, V90, P2166, DOI 10.1099/vir.0.011585-0
   Ronquist F, 2003, BIOINFORMATICS, V19, P1572, DOI 10.1093/bioinformatics/btg180
   Rosa EST, 2005, VECTOR-BORNE ZOONOT, V5, P11, DOI 10.1089/vbz.2005.5.11
   Sanchez AJ, 2001, VIROLOGY, V286, P345, DOI 10.1006/viro.2001.0983
   Sobreira M, 2008, ACTA TROP, V107, P150, DOI 10.1016/j.actatropica.2008.05.018
   Suzuki A, 2004, EMERG INFECT DIS, V10, P2127, DOI 10.3201/eid1012.040295
   THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673
   Weksler M., 2005, ARQUIVOS MUSEU NACL, V63, P113
NR 33
TC 24
Z9 24
U1 0
U2 5
PU ELSEVIER
PI AMSTERDAM
PA RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS
SN 0001-706X
EI 1873-6254
J9 ACTA TROP
JI Acta Trop.
PD NOV
PY 2009
VL 112
IS 2
BP 212
EP 218
DI 10.1016/j.actatropica.2009.07.029
PG 7
WC Parasitology; Tropical Medicine
SC Parasitology; Tropical Medicine
GA 513SZ
UT WOS:000271345000020
PM 19660427
DA 2020-12-01
ER

PT J
AU Trindade, GF
   Marchevsky, RS
   De Fillipis, AMB
   Nogueira, RMR
   Bonaldo, MC
   Acero, PC
   Caride, E
   Freire, MS
   Galler, R
AF Trindade, Gisela F.
   Marchevsky, Renato S.
   De Fillipis, Ana M. B.
   Nogueira, Rita M. R.
   Bonaldo, Myrna C.
   Acero, Pedro C.
   Caride, Elena
   Freire, Marcos S.
   Galler, Ricardo
TI Limited replication of yellow fever 17DD and 17D-Dengue recombinant
   viruses in rhesus monkeys
SO ANAIS DA ACADEMIA BRASILEIRA DE CIENCIAS
LA English
DT Article
DE yellow fever; dengue; vaccine; attenuation; replication; real-time
   RT-PCR
ID ATTENUATED DENGUE VACCINES; REAL-TIME PCR; NEUROLOGICAL MANIFESTATIONS;
   ANTIBODY-RESPONSES; NONHUMAN-PRIMATES; TYPE-2 VIRUS; IMMUNOGENICITY;
   INFECTION; VIREMIA; SAFETY
AB For the development of safe live attenuated flavivirus vaccines one of the main properties to be established is viral replication. We have used real-time reverse transcriptase-polymerase chain reaction and virus titration by plaque assay to determine the replication of yellow fever 17DD virus ( YFV 17DD) and recombinant yellow fever 17D viruses expressing envelope proteins of dengue virus serotypes 2 and 4 (17D-DENV- 2 and 17D-DENV- 4). Serum samples from rhesus monkeys inoculated with YFV 17DD and 17D-DENV chimeras by intracerebral or subcutaneous route were used to determine and compare the viremia induced by these viruses. Viral load quantification in samples from monkeys inoculated by either route with YFV 17DD virus suggested a restricted capability of the virus to replicate reaching not more than 2.0 log(10) PFUmL(-1) or 3.29 log(10) copiesmL(-1). Recombinant 17D-dengue viruseswere shown by plaquing and real-time PCR to be as attenuated as YF 17DD virus with the highest mean peak titer of 1.97 log(10) PFU mL(-1) or 3.53 log(10) copies mL(-1). These data serve as a comparative basis for the characterization of other 17D-based live attenuated candidate vaccines against other diseases.
C1 [Trindade, Gisela F.; Marchevsky, Renato S.; Bonaldo, Myrna C.; Caride, Elena; Freire, Marcos S.; Galler, Ricardo] Fundacao Oswaldo Cruz, Inst Tecnol Immunobiol, Dept Bioquim & Biol Mol, BR-21045900 Rio De Janeiro, Brazil.
   [Trindade, Gisela F.; De Fillipis, Ana M. B.; Nogueira, Rita M. R.] Fundacao Oswaldo Cruz, Dept Virol, BR-21045900 Rio De Janeiro, Brazil.
   [Acero, Pedro C.] Fundacao Oswaldo Cruz, Dept Genet, BR-21045900 Rio De Janeiro, Brazil.
RP Galler, R (corresponding author), Fundacao Oswaldo Cruz, Inst Tecnol Immunobiol, Dept Bioquim & Biol Mol, Av Brasil 4365, BR-21045900 Rio De Janeiro, Brazil.
EM rgaller@bio.fiocruz.br
RI Galler, Ricardo/B-3280-2014; Bonaldo, Myrna C/D-9494-2013
OI Trindade, Gisela/0000-0002-1630-4143; Marchevsky,
   Renato/0000-0003-1174-3902
CR Bae HG, 2003, J VIROL METHODS, V110, P185, DOI 10.1016/S0166-0934(03)00129-0
   Bente Dennis A, 2006, Drug Discov Today Dis Models, V3, P97, DOI 10.1016/j.ddmod.2006.03.014
   Blaney JE, 2005, J VIROL, V79, P5516, DOI 10.1128/JVI.79.9.5516-5528.2005
   CALISHER CH, 1989, J GEN VIROL, V70, P37, DOI 10.1099/0022-1317-70-1-37
   Drosten C, 2002, J CLIN MICROBIOL, V40, P2323, DOI 10.1128/JCM.40.7.2323-2330.2002
   Durbin AP, 2001, AM J TROP MED HYG, V65, P405, DOI 10.4269/ajtmh.2001.65.405
   Edelman R, 2003, AM J TROP MED HYG, V69, P48, DOI 10.4269/ajtmh.2003.69.48
   Galler R, 2005, BRAZ J MED BIOL RES, V38, P1835, DOI 10.1590/S0100-879X2005001200012
   Gubler DJ, 2004, COMP IMMUNOL MICROB, V27, P319, DOI 10.1016/j.cimid.2004.03.013
   Guirakhoo F, 2000, J VIROL, V74, P5477, DOI 10.1128/JVI.74.12.5477-5485.2000
   Guirakhoo F, 2002, VIROLOGY, V298, P146, DOI 10.1006/viro.2002.1462
   Guirakhoo F, 2006, HUM VACCINES, V2, P60, DOI 10.4161/hv.2.2.2555
   Houng HSH, 2001, J VIROL METHODS, V95, P19, DOI 10.1016/S0166-0934(01)00280-4
   Kalita J, 2006, CLIN NEUROPHYSIOL, V117, P2252, DOI 10.1016/j.clinph.2006.07.132
   Lai Ching-Juh, 2003, Adv Virus Res, V61, P469, DOI 10.1016/S0065-3527(03)61013-4
   Linderbach BD, 2001, FIELDS VIROLOGY, P991
   Marchevsky RS, 2006, BIOLOGICALS, V34, P191, DOI 10.1016/j.biologicals.2005.09.005
   Marchevsky RS, 2003, VIROLOGY, V316, P55, DOI 10.1016/S0042-6822(03)00583-X
   MONATH TP, 1981, AM J TROP MED HYG, V30, P431, DOI 10.4269/ajtmh.1981.30.431
   Monath TP, 2003, VACCINES, P1095
   NET ALK, 2001, VACCINE, V30, P3179
   Poersch CD, 2005, J CLIN VIROL, V32, P272, DOI 10.1016/j.jcv.2004.08.008
   Puig M, 2002, J VIROL METHODS, V105, P253, DOI 10.1016/S0166-0934(02)00119-2
   Putnak JR, 2005, VACCINE, V23, P4442, DOI 10.1016/j.vaccine.2005.03.042
   RUSSELL PK, 1967, J IMMUNOL, V99, P291
   Sabchareon A, 2004, PEDIATR INFECT DIS J, V23, P99, DOI 10.1097/01.inf.0000109289.55856.27
   Sabchareon A, 2002, AM J TROP MED HYG, V66, P264, DOI 10.4269/ajtmh.2002.66.264
   Soares CN, 2006, J NEUROL SCI, V249, P19, DOI 10.1016/j.jns.2006.05.068
   Solomon T, 2000, LANCET, V355, P1053, DOI 10.1016/S0140-6736(00)02036-5
   Sun W, 2003, AM J TROP MED HYG, V69, P24
   Sun W, 2006, J INFECT DIS, V193, P1658, DOI 10.1086/503372
   THEILER M, 1951, YELLOW FEVER, P39
   Vaughn DW, 2000, J INFECT DIS, V181, P2, DOI 10.1086/315215
   Vaughn DW, 1997, J INFECT DIS, V176, P322, DOI 10.1086/514048
   *WHO, 1998, WHO TECH REP SER, V872, P31
NR 35
TC 9
Z9 9
U1 0
U2 4
PU ACAD BRASILEIRA DE CIENCIAS
PI RIO JANEIRO
PA RUA ANFILOFIO DE CARVALHO, 29, 3 ANDAR, 20030-060 RIO JANEIRO, BRAZIL
SN 0001-3765
J9 AN ACAD BRAS CIENC
JI An. Acad. Bras. Cienc.
PD JUN
PY 2008
VL 80
IS 2
BP 311
EP 321
DI 10.1590/S0001-37652008000200009
PG 11
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA 306BH
UT WOS:000256221300009
PM 18506257
OA DOAJ Gold
DA 2020-12-01
ER

PT J
AU Bonaldo, MC
   Mello, SM
   Trindade, GF
   Rangel, AA
   Duarte, AS
   Oliveira, PJ
   Freire, MS
   Kubelka, CF
   Galler, R
AF Bonaldo, Myrna C.
   Mello, Samanta M.
   Trindade, Gisela F.
   Rangel, Aymara A.
   Duarte, Adriana S.
   Oliveira, Prisciliana J.
   Freire, Marcos S.
   Kubelka, Claire F.
   Galler, Ricardo
TI Construction and characterization of recombinant flaviviruses bearing
   insertions between E and NSI genes
SO VIROLOGY JOURNAL
LA English
DT Article
ID YELLOW-FEVER VIRUS; BORNE ENCEPHALITIS-VIRUS; ENDOPLASMIC-RETICULUM;
   KUNJIN VIRUS; CTL EPITOPES; PROTEIN-E; VACCINE; 17D; ENVELOPE;
   REPLICATION
AB Background: The yellow fever virus, a member of the genus Flavivirus, is an arthropod-borne pathogen causing severe disease in humans. The attenuated yellow fever 17D virus strain has been used for human vaccination for 70 years and has several characteristics that are desirable for the development of new, live attenuated vaccines. We described here a methodology to construct a viable, and immunogenic recombinant yellow fever 17D virus expressing a green fluorescent protein variant (EGFP). This approach took into account the presence of functional motifs and amino acid sequence conservation flanking the E and NSI intergenic region to duplicate and fuse them to the exogenous gene and thereby allow the correct processing of the viral polyprotein precursor.
   Results: YF 17D EGFP recombinant virus was grew in Vero cells and reached a peak titer of approximately 6.45 +/- 0.4 log10 PFU/mL at 96 hours post- infection. Immunoprecipitation and confocal laser scanning microscopy demonstrated the expression of the EGFP, which was retained in the endoplasmic reticulum and not secreted from infected cells. The association with the ER compartment did not interfere with YF assembly, since the recombinant virus was fully competent to replicate and exit the cell. This virus was genetically stable up to the tenth serial passage in Vero cells. The recombinant virus was capable to elicit a neutralizing antibody response to YF and antibodies to EGFP as evidenced by an ELISA test. The applicability of this cloning strategy to clone gene foreign sequences in other flavivirus genomes was demonstrated by the construction of a chimeric recombinant YF 17D/DEN4 virus.
   Conclusion: This system is likely to be useful for a broader live attenuated YF 17D virus-based vaccine development for human diseases. Moreover, insertion of foreign genes into the flavivirus genome may also allow in vivo studies on flavivirus cell and tissue tropism as well as cellular processes related to flavivirus infection.
C1 [Bonaldo, Myrna C.; Mello, Samanta M.; Trindade, Gisela F.; Duarte, Adriana S.; Oliveira, Prisciliana J.] Fundacao Oswaldo Cruz, Lab Biol Mol, Inst Oswaldo Cruz, BR-21045900 Rio De Janeiro, Brazil.
   [Rangel, Aymara A.; Freire, Marcos S.; Galler, Ricardo] Fundacao Oswaldo Cruz, Inst Tecnol Imunobiol, Rio De Janeiro, Brazil.
   [Kubelka, Claire F.] Fundacao Oswaldo Cruz, Inst Oswaldo Cruz, Lab Imunol Viral, Rio De Janeiro, Brazil.
RP Bonaldo, MC (corresponding author), Fundacao Oswaldo Cruz, Lab Biol Mol, Inst Oswaldo Cruz, Fdn Oswaldo Cruz Ave Brasil 4365, BR-21045900 Rio De Janeiro, Brazil.
EM mbonaldo@ioc.fiocruz.br; samello@ioc.fiocruz.br;
   gfreitas@ioc.fiocruz.br; aymara@bio.fiocruz.br; adriduar@ioc.fiocruz.br;
   priscilian@ig.com.br; freire@bio.fiocruz.br; claire@ioc.fiocruz.br;
   rgaller@bio.fiocruz.br
RI Kubelka, Claire F/C-5558-2009; Galler, Ricardo/B-3280-2014; Bonaldo,
   Myrna C/D-9494-2013
OI Trindade, Gisela/0000-0002-1630-4143
CR Allison SL, 1999, J VIROL, V73, P5605, DOI 10.1128/JVI.73.7.5605-5612.1999
   ANDINO R, 2002, RECOMBINANT BICISTRO
   Barba-Spaeth G, 2005, J EXP MED, V202, P1179, DOI 10.1084/jem.20051352
   Bonaldo MC, 2005, J VIROL, V79, P8602, DOI 10.1128/JVI.79.13.8602-8613.2005
   Bonaldo MC, 2002, J MOL BIOL, V315, P873, DOI 10.1006/jmbi.2001.5258
   Bredenbeek PJ, 2006, VIROLOGY, V345, P299, DOI 10.1016/j.virol.2005.12.001
   Caufour PS, 2001, VIRUS RES, V79, P1, DOI 10.1016/S0168-1702(01)00273-8
   CHAMBERS TJ, 1990, P NATL ACAD SCI USA, V87, P8898, DOI 10.1073/pnas.87.22.8898
   CHU PWG, 1985, VIROLOGY, V140, P68, DOI 10.1016/0042-6822(85)90446-5
   Co MDT, 2002, VIROLOGY, V293, P151, DOI 10.1006/viro.2001.1255
   Cocquerel L, 2000, J VIROL, V74, P3623, DOI 10.1128/JVI.74.8.3623-3633.2000
   De Beeck AO, 2004, J VIROL, V78, P12591, DOI 10.1128/JVI.78.22.12591-12602.2004
   De Beeck AO, 2003, J VIROL, V77, P813, DOI 10.1128/JVI.77.2.813-820.2003
   Galler R, 2001, VIROLOGY, V290, P309, DOI 10.1006/viro.2001.1168
   Guirakhoo F, 2006, HUM VACCINES, V2, P60, DOI 10.4161/hv.2.2.2555
   Harvey TJ, 2004, J VIROL, V78, P531, DOI [10.1128/JVI.78.1.531-538.2004, 10.1128/JVI.78.22.12225-12235.2004]
   Higy M, 2004, BIOCHEMISTRY-US, V43, P12716, DOI 10.1021/bi048368m
   Jones CT, 2005, VIROLOGY, V331, P247, DOI 10.1016/j.virol.2004.10.034
   Lai Ching-Juh, 2003, Adv Virus Res, V61, P469, DOI 10.1016/S0065-3527(03)61013-4
   Lefeuvre A, 2006, MICROBES INFECT, V8, P1530, DOI 10.1016/j.micinf.2006.01.013
   Lobigs M, 2004, J VIROL, V78, P178, DOI 10.1128/JVI.78.1.178-186.2004
   Lorenz IC, 2003, J VIROL, V77, P4370, DOI 10.1128/JVI.77.7.4370-4382.2003
   MacKenzie JM, 2001, J VIROL, V75, P10787, DOI 10.1128/JVI.75.22.10787-10799.2001
   Marchevsky RS, 2003, VIROLOGY, V316, P55, DOI 10.1016/S0042-6822(03)00583-X
   MARCHEVSKY RS, 1995, AM J TROP MED HYG, V52, P75, DOI 10.4269/ajtmh.1995.52.75
   Mason PW, 2006, VIROLOGY, V351, P432, DOI 10.1016/j.virol.2006.04.003
   McAllister A, 2000, J VIROL, V74, P9197, DOI 10.1128/JVI.74.19.9197-9205.2000
   Monath T. P, 2004, VACCINES, P1095
   Mukhopadhyay S, 2005, NAT REV MICROBIOL, V3, P13, DOI 10.1038/nrmicro1067
   Mutebi JP, 2004, J VIROL, V78, P9652, DOI 10.1128/JVI.78.18.9652-9665.2004
   Nielsen H, 1997, PROTEIN ENG, V10, P1, DOI 10.1093/protein/10.1.1
   Pierson TC, 2005, VIROLOGY, V334, P28, DOI 10.1016/j.virol.2005.01.021
   POST PR, 1991, VIRUS RES, V18, P291, DOI 10.1016/0168-1702(91)90025-Q
   Pugachev KV, 2005, CURR OPIN INFECT DIS, V18, P387, DOI 10.1097/01.qco.0000178823.28585.ad
   Querec T, 2006, J EXP MED, V203, P413, DOI 10.1084/jem.20051720
   REY FA, 1995, NATURE, V375, P291, DOI 10.1038/375291a0
   RICE C M, 1989, New Biologist, V1, P285
   Tannis LL, 2005, VACCINE, V23, P4189, DOI 10.1016/j.vaccine.2005.04.005
   Tao D, 2005, J EXP MED, V201, P201, DOI 10.1084/jem.20041526
   van der Most RG, 2002, VIROLOGY, V296, P117, DOI 10.1006/viro.2002.1432
   Van Epps HL, 2005, J EXP MED, V201, P165, DOI 10.1084/jem.20042565
   Westaway EG, 2003, ADV VIRUS RES, V59, P99, DOI 10.1016/S0065-3527(03)59004-2
   *WHO EXP COMM BIOL, 1998, WHO TECH REP SER, V872, pR1
   Yu CY, 2006, J VIROL, V80, P11868, DOI 10.1128/JVI.00879-06
   Zhang W, 2003, NAT STRUCT BIOL, V10, P907, DOI 10.1038/nsb990
NR 45
TC 41
Z9 45
U1 0
U2 0
PU BMC
PI LONDON
PA CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
SN 1743-422X
J9 VIROL J
JI Virol. J.
PD OCT 30
PY 2007
VL 4
AR 115
DI 10.1186/1743-422X-4-115
PG 16
WC Virology
SC Virology
GA 250AK
UT WOS:000252272200002
PM 17971212
OA DOAJ Gold, Green Published
DA 2020-12-01
ER

PT J
AU Freire, MS
   Marchevsky, RS
   Almeida, LFC
   Yamamura, AMY
   Caride, EC
   Brindeiro, PA
   Motta, MCA
   Nogueira, RMR
   Kubelka, CF
   Bonaldo, MC
   Galler, R
AF Freire, M. S.
   Marchevsky, R. S.
   Almeida, L. F. C.
   Yamamura, A. M. Y.
   Caride, E. C.
   Brindeiro, P. A.
   Motta, M. C. A.
   Nogueira, R. M. R.
   Kubelka, C. F.
   Bonaldo, M. C.
   Galler, R.
TI Wild dengue virus types 1, 2 and 3 viremia in rhesus monkeys
SO MEMORIAS DO INSTITUTO OSWALDO CRUZ
LA English
DT Article
DE flaviviruses; dengue virus; infectivity; rhesus monkeys
ID CLINICAL LABORATORY RESPONSES; DOG KIDNEY-CELLS; YELLOW-FEVER;
   NEUTRALIZING ANTIBODY; VACCINE FORMULATIONS; HEMORRHAGIC-FEVER;
   NONHUMAN-PRIMATES; DNA VACCINE; IMMUNOGENICITY; RECOMBINANT
AB Among the flaviviruses, dengue, with its four serotypes, has spread throughout the tropics. The most advanced vaccines developed so far include live attenuated viruses, which have been tested in humans but none has been licensed. Preclinical testing of dengue vaccine candidates is performed initially in mice and in nonhuman primates. In the latter the main criteria used to assay protection are neutralizing antibodies elicited by the vaccine candidate and the magnitude and duration of peripheral viremia upon challenge of previously immunized animals. Towards the identification of wild-type viruses that could be used in challenge experiments a total of 31 rhesus monkeys were inoculated subcutaneously of wild dengue types 1, 2, and 3 viruses. The viremia caused by the different viruses was variable but it was possible to identify dengue viruses useful as challenge strains.
C1 Fiocruz MS, Inst Oswaldo Cruz, Dept Virol, Inst Tecnol Imunobiol, BR-21040900 Rio De Janeiro, Brazil.
   Fiocruz MS, Inst Oswaldo Cruz, Dept Bioquim & Biol Mol, BR-21040900 Rio De Janeiro, Brazil.
RP Galler, R (corresponding author), Fiocruz MS, Inst Oswaldo Cruz, Dept Virol, Inst Tecnol Imunobiol, Av Brasil 4365, BR-21040900 Rio De Janeiro, Brazil.
EM rgaller@bio.fiocruz.br
RI Bonaldo, Myrna C/D-9494-2013; Kubelka, Claire F/C-5558-2009; Galler,
   Ricardo/B-3280-2014
OI Marchevsky, Renato/0000-0003-1174-3902
CR Abu Al-Soud W, 2000, J CLIN MICROBIOL, V38, P345
   Angsubhakorn Subhkij, 1994, Southeast Asian Journal of Tropical Medicine and Public Health, V25, P554
   Bente Dennis A, 2006, Drug Discov Today Dis Models, V3, P97, DOI 10.1016/j.ddmod.2006.03.014
   Bhamarapravati N, 2000, VACCINE, V18, P44, DOI 10.1016/S0264-410X(00)00040-2
   Blaney JE, 2005, J VIROL, V79, P5516, DOI 10.1128/JVI.79.9.5516-5528.2005
   Butrapet Siritorn, 2002, Southeast Asian Journal of Tropical Medicine and Public Health, V33, P589
   Caufour PS, 2001, VIRUS RES, V79, P1, DOI 10.1016/S0168-1702(01)00273-8
   De Simone TS, 2004, T ROY SOC TROP MED H, V98, P553, DOI 10.1016/j.trstmh.2003.09.003
   Eckels KH, 2003, AM J TROP MED HYG, V69, P12, DOI 10.4269/ajtmh.2003.69.12
   Edelman R, 2003, AM J TROP MED HYG, V69, P48, DOI 10.4269/ajtmh.2003.69.48
   Galler R, 2005, BRAZ J MED BIOL RES, V38, P1835, DOI 10.1590/S0100-879X2005001200012
   Goncalvez AP, 2002, VIROLOGY, V303, P110, DOI 10.1006/viro.2002.1686
   Green S, 2006, CURR OPIN INFECT DIS, V19, P429, DOI 10.1097/01.qco.0000244047.31135.fa
   Gubler DJ, 2004, COMP IMMUNOL MICROB, V27, P319, DOI 10.1016/j.cimid.2004.03.013
   Guirakhoo F, 2004, J VIROL, V78, P4761, DOI 10.1128/JVI.78.9.4761-4775.2004
   Guirakhoo F, 2002, VIROLOGY, V298, P146, DOI 10.1006/viro.2002.1462
   HALSTEAD SB, 1973, J INFECT DIS, V128, P15, DOI 10.1093/infdis/128.1.15
   Halstead SB, 2003, AM J TROP MED HYG, V69, P5
   HALSTEAD SB, 1973, J INFECT DIS, V128, P7, DOI 10.1093/infdis/128.1.7
   HAMMON WM, 1960, SCIENCE, V131, P1102, DOI 10.1126/science.131.3407.1102
   Hanley KA, 2004, VACCINE, V22, P3440, DOI 10.1016/j.vaccine.2004.02.031
   Houng HSH, 2001, J VIROL METHODS, V95, P19, DOI 10.1016/S0166-0934(01)00280-4
   Mateu GP, 2007, T ROY SOC TROP MED H, V101, P289, DOI 10.1016/j.trstmh.2006.08.006
   Miagostovich Marize P., 2003, Rev. Inst. Med. trop. S. Paulo, V45, P17, DOI 10.1590/S0036-46652003000100004
   Monath TP, 1996, FLAVIVIRUSES
   MONATH TP, 2003, YELLOW FEVER VACCINE
   NOGUEIRA RMR, 1991, MEM I OSWALDO CRUZ, V86, P269, DOI 10.1590/S0074-02761991000200018
   Poersch CD, 2005, J CLIN VIROL, V32, P272, DOI 10.1016/j.jcv.2004.08.008
   Raviprakash K, 2003, VIROLOGY, V315, P345, DOI 10.1016/S0042-6822(03)00542-7
   Raviprakash K, 2006, VIROLOGY, V353, P166, DOI 10.1016/j.virol.2006.05.005
   Rico-Hesse R, 2003, ADV VIRUS RES, V59, P315, DOI 10.1016/S0065-3527(03)59009-1
   RicoHesse R, 1997, VIROLOGY, V230, P244, DOI 10.1006/viro.1997.8504
   Sabchareon A, 2004, PEDIATR INFECT DIS J, V23, P99, DOI 10.1097/01.inf.0000109289.55856.27
   Sabchareon A, 2002, AM J TROP MED HYG, V66, P264, DOI 10.4269/ajtmh.2002.66.264
   Sun W, 2003, AM J TROP MED HYG, V69, P24
   Sun W, 2006, J INFECT DIS, V193, P1658, DOI 10.1086/503372
NR 36
TC 18
Z9 18
U1 0
U2 1
PU FUNDACO OSWALDO CRUZ
PI RIO DE JANEIRO, RJ
PA AV BRASIL 4365, 21045-900 RIO DE JANEIRO, RJ, BRAZIL
SN 0074-0276
EI 1678-8060
J9 MEM I OSWALDO CRUZ
JI Mem. Inst. Oswaldo Cruz
PD MAY 31
PY 2007
VL 102
IS 2
BP 203
EP 208
DI 10.1590/S0074-02762007005000011
PG 6
WC Parasitology; Tropical Medicine
SC Parasitology; Tropical Medicine
GA 172KD
UT WOS:000246802300013
PM 17426886
OA DOAJ Gold, Green Published
DA 2020-12-01
ER

PT J
AU Mateu, GP
   Marchevsky, RS
   Liprandi, F
   Bonaldo, MC
   Coutinho, ESF
   Dieudonne, M
   Caride, E
   Jabor, AV
   Freire, MS
   Galler, R
AF Mateu, G. P.
   Marchevsky, R. S.
   Liprandi, F.
   Bonaldo, M. C.
   Coutinho, E. S. F.
   Dieudonne, M.
   Caride, E.
   Jabor, A. V.
   Freire, M. S.
   Galler, R.
TI Construction and biological properties of yellow fever 17D/dengue type 1
   recombinant virus
SO TRANSACTIONS OF THE ROYAL SOCIETY OF TROPICAL MEDICINE AND HYGIENE
LA English
DT Article
DE yellow fever; dengue; envelope gene; attenuation; vaccine
ID ATTENUATED DENGUE VACCINES; NONHUMAN-PRIMATES; ENVELOPE PROTEIN;
   IMMUNOGENICITY; SAFETY; NEUROVIRULENCE; CANDIDATE; GLYCOSYLATION;
   ENCEPHALITIS; VOLUNTEERS
AB Dengue virus, a mosquito-borne flavivirus, is one of the most formidable public health threats in tropical and subtropical regions. As yet, there is no licensed vaccine to protect against the disease. A chimeric yellow fever (YF) 17D/dengue (DEN) type 1 virus was constructed by replacing the pre-membrane and envelope genes of YF 17D virus with those from DEN 1 VeMir95 virus, a Venezuelan isolate. The chimeric YF 17D/DEN 1 VeMir95 virus was regenerated from full-length infectious clones stably propagated in Escherichia coli by transfection of Vero cells with in vitro transcribed RNA. The chimeric virus proliferated efficiently in Vero cells (similar to 6.6log(10) plaque-forming units/ml). The chimeric virus was not neurovirulent to 3-week-old Swiss Webster mice inoculated by the intracerebral route, in contrast to the YF 17DD vaccine strain that was lethal for 90% of the mice. The YF 17D/DEN 1 virus at Passage 6 was more attenuated for rhesus monkeys than the YF 17DD commercial vaccine after intracerebral inoculation according to the standard neurovirulence test. This virus is a potential candidate to be included in a tetravalent DEN vaccine formulation. The availability of the cloned cDNA allows further structure/function studies on the viral envelope. (c) 2006 Royal Society of Tropical Medicine and Hygiene. Published by Elsevier Ltd. All rights reserved.
C1 Fundacao Oswaldo Cruz, Dept Bioquim & Biol Mol, BR-21045900 Rio De Janeiro, RJ, Brazil.
   IVIC, Caracas, Venezuela.
   Fundacao Oswaldo Cruz, Inst Tecnol Imunobiol, Dept Desenvolvimento Tecnol, Rio De Janeiro, Brazil.
   Escola Nacl Saude Publica, Rio De Janeiro, Brazil.
RP Galler, R (corresponding author), Fundacao Oswaldo Cruz, Dept Bioquim & Biol Mol, Ave Brasil 4365, BR-21045900 Rio De Janeiro, RJ, Brazil.
EM rgaller@bio.fiocruz.br
RI Coutinho, Evandro S/E-2408-2011; Galler, Ricardo/B-3280-2014; Bonaldo,
   Myrna C/D-9494-2013
OI Marchevsky, Renato/0000-0003-1174-3902
CR ANGSUBHAKORN S, 1988, T ROY SOC TROP MED H, V82, P746, DOI 10.1016/0035-9203(88)90224-6
   Angsubhakorn Subhkij, 1994, Southeast Asian Journal of Tropical Medicine and Public Health, V25, P554
   Bonaldo MC, 2002, J MOL BIOL, V315, P873, DOI 10.1006/jmbi.2001.5258
   BURKE DS, 1988, AM J TROP MED HYG, V38, P172, DOI 10.4269/ajtmh.1988.38.172
   BURKE DS, 2001, FIELDS VIROLOGY, P1049
   CALISHER CH, 1989, J GEN VIROL, V70, P37, DOI 10.1099/0022-1317-70-1-37
   Caufour PS, 2001, VIRUS RES, V79, P1, DOI 10.1016/S0168-1702(01)00273-8
   Durbin AP, 2001, AM J TROP MED HYG, V65, P405, DOI 10.4269/ajtmh.2001.65.405
   Edelman R, 2003, AM J TROP MED HYG, V69, P48, DOI 10.4269/ajtmh.2003.69.48
   Galler R, 2001, VIROLOGY, V290, P309, DOI 10.1006/viro.2001.1168
   Goncalvez AP, 2002, VIROLOGY, V303, P110, DOI 10.1006/viro.2002.1686
   Guirakhoo F, 2004, J VIROL, V78, P9998, DOI 10.1128/JVI.78.18.9998-10008.2004
   Guirakhoo F, 2004, J VIROL, V78, P4761, DOI 10.1128/JVI.78.9.4761-4775.2004
   Guirakhoo F, 2002, VIROLOGY, V298, P146, DOI 10.1006/viro.2002.1462
   Guirakhoo F, 2001, J VIROL, V75, P7290, DOI 10.1128/JVI.75.16.7290-7304.2001
   HALSTEAD SB, 1988, SCIENCE, V239, P476, DOI 10.1126/science.3277268
   Hommel D, 1998, RES VIROLOGY, V149, P235, DOI 10.1016/S0923-2516(98)80005-8
   Huang CYH, 2000, J VIROL, V74, P3020, DOI 10.1128/JVI.74.7.3020-3028.2000
   JOHNSON AJ, 1994, VIROLOGY, V203, P241, DOI 10.1006/viro.1994.1481
   Kanesa-Thasan N, 2003, AM J TROP MED HYG, V69, P17, DOI 10.4269/ajtmh.2003.69.17
   Kanesa-thasan N, 2001, VACCINE, V19, P3179, DOI 10.1016/S0264-410X(01)00020-2
   KLIKS SC, 1989, AM J TROP MED HYG, V40, P444, DOI 10.4269/ajtmh.1989.40.444
   Lai Ching-Juh, 2003, Adv Virus Res, V61, P469, DOI 10.1016/S0065-3527(03)61013-4
   Leão Raimundo N.Q., 2002, Rev. Soc. Bras. Med. Trop., V35, P401, DOI 10.1590/S0037-86822002000400018
   LEVENBOOK IS, 1987, J BIOL STAND, V15, P305, DOI 10.1016/S0092-1157(87)80003-3
   Lum LCS, 1996, AM J TROP MED HYG, V54, P256, DOI 10.4269/ajtmh.1996.54.256
   Marchevsky RS, 2006, BIOLOGICALS, V34, P191, DOI 10.1016/j.biologicals.2005.09.005
   Marchevsky RS, 2003, VIROLOGY, V316, P55, DOI 10.1016/S0042-6822(03)00583-X
   Modis Y, 2003, P NATL ACAD SCI USA, V100, P6986, DOI 10.1073/pnas.0832193100
   MONATH TP, 2003, YELLOW FEVER VACCINE
   NATHANSON N, 1966, AM J EPIDEMIOL, V84, P524, DOI 10.1093/oxfordjournals.aje.a120664
   NEUGOONPIPAT A, 2004, VIROLOGY, V329, P505
   POST PR, 1992, VIROLOGY, V188, P160, DOI 10.1016/0042-6822(92)90745-B
   Pugachev KV, 2004, J VIROL, V78, P1032, DOI 10.1128/JVI.78.2.1032-1038.2004
   RICE C M, 1989, New Biologist, V1, P285
   RICE CM, 1996, FIELDS VIROLOGY, P931
   Rico-Hesse R, 2003, ADV VIRUS RES, V59, P315, DOI 10.1016/S0065-3527(03)59009-1
   Rigau-Perez JG, 1998, LANCET, V352, P971, DOI 10.1016/S0140-6736(97)12483-7
   Rothman Alan L., 1997, P245
   Ruggli N, 1996, J VIROL, V70, P3478, DOI 10.1128/JVI.70.6.3478-3487.1996
   Sabchareon A, 2004, PEDIATR INFECT DIS J, V23, P99, DOI 10.1097/01.inf.0000109289.55856.27
   Sabchareon A, 2002, AM J TROP MED HYG, V66, P264, DOI 10.4269/ajtmh.2002.66.264
   Saluzzo Jean-Francois, 2003, Adv Virus Res, V61, P419, DOI 10.1016/S0065-3527(03)61011-0
   Sun W, 2003, AM J TROP MED HYG, V69, P24
   *WHO, 1998, TECHN REP SER WHO, V872, P31
   WHO. World Health Organization, 2002, DENG DENG HAEM FEV
   Zhang W, 2003, NAT STRUCT BIOL, V10, P907, DOI 10.1038/nsb990
NR 47
TC 10
Z9 13
U1 1
U2 4
PU OXFORD UNIV PRESS
PI OXFORD
PA GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND
SN 0035-9203
EI 1878-3503
J9 T ROY SOC TROP MED H
JI Trans. Roy. Soc. Trop. Med. Hyg.
PD MAR
PY 2007
VL 101
IS 3
BP 289
EP 298
DI 10.1016/j.trstmh.2006.08.006
PG 10
WC Public, Environmental & Occupational Health; Tropical Medicine
SC Public, Environmental & Occupational Health; Tropical Medicine
GA 135CE
UT WOS:000244130600013
PM 17169387
DA 2020-12-01
ER

PT J
AU Bonaldo, MC
   Garratt, RC
   Freire, MS
   Galler, R
AF Bonaldo, MC
   Garratt, RC
   Freire, MS
   Galler, R
TI Expression of foreign protein epitopes at the surface of recombinant
   yellow fever 17D viruses based on three-dimensional modeling of its
   envelope protein
SO CELL BIOCHEMISTRY AND BIOPHYSICS
LA English
DT Article; Proceedings Paper
CT 1st Latin-American-Protein-Society Meeting
CY NOV 08-12, 2004
CL Angra dos Reis, BRAZIL
SP Latin Amer Protein Soc
DE yellow fever 17D virus; E protein structure; foreign epitope expression;
   attenuation
ID T-CELL RESPONSE; DENGUE VIRUS; DOMAIN-III; MULTIPLE EPITOPES; B-CELL;
   IMMUNOGENICITY; GLYCOPROTEIN; FUSION; SEQUENCES; PEPTIDE
AB The yellow fever (YF) 17D vaccine is a live attenuated virus, and its genetic manipulation constitutes a new platform for vaccine development. In this article, we review one of the possible approaches to enable this development, which is the insertion of foreign protein epitopes into different locations of the genome. We describe the three-dimensional (3D) modeling of the YF 17D virus E protein structure based on tick-borne encephalitis (TBE) and the identification of a potential insertion site located at the YF 17D fg loop. Further 3D analysis revealed that it is possible to accommodate inserts of different sizes and amino acid composition in the flavivirus E protein fg loop. We demonstrate that seven YF 17D viruses bearing foreign epitopes that vary in sequence and length show differential growth characteristics in cell culture. The testing of recombinant viruses for mouse neurovirulence suggests that insertions at the 17D E protein fg loop do not compromise the attenuated phenotype of YF 17D virus, further confirming the potential use of this site for the development of new live attenuated 17D virus-based vaccines.
C1 Inst Oswaldo Cruz, Dept Bioquim & Biol Mol, Fdn Oswaldo Cruz, BR-20001 Rio De Janeiro, Brazil.
   Univ Sao Paulo, Inst Fis Sao Carlos, BR-13560 Sao Carlos, Brazil.
   Fundacao Oswaldo Cruz, Dept Desenvolvimento Tecnol, Inst Tecnol Imunobiol, Rio De Janeiro, Brazil.
RP Bonaldo, MC (corresponding author), Inst Oswaldo Cruz, Dept Bioquim & Biol Mol, Fdn Oswaldo Cruz, BR-20001 Rio De Janeiro, Brazil.
EM mbonaldo@ioc.fiocruz.br
RI garratt, richard c/F-6921-2011; Bonaldo, Myrna C/D-9494-2013; Galler,
   Ricardo/B-3280-2014
CR Allison SL, 2001, J VIROL, V75, P4268, DOI 10.1128/JVI.75.9.4268-4275.2001
   Avall-Jaaskelainen S, 2002, APPL ENVIRON MICROB, V68, P5943, DOI 10.1128/AEM.68.12.5943-5951.2002
   BARTON GJ, 1987, J MOL BIOL, V198, P327, DOI 10.1016/0022-2836(87)90316-0
   Beasley DWC, 2002, J VIROL, V76, P13097, DOI 10.1128/JVI.76.24.13097-13100.2002
   Bendahmane M, 1999, J MOL BIOL, V290, P9, DOI 10.1006/jmbi.1999.2860
   Birkett A, 2002, INFECT IMMUN, V70, P6860, DOI 10.1128/IAI.70.12.6860-6870.2002
   Bonaldo MC, 2002, J MOL BIOL, V315, P873, DOI 10.1006/jmbi.2001.5258
   BOWIE JU, 1991, SCIENCE, V253, P164, DOI 10.1126/science.1853201
   BRAUN W, 1985, J MOL BIOL, V186, P611, DOI 10.1016/0022-2836(85)90134-2
   Bressanelli S, 2004, EMBO J, V23, P728, DOI 10.1038/sj.emboj.7600064
   Caufour PS, 2001, VIRUS RES, V79, P1, DOI 10.1016/S0168-1702(01)00273-8
   CHAMBERS TJ, 1990, ANNU REV MICROBIOL, V44, P649, DOI 10.1146/annurev.mi.44.100190.003245
   Co MDT, 2002, VIROLOGY, V293, P151, DOI 10.1006/viro.2001.1255
   Crill WD, 2001, J VIROL, V75, P7769, DOI 10.1128/JVI.75.16.7769-7773.2001
   de Vries AAF, 2000, VIROLOGY, V270, P84, DOI 10.1006/viro.2000.0245
   Eisenberg D, 1997, METHOD ENZYMOL, V277, P396, DOI 10.1016/S0076-6879(97)77022-8
   Fayolle C, 2001, J VIROL, V75, P7330, DOI 10.1128/JVI.75.16.7330-7338.2001
   Gedvilaite A, 2000, VIROLOGY, V273, P21, DOI 10.1006/viro.2000.0392
   Halim SS, 2000, VACCINE, V19, P958, DOI 10.1016/S0264-410X(00)00214-0
   Heal KG, 2000, BIOTECHNIQUES, V28, P228, DOI 10.2144/00282bm08
   Heinz FX, 2001, CURR OPIN MICROBIOL, V4, P450, DOI 10.1016/S1369-5274(00)00234-4
   Kuhn RJ, 2002, CELL, V108, P717, DOI 10.1016/S0092-8674(02)00660-8
   Lai Ching-Juh, 2003, Adv Virus Res, V61, P469, DOI 10.1016/S0065-3527(03)61013-4
   LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944
   LEMON SM, 1992, VIROLOGY, V188, P285, DOI 10.1016/0042-6822(92)90758-H
   LESZCZYNSKI JF, 1986, SCIENCE, V234, P849, DOI 10.1126/science.3775366
   LONDON SD, 1992, P NATL ACAD SCI USA, V89, P207, DOI 10.1073/pnas.89.1.207
   LUTHY R, 1992, NATURE, V356, P83, DOI 10.1038/356083a0
   Mebatsion T, 2002, J VIROL, V76, P10138, DOI 10.1128/JVI.76.20.10138-10146.2002
   Modis Y, 2003, P NATL ACAD SCI USA, V100, P6986, DOI 10.1073/pnas.0832193100
   Modis Y, 2005, J VIROL, V79, P1223, DOI 10.1128/JVI.79.2.1223-1231.2005
   Modis Y, 2004, NATURE, V427, P313, DOI 10.1038/nature02165
   Monath TP, 2003, ADV VIRUS RES, V60, P343, DOI 10.1016/S0065-3527(03)60009-6
   Moradpour D, 2004, J VIROL, V78, P7400, DOI 10.1128/JVI.78.14.7400-7409.2004
   Murr L. E., 1988, Journal of Superconductivity, V1, P3, DOI 10.1007/BF00617947
   NICHOLLS A, 1991, PROTEINS, V11, P281, DOI 10.1002/prot.340110407
   Nickells M, 2003, J VIROL, V77, P12232, DOI 10.1128/JVI.77.22.12232-12242.2003
   Pugachev KV, 2003, INT J PARASITOL, V33, P567, DOI 10.1016/S0020-7519(03)00063-8
   REY FA, 1995, NATURE, V375, P291, DOI 10.1038/375291a0
   RICE CM, 1985, SCIENCE, V229, P726, DOI 10.1126/science.4023707
   RICE CM, 1984, NEW BIOL, V1, P285
   ROSE CSP, 1991, TRENDS BIOTECHNOL, V9, P415, DOI 10.1016/0167-7799(91)90142-5
   Rothman AL, 2004, J CLIN INVEST, V113, P946, DOI 10.1172/JCI200421512
   Rothman AL, 1996, J VIROL, V70, P6540, DOI 10.1128/JVI.70.10.6540-6546.1996
   Rueda P, 1999, VIROLOGY, V263, P89, DOI 10.1006/viro.1999.9911
   SALI A, 1993, J MOL BIOL, V234, P779, DOI 10.1006/jmbi.1993.1626
   SEDLIK C, 1995, J GEN VIROL, V76, P2361, DOI 10.1099/0022-1317-76-9-2361
   Stiasny K, 1996, J VIROL, V70, P8142, DOI 10.1128/JVI.70.11.8142-8147.1996
   Takahashi D, 2001, IEEE SIGNAL PROC LET, V8, P145, DOI 10.1109/97.917698
   Ulrich R, 1999, J BIOTECHNOL, V73, P141, DOI 10.1016/S0168-1656(99)00117-0
   van der Most RG, 2002, VIROLOGY, V296, P117, DOI 10.1006/viro.2002.1432
   Volk DE, 2004, J BIOL CHEM, V279, P38755, DOI 10.1074/jbc.M402385200
   VRIEND G, 1993, J APPL CRYSTALLOGR, V26, P47, DOI 10.1107/S0021889892008240
   VRIEND G, 1990, J MOL GRAPHICS, V8, P52, DOI 10.1016/0263-7855(90)80070-V
   WALLACE AC, 1995, PROTEIN ENG, V8, P127, DOI 10.1093/protein/8.2.127
   Zhang Y, 2004, STRUCTURE, V12, P1607, DOI 10.1016/j.str.2004.06.019
NR 56
TC 8
Z9 10
U1 0
U2 0
PU HUMANA PRESS INC
PI TOTOWA
PA 999 RIVERVIEW DRIVE SUITE 208, TOTOWA, NJ 07512 USA
SN 1085-9195
EI 1559-0283
J9 CELL BIOCHEM BIOPHYS
JI Cell Biochem. Biophys.
PY 2006
VL 44
IS 3
BP 313
EP 324
DI 10.1385/CBB:44:3:313
PG 12
WC Biochemistry & Molecular Biology; Biophysics; Cell Biology
SC Biochemistry & Molecular Biology; Biophysics; Cell Biology
GA 040TR
UT WOS:000237403800001
PM 16679518
DA 2020-12-01
ER

PT J
AU Galler, R
   Marchevsky, RS
   Caride, E
   Almeida, LFC
   Yamamura, AMY
   Jabor, AV
   Motta, MCA
   Bonaldo, MC
   Coutinho, ESF
   Freire, MS
AF Galler, R
   Marchevsky, RS
   Caride, E
   Almeida, LFC
   Yamamura, AMY
   Jabor, AV
   Motta, MCA
   Bonaldo, MC
   Coutinho, ESF
   Freire, MS
TI Attenuation and immunogenicity of recombinant yellow fever 17D-dengue
   type 2 virus for rhesus monkeys
SO BRAZILIAN JOURNAL OF MEDICAL AND BIOLOGICAL RESEARCH
LA English
DT Article
DE YF 17D virus recombinants; dengue vaccine; immunogenicity; attenuation;
   rhesus monkeys
ID T-CELL RESPONSE; DENGUE VACCINE; CYNOMOLGUS MONKEYS; NONHUMAN-PRIMATES;
   ENCEPHALITIS; NEUROVIRULENCE; PROTECTION; SAFETY; IMMUNIZATION; MICE
AB A chimeric yellow fever (YF)-dengue serotype 2 (dengue 2) virus was constructed by replacing the premembrane and envelope genes of the YF 17D virus with those from dengue 2 virus strains of Southeast Asian genotype. The virus grew to high titers in Vero cells and, after passage 2, was used for immunogenicity and attenuation studies in rhesus monkeys. Subcutaneous immunization of naive rhesus monkeys with the 17D-D2 chimeric virus induced a neutralizing antibody response associated with the protection of 6 of 7 monkeys against viremia by wild-type dengue 2 virus. Neutralizing antibody titers to dengue 2 were significantly lower in YF-immune animals than in YF-naive monkeys and protection against challenge with wild-type dengue 2 virus was observed in only 2 of 11 YF-immune monkeys. An anamnestic response to dengue 2 indicated by a sharp increase of, neutralizing antibody titers, was observed in the majority of the monkeys after challenge with wild-type virus. Virus attenuation was demonstrated using the standard monkey neurovirulence test. The 17D-D2 chimera caused significantly fewer histological lesions than the YF 17DD virus. The attenuated phenotype could also be inferred from the limited viremias compared to the YF 17DD vaccine. Overall. these results provide further support for the use of chimeric viruses for the development of a new live tetravalent dengue vaccine.
C1 Fiocruz MS, Inst Oswaldo Cruz, Dept Bioquim & Biol Mol, BR-21045900 Rio De Janeiro, Brazil.
   Escola Nacl Saude Publica, Rio De Janeiro, Brazil.
   Inst Tecnol Imunobiol, Dept Desenvolvimento Tecnol, Rio De Janeiro, Brazil.
   Inst Tecnol Imunobiol, Dept Qualidade, Rio De Janeiro, Brazil.
RP Galler, R (corresponding author), Fiocruz MS, Inst Oswaldo Cruz, Dept Bioquim & Biol Mol, BR-21045900 Rio De Janeiro, Brazil.
EM rgaller@ioc.fiocruz.br
RI Coutinho, Evandro S/E-2408-2011; Galler, Ricardo/B-3280-2014; Bonaldo,
   Myrna C/D-9494-2013; Nogueira, Raquel Tayar/F-6475-2019
OI Nogueira, Raquel Tayar/0000-0002-0581-763X; Marchevsky,
   Renato/0000-0003-1174-3902
CR ANGSUBHAKORN S, 1986, Southeast Asian Journal of Tropical Medicine and Public Health, V17, P604
   ANGSUBHAKORN S, 1987, Southeast Asian Journal of Tropical Medicine and Public Health, V18, P52
   ANGSUBHAKORN S, 1987, J VIROL METHODS, V18, P13, DOI 10.1016/0166-0934(87)90106-6
   ANGSUBHAKORN S, 1988, T ROY SOC TROP MED H, V82, P746, DOI 10.1016/0035-9203(88)90224-6
   Angsubhakorn Subhkij, 1994, Southeast Asian Journal of Tropical Medicine and Public Health, V25, P554
   Bhamarapravati N, 2000, VACCINE, V18, P44, DOI 10.1016/S0264-410X(00)00040-2
   BRAY M, 1991, P NATL ACAD SCI USA, V88, P10342, DOI 10.1073/pnas.88.22.10342
   Caufour PS, 2001, VIRUS RES, V79, P1, DOI 10.1016/S0168-1702(01)00273-8
   Chambers TJ, 2003, J VIROL, V77, P3655, DOI 10.1128/JVI.77.6.3655-3668.2003
   Co MDT, 2002, VIROLOGY, V293, P151, DOI 10.1006/viro.2001.1255
   Edelman R, 2003, AM J TROP MED HYG, V69, P48, DOI 10.4269/ajtmh.2003.69.48
   Fox JP, 1942, AM J HYG, V36, P117, DOI 10.1093/oxfordjournals.aje.a118811
   Galler R, 2001, VIROLOGY, V290, P309, DOI 10.1006/viro.2001.1168
   Gubler Duane J., 2002, Trends in Microbiology, V10, P100, DOI 10.1016/S0966-842X(01)02288-0
   Guirakhoo F, 2000, J VIROL, V74, P5477, DOI 10.1128/JVI.74.12.5477-5485.2000
   Guirakhoo F, 2004, J VIROL, V78, P4761, DOI 10.1128/JVI.78.9.4761-4775.2004
   Hommel D, 1998, RES VIROLOGY, V149, P235, DOI 10.1016/S0923-2516(98)80005-8
   Lai Ching-Juh, 2003, Adv Virus Res, V61, P469, DOI 10.1016/S0065-3527(03)61013-4
   Leão Raimundo N.Q., 2002, Rev. Soc. Bras. Med. Trop., V35, P401, DOI 10.1590/S0037-86822002000400018
   LEVENBOOK IS, 1987, J BIOL STAND, V15, P305, DOI 10.1016/S0092-1157(87)80003-3
   Lum LCS, 1996, AM J TROP MED HYG, V54, P256, DOI 10.4269/ajtmh.1996.54.256
   Marchevsky RS, 2003, VIROLOGY, V316, P55, DOI 10.1016/S0042-6822(03)00583-X
   Monath TP, 1996, FIELDS VIROLOGY, P961
   MONATH TP, 2003, YELLOW FEVER VACCINE
   NATHANSON N, 1966, AM J EPIDEMIOL, V84, P524, DOI 10.1093/oxfordjournals.aje.a120664
   Pugachev KV, 2003, INT J PARASITOL, V33, P567, DOI 10.1016/S0020-7519(03)00063-8
   RICE CM, 1985, SCIENCE, V229, P726, DOI 10.1126/science.4023707
   RicoHesse R, 1997, VIROLOGY, V230, P244, DOI 10.1006/viro.1997.8504
   Rothman AL, 2004, J CLIN INVEST, V113, P946, DOI 10.1172/JCI200421512
   Sabchareon A, 2004, PEDIATR INFECT DIS J, V23, P99, DOI 10.1097/01.inf.0000109289.55856.27
   Sabchareon A, 2002, AM J TROP MED HYG, V66, P264, DOI 10.4269/ajtmh.2002.66.264
   SCHLESINGER JJ, 1993, VIROLOGY, V192, P132, DOI 10.1006/viro.1993.1015
   SCHLESINGER JJ, 1985, J IMMUNOL, V135, P2805
   SCHLESINGER JJ, 1986, J VIROL, V60, P1153, DOI 10.1128/JVI.60.3.1153-1155.1986
   Stefano I, 1999, VACCINE, V17, P1042, DOI 10.1016/S0264-410X(98)00320-X
   Sun W, 2003, AM J TROP MED HYG, V69, P24
   Van Der Most RG, 2000, J VIROL, V74, P8094, DOI 10.1128/JVI.74.17.8094-8101.2000
   van der Most RG, 2002, VIROLOGY, V296, P117, DOI 10.1006/viro.2002.1432
   *WHO, 1998, WHO TECH REP SER, V872, P31
NR 39
TC 20
Z9 22
U1 0
U2 2
PU ASSOC BRAS DIVULG CIENTIFICA
PI SAO PAULO
PA FACULDADE MEDICINA, SALA 21, 14049 RIBEIRAO PRETO, SAO PAULO, BRAZIL
SN 0100-879X
J9 BRAZ J MED BIOL RES
JI Brazilian J. Med. Biol. Res.
PD DEC
PY 2005
VL 38
IS 12
BP 1835
EP 1846
DI 10.1590/S0100-879X2005001200012
PG 12
WC Biology; Medicine, Research & Experimental
SC Life Sciences & Biomedicine - Other Topics; Research & Experimental
   Medicine
GA 990LC
UT WOS:000233743500012
PM 16302098
OA DOAJ Gold
DA 2020-12-01
ER

PT J
AU Bonaldo, MC
   Garratt, RC
   Marchevsky, RS
   Coutinho, ESF
   Jabor, AV
   Almeida, LFC
   Yamamura, AMY
   Duarte, AS
   Oliveira, PJ
   Lizeu, JOP
   Camacho, LAB
   Freire, MS
   Galler, R
AF Bonaldo, MC
   Garratt, RC
   Marchevsky, RS
   Coutinho, ESF
   Jabor, AV
   Almeida, LFC
   Yamamura, AMY
   Duarte, AS
   Oliveira, PJ
   Lizeu, JOP
   Camacho, LAB
   Freire, MS
   Galler, R
TI Attenuation of recombinant yellow fever 17D viruses expressing foreign
   protein epitopes at the surface
SO JOURNAL OF VIROLOGY
LA English
DT Article
ID BORNE ENCEPHALITIS-VIRUS; ENVELOPE GLYCOPROTEIN; MEMBRANE-FUSION;
   RHESUS-MONKEYS; VACCINE VIRUS; NEUROVIRULENCE; SAFETY; PROTECTION;
   MODEL; MICE
AB The yellow fever (YF) 17D vaccine is a live attenuated virus. Three-dimensional (3D) homology modeling of the E protein structure from YF 17D virus and its comparison with that from tick-borne encephalitis virus revealed that it is possible to accommodate inserts of different sizes and amino acid compositions in the flavivirus E protein fg loop. This is consistent with the 3D structures of both the dimeric and trimeric forms in which the fg loop lies exposed to solvents. We demonstrate here that YF 17D viruses bearing foreign Immoral (17D/8) and T-cell (17D/13) epitopes, which vary in sequence and length, displayed growth restriction. It is hypothesized that interference with the dimer-trimer transition and with the formation of a ring of such trimers in order to allow fusion compromises the capability of the E protein to induce fusion of viral and endosomal membranes, and a slower rate of fusion may delay the extent of virus production. This would account for the lower levels of replication in cultured cells and of viremia in monkeys, as well as for the more attenuated phenotype of the recombinant viruses in monkeys. Testing of both recombinant viruses (17D/8 and 17D/13) for monkey neurovirulence also suggests that insertion at the 17D E protein fg loop does not compromise the attenuated phenotype of YF 17D virus, further confirming the potential use of this site for the development of new live attenuated 17D virus-based vaccines.
C1 Fundacao Oswaldo Cruz, Dept Bioquim & Biol Mol, BR-21040900 Rio De Janeiro, Brazil.
   Escola Nacl Saude Publica, Rio De Janeiro, Brazil.
   Univ Sao Paulo, Inst Fis Sao Carlos, Sao Carlos, SP, Brazil.
RP Galler, R (corresponding author), Fundacao Oswaldo Cruz, Dept Bioquim & Biol Mol, Ave Brasil 4365, BR-21040900 Rio De Janeiro, Brazil.
EM rgaller@ioc.fiocruz.br
RI Bonaldo, Myrna C/D-9494-2013; Galler, Ricardo/B-3280-2014; garratt,
   richard c/F-6921-2011; Coutinho, Evandro S/E-2408-2011; Nogueira, Raquel
   Tayar/F-6475-2019
OI Nogueira, Raquel Tayar/0000-0002-0581-763X; Marchevsky,
   Renato/0000-0003-1174-3902
CR Bonaldo MC, 2002, J MOL BIOL, V315, P873, DOI 10.1006/jmbi.2001.5258
   Bressanelli S, 2004, EMBO J, V23, P728, DOI 10.1038/sj.emboj.7600064
   Caufour PS, 2001, VIRUS RES, V79, P1, DOI 10.1016/S0168-1702(01)00273-8
   Fox JP, 1942, AM J HYG, V36, P117, DOI 10.1093/oxfordjournals.aje.a118811
   Galler R, 2001, VIROLOGY, V290, P309, DOI 10.1006/viro.2001.1168
   Gibbons DL, 2003, CELL, V114, P573, DOI 10.1016/S0092-8674(03)00683-4
   Guirakhoo F, 2004, J VIROL, V78, P9998, DOI 10.1128/JVI.78.18.9998-10008.2004
   Guirakhoo F, 2004, J VIROL, V78, P4761, DOI 10.1128/JVI.78.9.4761-4775.2004
   HOLZMANN H, 1995, ARCH VIROL, V140, P213, DOI 10.1007/BF01309857
   Lai Ching-Juh, 2003, Adv Virus Res, V61, P469, DOI 10.1016/S0065-3527(03)61013-4
   LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944
   LEVENBOOK IS, 1987, J BIOL STAND, V15, P305, DOI 10.1016/S0092-1157(87)80003-3
   LUTHY R, 1992, NATURE, V356, P83, DOI 10.1038/356083a0
   MANDL CW, 1989, J VIROL, V63, P564, DOI 10.1128/JVI.63.2.564-571.1989
   Marchevsky RS, 2003, VIROLOGY, V316, P55, DOI 10.1016/S0042-6822(03)00583-X
   MARCHEVSKY RS, 1995, AM J TROP MED HYG, V52, P75, DOI 10.4269/ajtmh.1995.52.75
   Modis Y, 2003, P NATL ACAD SCI USA, V100, P6986, DOI 10.1073/pnas.0832193100
   Modis Y, 2004, NATURE, V427, P313, DOI 10.1038/nature02165
   Monath TP, 2000, J VIROL, V74, P1742, DOI 10.1128/JVI.74.4.1742-1751.2000
   MONATH TP, 2003, YELLOW FEVER VACCINE
   Rey FA, 2003, P NATL ACAD SCI USA, V100, P6899, DOI 10.1073/pnas.1332695100
   REY FA, 1995, NATURE, V375, P291, DOI 10.1038/375291a0
   RICE C M, 1989, New Biologist, V1, P285
   RICE CM, 1985, SCIENCE, V229, P726, DOI 10.1126/science.4023707
   SALI A, 1993, J MOL BIOL, V234, P779, DOI 10.1006/jmbi.1993.1626
   Stefano I, 1999, VACCINE, V17, P1042, DOI 10.1016/S0264-410X(98)00320-X
   Tao D, 2005, J EXP MED, V201, P201, DOI 10.1084/jem.20041526
   Tsuji M, 1998, J VIROL, V72, P6907, DOI 10.1128/JVI.72.8.6907-6910.1998
   VRIEND G, 1990, J MOL GRAPHICS, V8, P52, DOI 10.1016/0263-7855(90)80070-V
   *WHO, 1998, WHO TECH REP SER, V872, P31
NR 30
TC 16
Z9 23
U1 0
U2 1
PU AMER SOC MICROBIOLOGY
PI WASHINGTON
PA 1752 N ST NW, WASHINGTON, DC 20036-2904 USA
SN 0022-538X
EI 1098-5514
J9 J VIROL
JI J. Virol.
PD JUL
PY 2005
VL 79
IS 13
BP 8602
EP 8613
DI 10.1128/JVI.79.13.8602-8613.2005
PG 12
WC Virology
SC Virology
GA 936PA
UT WOS:000229866700061
PM 15956601
OA Green Published, Bronze
DA 2020-12-01
ER

PT J
AU Soares, RMD
   dos Santos, ALS
   Bonaldo, MC
   de Andrade, AFB
   Alviano, CS
   Angluster, J
   Goldenberg, S
AF Soares, RMD
   dos Santos, ALS
   Bonaldo, MC
   de Andrade, AFB
   Alviano, CS
   Angluster, J
   Goldenberg, S
TI Leishmania (Leishmania) amazonensis: differential expression of
   proteinases and cell-surface polypeptides in avirulent and virulent
   promastigotes
SO EXPERIMENTAL PARASITOLOGY
LA English
DT Article
DE cell-surface protein; Leishmania (L.) amazonensis; protemases;
   promastigotes; trypanosomatid; virulence; BSA; bovine serum albumin;
   CRD; cross-reacting determinant; DTT; dithiothreitol; E-64;
   trans-epoxysuccinyl L-leucylamido-(4-guanidino) butane; EDTA;
   ethylenediaminetetraacetic acid; GPI; glycosylphosphatidylinositol; kDa;
   kilodalton; LPG; lipophosphoglycan; PLC; phospholipase C; PMSF;
   phenylmethylsulphonyl fluoride; SDS-PAGE; dodecyl sulfate
   sodium-polyacrylamide gel electrophoresis; VSG; variant surface
   glycoprotein
ID CYSTEINE PROTEINASES; METACYCLIC PROMASTIGOTES; COMPLEMENT RESISTANCE;
   PHOSPHOLIPASE-C; PROTEASE GP63; MEXICANA; METALLOPROTEASE; GENE;
   IDENTIFICATION; CARBOHYDRATE
AB A comparative study of proteolytic enzymes and cell-surface protein composition in virulent and avirulent Leishmania (Leishmania) amazonensis promastigote forms was carried out using one- and two-dimensional dodecyl sulfate sodium polyacrylamide gel electrophoresis (SDS-PAGE). The surface iodinated protein profiles showed two major polypeptides of 65-60 and 50-47 kDa that were expressed in both virulent and avirulent promastigote forms. However, minor quantitative differences were observed in the cell-surface profile between the avirulent and virulent promastigotes. These included polypeptides of 115, 52, 45, 32, and 25 kDa that were preferentially expressed in the virulent forms. Two-dimensional SDS-PAGE showed an accentuated expression of acidic polypeptides; some of them differentially expressed in the promastigote forms analyzed. Live parasites treated with glycosylphosphatidylinositol (GPI)-specific phospholipase C (PLC) from Trypanosoma brucei and immunoprecipitated with the cross-reacting determinant (CRD) antibody recognized three major polypeptides of 65-60, 52, and 50-47 kDa, hence suggesting that these peptides were anchored to the plasma membrane domains through GPI anchor. Moreover, the polypeptides of 65-60 and 52 kDa were also recognized by the gp63 antiserum. Several metalloproteinase activities were similar in both virulent and avirulent promastigote forms, whereas cysteine proteinase activities, sensitive to E-64, were preferentially expressed in virulent promastigotes. These results suggest that cell-surface polypeptides and intracellular cysteine proteinases might play an important role in the virulence of L. (L.) amazonensis. (C) 2003 Published by Elsevier Inc.
C1 Univ Brasil, Ctr Ciencias Saude, IMPPG, Dept Microbiol Geral, BR-21941590 Rio De Janeiro, RJ, Brazil.
   Fundacao Oswaldo Cruz, Dept Bioquim & Biol Mol, Rio De Janeiro, RJ, Brazil.
   Univ Estado Rio De Janeiro, Fac Ciencias Med, Disciplina Microbiol & Imunol, BR-20551030 Rio De Janeiro, RJ, Brazil.
   IBMP, BR-81350010 Parana, PR, Brazil.
RP Soares, RMD (corresponding author), Univ Brasil, Ctr Ciencias Saude, IMPPG, Dept Microbiol Geral, Bloco 1, BR-21941590 Rio De Janeiro, RJ, Brazil.
EM rasoares@micro.ufrj.br
RI Bonaldo, Myrna C/D-9494-2013; Alviano, Celuta/V-3878-2019; Santos,
   Andre/Z-5853-2019; P, CM/B-1358-2013; GOLDENBERG, SAMUEL/B-4116-2009
OI Alviano, Celuta/0000-0002-0806-6712; Santos, Andre/0000-0003-0821-8592;
   GOLDENBERG, SAMUEL/0000-0002-4892-163X
CR Alexander J, 1998, J IMMUNOL, V161, P6794
   ALFIERI SC, 1995, PARASITOL RES, V81, P240
   ANDREWS NW, 1988, J EXP MED, V167, P300, DOI 10.1084/jem.167.2.300
   BANDYOPADHYAY P, 1991, J PARASITOL, V77, P411, DOI 10.2307/3283129
   BART G, 1995, MOL BIOCHEM PARASIT, V73, P271, DOI 10.1016/0166-6851(95)00113-F
   BATES PA, 1994, J EUKARYOT MICROBIOL, V41, P199, DOI 10.1111/j.1550-7408.1994.tb01497.x
   BONALDO MC, 1991, EXP PARASITOL, V73, P44, DOI 10.1016/0014-4894(91)90006-I
   BONALDO MC, 1988, J CELL BIOL, V106, P1349, DOI 10.1083/jcb.106.4.1349
   BORDIER C, 1981, J BIOL CHEM, V256, P1604
   BOUVIER J, 1990, BIOCHEMISTRY-US, V29, P10113, DOI 10.1021/bi00495a015
   BOUVIER J, 1989, MOL BIOCHEM PARASIT, V37, P235, DOI 10.1016/0166-6851(89)90155-2
   Brittingham A, 1999, INFECT IMMUN, V67, P4477, DOI 10.1128/IAI.67.9.4477-4484.1999
   BRITTINGHAM A, 1995, J IMMUNOL, V155, P3102
   Cardoso de Almeida M. Lucia, 1993, Biological Research, V26, P285
   CHAUDHURI G, 1988, MOL BIOCHEM PARASIT, V27, P43, DOI 10.1016/0166-6851(88)90023-0
   CHAUDHURI G, 1989, J BIOL CHEM, V264, P7483
   CONNELL ND, 1993, P NATL ACAD SCI USA, V90, P11473, DOI 10.1073/pnas.90.24.11473
   Coombs Graham H., 1997, P177
   Descoteaux A, 1999, BBA-MOL BASIS DIS, V1455, P341, DOI 10.1016/S0925-4439(99)00065-4
   DeSouza W, 1995, MICRON, V26, P405, DOI 10.1016/0968-4328(95)00010-0
   ETGES RJ, 1985, MOL BIOCHEM PARASIT, V14, P141, DOI 10.1016/0166-6851(85)90033-7
   Ferguson MAJ, 1999, J CELL SCI, V112, P2799
   HERELD D, 1986, J BIOL CHEM, V261, P3813
   Hernandez A. G., 1981, The biochemistry of parasites. (Proc. Satellite Conf. of 13th Meet., Fed. Euro. Biochem. Soc. (FEBS), Jerusalem, Aug. 1980), P47
   HOWARD MK, 1987, EXP PARASITOL, V64, P147, DOI 10.1016/0014-4894(87)90138-X
   Ilgoutz SC, 2001, INT J PARASITOL, V31, P899, DOI 10.1016/S0020-7519(01)00197-7
   JAFFE CL, 1988, J PARASITOL, V74, P548, DOI 10.2307/3282170
   LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0
   MCCONVILLE MJ, 1993, BIOCHEM J, V294, P305, DOI 10.1042/bj2940305
   McGwire BS, 2002, J BIOL CHEM, V277, P8802, DOI 10.1074/jbc.M109072200
   McGwire BS, 1996, J BIOL CHEM, V271, P7903, DOI 10.1074/jbc.271.14.7903
   MEDINAACOSTA E, 1989, MOL BIOCHEM PARASIT, V37, P263, DOI 10.1016/0166-6851(89)90158-8
   MEDINAACOSTA E, 1993, MOL BIOCHEM PARASIT, V57, P31, DOI 10.1016/0166-6851(93)90241-O
   Mottram JC, 1998, CURR OPIN MICROBIOL, V1, P455, DOI 10.1016/S1369-5274(98)80065-9
   MOTTRAM JC, 1992, MOL MICROBIOL, V6, P1925, DOI 10.1111/j.1365-2958.1992.tb01365.x
   Mottram JC, 1996, P NATL ACAD SCI USA, V93, P6008, DOI 10.1073/pnas.93.12.6008
   MURRAY PJ, 1990, EXP PARASITOL, V71, P294, DOI 10.1016/0014-4894(90)90034-A
   OFARRELL PH, 1975, J BIOL CHEM, V250, P4007
   ROBERTSON CD, 1992, FEMS MICROBIOL LETT, V94, P127, DOI 10.1111/j.1574-6968.1992.tb05301.x
   Rosenthal PJ, 1999, ADV PARASIT, V43, P105, DOI 10.1016/S0065-308X(08)60242-0
   RUSSELL DG, 1989, INFECT IMMUN, V57, P630, DOI 10.1128/IAI.57.2.630-632.1989
   SACKS DL, 1985, J IMMUNOL, V135, P564
   SACKS DL, 1987, J IMMUNOL, V139, P3099
   Sakanari JA, 1997, EXP PARASITOL, V85, P63, DOI 10.1006/expr.1996.4116
   Salotra P, 2000, INT J BIOCHEM CELL B, V32, P309, DOI 10.1016/S1357-2725(99)00134-X
   SANTOS ALS, 2002, CURR MICROBIOL, V45, P293
   SANTOS ALS, 1999, CURR MICROBIOL, V39, P61
   SARAIVA EMB, 1986, EUR J CELL BIOL, V40, P219
   SCHNEIDER P, 1992, EXP PARASITOL, V75, P196, DOI 10.1016/0014-4894(92)90179-E
   Selzer PM, 1999, P NATL ACAD SCI USA, V96, P11015, DOI 10.1073/pnas.96.20.11015
   STANLEY SL, 1995, INFECT IMMUN, V63, P1587, DOI 10.1128/IAI.63.4.1587-1590.1995
   Streit JA, 2001, J IMMUNOL, V166, P1921, DOI 10.4049/jimmunol.166.3.1921
   TRAUBCSEKO YM, 1993, MOL BIOCHEM PARASIT, V57, P101, DOI 10.1016/0166-6851(93)90248-V
   VANNIERSANTOS MA, 1995, EUR J CELL BIOL, V67, P112
   VANSTRIJP JAG, 1993, J IMMUNOL, V151, P3324
   WALTERS LL, 1993, J EUKARYOT MICROBIOL, V40, P196, DOI 10.1111/j.1550-7408.1993.tb04904.x
   *WHO, 1993, 8 UNDP WHO, P77
   WILSON ME, 1989, J IMMUNOL, V143, P678
NR 58
TC 23
Z9 23
U1 0
U2 3
PU ACADEMIC PRESS INC ELSEVIER SCIENCE
PI SAN DIEGO
PA 525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA
SN 0014-4894
EI 1090-2449
J9 EXP PARASITOL
JI Exp. Parasitol.
PD JUL-AUG
PY 2003
VL 104
IS 3-4
BP 104
EP 112
DI 10.1016/S0014-4894(03)00135-8
PG 9
WC Parasitology
SC Parasitology
GA 733MZ
UT WOS:000186005900003
PM 14552857
DA 2020-12-01
ER

PT J
AU Bonaldo, MC
   Garratt, RC
   Caufour, PS
   Freire, MS
   Rodrigeus, MM
   Nussenzweig, RS
   Galler, R
AF Bonaldo, MC
   Garratt, RC
   Caufour, PS
   Freire, MS
   Rodrigeus, MM
   Nussenzweig, RS
   Galler, R
TI Surface expression of an immunodominant malaria protein B cell epitope
   by yellow fever virus
SO JOURNAL OF MOLECULAR BIOLOGY
LA English
DT Article
DE yellow fever 17D virus; E protein structure; foreign epitope expression;
   malaria vaccine
ID N-LINKED GLYCOSYLATION; FULL-LENGTH CDNA; PLASMODIUM-FALCIPARUM;
   ENVELOPE PROTEIN; CIRCUMSPOROZOITE PROTEINS; 3-DIMENSIONAL PROFILES;
   NONSTRUCTURAL PROTEIN; SECONDARY STRUCTURE; ENCEPHALITIS-VIRUS;
   NONHUMAN-PRIMATES
AB The yellow fever 17D virus (YF17D) has several characteristics that are desirable for the development of new, live attenuated vaccines. We approached its development as a vector for heterologous antigens by studying the expression of a humoral epitope at the surface of the E protein based on the results of modelling its three-dimensional structure. This model indicated that the most promising insertion site is between beta-strands f and g, a site that is exposed at the external surface of the virus. The large deletion of six residues from the fg loop of the E protein,, from yellow fever virus, compared to tick-born encephalitis virus, leaves, space at the dimer interface for a large insertion without creating steric hindrance. We have tested this hypothesis by inserting a model humoral epitope from the circurnsporozoite protein of Plasmodium falciparian consisting of triple NANP repeats. Recombinant virus (17D/8) expressing this insertion flanked by two glycine residues at each end, is specifically neutralized by a monoclonal antibody to the model epitope. Furthermore, mouse antibodies raised to the recombinant virus recognize the parasite protein in an ELISA assay. Serial passage analysis confirmed the genetic stability of the insertion made in the viral genome and the resulting 17D/8 virus is significantly more attenuated in mouse neurovirulence tests than the 17DD vaccine. The fg loop belongs to the dimerization domain of the E protein and lies at the interface between monomers. This domain undergoes a low pH transition, which is related to the fusion of the viral envelope to the endosome membrane. It is conceivable that a slower rate of fusion, resulting from the insertion close to the dimer interface, may delay the onset of virus production and thereby lead to a milder infection of the host. This would account for the more attenuated phenotype of the recombinant virus in the mouse model and tower extent of replication in cultured cells. The vectorial capacity of the yellow fever virus is being further explored for the expression and presentation of other epitopes, including those mediating T-cell responses. (C) 2002 Academic Press.
C1 Fdn Oswaldo Cruz, Inst Oswaldo Cruz, Dept Bioquim & Biol Mol, BR-21045900 Rio De Janeiro, Brazil.
   Univ Sao Paulo, Inst Fis Sao Carlos, BR-13566590 Sao Carlos, SP, Brazil.
   Fdn Oswaldo Cruz, Inst Tecnol Imunobiol, Dept Desenvolvimento Tecnol, BR-21045900 Rio De Janeiro, Brazil.
   Escola Paulista Med, Dept Microbiol Parasitol & Imunol, BR-04023062 Sao Paulo, Brazil.
   NYU, Sch Med, Dept Med & Mol Parasitol, New York, NY 10010 USA.
RP Galler, R (corresponding author), Fdn Oswaldo Cruz, Inst Oswaldo Cruz, Dept Bioquim & Biol Mol, BR-21045900 Rio De Janeiro, Brazil.
RI Galler, Ricardo/B-3280-2014; Bonaldo, Myrna C/D-9494-2013; Nogueira,
   Raquel Tayar/F-6475-2019; garratt, richard c/F-6921-2011
OI Nogueira, Raquel Tayar/0000-0002-0581-763X; 
CR BARTON GJ, 1987, J MOL BIOL, V198, P327, DOI 10.1016/0022-2836(87)90316-0
   Bendahmane M, 1999, J MOL BIOL, V290, P9, DOI 10.1006/jmbi.1999.2860
   BRAUN W, 1985, J MOL BIOL, V186, P611, DOI 10.1016/0022-2836(85)90134-2
   CalvoCalle JM, 1997, J IMMUNOL, V159, P1362
   Caufour PS, 2001, VIRUS RES, V79, P1, DOI 10.1016/S0168-1702(01)00273-8
   CERAMI C, 1992, CELL, V70, P1021, DOI 10.1016/0092-8674(92)90251-7
   Chambers TJ, 1999, J VIROL, V73, P3095, DOI 10.1128/JVI.73.4.3095-3101.1999
   CHAMBERS TJ, 1990, P NATL ACAD SCI USA, V87, P8898, DOI 10.1073/pnas.87.22.8898
   CHAMBERS TJ, 1990, ANNU REV MICROBIOL, V44, P649, DOI 10.1146/annurev.mi.44.100190.003245
   de Vries AAF, 2000, VIROLOGY, V270, P84, DOI 10.1006/viro.2000.0245
   Eisenberg D, 1997, METHOD ENZYMOL, V277, P396, DOI 10.1016/S0076-6879(97)77022-8
   Guirakhoo F, 2000, J VIROL, V74, P5477, DOI 10.1128/JVI.74.12.5477-5485.2000
   LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944
   LEMON SM, 1992, VIROLOGY, V188, P285, DOI 10.1016/0042-6822(92)90758-H
   LESZCZYNSKI JF, 1986, SCIENCE, V234, P849, DOI 10.1126/science.3775366
   LI SQ, 1993, J VIROL, V67, P6659, DOI 10.1128/JVI.67.11.6659-6666.1993
   LONDON SD, 1992, P NATL ACAD SCI USA, V89, P207, DOI 10.1073/pnas.89.1.207
   LUTHY R, 1992, NATURE, V356, P83, DOI 10.1038/356083a0
   McAllister A, 2000, J VIROL, V74, P9197, DOI 10.1128/JVI.74.19.9197-9205.2000
   Miyahira Y, 1998, P NATL ACAD SCI USA, V95, P3954, DOI 10.1073/pnas.95.7.3954
   Monath TP, 2000, J VIROL, V74, P1742, DOI 10.1128/JVI.74.4.1742-1751.2000
   Monath TP, 1999, VACCINE, V17, P1869, DOI 10.1016/S0264-410X(98)00487-3
   Monath TP, 1999, VACCINES, P815
   Monath TP, 1996, FIELDS VIROLOGY, P961
   Murr L. E., 1988, Journal of Superconductivity, V1, P3, DOI 10.1007/BF00617947
   Muylaert IR, 1997, J VIROL, V71, P291, DOI 10.1128/JVI.71.1.291-298.1997
   Muylaert IR, 1996, VIROLOGY, V222, P159, DOI 10.1006/viro.1996.0406
   NARDIN EH, 1982, J EXP MED, V156, P20, DOI 10.1084/jem.156.1.20
   O'Reilly EK, 1998, VIROLOGY, V252, P287, DOI 10.1006/viro.1998.9463
   POST PR, 1992, VIROLOGY, V188, P160, DOI 10.1016/0042-6822(92)90745-B
   REY FA, 1995, NATURE, V375, P291, DOI 10.1038/375291a0
   RICE C M, 1989, New Biologist, V1, P285
   Ruggli N, 1996, J VIROL, V70, P3478, DOI 10.1128/JVI.70.6.3478-3487.1996
   SALI A, 1993, J MOL BIOL, V234, P779, DOI 10.1006/jmbi.1993.1626
   SCHLESINGER JJ, 1983, VIROLOGY, V125, P8, DOI 10.1016/0042-6822(83)90059-4
   Stefano I, 1999, VACCINE, V17, P1042, DOI 10.1016/S0264-410X(98)00320-X
   Tsuji M, 1998, J VIROL, V72, P6907, DOI 10.1128/JVI.72.8.6907-6910.1998
   van der Most RG, 1999, VIROLOGY, V265, P83, DOI 10.1006/viro.1999.0026
   VRIEND G, 1993, J APPL CRYSTALLOGR, V26, P47, DOI 10.1107/S0021889892008240
   VRIEND G, 1990, J MOL GRAPHICS, V8, P52, DOI 10.1016/0263-7855(90)80070-V
   WALLACE AC, 1995, PROTEIN ENG, V8, P127, DOI 10.1093/protein/8.2.127
   WENGLER G, 1993, VIROLOGY, V197, P265, DOI 10.1006/viro.1993.1587
   ZAVALA F, 1983, J EXP MED, V157, P1947, DOI 10.1084/jem.157.6.1947
NR 43
TC 35
Z9 41
U1 0
U2 4
PU ACADEMIC PRESS LTD ELSEVIER SCIENCE LTD
PI LONDON
PA 24-28 OVAL RD, LONDON NW1 7DX, ENGLAND
SN 0022-2836
J9 J MOL BIOL
JI J. Mol. Biol.
PD JAN 25
PY 2002
VL 315
IS 4
BP 873
EP 885
DI 10.1006/jmbi.2001.5258
PG 13
WC Biochemistry & Molecular Biology
SC Biochemistry & Molecular Biology
GA 521JL
UT WOS:000173836800031
PM 11812154
DA 2020-12-01
ER

PT J
AU Caufour, PS
   Motta, MCA
   Yamamura, AMY
   Vazquez, S
   Ferreira, II
   Jabor, AV
   Bonaldo, MC
   Freire, MS
   Galler, R
AF Caufour, PS
   Motta, MCA
   Yamamura, AMY
   Vazquez, S
   Ferreira, II
   Jabor, AV
   Bonaldo, MC
   Freire, MS
   Galler, R
TI Construction, characterization and immunogenicity of recombinant yellow
   fever 17D-dengue type 2 viruses
SO VIRUS RESEARCH
LA English
DT Article
DE YF 17D virus recombinants; dengue vaccine; immunogenicity
ID NEW-GUINEA-C; NUCLEOTIDE-SEQUENCE; JAPANESE ENCEPHALITIS; ENVELOPE
   PROTEIN; VACCINE STRAINS; DENGUE VACCINE; IN-VITRO; PRM; EXPRESSION;
   CLEAVAGE
AB Chimeric yellow fever (YF)-dengue type 2 (Den 2) viruses were constructed by replacing the premembrane (prM) and envelope (E) genes of YF 17D virus with those from Den 2 virus strains of south-east Asian genotype. Whereas viable chimeric viruses were successfully recovered when the YF 17D C gene and the Den 2 prM gene were fused at the signalase cleavage site, no virus could be rescued from the constructions fused at the viral protease cleavage site. Unlike YF virus that replicated in all the cell lines tested and similar to the Den 2 virus, the recombinant viruses did not replicate in vaccine-production certified CEF and MRC5 cells. Besides, chimeric 17D/Den 2 viruses and their parental viruses reached similar growth titers in Vero and C6/36 cell cultures. Analysis of mouse neurovirulence, performed by intracerebral inoculation, demonstrated that the 17D/Den 2 chimera is more attenuated in this system than the YF 17DD virus. Immunization of mice with this chimera induced a neutralizing antibody response associated with a partial protection against an otherwise lethal dose of mouse neurovirulent Den 2 NGC virus. Overall, these results provide further support for the use of chimeric viruses as an attractive methodology for the development of new live flavivirus vaccines. (C) 2001 Elsevier Science B.V. All rights reserved.
C1 Fundacao Oswaldo Cruz, Inst Oswaldo Cruz, Dept Bioquim & Biol Mol, BR-21045900 Rio De Janeiro, Brazil.
   Inst Tecnol Imunobiol, Dept Desenvolvimento Tecnol, BR-21045900 Rio De Janeiro, Brazil.
   Inst Med Trop Pedro Kouri, Dept Virol, Havana 10400, Cuba.
RP Galler, R (corresponding author), Fundacao Oswaldo Cruz, Inst Oswaldo Cruz, Dept Bioquim & Biol Mol, BR-21045900 Rio De Janeiro, Brazil.
RI Nogueira, Raquel Tayar/F-6475-2019; Bonaldo, Myrna C/D-9494-2013;
   Galler, Ricardo/B-3280-2014
OI Nogueira, Raquel Tayar/0000-0002-0581-763X; 
CR AMBERG SM, 1994, J VIROL, V68, P3794, DOI 10.1128/JVI.68.6.3794-3802.1994
   Barrett ADT, 1997, BIOLOGICALS, V25, P27, DOI 10.1006/biol.1997.0057
   Bhamarapravati N, 2000, VACCINE, V18, P44, DOI 10.1016/S0264-410X(00)00040-2
   BOYER JC, 1994, VIROLOGY, V198, P415, DOI 10.1006/viro.1994.1053
   BRAY M, 1991, P NATL ACAD SCI USA, V88, P10342, DOI 10.1073/pnas.88.22.10342
   Chambers TJ, 1999, J VIROL, V73, P3095, DOI 10.1128/JVI.73.4.3095-3101.1999
   CHAMBERS TJ, 1990, ANNU REV MICROBIOL, V44, P649, DOI 10.1146/annurev.mi.44.100190.003245
   EYLAR OR, 1978, P SOC EXP BIOL MED, V157, P322
   Galler R, 1997, BRAZ J MED BIOL RES, V30, P157, DOI 10.1590/S0100-879X1997000200002
   GERLIN B, 1998, JORDAN REPORT, P96
   GRUENBERG A, 1988, J GEN VIROL, V69, P1391, DOI 10.1099/0022-1317-69-6-1391
   Guirakhoo F, 2000, J VIROL, V74, P5477, DOI 10.1128/JVI.74.12.5477-5485.2000
   HAHN YS, 1988, VIROLOGY, V162, P167, DOI 10.1016/0042-6822(88)90406-0
   HEINZ FX, 1994, VIROLOGY, V198, P109, DOI 10.1006/viro.1994.1013
   Huang CYH, 2000, J VIROL, V74, P3020, DOI 10.1128/JVI.74.7.3020-3028.2000
   IRIE K, 1989, GENE, V75, P197, DOI 10.1016/0378-1119(89)90266-7
   Konishi E, 2000, VACCINE, V18, P1133, DOI 10.1016/S0264-410X(99)00376-X
   Lee E, 2000, J VIROL, V74, P24, DOI 10.1128/JVI.74.1.24-32.2000
   Leitmeyer KC, 1999, J VIROL, V73, P4738, DOI 10.1128/JVI.73.6.4738-4747.1999
   LEWIS JA, 1993, VIROLOGY, V197, P216, DOI 10.1006/viro.1993.1582
   LOBIGS M, 1993, P NATL ACAD SCI USA, V90, P6218, DOI 10.1073/pnas.90.13.6218
   Monath TP, 1999, VACCINES, P815
   Monath TP, 1996, FIELDS VIROLOGY, P961
   PLETNEV AG, 1992, P NATL ACAD SCI USA, V89, P10532, DOI 10.1073/pnas.89.21.10532
   POST PR, 1992, VIROLOGY, V188, P160, DOI 10.1016/0042-6822(92)90745-B
   POST PR, 1990, VIRUS RES, V18, P291
   REED L. J., 1938, AMER JOUR HYG, V27, P493
   RICE C M, 1989, New Biologist, V1, P285
   RICE CM, 1985, SCIENCE, V229, P726, DOI 10.1126/science.4023707
   RicoHesse R, 1997, VIROLOGY, V230, P244, DOI 10.1006/viro.1997.8504
   Ruggli N, 1996, J VIROL, V70, P3478, DOI 10.1128/JVI.70.6.3478-3487.1996
   SCHLESINGER JJ, 1983, VIROLOGY, V125, P8, DOI 10.1016/0042-6822(83)90059-4
   Silver J, 1995, PCR STRATEGIES, P179
   Stefano I, 1999, VACCINE, V17, P1042, DOI 10.1016/S0264-410X(98)00320-X
   Stocks CE, 1998, J VIROL, V72, P2141, DOI 10.1128/JVI.72.3.2141-2149.1998
   Van Der Most RG, 2000, J VIROL, V74, P8094, DOI 10.1128/JVI.74.17.8094-8101.2000
   Watts DM, 1999, LANCET, V354, P1431, DOI 10.1016/S0140-6736(99)04015-5
   Yamshchikov VF, 1997, J VIROL, V71, P4364, DOI 10.1128/JVI.71.6.4364-4371.1997
NR 38
TC 54
Z9 55
U1 0
U2 3
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0168-1702
J9 VIRUS RES
JI Virus Res.
PD NOV 5
PY 2001
VL 79
IS 1-2
BP 1
EP 14
DI 10.1016/S0168-1702(01)00273-8
PG 14
WC Virology
SC Virology
GA 477GL
UT WOS:000171274900001
PM 11551641
DA 2020-12-01
ER

PT J
AU Bonaldo, MC
   Caufour, PS
   Freire, MS
   Galler, R
AF Bonaldo, MC
   Caufour, PS
   Freire, MS
   Galler, R
TI The yellow fever 17D vaccine virus as a vector for the expression of
   foreign proteins: Development of new live flavivirus vaccines
SO MEMORIAS DO INSTITUTO OSWALDO CRUZ
LA English
DT Article; Proceedings Paper
CT International Symposium on Perspectives of Biomedical Research in the
   XXIst Century
CY MAY 21-26, 2000
CL RIO JANEIRO, BRAZIL
SP CNPq, Capes, Finep, Fdn Amparo Pesquisa Rio Janeiro, Fdn Oswaldo Cruz, Linha Amarela SA, Minist Cultura, Prefeitura Rio Janeiro
DE yellow fever virus; 17D vaccine; foreign gene expression; recombinant
   viruses; vaccine development
ID TICK-BORNE ENCEPHALITIS; DENGUE TYPE-4 VIRUSES; JAPANESE ENCEPHALITIS;
   NONSTRUCTURAL PROTEINS; MOUSE NEUROVIRULENCE; NUCLEOTIDE-SEQUENCE;
   COMPLEMENTARY-DNA; NS2B-NS3 PROTEASE; LENGTH CDNA; NS1 PROTEIN
AB The Flaviviridae is a family of about 70 mostly arthropod-borne viruses many of which are major public health problems with members being present in most continents. Among the most important are yellow fever (YF), dengue with its four serotypes and Japanese encephalitis virus. A live attenuated virus is used as a cost effective, safe and efficacious vaccine against YF but no other live flavivirus vaccines have been licensed. The rise of recombinant DNA technology and its application to study flavivirus genome structure and expression has opened new possibilities for flavivirus vaccine development. One new approach is the use of cDNAs encopassing the whole viral genome to generate infectious RNA after in vitro transcription. This methodology allows the genetic mapping of specific viral functions and the design of viral mutants with considerable potential as new live attenuated viruses. The use of infectious cDNA as a carrier for heterologous antigens is gaining importance as chimeric viruses are shown to be viable, immunogenic and less virulent as compared to the parental viruses. The use of DNA to overcome mutation rates intrinsic of RNA virus populations in conjunction with vaccine production in cell culture should improve the reliability and lower the cost for production of live attenuated vaccines. The YF virus despite a long period ignored by researchers probably due to the effectiveness of the vaccine has made a come back, both in nature as human populations grow and reach endemic areas as well as in the laboratory being a suitable model to understand the biology of flaviviruses in general and providing new alternatives for vaccine development through the use of the 17D vaccine strain.
C1 Fiocruz MS, Inst Oswaldo Cruz, Dept Bioquim & Biol Mol, BR-21045900 Rio De Janeiro, RJ, Brazil.
   Fiocruz MS, Inst Tecnol Imunobiol, Dept Desenvolvimento Tecnol, BR-21045900 Rio De Janeiro, RJ, Brazil.
RP Galler, R (corresponding author), Fiocruz MS, Inst Oswaldo Cruz, Dept Bioquim & Biol Mol, Ave Brasil 4365, BR-21045900 Rio De Janeiro, RJ, Brazil.
EM rgaller@gene.dbbm.fiocruz.br
RI Galler, Ricardo/B-3280-2014; Bonaldo, Myrna C/D-9494-2013; Nogueira,
   Raquel Tayar/F-6475-2019
OI Nogueira, Raquel Tayar/0000-0002-0581-763X
CR Bhamarapravati N, 2000, VACCINE, V18, P44, DOI 10.1016/S0264-410X(00)00040-2
   Bray M, 1998, J VIROL, V72, P1647, DOI 10.1128/JVI.72.2.1647-1651.1998
   BRAY M, 1991, P NATL ACAD SCI USA, V88, P10342, DOI 10.1073/pnas.88.22.10342
   Butrapet S, 2000, J VIROL, V74, P3011, DOI 10.1128/JVI.74.7.3011-3019.2000
   CAHOUR A, 1995, VIROLOGY, V207, P68, DOI 10.1006/viro.1995.1052
   CHAMBERS TJ, 1993, J VIROL, V67, P6797, DOI 10.1128/JVI.67.11.6797-6807.1993
   Chambers TJ, 1999, J VIROL, V73, P3095, DOI 10.1128/JVI.73.4.3095-3101.1999
   CHAMBERS TJ, 1990, P NATL ACAD SCI USA, V87, P8898, DOI 10.1073/pnas.87.22.8898
   CHAMBERS TJ, 1990, ANNU REV MICROBIOL, V44, P649, DOI 10.1146/annurev.mi.44.100190.003245
   DOSSANTOS CND, 1995, VIRUS RES, V35, P35
   FALGOUT B, 1989, J VIROL, V63, P1852, DOI 10.1128/JVI.63.5.1852-1860.1989
   FALGOUT B, 1991, J VIROL, V65, P2467, DOI 10.1128/JVI.65.5.2467-2475.1991
   GORBALENYA AE, 1989, NUCLEIC ACIDS RES, V17, P4713, DOI 10.1093/nar/17.12.4713
   Gualano RC, 1998, J GEN VIROL, V79, P437, DOI 10.1099/0022-1317-79-3-437
   Guirakhoo F, 2000, J VIROL, V74, P5477, DOI 10.1128/JVI.74.12.5477-5485.2000
   Guirakhoo F, 1999, VIROLOGY, V257, P363, DOI 10.1006/viro.1999.9695
   HALSTEAD SB, 1988, SCIENCE, V239, P476, DOI 10.1126/science.3277268
   Huang CYH, 2000, J VIROL, V74, P3020, DOI 10.1128/JVI.74.7.3020-3028.2000
   JAN LR, 1995, J GEN VIROL, V76, P573, DOI 10.1099/0022-1317-76-3-573
   KAPOOR M, 1995, GENE, V162, P175, DOI 10.1016/0378-1119(95)00332-Z
   Khromykh AA, 2000, J VIROL, V74, P3253, DOI 10.1128/JVI.74.7.3253-3263.2000
   KHROMYKH AA, 1994, J VIROL, V68, P4580, DOI 10.1128/JVI.68.7.4580-4588.1994
   Kinney RM, 1997, VIROLOGY, V230, P300, DOI 10.1006/viro.1997.8500
   Lai CJ, 1998, CLIN DIAGN VIROL, V10, P173, DOI 10.1016/S0928-0197(98)00035-X
   LAI CJ, 1991, P NATL ACAD SCI USA, V88, P5139, DOI 10.1073/pnas.88.12.5139
   LIN C, 1993, J VIROL, V67, P2327, DOI 10.1128/JVI.67.4.2327-2335.1993
   Lindenbach BD, 1999, J VIROL, V73, P4611, DOI 10.1128/JVI.73.6.4611-4621.1999
   Lindenbach BD, 1997, J VIROL, V71, P9608, DOI 10.1128/JVI.71.12.9608-9617.1997
   LLOYD Wray, 1936, Transactions of the Royal Society of Tropical Medicine and Hygiene, V29, P481, DOI 10.1016/S0035-9203(36)90002-0
   Mandl CW, 1998, J VIROL, V72, P2132, DOI 10.1128/JVI.72.3.2132-2140.1998
   MARCHEVSKY RS, 1995, AM J TROP MED HYG, V52, P75, DOI 10.4269/ajtmh.1995.52.75
   Men RH, 1996, J VIROL, V70, P3930, DOI 10.1128/JVI.70.6.3930-3937.1996
   MONATH TP, 1988, NEW ENGL J MED, V319, P641, DOI 10.1056/NEJM198809083191009
   Monath TP, 2000, J VIROL, V74, P1742, DOI 10.1128/JVI.74.4.1742-1751.2000
   Monath TP, 1999, VACCINE, V17, P1869, DOI 10.1016/S0264-410X(98)00487-3
   Monath TP, 1999, VACCINES, P815
   Muylaert IR, 1997, J VIROL, V71, P291, DOI 10.1128/JVI.71.1.291-298.1997
   Muylaert IR, 1996, VIROLOGY, V222, P159, DOI 10.1006/viro.1996.0406
   NESTOROWICZ A, 1994, VIROLOGY, V199, P114, DOI 10.1006/viro.1994.1103
   O'Reilly EK, 1998, VIROLOGY, V252, P287, DOI 10.1006/viro.1998.9463
   PLETNEV AG, 1993, J VIROL, V67, P4956, DOI 10.1128/JVI.67.8.4956-4963.1993
   PLETNEV AG, 1992, P NATL ACAD SCI USA, V89, P10532, DOI 10.1073/pnas.89.21.10532
   Pletnev AG, 1998, P NATL ACAD SCI USA, V95, P1746, DOI 10.1073/pnas.95.4.1746
   Pryor MJ, 1998, J GEN VIROL, V79, P2631, DOI 10.1099/0022-1317-79-11-2631
   Puri B, 2000, VIRUS GENES, V20, P57, DOI 10.1023/A:1008160123754
   RACANIELLO VR, 1981, SCIENCE, V214, P916, DOI 10.1126/science.6272391
   RICE C M, 1989, New Biologist, V1, P285
   RICE CM, 1985, SCIENCE, V229, P726, DOI 10.1126/science.4023707
   RICE CM, 1996, FIELDS VIROLOGY, P931
   ROSE CSP, 1991, TRENDS BIOTECHNOL, V9, P415, DOI 10.1016/0167-7799(91)90142-5
   SMITH H. H., 1938, AMER JOUR TROP MED, V18, P437
   Steffens S, 1999, J GEN VIROL, V80, P2583, DOI 10.1099/0022-1317-80-10-2583
   Stocks CE, 1998, J VIROL, V72, P2141, DOI 10.1128/JVI.72.3.2141-2149.1998
   STOKES ADRIAN, 1928, AMER JOUR TROP MED, V8, P103
   SUMIYOSHI H, 1992, J VIROL, V66, P5425, DOI 10.1128/JVI.66.9.5425-5431.1992
   Theiler M, 1937, J EXP MED, V65, P767, DOI 10.1084/jem.65.6.767
   Theiler M, 1937, J EXP MED, V65, P787, DOI 10.1084/jem.65.6.787
   WENGLER G, 1993, VIROLOGY, V197, P265, DOI 10.1006/viro.1993.1587
   WENGLER G, 1985, VIROLOGY, V147, P264, DOI 10.1016/0042-6822(85)90129-1
   *WHO, 1993, IMM BAS IMM 8 YELL F
   Yamshchikov VF, 1997, J VIROL, V71, P4364, DOI 10.1128/JVI.71.6.4364-4371.1997
   YAMSHCHIKOV VF, 1995, J VIROL, V69, P1995, DOI 10.1128/JVI.69.4.1995-2003.1995
NR 62
TC 7
Z9 8
U1 0
U2 1
PU FUNDACO OSWALDO CRUZ
PI RIO DE JANEIRO, RJ
PA AV BRASIL 4365, 21045-900 RIO DE JANEIRO, RJ, BRAZIL
SN 0074-0276
EI 1678-8060
J9 MEM I OSWALDO CRUZ
JI Mem. Inst. Oswaldo Cruz
PY 2000
VL 95
SU 1
BP 215
EP 223
DI 10.1590/S0074-02762000000700037
PG 9
WC Parasitology; Tropical Medicine
SC Parasitology; Tropical Medicine
GA 377RD
UT WOS:000165526400038
PM 11142718
OA DOAJ Gold
DA 2020-12-01
ER

PT J
AU Coutinho, CMLM
   Cavalcanti, GH
   Bonaldo, MC
   Mortensen, RF
   Araujo-Jorge, TC
AF Coutinho, CMLM
   Cavalcanti, GH
   Bonaldo, MC
   Mortensen, RF
   Araujo-Jorge, TC
TI Trypanosoma cruzi: Detection of a surface antigen cross-reactive to
   human C-reactive protein
SO EXPERIMENTAL PARASITOLOGY
LA English
DT Article
DE C-reactive protein; neo-CRP; Trypanosoma cruzi; Chagas' disease;
   parasite-host cell; interaction
ID HEART-MUSCLE CELLS; TUMORICIDAL ACTIVITY; COMPLEMENT-SYSTEM;
   GENE-EXPRESSION; BINDING; MACROPHAGES; LYMPHOCYTES; GALACTOSE; RECEPTOR;
   CRP
AB C-reactive protein (CRP) is an acute phase protein secreted by liver hepatocytes, and is also found on the surface of lymphocytes and as a membrane-associated protein expressed on rat liver macrophages and human monocytes. C-reactive protein levels increase in the sera of children infected with Trypanosoma cruzi, during the acute phase of Chagas' disease, bur its role in the course of this infection is unknown. Experiments designed to detect the binding of CRP to circulating forms of T. cruzi failed to observe it because anti-human CRP antibodies bind to the parasite. The present work intended to further clarify this novel question related to the anti-CRP cross-reactivity with the parasite. Indirect immunofluorescence: immunoenzymatic, flow cytometry, and Western blot assays showed that three different polyclonal anti-human CRP antibody preparations bind to T. cruzi surface. This binding is dose-dependent, saturable, and is inhibited when anti-CRP antibodies from different species were allowed to compete, indicating the specificity of the reactivity. The antibodies recognized a protein band below 23 kDa in Western blot analysis of parasite extracts. The divalent cation chelators EDTA and EGTA impaired the antigen recognition by the antibodies. The binding to parasite surface was also observed with some available monoclonal antibodies raised against human CRP. A polyclonal anti-human CRP presented an inhibitory effect on invasion of heart muscle cells by T. cruzi. Our results indicate that a molecule antigenically related to CRP, a possible CRP-like molecule, is expressed on the surface of T. cruzi. (C) 1998 Academic Press.
C1 Fdn Oswaldo Cruz, Inst Oswaldo Cruz, Dept Ultraestrutura & Biol Celular, BR-21045900 Rio De Janeiro, Brazil.
   Univ Fed Fluminense, Inst Biol, Dept Biol Celular & Mol, BR-24001970 Niteroi, RJ, Brazil.
   Fdn Oswaldo Cruz, Inst Oswaldo Cruz, Dept Bioquim & Biol Mol, BR-21045900 Rio De Janeiro, Brazil.
   Ohio State Univ, Dept Microbiol, Columbus, OH 43210 USA.
RP Coutinho, CMLM (corresponding author), Fdn Oswaldo Cruz, Inst Oswaldo Cruz, Dept Ultraestrutura & Biol Celular, Av Brasil 4365, BR-21045900 Rio De Janeiro, Brazil.
EM claudia@gene.dbbm.fiocruz.br
RI Bonaldo, Myrna C/D-9494-2013; Araujo-Jorge, Tania/F-1030-2014
OI Araujo-Jorge, Tania/0000-0002-8233-5845
CR ARAUJOJORGE TC, 1988, ACTA TROP, V45, P127
   ARAUJOJORGE TC, 1992, PARASITOL RES, V78, P215, DOI 10.1007/BF00931729
   BALTZ ML, 1982, ANN NY ACAD SCI, V389, P49, DOI 10.1111/j.1749-6632.1982.tb22125.x
   BARBOSA HS, 1992, PARASITOL RES, V78, P404, DOI 10.1007/BF00931696
   BONALDO MC, 1988, J CELL BIOL, V106, P1349, DOI 10.1083/jcb.106.4.1349
   BRAY RA, 1988, J IMMUNOL, V140, P4271
   BURLEIGH BA, 1995, ANNU REV MICROBIOL, V49, P175, DOI 10.1146/annurev.mi.49.100195.001135
   CONTRERAS VT, 1985, MOL BIOCHEM PARASIT, V14, P83, DOI 10.1016/0166-6851(85)90108-2
   Coutinho CMLM, 1997, PARASITOL RES, V83, P144, DOI 10.1007/s004360050224
   DEGETT J, 1990, MICROSC ELECTRON BIO, V14, P11
   DEMIRANDASANTOS IKF, 1981, J EXP MED, V154, P1732, DOI 10.1084/jem.154.6.1732
   GANTER U, 1989, EMBO J, V8, P3773, DOI 10.1002/j.1460-2075.1989.tb08554.x
   GEWURZ H, 1995, CURR OPIN IMMUNOL, V7, P54, DOI 10.1016/0952-7915(95)80029-8
   HAMOUDI W, 1986, J EXP MED, V157, P301
   IKUTA T, 1986, INFLAMMATION, V10, P223, DOI 10.1007/BF00916118
   KAPLAN MH, 1974, J IMMUNOL, V112, P2135
   KEMPKA G, 1985, BIOCHIM BIOPHYS ACTA, V847, P108, DOI 10.1016/0167-4889(85)90160-0
   KEMPKA G, 1990, J IMMUNOL, V144, P1004
   KHATTRI R, 1994, CELL IMMUNOL, V15, P457
   KILPATRICK JM, 1985, J IMMUNOL, V134, P3364
   KOLBBACHOFEN V, 1995, GLYCOCONJUGATE J, V12, P122, DOI 10.1007/BF00731355
   LIN LW, 1993, J BIOL CHEM, V268, P6809
   LUZ MRMP, 1995, PARASITOL RES, V81, P662, DOI 10.1007/BF00931843
   MARNELL LL, 1995, J IMMUNOL, V155, P2185
   MEDRANOMERCADO N, 1995, TROPICAL MED, V53, P82
   MEIRELLES MNL, 1986, EUR J CELL BIOL, V41, P198
   MORTENSEN RF, 1976, J IMMUNOL, V117, P774
   MULLENIX MC, 1994, MOL IMMUNOL, V31, P615, DOI 10.1016/0161-5890(94)90169-4
   OSMAND AP, 1975, J EXP MED, V142, P1065
   OUAISSI MA, 1986, SCIENCE, V234, P603, DOI 10.1126/science.3094145
   RIMOLDI MT, 1988, P NATL ACAD SCI USA, V85, P193, DOI 10.1073/pnas.85.1.193
   ROBEY FA, 1981, J BIOL CHEM, V256, P969
   SCHLIMGEN AK, 1995, NEURON, V14, P519, DOI 10.1016/0896-6273(95)90308-9
   STEEL DM, 1994, IMMUNOL TODAY, V15, P81, DOI 10.1016/0167-5699(94)90138-4
   SWANSON SJ, 1991, J IMMUNOL, V147, P2248
   TEBO JM, 1991, BIOCHIM BIOPHYS ACTA, V1095, P210, DOI 10.1016/0167-4889(91)90101-3
   TOWBIN H, 1979, P NATL ACAD SCI USA, V76, P4350, DOI 10.1073/pnas.76.9.4350
   TSENG J, 1988, HYBRIDOMA, V7, P185, DOI 10.1089/hyb.1988.7.185
   *WHO, 1991, WHO TECH REP SER, V811, P1
   WIRTH JJ, 1984, J IMMUNOL, V133, P460
   YING SC, 1989, J IMMUNOL, V143, P221
   ZAHEDI K, 1989, J IMMUNOL, V142, P2384
   ZAHEDI K, 1986, CANCER RES, V46, P5077
NR 43
TC 8
Z9 8
U1 0
U2 2
PU ACADEMIC PRESS INC ELSEVIER SCIENCE
PI SAN DIEGO
PA 525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA
SN 0014-4894
EI 1090-2449
J9 EXP PARASITOL
JI Exp. Parasitol.
PD OCT
PY 1998
VL 90
IS 2
BP 143
EP 153
DI 10.1006/expr.1998.4323
PG 11
WC Parasitology
SC Parasitology
GA 128EC
UT WOS:000076391500001
PM 9769244
DA 2020-12-01
ER

PT J
AU Lowndes, CM
   Bonaldo, MC
   Thomaz, N
   Goldenberg, S
AF Lowndes, CM
   Bonaldo, MC
   Thomaz, N
   Goldenberg, S
TI Heterogeneity of metalloprotease expression in Trypanosoma cruzi
SO PARASITOLOGY
LA English
DT Article
DE Trypanosoma cruzi; metacyclogenesis; metalloproteases; cysteine
   proteases; heterogeneity
ID MAJOR CYSTEINE PROTEINASE; PARASITIC PROTOZOA; IDENTIFICATION;
   LEISHMANIA; PROTEASES
AB Expression of metalloprotease activities during metacyclogenesis of a series of strains and clones of Trypanosoma cruzi was investigated using SDS-polyacrylamide gel electrophoresis with a range of different co-polymerized proteolytic substrates. A complex pattern of metalloprotease expression, with considerable quantitative and qualitative variability between strains and life-cycle stages, was apparent. This is in contrast to previously published data, and data presented in this study, which demonstrate a high degree of conservation of expression of cysteine proteases in different strains and clones of T. cruzi. All the metalloprotease activities identified partitioned into the detergent phase of a Triton X-114 extract, suggesting that they are membrane-bound. Developmental regulation of expression during metacyclogenesis, either in terms of quantity, or in terms of difference in relative amounts of different isoforms, was apparent for all isolates studied except CL14. However, a clearly metacyclic-specific/metacyclic-enriched metalloprotease was detected only in T. cruzi Dm28c and 383, and our results demonstrate that a metacyclic-specific metalloprotease common to all isolates of the parasite could not be detected, at least at this level of analysis.
C1 ESCOLA NACL SAUDE PUBL, DEPT BIOQUIM & BIOL MOLEC, BR-21041210 RIO DE JANEIRO, BRAZIL.
   ESCOLA NACL SAUDE PUBL, INST OSWALDO CRUZ, DEPT PROTOZOOL, BR-21041210 RIO DE JANEIRO, BRAZIL.
   FDN OSWALDO CRUZ, BR-21040900 RIO DE JANEIRO, BRAZIL.
RP Lowndes, CM (corresponding author), ESCOLA NACL SAUDE PUBL, DEPT EPIDEMIOL, FDN OSWALDO CRUZ, RUA LEOPOLDO BULHOES 1480, BR-21041210 RIO DE JANEIRO, BRAZIL.
RI P, CM/B-1358-2013; GOLDENBERG, SAMUEL/B-4116-2009; Bonaldo, Myrna
   C/D-9494-2013
OI GOLDENBERG, SAMUEL/0000-0002-4892-163X; 
CR ASHALL F, 1990, MOL BIOCHEM PARASIT, V38, P77, DOI 10.1016/0166-6851(90)90207-3
   Auxiliadora de Sousa M., 1983, Memorias do Instituto Oswaldo Cruz, V78, P317, DOI 10.1590/S0074-02761983000300009
   BONALDO MC, 1991, EXP PARASITOL, V73, P44, DOI 10.1016/0014-4894(91)90006-I
   BONALDO MC, 1988, J CELL BIOL, V106, P1349, DOI 10.1083/jcb.106.4.1349
   BONTEMPI E, 1984, COMP BIOCHEM PHYS B, V77, P599, DOI 10.1016/0305-0491(84)90282-7
   BORDIER C, 1981, J BIOL CHEM, V256, P1604
   BORDIER C, 1987, PARASITOL TODAY, V3, P151, DOI 10.1016/0169-4758(87)90199-2
   BRENER Z, 1973, ANNU REV MICROBIOL, V27, P347, DOI 10.1146/annurev.mi.27.100173.002023
   BRENER Z, 1963, Rev Inst Med Trop Sao Paulo, V5, P220
   CamargO E. P., 1964, Revista do Instituto de Medicina Tropical de Sao Paulo, V6, P93
   CAMPETELLA O, 1990, FEMS MICROBIOL LETT, V67, P145, DOI 10.1016/0378-1097(90)90184-R
   CAMPETELLA O, 1992, MOL BIOCHEM PARASIT, V50, P225, DOI 10.1016/0166-6851(92)90219-A
   CAZZULO JJ, 1989, MOL BIOCHEM PARASIT, V33, P33, DOI 10.1016/0166-6851(89)90039-X
   Chagas C., 1909, MEM I OSWALDO CRUZ, V1, P159, DOI DOI 10.1590/S0074-02761909000200008
   CHIARI E, THESIS U FEDERAL MIN
   CONTRERAS V T, 1988, Memorias do Instituto Oswaldo Cruz, V83, P123, DOI 10.1590/S0074-02761988000100016
   EAKIN AE, 1992, J BIOL CHEM, V267, P7411
   ETGES R, 1992, ACTA TROP, V50, P205, DOI 10.1016/0001-706X(92)90077-B
   FEDERICI EE, 1964, AM J TROP MED HYG, V13, P272, DOI 10.4269/ajtmh.1964.13.272
   GREIG S, 1990, MOL BIOCHEM PARASIT, V39, P31, DOI 10.1016/0166-6851(90)90005-7
   HARLOW E, 1988, ANTIBODIES LAB MANUA, P285
   HEUSSEN C, 1980, ANAL BIOCHEM, V102, P196, DOI 10.1016/0003-2697(80)90338-3
   ITOW S, 1977, J PROTOZOOL, V24, P591, DOI 10.1111/j.1550-7408.1977.tb01021.x
   JANSEN AM, 1991, EXP PARASITOL, V73, P249, DOI 10.1016/0014-4894(91)90096-F
   MCKERROW JH, 1993, ANNU REV MICROBIOL, V47, P821, DOI 10.1146/annurev.mi.47.100193.004133
   MEDINAACOSTA E, 1994, MOL BIOCHEM PARASIT, V64, P273, DOI 10.1016/0166-6851(94)00029-8
   MURTA ACM, 1990, MOL BIOCHEM PARASIT, V43, P27, DOI 10.1016/0166-6851(90)90127-8
   NORTH MJ, 1990, PARASITOL TODAY, V6, P270, DOI 10.1016/0169-4758(90)90189-B
   NOVY FG, 1903, AM J TROP MED, V5, P63
   SIBAJEV A, 1991, THESIS I OSWALDO CRU
   Silva L. H. P., 1953, FOLIA CLIN BIOL, V20, P191
   URBINA JA, 1994, PARASITOL TODAY, V10, P107, DOI 10.1016/0169-4758(94)90010-8
NR 32
TC 18
Z9 19
U1 0
U2 0
PU CAMBRIDGE UNIV PRESS
PI NEW YORK
PA 32 AVENUE OF THE AMERICAS, NEW YORK, NY 10013-2473 USA
SN 0031-1820
EI 1469-8161
J9 PARASITOLOGY
JI Parasitology
PD APR
PY 1996
VL 112
BP 393
EP 399
DI 10.1017/S0031182000066622
PN 4
PG 7
WC Parasitology
SC Parasitology
GA UF333
UT WOS:A1996UF33300005
PM 8935950
DA 2020-12-01
ER

PT J
AU Branquinha, MH
   Vermelho, AB
   Goldenberg, S
   Bonaldo, MC
AF Branquinha, MH
   Vermelho, AB
   Goldenberg, S
   Bonaldo, MC
TI Ubiquity of cysteine- and metalloproteinase activities in a wide range
   of trypanosomatids
SO JOURNAL OF EUKARYOTIC MICROBIOLOGY
LA English
DT Article
DE gelatin-SDS-PAGE; trypanosomatidae
ID SODIUM DODECYL-SULFATE; CRITHIDIA-FASCICULATA; POLYACRYLAMIDE GELS;
   LEISHMANIA-TARENTOLAE; PARASITIC PROTOZOA; CRUZI; IDENTIFICATION;
   PROTEINASE; EXPRESSION; PROTEASES
AB We have analysed the proteinase profiles of 11 species from 7 different genera of trypanosomatids by in situ detection of enzyme activities on SDS-PAGE gels containing co-polymerized gelatin as substrate, and the use of specific proteinase inhibitors. Our survey indicates that while cysteine- and metalloproteinases are distributed ubiquitously among trypanosomatids, there are marked differences between the enzyme profiles from the monogenetic (Crithidia, Herpetomonas, Leptomonas) and digenetic (Trypanosoma, Endotrypanum, Phytomonas, Leishmania) species. The detected metalloproteinase activities, ranging in size from 50-100 kDa, partitioned into the detergent-phase after Triton X-114 extraction, while most of cysteine proteinases, of three distinct molecular mass ranges (30-50 kDa, 80-100 kDa and 116-205 kDa), partitioned into the aqueous phase. Thus, within this group of organisms, the metalloproteinase activities seem to be predominantly membrane-associated proteins. We also show that the plant parasites of the genus Phytomonas exhibit a distinctive cysteine proteinase profile that might be exploited further as a criterion for taxonomy of the genus.
C1 UNIV FED RIO DE JANEIRO, INST MICROBIOL, DEPT MICROBIOL GERAL, BR-21949900 RIO DE JANEIRO, BRAZIL.
   INST OSWALDO CRUZ, DEPT BIOQUIM & BIOL MOLEC, FIOCRUZ, BR-21045900 RIO DE JANEIRO, BRAZIL.
RI GOLDENBERG, SAMUEL/B-4116-2009; VERMELHO/J-8803-2013; P, CM/B-1358-2013;
   Branquinha, Marta/AAA-3084-2019; Bonaldo, Myrna C/D-9494-2013
OI GOLDENBERG, SAMUEL/0000-0002-4892-163X; VERMELHO/0000-0001-5926-4172; 
CR ASHALL F, 1990, BIOCHIM BIOPHYS ACTA, V1035, P293, DOI 10.1016/0304-4165(90)90091-A
   BONALDO MC, 1991, EXP PARASITOL, V73, P44, DOI 10.1016/0014-4894(91)90006-I
   BONTEMPI E, 1984, COMP BIOCHEM PHYS B, V77, P599, DOI 10.1016/0305-0491(84)90282-7
   BUTTON LL, 1991, MOL BIOCHEM PARASIT, V44, P213, DOI 10.1016/0166-6851(91)90007-S
   CAMARGO EP, 1992, J PARASITOL, V78, P40, DOI 10.2307/3283683
   CAMPBELL DA, 1992, FEMS MICROBIOL LETT, V96, P89, DOI 10.1111/j.1574-6968.1992.tb05398.x
   Coombs G.H., 1991, P208
   ETGES R, 1992, ACTA TROP, V50, P205, DOI 10.1016/0001-706X(92)90077-B
   ETGES RJ, 1986, J BIOL CHEM, V261, P9099
   FERNANDES AP, 1993, P NATL ACAD SCI USA, V90, P11608, DOI 10.1073/pnas.90.24.11608
   GREIG S, 1990, MOL BIOCHEM PARASIT, V39, P31, DOI 10.1016/0166-6851(90)90005-7
   HEUSSEN C, 1980, ANAL BIOCHEM, V102, P196, DOI 10.1016/0003-2697(80)90338-3
   ILG T, 1993, FEBS LETT, V327, P103, DOI 10.1016/0014-5793(93)81049-6
   INVERSO JA, 1993, MOL BIOCHEM PARASIT, V57, P47, DOI 10.1016/0166-6851(93)90242-P
   LONSDALEECCLES JD, 1986, EUR J BIOCHEM, V155, P469, DOI 10.1111/j.1432-1033.1986.tb09513.x
   MCKERROW JH, 1993, ANNU REV MICROBIOL, V47, P821, DOI 10.1146/annurev.mi.47.100193.004133
   MEDINAACOSTA E, 1993, INFECT AGENT DIS, V2, P25
   MEDINAACOSTA E, 1994, MOL BIOCHEM PARASIT, V64, P273, DOI 10.1016/0166-6851(94)00029-8
   MURTA ACM, 1990, MOL BIOCHEM PARASIT, V43, P27, DOI 10.1016/0166-6851(90)90127-8
   North M.J., 1991, P180
   NORTH MJ, 1990, PARASITOL TODAY, V6, P270, DOI 10.1016/0169-4758(90)90189-B
   NORTH MJ, 1982, MICROBIOL REV, V46, P308, DOI 10.1128/MMBR.46.3.308-340.1982
   NORTH MJ, 1983, MOL BIOCHEM PARASIT, V9, P161, DOI 10.1016/0166-6851(83)90107-X
   PLESSMANNCAMARGO E, 1978, J PARASITOL, V64, P1120, DOI 10.2307/3279739
   SCHNEIDER PG, 1993, MOL BIOCHEM PARASIT, V28, P277
   SOUTOPADRON T, 1990, J CELL SCI, V96, P485
   TOWBIN H, 1979, P NATL ACAD SCI USA, V76, P4350, DOI 10.1073/pnas.76.9.4350
   URBINA JA, 1994, PARASITOL TODAY, V10, P107, DOI 10.1016/0169-4758(94)90010-8
   WALLACE FG, 1983, J PROTOZOOL, V30, P308, DOI 10.1111/j.1550-7408.1983.tb02921.x
NR 29
TC 29
Z9 31
U1 0
U2 0
PU WILEY-BLACKWELL
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1066-5234
EI 1550-7408
J9 J EUKARYOT MICROBIOL
JI J. Eukaryot. Microbiol.
PD MAR-APR
PY 1996
VL 43
IS 2
BP 131
EP 135
DI 10.1111/j.1550-7408.1996.tb04493.x
PG 5
WC Microbiology
SC Microbiology
GA UA109
UT WOS:A1996UA10900010
PM 8720943
DA 2020-12-01
ER

PT J
AU BRANQUINHA, MH
   VERMELHO, AB
   GOLDENBERG, S
   BONALDO, MC
AF BRANQUINHA, MH
   VERMELHO, AB
   GOLDENBERG, S
   BONALDO, MC
TI CHARACTERIZATION OF PROTEINASES IN TRYPANOSOMATIDS
SO BRAZILIAN JOURNAL OF MEDICAL AND BIOLOGICAL RESEARCH
LA English
DT Article; Proceedings Paper
CT GPI-Anchor Proteins: Structure and Function - 1994 Meeting
CY FEB 20-26, 1994
CL ANGRA DOS REIS, BRAZIL
DE PROTEINASES; TRYPANOSOMATIDS; PROTEINS
ID PROTEOLYTIC ACTIVITIES; CYSTEINE PROTEINASE; LEISHMANIA-MEXICANA; CRUZI;
   GLYCOPROTEIN; IDENTIFICATION; PROTEASE; GP63
AB Proteinases are important factors in the pathogenicity of many parasitic diseases. In this study, the proteolytic activities of 10 trypanosomatids from five different genera (Crithidia, Phytomonas, Endotrypanum, Trypanosoma and Leishmania) were determined by SDS-PAGE containing copolymerized gelatin as substrate. In almost all species we could detect two proteolytic classes, cysteine-and metalloproteinases, based on the inhibition of their activities by E-64 and 1,10-phenanthroline, respectively. In all cases, the metalloproteinase activities did not change over a broad pH range (from 5.5 to 10). E. schaudinni, T. mega, T. dionisii, C. Iuciliae, C. fasciculata, C. oncopelti and C. guilhermei expressed one or two metalloproteinases of 45-66 kDa, whereas in P. serpens and P. hyssopifolia a double band of this endopeptidase was detected at 94 kDa. In contrast, no metalloproteinase activity was observed in L. tarentolae. The optimal pH for the cysteine-proteinase activities was acidic (about 5.5). In E. schaudinni, T. mega and in Crithidia sp., these proteinases had an apparent molecular weight of 66-94 kDa, while L. tarentolae expressed a broad band from 29 to 45 kDa. In Phytomonas sp., this class of endopeptidase showed a unique feature, in that major cysteine-proteinases were found at 29-66 kDa, but multiple, low-activity bands were detected from 116 to 200 kDa. The most striking characteristic, however, was the very intense cysteine-proteinase activity expressed by T. dionisii (29-66 kDa). We conclude that these differences in the proteolytic profiles could be useful markers to characterize and compare trypanosomatids.
C1 FIOCRUZ MS,INST OSWALDO CRUZ,DEPT BIOQUIM & BIOL MOLEC,BR-21045900 RIO JANEIRO,RJ,BRAZIL.
RP BRANQUINHA, MH (corresponding author), UNIV FED RIO DE JANEIRO,INST MICROBIOL,DEPT MICROBIOL GERAL,BR-21949900 RIO JANEIRO,RJ,BRAZIL.
RI VERMELHO/J-8803-2013; GOLDENBERG, SAMUEL/B-4116-2009; Bonaldo, Myrna
   C/D-9494-2013; Branquinha, Marta/AAA-3084-2019; P, CM/B-1358-2013
OI VERMELHO/0000-0001-5926-4172; GOLDENBERG, SAMUEL/0000-0002-4892-163X; 
CR ASCHALL F, 1990, MOL BIOCHEM PARASIT, V38, P77
   BONALDO MC, 1991, EXPT PARASITOLOGY, V73, P444
   BONTEMPI E, 1989, MOL BIOCHEM PARASIT, V33, P43, DOI 10.1016/0166-6851(89)90040-6
   BORDIER C, 1987, PARASITOL TODAY, V3, P151, DOI 10.1016/0169-4758(87)90199-2
   BOUVIER J, 1989, MOL BIOCHEM PARASIT, V37, P235, DOI 10.1016/0166-6851(89)90155-2
   BRAUNBRETON C, 1988, NATURE, V332, P457, DOI 10.1038/332457a0
   CHANG CS, 1986, P NATL ACAD SCI USA, V83, P100, DOI 10.1073/pnas.83.1.100
   CHAUDHURI G, 1989, J BIOL CHEM, V264, P7483
   ETGES R, 1992, ACTA TROP, V50, P205, DOI 10.1016/0001-706X(92)90077-B
   ETGES RJ, 1987, J BIOL CHEM, V261, P9099
   HEUSSEN C, 1980, ANAL BIOCHEM, V102, P196, DOI 10.1016/0003-2697(80)90338-3
   ITOW S, 1977, J PROTOZOOL, V24, P591, DOI 10.1111/j.1550-7408.1977.tb01021.x
   MCKERROW JH, 1989, EXP PARASITOL, V68, P111, DOI 10.1016/0014-4894(89)90016-7
   MURTA ACM, 1990, MOL BIOCHEM PARASIT, V43, P27, DOI 10.1016/0166-6851(90)90127-8
   PIRAS MM, 1985, MOL BIOCHEM PARASIT, V14, P151, DOI 10.1016/0166-6851(85)90034-9
   RUSSELL DG, 1987, EUR J BIOCHEM, V164, P213, DOI 10.1111/j.1432-1033.1987.tb11013.x
   SCHARFSTEIN J, 1986, J IMMUNOL, V137, P1336
   TORRUELLA M, 1981, COMP BIOCHEM PHYS B, V70, P463, DOI 10.1016/0305-0491(81)90283-2
NR 18
TC 7
Z9 7
U1 0
U2 0
PU ASSOC BRAS DIVULG CIENTIFICA
PI SAO PAULO
PA FACULDADE MEDICINA, SALA 21, 14049 RIBEIRAO PRETO, SAO PAULO, BRAZIL
SN 0100-879X
J9 BRAZ J MED BIOL RES
JI Brazilian J. Med. Biol. Res.
PD FEB
PY 1994
VL 27
IS 2
BP 495
EP 499
PG 5
WC Biology; Medicine, Research & Experimental
SC Life Sciences & Biomedicine - Other Topics; Research & Experimental
   Medicine
GA MX609
UT WOS:A1994MX60900059
PM 8081271
DA 2020-12-01
ER

PT J
AU BONALDO, MC
   SALLES, JM
   DESCOFFIER, LN
   GOLDENBERG, S
AF BONALDO, MC
   SALLES, JM
   DESCOFFIER, LN
   GOLDENBERG, S
TI CHARACTERIZATION OF METALLOPROTEINASES IN TRYPANOSOMA-CRUZI
SO JOURNAL OF CELLULAR BIOCHEMISTRY
LA English
DT Meeting Abstract
C1 FIOCRUZ MS,DEPT BIOCHEM MOLEC BIOL,BR-21045900 RIO JANEIRO,BRAZIL.
RI Bonaldo, Myrna C/D-9494-2013; P, CM/B-1358-2013
NR 0
TC 0
Z9 0
U1 0
U2 0
PU WILEY-LISS
PI NEW YORK
PA DIV JOHN WILEY & SONS INC 605 THIRD AVE, NEW YORK, NY 10158-0012
SN 0730-2312
J9 J CELL BIOCHEM
JI J. Cell. Biochem.
PY 1994
SU 18D
BP 165
EP 165
PG 1
WC Biochemistry & Molecular Biology; Cell Biology
SC Biochemistry & Molecular Biology; Cell Biology
GA NE254
UT WOS:A1994NE25400516
DA 2020-12-01
ER

PT J
AU BONALDO, MC
   DESCOFFIER, LN
   SALLES, JM
   GOLDENBERG, S
AF BONALDO, MC
   DESCOFFIER, LN
   SALLES, JM
   GOLDENBERG, S
TI CHARACTERIZATION AND EXPRESSION OF PROTEASES DURING TRYPANOSOMA-CRUZI
   METACYCLOGENESIS
SO EXPERIMENTAL PARASITOLOGY
LA English
DT Article
DE TRYPANOSOMA-CRUZI; CELL DIFFERENTIATION; PROTEASES; TRANS-EPOXYSUCCINIL
   LEUCYLAMIDO-(4-GUANIDINO) BUTANE (E-64); N-ALPHA-TOSYL-L-LYSINE
   CHLOROMETHYL KETONE (TLCK); TOSYL PHENYLALANYL CHLOROMETHYL KETONE
   (TPCK); PHENYLMETHYLSULFONYL FLUORIDE (PMSF); ETHYLENEDIAMINETETRAACETIC
   ACID (EDTA); ETHYLENE-BIS(OXY-ETHYLENENITRILO) TETRAACETIC ACID (EGTA);
   LIVER INFUSION TRYPTOSE (LIT); ARTIFICIAL TRIATOMINE URINE (TAU);
   DIETHYLAMINOETHANE (DEAE); NONIDET-P40 (NP-40); SODIUM DODECYL SULFATE
   (SDS); PHOSPHATE-BUFFERED SALINE (PBS);
   BENZYLOXYCARBONYLPHENYLALANYLDIAZOMETHANE (Z-PHE-ALA-CHN2)
RP BONALDO, MC (corresponding author), FUNDACAO OSWALDO CRUZ, DEPT BIOQUIM & BIOL MOLEC, AVE BRASIL 4365, BR-21040 RIO DE JANEIRO, BRAZIL.
RI Bonaldo, Myrna C/D-9494-2013; GOLDENBERG, SAMUEL/B-4116-2009; P,
   CM/B-1358-2013
OI GOLDENBERG, SAMUEL/0000-0002-4892-163X; 
CR ASHALL F, 1990, MOL BIOCHEM PARASIT, V38, P77, DOI 10.1016/0166-6851(90)90207-3
   Auxiliadora de Sousa M., 1983, Memorias do Instituto Oswaldo Cruz, V78, P317, DOI 10.1590/S0074-02761983000300009
   BARRETT AJ, 1982, BIOCHEM J, V201, P189, DOI 10.1042/bj2010189
   BONALDO MC, 1988, J CELL BIOL, V106, P1349, DOI 10.1083/jcb.106.4.1349
   BONALDO MC, 1991, IN PRESS PARASITOLOG
   BONGERTZ V, 1978, EXP PARASITOL, V45, P8, DOI 10.1016/0014-4894(78)90039-5
   BONTEMPI E, 1989, MOL BIOCHEM PARASIT, V33, P43, DOI 10.1016/0166-6851(89)90040-6
   BONTEMPI E, 1984, COMP BIOCHEM PHYS B, V77, P599, DOI 10.1016/0305-0491(84)90282-7
   BORDIER C, 1987, PARASITOL TODAY, V3, P151, DOI 10.1016/0169-4758(87)90199-2
   BOUVIER J, 1989, MOL BIOCHEM PARASIT, V37, P235, DOI 10.1016/0166-6851(89)90155-2
   BRAUNBRETON C, 1988, NATURE, V332, P457, DOI 10.1038/332457a0
   CamargO E. P., 1964, Revista do Instituto de Medicina Tropical de Sao Paulo, V6, P93
   CONTRERAS V T, 1988, Memorias do Instituto Oswaldo Cruz, V83, P123, DOI 10.1590/S0074-02761988000100016
   DESOUZA W, 1984, INT REV CYTOL, V86, P197, DOI 10.1016/S0074-7696(08)60180-1
   EAKIN AE, 1990, MOL BIOCHEM PARASIT, V39, P1, DOI 10.1016/0166-6851(90)90002-4
   GREIG S, 1990, MOL BIOCHEM PARASIT, V39, P31, DOI 10.1016/0166-6851(90)90005-7
   HEUSSEN C, 1980, ANAL BIOCHEM, V102, P196, DOI 10.1016/0003-2697(80)90338-3
   ITOW S, 1977, J PROTOZOOL, V24, P591, DOI 10.1111/j.1550-7408.1977.tb01021.x
   KIRSCHKE H, 1981, BIOCHEM BIOPH RES CO, V101, P454, DOI 10.1016/0006-291X(81)91281-X
   MCKERROW JH, 1989, EXP PARASITOL, V68, P111, DOI 10.1016/0014-4894(89)90016-7
   MOTTRAM JC, 1989, FEBS LETT, V258, P211, DOI 10.1016/0014-5793(89)81655-2
   MURTA ACM, 1990, MOL BIOCHEM PARASIT, V43, P27, DOI 10.1016/0166-6851(90)90127-8
   OFARRELL PH, 1975, J BIOL CHEM, V250, P4007
   PIRAS MM, 1985, MOL BIOCHEM PARASIT, V14, P151, DOI 10.1016/0166-6851(85)90034-9
   RANGEL HA, 1981, TROPENMED PARASITOL, V32, P87
   SCHARFSTEIN J, 1986, J IMMUNOL, V137, P1336
   TORRUELLA M, 1981, COMP BIOCHEM PHYS B, V70, P463, DOI 10.1016/0305-0491(81)90283-2
   TOWBIN H, 1979, P NATL ACAD SCI USA, V76, P4350, DOI 10.1073/pnas.76.9.4350
NR 28
TC 78
Z9 80
U1 0
U2 1
PU ACADEMIC PRESS INC ELSEVIER SCIENCE
PI SAN DIEGO
PA 525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA
SN 0014-4894
EI 1090-2449
J9 EXP PARASITOL
JI Exp. Parasitol.
PD JUL
PY 1991
VL 73
IS 1
BP 44
EP 51
DI 10.1016/0014-4894(91)90006-I
PG 8
WC Parasitology
SC Parasitology
GA FW118
UT WOS:A1991FW11800005
PM 2055300
DA 2020-12-01
ER

PT J
AU BONALDO, MC
   SCHARFSTEIN, J
   MURTA, ACM
   GOLDENBERG, S
AF BONALDO, MC
   SCHARFSTEIN, J
   MURTA, ACM
   GOLDENBERG, S
TI FURTHER CHARACTERIZATION OF TRYPANOSOMA-CRUZI GP57/51 AS THE MAJOR
   ANTIGEN EXPRESSED BY DIFFERENTIATING EPIMASTIGOTES
SO PARASITOLOGY RESEARCH
LA English
DT Article
ID VECTOR TRIATOMA-INFESTANS; CYSTEINE PROTEINASE; CHAGAS-DISEASE;
   IDENTIFICATION; BIOLOGY; STRAINS; RECTUM; CELLS
AB Study of Trypanosoma cruzi metacyclogenesis under chemically defined conditions showed that the expression of a group of acidic polypeptides with a molecular weight of 45-50 kDa is markedly increased on adhesion of epimastigotes to the culture vessels. Immunochemical analysis revealed that these developmentally regulated polypeptides are structurally related to, and possibly homologous with, a major T. cruzi antigen, namely, GP57/51, a glycoprotein that has recently been characterized as a cysteine proteinase. The differentiation of epimastigotes into metacyclic trypomastigotes is accompanied by a 2- to 5-fold reduction in the concentration of GP57/51 antigen as determined by radioimmunoassays using monoclonal antibodies. Two-dimensional polyacrylamide gel electrophoretic analysis of metabolically labelled parasites indicated that this antigen is synthesized as a precursor with a molecular weight of 60 kDa, which is then processed to a level of 45-50 kDa via the formation of at least one intermediate processing product. The observation that expression of GP57/51-related products increases during epimastigote differentiation suggests an important role for this proteinase during the life cycle of T. cruzi.
C1 FUNDACAO OSWALDO CRUZ, DEPT BIOQUIM & BIOL MOLEC, AVE BRASIL 4365, BR-21040 RIO DE JANEIRO, BRAZIL.
   UNIV FED RIO DE JANEIRO, INST BIOFIS CARLOS CHAGAS FILHO, RIO DE JANEIRO, BRAZIL.
RI P, CM/B-1358-2013; Bonaldo, Myrna C/D-9494-2013; GOLDENBERG,
   SAMUEL/B-4116-2009
OI GOLDENBERG, SAMUEL/0000-0002-4892-163X
CR Auxiliadora de Sousa M., 1983, Memorias do Instituto Oswaldo Cruz, V78, P317, DOI 10.1590/S0074-02761983000300009
   BOKER CA, 1984, Z PARASITENKD, V70, P459, DOI 10.1007/BF00926686
   BONALDO MC, 1988, J CELL BIOL, V106, P1349, DOI 10.1083/jcb.106.4.1349
   BONALDO MC, 1991, IN PRESS EXP PARASIT
   BRENER Z, 1973, ANNU REV MICROBIOL, V27, P347, DOI 10.1146/annurev.mi.27.100173.002023
   CamargO E. P., 1964, Revista do Instituto de Medicina Tropical de Sao Paulo, V6, P93
   CAZZULO JJ, 1989, MOL BIOCHEM PARASIT, V33, P33, DOI 10.1016/0166-6851(89)90039-X
   CONTRERAS V T, 1988, Memorias do Instituto Oswaldo Cruz, V83, P123, DOI 10.1590/S0074-02761988000100016
   CONTRERAS VT, 1985, MOL BIOCHEM PARASIT, V16, P315, DOI 10.1016/0166-6851(85)90073-8
   DESOUZA W, 1984, INT REV CYTOL, V86, P197, DOI 10.1016/S0074-7696(08)60180-1
   Dias E., 1934, Memorias do Instituto Oswaldo Cruz, V28, P1, DOI 10.1590/S0074-02761934000100001
   EAKIN AE, 1990, MOL BIOCHEM PARASIT, V39, P1, DOI 10.1016/0166-6851(90)90002-4
   GAZZINELLI RT, 1990, INFECT IMMUN, V58, P1437, DOI 10.1128/IAI.58.5.1437-1444.1990
   Gutteridge W.E., 1979, P619
   LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0
   LASKEY RA, 1977, FEBS LETT, V82, P314, DOI 10.1016/0014-5793(77)80609-1
   MASON RW, 1986, BIOCHEM J, V240, P373, DOI 10.1042/bj2400373
   MENDONCAPREVIATO L, 1983, BIOCHEMISTRY-US, V22, P4980, DOI 10.1021/bi00290a016
   MURTA ACM, 1990, MOL BIOCHEM PARASIT, V43, P27, DOI 10.1016/0166-6851(90)90127-8
   OFARRELL PZ, 1977, CELL, V12, P1133, DOI 10.1016/0092-8674(77)90176-3
   RANGEL HA, 1981, TROPENMED PARASITOL, V32, P87
   SCHARFSTEIN J, 1986, J IMMUNOL, V137, P1336
   SCHARFSTEIN J, 1985, AM J TROP MED HYG, V34, P1153, DOI 10.4269/ajtmh.1985.34.1153
   SCHARFSTEIN J, 1983, J IMMUNOL, V131, P972
   SCHAUB GA, 1989, EXP PARASITOL, V68, P260, DOI 10.1016/0014-4894(89)90108-2
   ZELEDON R, 1984, ACTA TROP, V41, P39
   ZINGALES B, 1985, CURR TOP MICROBIOL, V117, P129
NR 27
TC 21
Z9 21
U1 0
U2 1
PU SPRINGER
PI NEW YORK
PA 233 SPRING ST, NEW YORK, NY 10013 USA
SN 0932-0113
EI 1432-1955
J9 PARASITOL RES
JI Parasitol. Res.
PY 1991
VL 77
IS 7
BP 567
EP 571
DI 10.1007/BF00931014
PG 5
WC Parasitology
SC Parasitology
GA GG354
UT WOS:A1991GG35400004
PM 1792225
DA 2020-12-01
ER

PT J
AU KRIEGER, MA
   SALLES, JM
   ALMEIDA, E
   LINSS, J
   BONALDO, MC
   GOLDENBERG, S
AF KRIEGER, MA
   SALLES, JM
   ALMEIDA, E
   LINSS, J
   BONALDO, MC
   GOLDENBERG, S
TI EXPRESSION AND POLYMORPHISM OF A TRYPANOSOMA-CRUZI GENE ENCODING A
   CYTOPLASMIC REPETITIVE ANTIGEN
SO EXPERIMENTAL PARASITOLOGY
LA English
DT Article
C1 FUNDACAO OSWALDO CRUZ, DEPT BIOL MOLEC, BR-21040 RIO DE JANEIRO, BRAZIL.
   FUNDACAO OSWALDO CRUZ, DEPT BIOMANGUINHOS, BR-21040 RIO DE JANEIRO, BRAZIL.
   UNIV FED FLUMINENSE, BR-24000 NITEROI, RJ, BRAZIL.
RP KRIEGER, MA (corresponding author), FUNDACAO OSWALDO CRUZ, DEPT BIOQUIM, BRASIL 4365, BR-21040 RIO DE JANEIRO, BRAZIL.
RI Krieger, Marco/AAE-8611-2020; Bonaldo, Myrna C/D-9494-2013; GOLDENBERG,
   SAMUEL/B-4116-2009; P, CM/B-1358-2013
OI GOLDENBERG, SAMUEL/0000-0002-4892-163X; 
CR ANDREWS NW, 1987, EXP PARASITOL, V64, P474, DOI 10.1016/0014-4894(87)90062-2
   AYMERICH S, 1989, EXP PARASITOL, V69, P107, DOI 10.1016/0014-4894(89)90178-1
   BONALDO MC, 1988, J CELL BIOL, V106, P1349, DOI 10.1083/jcb.106.4.1349
   BONGERTZ V, 1983, AM J TROP MED HYG, V32, P716, DOI 10.4269/ajtmh.1983.32.716
   BUTTON LL, 1989, MOL BIOCHEM PARASIT, V32, P271, DOI 10.1016/0166-6851(89)90076-5
   CamargO E. P., 1964, Revista do Instituto de Medicina Tropical de Sao Paulo, V6, P93
   Chagas C., 1909, MEM I OSWALDO CRUZ, V1, P159, DOI DOI 10.1590/S0074-02761909000200008
   CHIRGWIN JM, 1979, BIOCHEMISTRY-US, V18, P5294, DOI 10.1021/bi00591a005
   CONTRERAS V T, 1988, Memorias do Instituto Oswaldo Cruz, V83, P123, DOI 10.1590/S0074-02761988000100016
   CONTRERAS VT, 1985, MOL BIOCHEM PARASIT, V14, P83, DOI 10.1016/0166-6851(85)90108-2
   DEANE MP, 1974, EXP PARASITOL, V35, P406, DOI 10.1016/0014-4894(74)90046-0
   ENGMAN DM, 1987, MOL BIOCHEM PARASIT, V22, P115, DOI 10.1016/0166-6851(87)90041-7
   FLINT JE, 1984, T ROY SOC TROP MED H, V78, P193, DOI 10.1016/0035-9203(84)90276-1
   GONZALEZ A, 1985, NUCLEIC ACIDS RES, V13, P5789, DOI 10.1093/nar/13.16.5789
   HOFT DF, 1989, INFECT IMMUN, V57, P1959, DOI 10.1128/IAI.57.7.1959-1967.1989
   IBANEZ CF, 1988, MOL BIOCHEM PARASIT, V30, P27, DOI 10.1016/0166-6851(88)90129-6
   JOHNSON PJ, 1987, CELL, V51, P273, DOI 10.1016/0092-8674(87)90154-1
   KATZIN AM, 1983, BIOCHIM BIOPHYS ACTA, V727, P403, DOI 10.1016/0005-2736(83)90425-X
   KIRCHHOFF LV, 1988, J BIOL CHEM, V263, P12698
   KIRCHHOFF LV, 1984, MOL BIOCHEM PARASIT, V11, P81, DOI 10.1016/0166-6851(84)90056-2
   KLOETZEL J, 1975, J PROTOZOOL, V22, P259, DOI 10.1111/j.1550-7408.1975.tb05862.x
   KOOTER JM, 1987, CELL, V51, P261, DOI 10.1016/0092-8674(87)90153-X
   LAFAILLE JJ, 1989, PARASITOLOGY, V35, P127
   LEHRACH H, 1977, BIOCHEMISTRY-US, V16, P4743, DOI 10.1021/bi00640a033
   MOREL C, 1980, P NATL ACAD SCI-BIOL, V77, P6810, DOI 10.1073/pnas.77.11.6810
   NOGUEIRA N, 1982, P NATL ACAD SCI-BIOL, V79, P1259, DOI 10.1073/pnas.79.4.1259
   NUSSENZWEIG V, 1963, EXP PARASITOL, V14, P221, DOI 10.1016/0014-4894(63)90027-4
   PETERSON DS, 1986, NATURE, V322, P566, DOI 10.1038/322566a0
   PLATA F, 1984, EUR J IMMUNOL, V14, P392, DOI 10.1002/eji.1830140503
   Silva L. H. P., 1953, FOLIA CLIN BIOL, V20, P191
   SNARY D, 1981, MOL BIOCHEM PARASIT, V3, P343, DOI 10.1016/0166-6851(81)90035-9
   SOUTHERN EM, 1975, J MOL BIOL, V98, P503, DOI 10.1016/S0022-2836(75)80083-0
   SOUTOPADRON T, 1985, BIOCHIM BIOPHYS ACTA, V814, P163, DOI 10.1016/0005-2736(85)90432-8
   SWINDLE J, 1988, EMBO J, V7, P1121, DOI 10.1002/j.1460-2075.1988.tb02921.x
   TIBAYRENC M, 1986, P NATL ACAD SCI USA, V83, P115, DOI 10.1073/pnas.83.1.115
   TIBAYRENC M, 1987, PARASITOL TODAY, V3, P189, DOI 10.1016/0169-4758(87)90179-7
   TOWBIN H, 1979, P NATL ACAD SCI USA, V76, P4350, DOI 10.1073/pnas.76.9.4350
   TSCHUDI C, 1988, EMBO J, V7, P455, DOI 10.1002/j.1460-2075.1988.tb02833.x
   VOLLER A, 1975, TROPENMED PARASITOL, V26, P247
   WISDOM GB, 1976, CLIN CHEM, V22, P1243
   ZINGALES B, 1984, ACTA TROP, V41, P5
NR 41
TC 15
Z9 15
U1 0
U2 2
PU ACADEMIC PRESS INC ELSEVIER SCIENCE
PI SAN DIEGO
PA 525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA
SN 0014-4894
EI 1090-2449
J9 EXP PARASITOL
JI Exp. Parasitol.
PD APR
PY 1990
VL 70
IS 3
BP 247
EP 254
DI 10.1016/0014-4894(90)90106-M
PG 8
WC Parasitology
SC Parasitology
GA CV477
UT WOS:A1990CV47700001
PM 1690143
DA 2020-12-01
ER

PT J
AU SOARES, MJ
   SOUTOPADRON, T
   BONALDO, MC
   GOLDENBERG, S
   DESOUZA, W
AF SOARES, MJ
   SOUTOPADRON, T
   BONALDO, MC
   GOLDENBERG, S
   DESOUZA, W
TI A STEREOLOGICAL STUDY OF THE DIFFERENTIATION PROCESS IN
   TRYPANOSOMA-CRUZI
SO PARASITOLOGY RESEARCH
LA English
DT Article
C1 UNIV FED RIO DE JANEIRO,INST BIOFIS CARLOS CHAGAS FILHO,BR-21941 RIO DE JANEIRO,RJ,BRAZIL.
   UNIV FED PERNAMBUCO,IMUNOPATOL KEIZO AZAMI LAB,BR-50000 RECIFE,PE,BRAZIL.
   INST OSWALDO CRUZ,DEPT ULTRASTRUTURA & BIOL CELULAR,BR-21040 RIO DE JANEIRO,RJ,BRAZIL.
   INST OSWALDO CRUZ,DEPT BIOQUIM & BIOL MOLEC,BR-21040 RIO DE JANEIRO,RJ,BRAZIL.
RI Bonaldo, Myrna C/D-9494-2013; Soares, Maurilio J/I-4627-2016; P,
   CM/B-1358-2013; GOLDENBERG, SAMUEL/B-4116-2009
OI Soares, Maurilio J/0000-0001-9701-836X; GOLDENBERG,
   SAMUEL/0000-0002-4892-163X
CR BOHRINGER S, 1974, J PROTOZOOL, V21, P694, DOI 10.1111/j.1550-7408.1974.tb03731.x
   BOHRINGER S, 1975, J PROTOZOOL, V22, P463, DOI 10.1111/j.1550-7408.1975.tb05210.x
   BONALDO MC, 1988, J CELL BIOL, V106, P1349, DOI 10.1083/jcb.106.4.1349
   BRENER Z, 1973, ANNU REV MICROBIOL, V27, P347, DOI 10.1146/annurev.mi.27.100173.002023
   BRETANA A, 1976, INT J PARASITOL, V6, P379, DOI 10.1016/0020-7519(76)90022-9
   CONTRERAS VT, 1985, MOL BIOCHEM PARASIT, V16, P315, DOI 10.1016/0166-6851(85)90073-8
   DESOUZA W, 1978, EXP PARASITOL, V45, P101, DOI 10.1016/0014-4894(78)90050-4
   DESOUZA W, 1984, INT REV CYTOL, V86, P197, DOI 10.1016/S0074-7696(08)60180-1
   DVORAK JA, 1982, J PROTOZOOL, V29, P430, DOI 10.1111/j.1550-7408.1982.tb05427.x
   FORBES MS, 1977, J ULTRA MOL STRUCT R, V60, P306, DOI 10.1016/S0022-5320(77)80016-6
   GOLDENBERG S, 1987, MOL STRATEGIES PARAS, P203
   GUTTERIDGE WE, 1979, BIOL KINETOPLASTIDA, V2, P619
   SOARES MJ, 1988, J SUBMICR CYTOL PATH, V20, P349
   SOARES MJ, 1987, J PROTOZOOL, V34, P199, DOI 10.1111/j.1550-7408.1987.tb03160.x
   Weibel E R, 1969, Int Rev Cytol, V26, P235, DOI 10.1016/S0074-7696(08)61637-X
NR 15
TC 43
Z9 44
U1 0
U2 1
PU SPRINGER VERLAG
PI NEW YORK
PA 175 FIFTH AVE, NEW YORK, NY 10010
SN 0044-3255
J9 PARASITOL RES
JI Parasitol. Res.
PY 1989
VL 75
IS 7
BP 522
EP 527
DI 10.1007/BF00931160
PG 6
WC Parasitology
SC Parasitology
GA AF314
UT WOS:A1989AF31400004
PM 2549536
DA 2020-12-01
ER

PT J
AU BONALDO, MC
   SOUTOPADRON, T
   DESOUZA, W
   GOLDENBERG, S
AF BONALDO, MC
   SOUTOPADRON, T
   DESOUZA, W
   GOLDENBERG, S
TI CELL SUBSTRATE ADHESION DURING TRYPANOSOMA-CRUZI DIFFERENTIATION
SO JOURNAL OF CELL BIOLOGY
LA English
DT Article
C1 UNIV FED RIO DE JANEIRO, INST BIOFIS CARLOS CHAGAS FILHO, ULTRAESTRUT CELULAR LAB, BR-21040 RIO DE JANEIRO, BRAZIL.
RP BONALDO, MC (corresponding author), FDN OSWALDO CRUZ, DEPT BIOQUIM & BIOL MOLEC, BR-21040 RIO DE JANEIRO, BRAZIL.
RI Bonaldo, Myrna C/D-9494-2013; P, CM/B-1358-2013; GOLDENBERG,
   SAMUEL/B-4116-2009
OI GOLDENBERG, SAMUEL/0000-0002-4892-163X
CR BOKER CA, 1984, Z PARASITENKD, V70, P459, DOI 10.1007/BF00926686
   BRENER Z, 1973, ANNU REV MICROBIOL, V27, P347, DOI 10.1146/annurev.mi.27.100173.002023
   CamargO E. P., 1964, Revista do Instituto de Medicina Tropical de Sao Paulo, V6, P93
   CAMARGO EP, 1982, J IMMUNOL METHODS, V52, P245, DOI 10.1016/0022-1759(82)90051-5
   CHAGAS C, 1909, MEM I O CRUZ RIO DE, V1, P1062
   CONTRERAS VT, 1985, MOL BIOCHEM PARASIT, V16, P315, DOI 10.1016/0166-6851(85)90073-8
   CONTRERAS VT, 1985, MOL BIOCHEM PARASIT, V14, P83, DOI 10.1016/0166-6851(85)90108-2
   DESOUZA W, 1984, INT REV CYTOL, V86, P197, DOI 10.1016/S0074-7696(08)60180-1
   Dias E., 1934, Memorias do Instituto Oswaldo Cruz, V28, P1, DOI 10.1590/S0074-02761934000100001
   EDELMAN GM, 1985, ANNU REV BIOCHEM, V54, P135, DOI 10.1146/annurev.bi.54.070185.001031
   FRAKER PJ, 1978, BIOCHEM BIOPH RES CO, V80, P849, DOI 10.1016/0006-291X(78)91322-0
   GERISCH G, 1986, J CELL SCI, P201
   Goldenberg S., 1987, UCLA (University of California Los Angeles) Symposia on Molecular and Cellular Biology New Series, V42, P203
   LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0
   LASKEY RA, 1977, FEBS LETT, V82, P314, DOI 10.1016/0014-5793(77)80609-1
   OFARRELL PH, 1975, J BIOL CHEM, V250, P4007
   SOUTOPADRON T, 1985, BIOCHIM BIOPHYS ACTA, V814, P163, DOI 10.1016/0005-2736(85)90432-8
   SOUTOPADRON T, 1984, ACTA TROP, V41, P215
   VICKERMAN K, 1976, BIOLOGY KINETOPLASTI, V1, P35
   ZELEDON R, 1984, ACTA TROP, V41, P39
NR 20
TC 134
Z9 134
U1 0
U2 6
PU ROCKEFELLER UNIV PRESS
PI NEW YORK
PA 950 THIRD AVE, 2ND FLR, NEW YORK, NY 10022 USA
SN 0021-9525
EI 1540-8140
J9 J CELL BIOL
JI J. Cell Biol.
PD APR
PY 1988
VL 106
IS 4
BP 1349
EP 1358
DI 10.1083/jcb.106.4.1349
PG 10
WC Cell Biology
SC Cell Biology
GA N1837
UT WOS:A1988N183700034
PM 3283152
OA Bronze, Green Published
DA 2020-12-01
ER

PT J
AU GIOVANNIDESIMONE, S
   BONALDO, MC
   PINHO, RT
   PONTESDECARVALHO, LC
   GALVAOCASTRO, B
   GOLDENBERG, S
AF GIOVANNIDESIMONE, S
   BONALDO, MC
   PINHO, RT
   PONTESDECARVALHO, LC
   GALVAOCASTRO, B
   GOLDENBERG, S
TI A STUDY ON THE AMPHIPHILIC PROTEINS OF 3 TRYPANOSOMA-CRUZI POPULATIONS
SO BRAZILIAN JOURNAL OF MEDICAL AND BIOLOGICAL RESEARCH
LA English
DT Article
C1 FDN OSWALDO CRUZ, DEPT BIOQUIM & BIOL MOLEC, AV BRASIL 4365, BR-21040 RIO DE JANEIRO, RJ, BRAZIL.
   WHO, COLLABORATING CTR IMMUNOL PARASIT DIS, DEPT IMUNOL, RIO DE JANIERO, RJ, BRAZIL.
RI Bonaldo, Myrna C/D-9494-2013; GOLDENBERG, SAMUEL/B-4116-2009; P,
   CM/B-1358-2013; De-Simone, Salvatore/I-2989-2013
OI GOLDENBERG, SAMUEL/0000-0002-4892-163X; De-Simone,
   Salvatore/0000-0002-2172-656X
CR ANDRADE S. G., 1974, Revista de Patologia Tropical, V3, P65
   Andrade S. G, 1970, Gaz. Med. Bahia, V70, P32
   ANDREWS NM, 1988, IN PRESS J EXPT MED
   ARAUJO FG, 1981, J IMMUNOL, V127, P855
   BORDIER C, 1981, J BIOL CHEM, V256, P1604
   BORDIER C, 1986, P NATL ACAD SCI USA, V83, P5988, DOI 10.1073/pnas.83.16.5988
   BRENER Z, 1973, ANNU REV MICROBIOL, V27, P347, DOI 10.1146/annurev.mi.27.100173.002023
   BRENER Z, 1963, Rev Inst Med Trop Sao Paulo, V5, P220
   BRENER Z, 1965, ANN TROP MED PARASIT, V59, P19, DOI 10.1080/00034983.1965.11686277
   CamargO E. P., 1964, Revista do Instituto de Medicina Tropical de Sao Paulo, V6, P93
   Cancado J.R., 1979, TRYPANOSOMA CRUZI DO, P362
   Chagas C., 1909, MEM I OSWALDO CRUZ, V1, P159, DOI DOI 10.1590/S0074-02761909000200008
   CONTRERAS VT, 1985, MOL BIOCHEM PARASIT, V16, P315, DOI 10.1016/0166-6851(85)90073-8
   CONTRERAS VT, 1985, MOL BIOCHEM PARASIT, V14, P83, DOI 10.1016/0166-6851(85)90108-2
   DASILVEIRA JF, 1979, BIOCHIM BIOPHYS ACTA, V550, P222, DOI 10.1016/0005-2736(79)90209-8
   DESIMONE SG, 1987, IN PRESS T ROYAL SOC
   FEDERICI EE, 1964, AM J TROP MED HYG, V13, P272, DOI 10.4269/ajtmh.1964.13.272
   FLINT JE, 1984, T ROY SOC TROP MED H, V78, P193, DOI 10.1016/0035-9203(84)90276-1
   KRETTLI AU, 1982, T ROY SOC TROP MED H, V76, P334, DOI 10.1016/0035-9203(82)90184-5
   LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0
   LOWRY OH, 1951, J BIOL CHEM, V193, P265
   MANCINI PE, 1982, BIOCHIM BIOPHYS ACTA, V688, P399, DOI 10.1016/0005-2736(82)90351-0
   MARKWELL MAK, 1978, BIOCHEMISTRY-US, V17, P4807, DOI 10.1021/bi00615a031
   MORGADO MG, 1985, Z PARASITENKD, V71, P169, DOI 10.1007/BF00926267
   Muniz Julio, 1945, REV BRASIL BIOL, V5, P563
   NUSSENZWEIG V, 1963, EXP PARASITOL, V14, P221, DOI 10.1016/0014-4894(63)90027-4
   OFARRELL PZ, 1977, CELL, V12, P1133, DOI 10.1016/0092-8674(77)90176-3
   PEREIRA NM, 1978, EXP PARASITOL, V46, P225, DOI 10.1016/0014-4894(78)90135-2
   SEGURA EL, 1974, J PROTOZOOL, V21, P571, DOI 10.1111/j.1550-7408.1974.tb03703.x
   SWANSTROM R, 1978, ANAL BIOCHEM, V86, P184, DOI 10.1016/0003-2697(78)90333-0
   WANG CS, 1975, ANAL BIOCHEM, V63, P414, DOI 10.1016/0003-2697(75)90363-2
   YOSHIDA N, 1983, INFECT IMMUN, V40, P836, DOI 10.1128/IAI.40.2.836-839.1983
   ZINGALES B, 1979, BIOCHIM BIOPHYS ACTA, V550, P233, DOI 10.1016/0005-2736(79)90210-4
NR 33
TC 2
Z9 2
U1 0
U2 0
PU ASSOC BRAS DIVULG CIENTIFICA
PI SAO PAULO
PA FACULDADE MEDICINA, SALA 21, 14049 RIBEIRAO PRETO, SAO PAULO, 00, BRAZIL
SN 0100-879X
EI 1678-4510
J9 BRAZ J MED BIOL RES
JI Brazilian J. Med. Biol. Res.
PY 1988
VL 21
IS 3
BP 435
EP 443
PG 9
WC Biology; Medicine, Research & Experimental
SC Life Sciences & Biomedicine - Other Topics; Research & Experimental
   Medicine
GA N9180
UT WOS:A1988N918000004
PM 2465801
DA 2020-12-01
ER

PT J
AU GOLDENBERG, S
   CONTRERAS, VT
   SALLES, JM
   BONALDO, MC
   FRANCO, MPAL
   LINSS, J
   LAFAILLE, J
   MOREL, CM
AF GOLDENBERG, S
   CONTRERAS, VT
   SALLES, JM
   BONALDO, MC
   FRANCO, MPAL
   LINSS, J
   LAFAILLE, J
   MOREL, CM
TI STATE SPECIFIC GENE-EXPRESSION DURING TRYPANOSOMA-CRUZI DEVELOPMENT
SO JOURNAL OF CELLULAR BIOCHEMISTRY
LA English
DT Meeting Abstract
C1 FIOCRUZ,DEPT BIOCHEM & MOLEC BIOL,RIO DE JANEIRO,BRAZIL.
RI P, CM/B-1358-2013; Morel, Carlos/Q-9657-2019; Bonaldo, Myrna
   C/D-9494-2013; Morel, Carlos M/B-4079-2009
OI Morel, Carlos/0000-0003-2752-0009; Morel, Carlos M/0000-0003-2752-0009
NR 0
TC 0
Z9 0
U1 0
U2 0
PU WILEY-LISS
PI NEW YORK
PA DIV JOHN WILEY & SONS INC 605 THIRD AVE, NEW YORK, NY 10158-0012
SN 0730-2312
J9 J CELL BIOCHEM
JI J. Cell. Biochem.
PY 1986
SU 10A
BP 174
EP 174
PG 1
WC Biochemistry & Molecular Biology; Cell Biology
SC Biochemistry & Molecular Biology; Cell Biology
GA AYE10
UT WOS:A1986AYE1000463
DA 2020-12-01
ER

PT J
AU BASTOS, MCF
   BONALDO, MC
   PENIDO, EGC
AF BASTOS, MCF
   BONALDO, MC
   PENIDO, EGC
TI CONSTITUTIVE ERYTHROMYCIN RESISTANCE PLASMID IN STAPHYLOCOCCUS-AUREUS
SO JOURNAL OF GENERAL MICROBIOLOGY
LA English
DT Note
RP BASTOS, MCF (corresponding author), UNIV FED RIO DE JANEIRO,INST MICROBIOL,DEPT MICROBIOL GERAL,BR-21941 RIO DE JANEIRO,BRAZIL.
RI Bonaldo, Myrna C/D-9494-2013; Bastos, Maria do Carmo F/K-2276-2016
CR Adams M.H., 1959, BACTERIOPHAGES
   BRONSON DL, 1972, CAN J MICROBIOL, V18, P429, DOI 10.1139/m72-067
   CHOPRA I, 1973, J GEN MICROBIOL, V79, P343, DOI 10.1099/00221287-79-2-343
   DORNBUSCH K, 1973, ACTA PATH MICRO IM B, VB 81, P497
   GARROD LP, 1957, BMJ-BRIT MED J, V2, P57, DOI 10.1136/bmj.2.5036.57
   GRUBB WB, 1972, GENET RES, V20, P43, DOI 10.1017/S0016672300013574
   Iordanescu S, 1976, Arch Roum Pathol Exp Microbiol, V35, P111
   IORDANESCU S, 1977, J BACTERIOL, V129, P71
   KONO M, 1976, ANTIMICROB AGENTS CH, V9, P706, DOI 10.1128/AAC.9.4.706
   LACEY RW, 1973, J MED MICROBIOL, V6, P511, DOI 10.1099/00222615-6-4-511
   LACEY RW, 1977, J CLIN PATHOL, V30, P602, DOI 10.1136/jcp.30.7.602
   LEDERBERG J, 1952, J BACTERIOL, V63, P390
   LINDBERG M, 1975, J VIROL, V16, P1367, DOI 10.1128/JVI.16.6.1367-1374.1975
   MEYERS JA, 1976, J BACTERIOL, V127, P1529, DOI 10.1128/JB.127.3.1529-1537.1976
   MITSUHAS.S, 1965, J BACTERIOL, V89, P988, DOI 10.1128/JB.89.4.988-992.1965
   NOVICK RP, 1971, ANN NY ACAD SCI, V182, P279, DOI 10.1111/j.1749-6632.1971.tb30664.x
   NOVICK RP, 1963, J GEN MICROBIOL, V33, P121, DOI 10.1099/00221287-33-1-121
   NOVICK RP, 1967, FED PROC, V26, P29
   NOVICK RP, 1979, P NATL ACAD SCI USA, V76, P400, DOI 10.1073/pnas.76.1.400
   ONO H, 1975, JPN J MICROBIOL, V19, P343, DOI 10.1111/j.1348-0421.1975.tb00890.x
   SCHWESINGER MD, 1975, J BACTERIOL, V123, P724, DOI 10.1128/JB.123.2.724-738.1975
   STIFFLER PW, 1974, J BACTERIOL, V120, P934, DOI 10.1128/JB.120.2.934-944.1974
NR 22
TC 17
Z9 17
U1 0
U2 0
PU SOC GENERAL MICROBIOLOGY
PI READING
PA MARLBOROUGH HOUSE, BASINGSTOKE RD, SPENCERS WOODS, READING, BERKS,
   ENGLAND RG7 1AE
SN 0022-1287
J9 J GEN MICROBIOL
JI J. Gen. Microbiol.
PY 1980
VL 121
IS DEC
BP 513
EP 516
PG 4
WC Microbiology
SC Microbiology
GA LH091
UT WOS:A1980LH09100033
PM 7264605
DA 2020-12-01
ER

EF